Sentence,class,file
2016 May;8(3):191-197. http://dx.doi.org/10.4168/aair.2016.8.3.191 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/76/76/aair-8-191.PMC4773206.pdf
"2016 May;8(3):191-197. http://dx.doi.org/10.4168/aair.2016.8.3.191Volume 8, Number 3, May 2016 192  http://e-aair.orgcies,3,8 and animal dander.9  There is a substantial need for research to elucidate the cur - rently unknown mechanisms of AIT, such as regulatory T  (Treg)-cell induction, early molecular markers and predictors,  and mechanisms of long-term maintenance of allergen toler - ance.10 Reliable biomarkers could be selected and validated  with the intention to select the patients who will benefit most  from AIT.",Non-OADS,/arxiv_data1/oa_pdf/76/76/aair-8-191.PMC4773206.pdf
"2016 May;8(3):191-197. http://dx.doi.org/10.4168/aair.2016.8.3.191AAIR http://e-aair.org   193cation of cytokine profile during AIT at the level of single cells  may provide evidence of the formation of Treg populations pro - ducing IL-10 and/or production of IFN- γ, indicating immune  deviation.",Non-OADS,/arxiv_data1/oa_pdf/76/76/aair-8-191.PMC4773206.pdf
"2016 May;8(3):191-197. http://dx.doi.org/10.4168/aair.2016.8.3.191Volume 8, Number 3, May 2016 194  http://e-aair.orglergen preparations, 2 different hypoallergenic derivatives of  the major birch pollen allergen Bet v 1 and placebo were com - pared.",Non-OADS,/arxiv_data1/oa_pdf/76/76/aair-8-191.PMC4773206.pdf
2016 May;8(3):191-197. http://dx.doi.org/10.4168/aair.2016.8.3.191AAIR http://e-aair.org   195 use of SLIT.,Non-OADS,/arxiv_data1/oa_pdf/76/76/aair-8-191.PMC4773206.pdf
"2016 May;8(3):191-197. http://dx.doi.org/10.4168/aair.2016.8.3.191Volume 8, Number 3, May 2016 196  http://e-aair.orgpecially biomarkers, that will provide help to identify subjects  who can potentially benefit from such modalities is still lacking.",Non-OADS,/arxiv_data1/oa_pdf/76/76/aair-8-191.PMC4773206.pdf
2016 May;8(3):191-197. http://dx.doi.org/10.4168/aair.2016.8.3.191AAIR http://e-aair.org   197venom phospholipase A2 induces specific T-cell anergy in patients  allergic to bee venom.,Non-OADS,/arxiv_data1/oa_pdf/76/76/aair-8-191.PMC4773206.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 198  http://e-aair.orgINTRODUCTION Asthma, chronic obstructive pulmonary disease (COPD), and  lung cancer are major diseases that impose high burden and  mortality worldwide.1,2 Biological contaminants in indoor air  can induce immune dysfunction and inflammation, resulting  in inflammatory pulmonary disorders, such as asthma and  COPD.3,4 Mild and moderate asthma are related to eosinophilic  inflammation, whereas severe asthma and COPD are associat - ed with neutrophilic inflammation.5,6 Cluster analysis to identi - fy asthma subtypes has shown that neutrophilic severe asthma  is characterized by fixed airway obstruction, whereas the eosin - ophilic subtype is reversible.7,8 COPD and lung cancer have  been suggested to share a common cause, namely, cigarette  smoking.",Non-OADS,/arxiv_data1/oa_pdf/23/9c/aair-8-198.PMC4773207.pdf
"However, some patients with COPD or lung cancer IgG Sensitization to Extracellular Vesicles in Indoor Dust Is Closely  Associated With the Prevalence of Non-Eosinophilic Asthma,  COPD, and Lung Cancer You-Sun Kim,1 Jun-Pyo Choi,2 Min-Hye Kim,2 Han-Ki Park,2 Sejung Yang,2 Youn-Seup Kim,3 Tae Bum Kim,4 You-Sook Cho,4   Yeon-Mok Oh,5* Young-Koo Jee,3* Sang-Do Lee,5 Yoon-Keun Kim2* 1Asan Institute for Life Science and University of Ulsan College of Medicine, Seoul, Korea 2Institute of Convergence Medicine, Ewha Womans University Medical Center and Ewha Womans University School of Medicine, Seoul, Korea 3Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea 4Department of Allergy and Clinical Immunology, Asan Medical Center, Seoul, Korea   5Department of Pulmonary and Critical Care Medicine, and Clinical Research Center for Chronic Obstructive Airway Disease, Asan Medical Center, Seoul, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/9c/aair-8-198.PMC4773207.pdf
2016 May;8(3):198-205. http://dx.doi.org/10.4168/aair.2016.8.3.198 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/23/9c/aair-8-198.PMC4773207.pdf
2016 May;8(3):198-205. http://dx.doi.org/10.4168/aair.2016.8.3.198AAIR http://e-aair.org   199have no history of exposure to cigarette smoking.,Non-OADS,/arxiv_data1/oa_pdf/23/9c/aair-8-198.PMC4773207.pdf
"2016 May;8(3):198-205. http://dx.doi.org/10.4168/aair.2016.8.3.198Volume 8, Number 3, May 2016 200  http://e-aair.orgRESULTS General characteristics of the study groups and their high anti- dust EV IgG levels in serum A total of 90 control subjects, 294 asthmatics, 242 COPD pa - tients, and 325 lung cancer patients were enrolled as shown in  Table 1.",Non-OADS,/arxiv_data1/oa_pdf/23/9c/aair-8-198.PMC4773207.pdf
2016 May;8(3):198-205. http://dx.doi.org/10.4168/aair.2016.8.3.198AAIR http://e-aair.org   201A high serum anti-dust EV IgG level as a potential risk factor  for lung cancer  Multiple logistic regression analysis was performed to evalu - ate risk factors for lung cancer (Table 2).,OADS,/arxiv_data1/oa_pdf/23/9c/aair-8-198.PMC4773207.pdf
"2016 May;8(3):198-205. http://dx.doi.org/10.4168/aair.2016.8.3.198Volume 8, Number 3, May 2016 202  http://e-aair.orgwere 2.8 (95% CI 0.8-9.6, P=0.1), 2.9 (95% CI 0.9-9.8, P=0.08),  3.7 (95% CI 1.1-12.3, P=0.03), and 3.1 (95% CI 0.8-11.4, P=0.10),  respectively.",Non-OADS,/arxiv_data1/oa_pdf/23/9c/aair-8-198.PMC4773207.pdf
"2016 May;8(3):198-205. http://dx.doi.org/10.4168/aair.2016.8.3.198AAIR http://e-aair.org   203gender, and cigarette smoking history in subjects with squa - mous cell carcinoma, adenocarcinoma, and small cell lung car - cinoma vs the control subjects.",Non-OADS,/arxiv_data1/oa_pdf/23/9c/aair-8-198.PMC4773207.pdf
"2016 May;8(3):198-205. http://dx.doi.org/10.4168/aair.2016.8.3.198Volume 8, Number 3, May 2016 204  http://e-aair.orgable to confirm a causal relationship between exposure to dust  EVs and the development of asthma, COPD, or lung cancer be - cause of the cross-sectional design of the present study.",Non-OADS,/arxiv_data1/oa_pdf/23/9c/aair-8-198.PMC4773207.pdf
2016 May;8(3):198-205. http://dx.doi.org/10.4168/aair.2016.8.3.198AAIR http://e-aair.org   205et al.,Non-OADS,/arxiv_data1/oa_pdf/23/9c/aair-8-198.PMC4773207.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 206  http://e-aair.orgINTRODUCTION Invariant natural killer T (iNKT) cells are unique CD1d-re - stricted T cells that act as a bridge between the innate and  adaptive immune systems.",Non-OADS,/arxiv_data1/oa_pdf/17/cb/aair-8-206.PMC4773208.pdf
"Because iNKT  cells can be activated by cytokine signaling as well as TCR sig - naling,14 alterations in the micro-environmental cytokine mi - lieu may modify the function of iNKT cells in asthma.2 Some Flagellin Modulates the Function of Invariant NKT Cells From  Patients With Asthma via Dendritic Cells Jae-Uoong Shim,1 Joon-Haeng Rhee,2 Ji-Ung Jeong,1 Young-Il Koh1* 1Department of Internal Medicine, Chonnam National University Medical School & Hospital, Gwangju, Korea 2Clinical Vaccine R &D Center, Department of Microbiology, Chonnam National University Medical School, Gwangju, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/cb/aair-8-206.PMC4773208.pdf
2016 May;8(3):206-215. http://dx.doi.org/10.4168/aair.2016.8.3.206 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/17/cb/aair-8-206.PMC4773208.pdf
"2016 May;8(3):206-215. http://dx.doi.org/10.4168/aair.2016.8.3.206AAIR http://e-aair.org   207bacterial components have been reported to anergize iNKT cells  in mice.15 It has been reported that bacterial flagellin B (FlaB)  from Vibrio vulnificus , a ligand of Toll-like receptor (TLR),5 in- duces IgA responses16 and that intranasal co-administration of  FlaB inhibits allergen-induced AHR and eosinophilic airway  inflammation in a mouse asthma model.15 In addition, flagellin  A inhibits IgE-mediated intestinal allergy in mice.17 The immu - nomodulatory effects of flagellin are primarily mediated via  TLR5 on DCs.18 Thus, the treatment of DCs with flagellin may  alter the surrounding cytokine milieu to modify the function of  iNKT cells.",Non-OADS,/arxiv_data1/oa_pdf/17/cb/aair-8-206.PMC4773208.pdf
"2016 May;8(3):206-215. http://dx.doi.org/10.4168/aair.2016.8.3.206Volume 8, Number 3, May 2016 208  http://e-aair.orgtracellular cytokines of iNKT cells and Foxp3+ iNKT cells were  measured using flow cytometry, and the secreted cytokines  from iNKT cells were determined by using enzyme-linked im - munosorbent assay (ELISA) (Fig.",OADS,/arxiv_data1/oa_pdf/17/cb/aair-8-206.PMC4773208.pdf
2016 May;8(3):206-215. http://dx.doi.org/10.4168/aair.2016.8.3.206AAIR http://e-aair.org   209ences) mAbs.,Non-OADS,/arxiv_data1/oa_pdf/17/cb/aair-8-206.PMC4773208.pdf
"2016 May;8(3):206-215. http://dx.doi.org/10.4168/aair.2016.8.3.206Volume 8, Number 3, May 2016 210  http://e-aair.orgthe cytokines should be produced by iNKT cells.",Non-OADS,/arxiv_data1/oa_pdf/17/cb/aair-8-206.PMC4773208.pdf
2016 May;8(3):206-215. http://dx.doi.org/10.4168/aair.2016.8.3.206AAIR http://e-aair.org   211inhibit IL-4 and IL-17 production via an IL-12-dependent mech - anism in iNKT cells from healthy controls.,Non-OADS,/arxiv_data1/oa_pdf/17/cb/aair-8-206.PMC4773208.pdf
"2016 May;8(3):206-215. http://dx.doi.org/10.4168/aair.2016.8.3.206Volume 8, Number 3, May 2016 212  http://e-aair.orgFig.",Non-OADS,/arxiv_data1/oa_pdf/17/cb/aair-8-206.PMC4773208.pdf
2016 May;8(3):206-215. http://dx.doi.org/10.4168/aair.2016.8.3.206AAIR http://e-aair.org   213ated by IL-10R mAb treatment.,Non-OADS,/arxiv_data1/oa_pdf/17/cb/aair-8-206.PMC4773208.pdf
"2016 May;8(3):206-215. http://dx.doi.org/10.4168/aair.2016.8.3.206Volume 8, Number 3, May 2016 214  http://e-aair.orgFlaB has been reported to induce the production of IL-12 from  DCs.37 It is likely that FlaB increases IL-12 production from DCs,  leading to the anergy of iNKT cells.15 Recently, we showed that  treatments with TLR4, TLR5, and TLR9 agonists suppress air - way iNKT cells in an IL-12-dependent manner.19 However, in  the present study, no increase in IL-12 following DC treatment  with FlaB from healthy volunteers was detected (Fig.",Non-OADS,/arxiv_data1/oa_pdf/17/cb/aair-8-206.PMC4773208.pdf
2016 May;8(3):206-215. http://dx.doi.org/10.4168/aair.2016.8.3.206AAIR http://e-aair.org   215treated dendritic cells on allergen-specific Th immune response.,Non-OADS,/arxiv_data1/oa_pdf/17/cb/aair-8-206.PMC4773208.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 216  http://e-aair.orgINTRODUCTION Group 2 innate lymphoid cells (ILC2s) were originally de - scribed as a novel population of lineage-negative cells that in - duced innate type 2 responses by producing the critical Th2- type cytokines IL-5 and IL-13 in response to IL-25 and IL-33.1-3  ILC2s are reported to contribute to helminth expulsion, airway  hyper-responsiveness, airway remodeling, and homeostasis,2,4-7  and also appear to serve as key players in the development of  allergic inflammation.",Non-OADS,/arxiv_data1/oa_pdf/53/2f/aair-8-216.PMC4773209.pdf
"”10 AR is an Allergen-Dependent Differences in ILC2s Frequencies in Patients  With Allergic Rhinitis Dachuan Fan,1,2,4 Xiangdong Wang,1,2 Min Wang,2 Yang Wang,2 Liang Zhang,2 Ying Li,2 Erzhong Fan,2 Feifei Cao,1,2   Koen Van Crombruggen,3 Luo Zhang1,2 1 Department of Otolaryngology Head and Neck Surgery and Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing 100730,  China 2Beijing Key Laboratory of Nasal diseases, Beijing Institute of Otolaryngology, Beijing 100005, China 3Upper Airways Research Laboratory, Department of Oto-Rhino-Laryngology, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium 4 Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital, Harbin Medical University, Harbin 150001, Heilongjiang Province,  China This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/2f/aair-8-216.PMC4773209.pdf
2016 May;8(3):216-222. http://dx.doi.org/10.4168/aair.2016.8.3.216 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/53/2f/aair-8-216.PMC4773209.pdf
"2016 May;8(3):216-222. http://dx.doi.org/10.4168/aair.2016.8.3.216AAIR http://e-aair.org   217inflammatory disease of the nasal mucous membrane, result - ing as a consequence of allergen-mediated response of mast  cells characterized by the release of a variety of Th2 cytokines,  which have clear-cut effects on eosinophil survival and aller - gen-specific IgE synthesis.11,12 More recently, Doherty et al .13  have reported that nasal challenge using cat allergen in cat-sen - sitized adults with a current history of rhinitis symptoms on ex - posure to cat significantly increase the percentage of ILC2s in  the peripheral blood of these subjects, compared to baseline  levels and diluent challenge, 4 hours after challenge.",Non-OADS,/arxiv_data1/oa_pdf/53/2f/aair-8-216.PMC4773209.pdf
"2016 May;8(3):216-222. http://dx.doi.org/10.4168/aair.2016.8.3.216Volume 8, Number 3, May 2016 218  http://e-aair.orgsidered ILC2s (Fig.",Non-OADS,/arxiv_data1/oa_pdf/53/2f/aair-8-216.PMC4773209.pdf
2016 May;8(3):216-222. http://dx.doi.org/10.4168/aair.2016.8.3.216AAIR http://e-aair.org   219Assessment of ILC2s in the peripheral blood of HDM/mugwort- AR patients and HC subjects The number of ILC2s was significantly higher in peripheral  blood of HDM-AR patients compared to HCs (Fig.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/aair-8-216.PMC4773209.pdf
"2016 May;8(3):216-222. http://dx.doi.org/10.4168/aair.2016.8.3.216Volume 8, Number 3, May 2016 220  http://e-aair.orgDISCUSSION This study demonstrated that Chinese HDM-AR patients con - tained a significantly higher level of blood ILC2s compared to  mugwort-AR patients and HC subjects.",Non-OADS,/arxiv_data1/oa_pdf/53/2f/aair-8-216.PMC4773209.pdf
2016 May;8(3):216-222. http://dx.doi.org/10.4168/aair.2016.8.3.216AAIR http://e-aair.org   221thus provide a plausible explanation for the clear differences in  ILC2s numbers noted between HDM- and mugwort-allergic  patients in our study.,Non-OADS,/arxiv_data1/oa_pdf/53/2f/aair-8-216.PMC4773209.pdf
"2016 May;8(3):216-222. http://dx.doi.org/10.4168/aair.2016.8.3.216Volume 8, Number 3, May 2016 222  http://e-aair.orgdisease, present treatments and future prospects.",Non-OADS,/arxiv_data1/oa_pdf/53/2f/aair-8-216.PMC4773209.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org   223INTRODUCTION Asthma is a chronic disease that is associated with reversible  respiratory obstruction, hypersensitivity caused by multiple  stimuli, and chronic inflammation.1 Clinically, it manifests as  the deterioration and resolution of respiratory symptoms.",Non-OADS,/arxiv_data1/oa_pdf/e0/4a/aair-8-223.PMC4773210.pdf
"Thus, data about asthmatic patients who present at EDs  can be valuable and may enable us to understand reasons for  asthma symptom exacerbations.5,8,9 Therefore, this study aimed  to investigate the seasonal patterns of asthma in children and  adolescents who presented at EDs throughout Korea by review -Seasonal Patterns of Asthma in Children and Adolescents  Presenting at Emergency Departments in Korea Youn Kyoung Won,1 Tae ho Hwang,1 Eui Jung Roh,2 Eun Hee Chung1* 1Department of Pediatrics, National Medical Center, Seoul, Korea 2Department of Pediatrics, Sun General Hospital, Daejeon, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/4a/aair-8-223.PMC4773210.pdf
2016 May;8(3):223-229. http://dx.doi.org/10.4168/aair.2016.8.3.223 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/e0/4a/aair-8-223.PMC4773210.pdf
"2016 May;8(3):223-229. http://dx.doi.org/10.4168/aair.2016.8.3.223Volume 8, Number 3, May 2016 224  http://e-aair.orging their ED data.",OADS,/arxiv_data1/oa_pdf/e0/4a/aair-8-223.PMC4773210.pdf
"2016 May;8(3):223-229. http://dx.doi.org/10.4168/aair.2016.8.3.223AAIR http://e-aair.org   225patients (OR =1.21, 95% CI =[1.16-1.26]) (Table).",OADS,/arxiv_data1/oa_pdf/e0/4a/aair-8-223.PMC4773210.pdf
"2016 May;8(3):223-229. http://dx.doi.org/10.4168/aair.2016.8.3.223Volume 8, Number 3, May 2016 226  http://e-aair.orgDISCUSSION To manage the chronic nature of asthma, preventative thera - pies are essential to prevent asthma exacerbations.",Non-OADS,/arxiv_data1/oa_pdf/e0/4a/aair-8-223.PMC4773210.pdf
2016 May;8(3):223-229. http://dx.doi.org/10.4168/aair.2016.8.3.223AAIR http://e-aair.org   227tion is stronger in children (85%) than in adults (55%).20 The  type of respiratory virus that is associated with asthma attacks  varies depending on patient age.,Non-OADS,/arxiv_data1/oa_pdf/e0/4a/aair-8-223.PMC4773210.pdf
"2016 May;8(3):223-229. http://dx.doi.org/10.4168/aair.2016.8.3.223Volume 8, Number 3, May 2016 228  http://e-aair.orgpollen,35 but it is difficult to conclude that pollen is associated  with the exacerbations of asthma symptoms that occur during  fall.",Non-OADS,/arxiv_data1/oa_pdf/e0/4a/aair-8-223.PMC4773210.pdf
Available from: http://www.in - dex.go.kr/potal/stts/idxMain/selectPoSttsIdxSearch.do?idx_cd=  2917&clas_div=&idx_sys_cd=544&idx_clas_cd=1.,OADS,/arxiv_data1/oa_pdf/e0/4a/aair-8-223.PMC4773210.pdf
2016 May;8(3):223-229. http://dx.doi.org/10.4168/aair.2016.8.3.223AAIR http://e-aair.org   22923.,Non-OADS,/arxiv_data1/oa_pdf/e0/4a/aair-8-223.PMC4773210.pdf
Available from:  http://www.cdc.go.kr/CDC/info/CdcKrInfo0301.jsp?,Non-OADS,/arxiv_data1/oa_pdf/e0/4a/aair-8-223.PMC4773210.pdf
Available  from: http://www.cdc.go.kr/CDC/info/CdcKrInfo0502.jsp?,Non-OADS,/arxiv_data1/oa_pdf/e0/4a/aair-8-223.PMC4773210.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 230  http://e-aair.orgINTRODUCTION Various diagnostic tools for atopic dermatitis (AD) have been  proposed due to the lack of definitive biomarkers and the  marked diversity of its clinical features.1,2 Hanifin and Rajka’s  criteria were developed for AD diagnosis at the individual level  in a hospital setting.3 As the criteria were based on the empiri - cal experiences of AD experts, they encompass numerous, mi - nor features unfamiliar to untrained examiners.",Non-OADS,/arxiv_data1/oa_pdf/93/5a/aair-8-230.PMC4773211.pdf
"Subsequently, Introduction of the Reliable Estimation of Atopic Dermatitis in  ChildHood: Novel, Diagnostic Criteria for Childhood Atopic  Dermatitis Seung-Chul Lee,1* Jung Min Bae,2 Ho-June Lee,1 Hyun Jung Kim,3 Byung-Soo Kim,4 Kapsok Li,5 Jae-We Cho,6   Chang Ook Park,7 Sang Hyun Cho,2 Kwang Hoon Lee,7 Do-Won Kim,8 Chun Wook Park,9 Kyu Han Kim10;   The Korean Atopic Dermatitis Association’s Atopic Dermatitis Criteria Group 1Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea  2Department of Dermatology, The Catholic University of Korea, Seoul, Korea  3Department of Dermatology, Seoul Medical Center, Seoul, Korea 4Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea 5Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea  6Department of Dermatology, Keimyung University School of Medicine, Daegu, Korea  7Department of Dermatology, Yonsei University College of Medicine, Seoul, Korea  8Department of Dermatology, Kyungpook National University College of Medicine, Daegu, Korea 9Department of Dermatology, Kangnam Sacred Heart Hospital, Seoul, Korea  10Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/5a/aair-8-230.PMC4773211.pdf
2016 May;8(3):230-238. http://dx.doi.org/10.4168/aair.2016.8.3.230 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/93/5a/aair-8-230.PMC4773211.pdf
"2016 May;8(3):230-238. http://dx.doi.org/10.4168/aair.2016.8.3.230AAIR http://e-aair.org   231the UK Working Group refined the criteria to improve their  practical applicability (UK’s criteria) that included a minimum  set of valid and reliable items for use in both hospital and com - munity settings.4-6 Meanwhile, questionnaire-based diagnostic  criteria for AD, including the International Study for Asthma  and Allergies in Childhood (ISAAC), were developed for epide - miological surveys in a community setting.1,7-9 Hospitals-detected AD patients who are diagnosed in the hos - pitals are known to have more severe symptoms than those  who are detected by community-based surveys.",Non-OADS,/arxiv_data1/oa_pdf/93/5a/aair-8-230.PMC4773211.pdf
"2016 May;8(3):230-238. http://dx.doi.org/10.4168/aair.2016.8.3.230Volume 8, Number 3, May 2016 232  http://e-aair.orgThe REACH was developed using a derivation set including  both elementary school (7-12 years of age) and preschool (4-6  years of age) children.",Non-OADS,/arxiv_data1/oa_pdf/93/5a/aair-8-230.PMC4773211.pdf
"2016 May;8(3):230-238. http://dx.doi.org/10.4168/aair.2016.8.3.230AAIR http://e-aair.org   233sified into major and minor categories following our panel dis - cussion, and based on experts’ opinions.",Non-OADS,/arxiv_data1/oa_pdf/93/5a/aair-8-230.PMC4773211.pdf
"2016 May;8(3):230-238. http://dx.doi.org/10.4168/aair.2016.8.3.230Volume 8, Number 3, May 2016 234  http://e-aair.orgspecificity, positive (PPV), negative predictive value (NPV), ER,  and Youden’s index.",OADS,/arxiv_data1/oa_pdf/93/5a/aair-8-230.PMC4773211.pdf
"2016 May;8(3):230-238. http://dx.doi.org/10.4168/aair.2016.8.3.230AAIR http://e-aair.org   235Derivation of the diagnostic criteria of the REACH  A total of 1,129 children from 2 different age groups of ele - mentary school children (n =988, 7-12 years old) and preschool  children (n =141, 4-6 years old) were enrolled in the survey as a  derivation set.",OADS,/arxiv_data1/oa_pdf/93/5a/aair-8-230.PMC4773211.pdf
"2016 May;8(3):230-238. http://dx.doi.org/10.4168/aair.2016.8.3.230Volume 8, Number 3, May 2016 236  http://e-aair.orgold) and preschool children (n =120, 4-6 years old).",Non-OADS,/arxiv_data1/oa_pdf/93/5a/aair-8-230.PMC4773211.pdf
"2016 May;8(3):230-238. http://dx.doi.org/10.4168/aair.2016.8.3.230AAIR http://e-aair.org   237Hanifin and Rajka’s and KDA’s criteria classified ‘atopy histo - ry’ in the major criteria as an important pathogenic factor of  AD.3,16 In contrast, we classified ‘atopy history’ in the minor cri - teria due to its low specificity: a positive atopy history was ob - served in 50.6% and 60.6% of non-AD children in hospital- and  community-based surveys, respectively.",Non-OADS,/arxiv_data1/oa_pdf/93/5a/aair-8-230.PMC4773211.pdf
"2016 May;8(3):230-238. http://dx.doi.org/10.4168/aair.2016.8.3.230Volume 8, Number 3, May 2016 238  http://e-aair.orgthree-item severity score.",Non-OADS,/arxiv_data1/oa_pdf/93/5a/aair-8-230.PMC4773211.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org   239INTRODUCTION Murine models are broadly used in the field of food allergy to  ascertain etiology, mechanisms, and preventive or therapeutic  strategies through studies which would otherwise not be possi - ble in human patients.1 Induction of oral sensitization to food  proteins in mice requires the use of adjuvants, such as cholera  toxin (CT) or staphylococcal enterotoxin B (SB), to overcome  their strong tendency to develop oral tolerance by promoting  Th2-polarized immune responses over Th1 responses, which  produce antigen-specific IgE.2 Subsequent oral challenge with  the food or allergen can cause gastrointestinal or systemic  signs, such as diarrhea and shock syndrome, respectively.3 Two main mouse strains with well-defined genetic back - grounds: BALB/c and C3H have been applied to stablish the in - duction and effector mechanisms of common food allergens.",Non-OADS,/arxiv_data1/oa_pdf/c6/5b/aair-8-239.PMC4773212.pdf
"In addition, there are available congenic mice of both strains  carrying a mutation in toll-like receptor 4 ( TLR4 ), which makes  them insensitive to lipopolysaccharide (LPS), and thus, to the  influence of gram-negative bacteria in the gastrointestinal tract.4 Studies conducted with these animal models have al - lowed testing experimentally the intrinsic properties of proteins  that promote oral sensitization, the differential capacity of aller - gens to trigger the manifestations of food allergy and the influ - ence of the food matrix and processing in their allergenic po - tential.5-7  However, recognition of proteins as immunogens is strain-de - pendent, leading to IgE or IgG-mediated responses.8 In fact,  there are 2 different pathways of systemic murine anaphylaxis  whose relative importance also depends on the route of admin - istration and on the characteristics and amounts of antigen  used to induce the antibody response and the anaphylactic re - action.3 Furthermore, several studies have documented that Antibody Production, Anaphylactic Signs, and T-Cell Responses  Induced by Oral Sensitization With Ovalbumin in BALB/c and  C3H/HeOuJ Mice Alba Pablos-Tanarro, Ivan López-Expósito, Daniel Lozano-Ojalvo, Rosina López-Fandiño, Elena Molina* Instituto de Investigación en Ciencias de la Alimentación (CIAL, CSIC-UAM), Nicolás Cabrera, Madrid, Spain This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/5b/aair-8-239.PMC4773212.pdf
2016 May;8(3):239-245. http://dx.doi.org/10.4168/aair.2016.8.3.239 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/c6/5b/aair-8-239.PMC4773212.pdf
"2016 May;8(3):239-245. http://dx.doi.org/10.4168/aair.2016.8.3.239Volume 8, Number 3, May 2016 240  http://e-aair.orgsusceptibility of mice to orally induced anaphylaxis varies with  the genetic background.9 In this respect, it should be taken into  account that the presence of a functional LPS receptor does not  correlate with the predisposition to sensitization or the severity  of anaphylaxis, which in turn depend greatly on the allergen  used.4 Therefore, previous knowledge underlines the need for  selecting the most appropriate mouse strain for accurate esti - mation of the sensitizing and eliciting capacity of a particular  allergen.",Non-OADS,/arxiv_data1/oa_pdf/c6/5b/aair-8-239.PMC4773212.pdf
"2016 May;8(3):239-245. http://dx.doi.org/10.4168/aair.2016.8.3.239AAIR http://e-aair.org   241were blocked and incubated overnight at 4°C with serum sam - ples (1/20 dilution for IgE, 1/5,000 dilution for IgG1, and 1/100  dilution for IgG2a) or serial dilutions of mouse IgE, IgG1, and Ig - G2a (BD Biosciences), respectively.",Non-OADS,/arxiv_data1/oa_pdf/c6/5b/aair-8-239.PMC4773212.pdf
"2016 May;8(3):239-245. http://dx.doi.org/10.4168/aair.2016.8.3.239Volume 8, Number 3, May 2016 242  http://e-aair.orgC3H/HeOuJ mice produced significantly more IgG2a than  BALB/c mice.",Non-OADS,/arxiv_data1/oa_pdf/c6/5b/aair-8-239.PMC4773212.pdf
2016 May;8(3):239-245. http://dx.doi.org/10.4168/aair.2016.8.3.239AAIR http://e-aair.org   243gy: BALB/c and C3H/HeOuJ.,Non-OADS,/arxiv_data1/oa_pdf/c6/5b/aair-8-239.PMC4773212.pdf
"2016 May;8(3):239-245. http://dx.doi.org/10.4168/aair.2016.8.3.239Volume 8, Number 3, May 2016 244  http://e-aair.orgWhile OVA seemed equally immunogenic in both mouse  strains, as judged by its capacity to generate IgE and IgG1 anti - bodies, oral challenge induced a more pronounced tempera - ture drop in C3H/HeOuJ than in BALB/c mice.",Non-OADS,/arxiv_data1/oa_pdf/c6/5b/aair-8-239.PMC4773212.pdf
2016 May;8(3):239-245. http://dx.doi.org/10.4168/aair.2016.8.3.239AAIR http://e-aair.org   245Clin Immunol 2007;120:506-15.,Non-OADS,/arxiv_data1/oa_pdf/c6/5b/aair-8-239.PMC4773212.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 246  http://e-aair.orgINTRODUCTION Air pollutants are believed to be a factor in the increasing  prevalence of asthma and to exacerbate respiratory diseases.1  Diesel exhaust particles (DEPs) as a major component of fine  particulate matter (PM2.5) in the atmosphere of urban areas  can induce airway hyperresponsiveness (AHR) and inflamma - tion by amplifying the T-helper 2 (Th2) immune response2-5  and are associated with cardiorespiratory mortality and the ag - gravation of disease.6-8 DEPs can induce acute AHR and acute  asthma exacerbations independent of their effects on allergic  sensitization.9 Long-term exposure to air pollution causes chronic respirato - ry disease,10 and chronic inhalation of DEPs leads to the devel - opment of cough and sputum.",Non-OADS,/arxiv_data1/oa_pdf/f3/ef/aair-8-246.PMC4773213.pdf
"Cytokines, Long-Term Effects of Diesel Exhaust Particles on Airway  Inflammation and Remodeling in a Mouse Model Byeong-Gon Kim,1 Pureun-Haneul Lee,1 Shin-Hwa Lee,1 Young-En Kim,1 Mee-Yong Shin,2 Yena Kang,1 Seong-Hwan Bae,1   Min-Jung Kim,1 TaiYoun Rhim,3 Choon-Sik Park,1 An-Soo Jang1* 1Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea 2Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Bucheon, Korea 3Department of Bioengineering, College of Engineering, Hanyang University, Seoul, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/ef/aair-8-246.PMC4773213.pdf
2016 May;8(3):246-256. http://dx.doi.org/10.4168/aair.2016.8.3.246 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/f3/ef/aair-8-246.PMC4773213.pdf
"2016 May;8(3):246-256. http://dx.doi.org/10.4168/aair.2016.8.3.246AAIR http://e-aair.org   247chemokines, and growth factors released from inflammatory  and structural cells in the airway are believed to play a pivotal  role in the development of remodeling.13-16 Chronic inflamma - tion is thought to initiate and perpetuate the cycles of tissue in - jury and repair in asthma, although remodeling may also occur  in parallel with inflammation.17 Although long-term, repeated exposure to DEPs in air pollu - tion increases the risk for chronic respiratory diseases and car - diorespiratory mortality,18 the biological mechanism and re - modeling remain poorly understood during chronic exposure  to DEPs.",Non-OADS,/arxiv_data1/oa_pdf/f3/ef/aair-8-246.PMC4773213.pdf
"2016 May;8(3):246-256. http://dx.doi.org/10.4168/aair.2016.8.3.246Volume 8, Number 3, May 2016 248  http://e-aair.orgchamber (All Medicus Co., Seoul, Korea), and baseline read - ings were taken and averaged for 3 minutes.",OADS,/arxiv_data1/oa_pdf/f3/ef/aair-8-246.PMC4773213.pdf
"2016 May;8(3):246-256. http://dx.doi.org/10.4168/aair.2016.8.3.246AAIR http://e-aair.org   249low-dose DEP group than in the control group at 4, 8, and 12  weeks, and there was a significant increase in the total cell  count in the high-dose DEP group than in the control group at  4 weeks ( P<0.05) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/f3/ef/aair-8-246.PMC4773213.pdf
"2016 May;8(3):246-256. http://dx.doi.org/10.4168/aair.2016.8.3.246Volume 8, Number 3, May 2016 250  http://e-aair.orgpg/100 μg of protein pg/100 μg of protein pg/100 μg of protein pg/100 μg of protein pg/100 μg of protein pg/100 μg of protein4 weeks 4 weeks8 weeks 8 weeksIL-5 IL-1312 weeks 12 weeks360 300 240 180 120 60 0 300 250 200 150 100 50 0360 300 240 180 120 60 0 300 250 200 150 100 50 0360 300 240 180 120 60 0 300 250 200 150 100 50 0 Control  Low DEP  High DEP A B Fig.",Non-OADS,/arxiv_data1/oa_pdf/f3/ef/aair-8-246.PMC4773213.pdf
2016 May;8(3):246-256. http://dx.doi.org/10.4168/aair.2016.8.3.246AAIR http://e-aair.org   251Lung fibrosis as shown by Masson trichrome staining of lung  tissues was more severe in the low- and high-dose DEP groups  than in the control group (Fig.,Non-OADS,/arxiv_data1/oa_pdf/f3/ef/aair-8-246.PMC4773213.pdf
"2016 May;8(3):246-256. http://dx.doi.org/10.4168/aair.2016.8.3.246Volume 8, Number 3, May 2016 252  http://e-aair.orgAHR in a dose-dependent manner.",Non-OADS,/arxiv_data1/oa_pdf/f3/ef/aair-8-246.PMC4773213.pdf
2016 May;8(3):246-256. http://dx.doi.org/10.4168/aair.2016.8.3.246AAIR http://e-aair.org   253Relative trichrome-stained area (%) Collagen (μg/mL) Relative trichrome-stained area (%) Collagen (μg/mL) Relative trichrome-stained area (%) Collagen (μg/mL)4 weeks 4 weeks8 weeks 8 weeks12 weeks 12 weeks10 8 6 4 2 0 40 30 20 10 010 8 6 4 2 0 40 30 20 10 010 8 6 4 2 0 40 30 20 10 0 Control  Low DEP  High DEP B C Fig.,Non-OADS,/arxiv_data1/oa_pdf/f3/ef/aair-8-246.PMC4773213.pdf
"2016 May;8(3):246-256. http://dx.doi.org/10.4168/aair.2016.8.3.246Volume 8, Number 3, May 2016 254  http://e-aair.org 12 weeks8 weeks4 weeksControl Low-DEP (100 μg/m3) High-DEP (3 mg/m3) Fig.",Non-OADS,/arxiv_data1/oa_pdf/f3/ef/aair-8-246.PMC4773213.pdf
2016 May;8(3):246-256. http://dx.doi.org/10.4168/aair.2016.8.3.246AAIR http://e-aair.org   255exert acute effects on airway inflammation and function in murine  allergen provocation models.,Non-OADS,/arxiv_data1/oa_pdf/f3/ef/aair-8-246.PMC4773213.pdf
"2016 May;8(3):246-256. http://dx.doi.org/10.4168/aair.2016.8.3.246Volume 8, Number 3, May 2016 256  http://e-aair.orgClin Immunol 2006;118:455-65.",Non-OADS,/arxiv_data1/oa_pdf/f3/ef/aair-8-246.PMC4773213.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org   257INTRODUCTION Atopic diseases, such as allergic rhinitis and asthma, affect up  to 30% of the population in Western countries.1 Allergen-specif - ic immunotherapy (SIT) is the only treatment available that has  the potential to ameliorate symptoms and to reduce or abro - gate allergic diseases.2,3 The success rates vary substantially de - pending on the allergen, the route of administration, and the  dosing regimen.4-6 To date, SIT has encompassed different dos - ing regimens and administration routes.",Non-OADS,/arxiv_data1/oa_pdf/26/36/aair-8-257.PMC4773214.pdf
"Importantly, these tests are only minimally Induction of Bronchial Tolerance After 1 Cycle of  Monophosphoryl-A-Adjuvanted Specific Immunotherapy in  Children With Grass Pollen Allergies Martin Rosewich,* Katharina Girod, Stefan Zielen, Ralf Schubert, Johannes Schulze Children’s Hospital, Department of Allergy, Pneumology and Cystic Fibrosis, Goethe-University, Frankfurt/Main, Germany  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/36/aair-8-257.PMC4773214.pdf
2016 May;8(3):257-263. http://dx.doi.org/10.4168/aair.2016.8.3.257 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/26/36/aair-8-257.PMC4773214.pdf
"2016 May;8(3):257-263. http://dx.doi.org/10.4168/aair.2016.8.3.257Volume 8, Number 3, May 2016 258  http://e-aair.orginfluenced by placebo effects.",Non-OADS,/arxiv_data1/oa_pdf/26/36/aair-8-257.PMC4773214.pdf
"2016 May;8(3):257-263. http://dx.doi.org/10.4168/aair.2016.8.3.257AAIR http://e-aair.org   259apy (SCIT) with a preparation containing an L-tyrosine-ad - sorbed birch allergoid with MPL (Pollinex® quattro, Bencard,  Munich, Germany, subsidiary of Allergy therapeutics, Worth - ing, West Sussex, UK).15 At weekly intervals, the patients re - ceived 300, 800, 2,000, and 2,000 units subcutaneously.",Non-OADS,/arxiv_data1/oa_pdf/26/36/aair-8-257.PMC4773214.pdf
"2016 May;8(3):257-263. http://dx.doi.org/10.4168/aair.2016.8.3.257Volume 8, Number 3, May 2016 260  http://e-aair.orgbirch.",Non-OADS,/arxiv_data1/oa_pdf/26/36/aair-8-257.PMC4773214.pdf
"2016 May;8(3):257-263. http://dx.doi.org/10.4168/aair.2016.8.3.257AAIR http://e-aair.org   261spectively, which were similar to those in the SAR and Asthma  group (34.0 ±24.0 and 32.3 ±26.2, respectively).",Non-OADS,/arxiv_data1/oa_pdf/26/36/aair-8-257.PMC4773214.pdf
"2016 May;8(3):257-263. http://dx.doi.org/10.4168/aair.2016.8.3.257Volume 8, Number 3, May 2016 262  http://e-aair.orgThe major disadvantages of conventional SCIT are the frequen - cy of injections and the risk of systemic adverse events.",Non-OADS,/arxiv_data1/oa_pdf/26/36/aair-8-257.PMC4773214.pdf
ORCID Martin Rosewich  http://orcid.org/0000-0002-6971-3485 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/26/36/aair-8-257.PMC4773214.pdf
2016 May;8(3):257-263. http://dx.doi.org/10.4168/aair.2016.8.3.257AAIR http://e-aair.org   263therapy for asthma.,Non-OADS,/arxiv_data1/oa_pdf/26/36/aair-8-257.PMC4773214.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 264  http://e-aair.orgINTRODUCTION Asthma and allergies are the most common chronic inflam - matory diseases associated with cockroach or house dust mite  (HDM) allergens characterized by airflow obstruction, airway  eosinophilic inflammation, goblet cell metaplasia, airway re - modeling, and airway hyper-responsiveness (AHR).1-3 Th2 cy - tokines such as IL-4, IL-5, IL-9, and IL-13 derived from helper T  cells and other cell types play a critical role in the pathophysiol - ogy of asthma,4 and the balance between Th1 and Th2 cells is  thought to be important in controlling disease symptoms.5 The  suppression of Th2 responses by induction of Th1 response or  regulatory T cells or by inhibiting Th2 inducing factors such as  IL-4, IL-5, and IL-13 have been extensively investigated for the  development of therapeutic drugs for asthma.6 CpG oligodeoxynucleotide (CpG-ODN) is a synthetic TLR9 li - gand, consisting of an unmethylated dinucleotide that activates immune responses similar to those in response to bacterial  DNA.7,8 CpG-ODN treatment has been extensively studied to  stimulate both innate and adaptive immunity as it induces  TNF-α expression in macrophages,9 augments IFN- γ and IL-12  expression and enhances the cytotoxic activity of NK cells10,11  and Th1 response, which can be used as immune adjuvants CpG Oligodeoxynucleotide Inhibits Cockroach-Induced Asthma via  Induction of IFN- γ+ Th1 Cells or Foxp3+ Regulatory T Cells in the  Lung Do-Hyun Kim,1,2 Jung-Ho Sohn,1,2,3 Hong-Jai Park,1,2 Jae-Hyun Lee,3 Jung-Won Park,3* Je-Min Choi1,2* 1Department of Life Science, College of Natural Sciences, Hanyang University, Seoul, Korea 2Research Institute for Natural Sciences, Hanyang University, Seoul, Korea  3Division of Allergy and Immunology, Department of Internal Medicine and Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/5d/aair-8-264.PMC4773215.pdf
2016 May;8(3):264-275. http://dx.doi.org/10.4168/aair.2016.8.3.264 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/bb/5d/aair-8-264.PMC4773215.pdf
"2016 May;8(3):264-275. http://dx.doi.org/10.4168/aair.2016.8.3.264AAIR http://e-aair.org   265and to modulate Th2 responses.12,13 In addition, CpG-ODN has  been shown to enhance type I IFN production from plasmacy - toid dendritic cells (pDCs),14,15 and induce IL-10 producing reg - ulatory T cells by indoleamine 2,3-dioxygenase (IDO) 1 pro - duction.16,17 Thus, CpG-ODN has been investigated as a potent  preventive as well as a therapeutic immune modulator in aller - gic inflammatory diseases.18,19 Cockroaches are known to be a significant environmental al - lergen resulting in atopic asthma,20,21 and among the various  environmental factors, cockroach allergen is recognized as a  major risk factor for pathogenesis of allergic asthma in hu - mans.22-24 Children who are exposed to high bedroom levels of  cockroach allergens showed an increased incidence of allergic  asthma, compared to other children.25,26 Also, among the many  indoor allergens, only cockroaches were significantly related to  recurrent asthmatic wheezing.23 Previous preventive and thera - peutic CpG-ODN treatment has been shown to suppress eosin - ophilic inflammation and hyper-responsiveness in the OVA/Al - um-induced asthma model.27 More recently, CpG-ODN treat - ment also suppressed airway inflammation and hyper-respon - siveness in the HDM-induced asthma model.28  However, the immune modulatory effects of CpG-ODN in  cockroach-induced asthma have not been investigated.",Non-OADS,/arxiv_data1/oa_pdf/bb/5d/aair-8-264.PMC4773215.pdf
"2016 May;8(3):264-275. http://dx.doi.org/10.4168/aair.2016.8.3.264Volume 8, Number 3, May 2016 266  http://e-aair.org-70°C for assessment of cytokine levels.",Non-OADS,/arxiv_data1/oa_pdf/bb/5d/aair-8-264.PMC4773215.pdf
"2016 May;8(3):264-275. http://dx.doi.org/10.4168/aair.2016.8.3.264AAIR http://e-aair.org   267treatment, we analyzed serum IgE levels, inflammatory cyto - kines and immune-suppressive regulatory T cell populations in  the lungs.",Non-OADS,/arxiv_data1/oa_pdf/bb/5d/aair-8-264.PMC4773215.pdf
"2016 May;8(3):264-275. http://dx.doi.org/10.4168/aair.2016.8.3.264Volume 8, Number 3, May 2016 268  http://e-aair.org % of F4/80+CD11chigh % of F4/80+CD11cint % of F4/80+CD11clow Sham Sham Sham CR/cODN CR/cODN CR/cODN CR/CpG CR/CpG CR/CpG80 60 40 20 025 20 15 10 5 020 15 10 5 0 B C DA *** **F4/80+CD11chigh F4/80+CD11cint F4/80+CD11clowSham CR/cODN CR/CpGCD11c F4/80105105105 104104104 103103103 -103-103-1030 0 0 -103-103-1030 0 0 10310310310410410410510510560.1 17.9 37.8 4.91 19.5 9.91 5.35 17.1 11.1 Fig.",Non-OADS,/arxiv_data1/oa_pdf/bb/5d/aair-8-264.PMC4773215.pdf
"2016 May;8(3):264-275. http://dx.doi.org/10.4168/aair.2016.8.3.264AAIR http://e-aair.org   269Intra-nasal CpG-ODN treatment prior to cockroach allergen  challenge prevents allergic airway inflammation and hyper- responsiveness Since DNA vaccinations, such as the Bacillus Calmette- Guerin (BCG) vaccine, were demonstrated to play preventive  roles in allergic inflammation in the lung33,34 and CpG-ODN is  known to mediate the equivalent TLR9 signaling pathway to  stimulate antigen presenting cells,35 we attempted a CpG-ODN  vaccination scheme to determine whether it could modulate the immune system and prevent Th2-mediated inflammatory  diseases via induction of Th1 cells prior to cockroach allergen  challenge.",Non-OADS,/arxiv_data1/oa_pdf/bb/5d/aair-8-264.PMC4773215.pdf
"2016 May;8(3):264-275. http://dx.doi.org/10.4168/aair.2016.8.3.264Volume 8, Number 3, May 2016 270  http://e-aair.orgwas significantly reduced in CpG-ODN-treated mice (Fig.",Non-OADS,/arxiv_data1/oa_pdf/bb/5d/aair-8-264.PMC4773215.pdf
2016 May;8(3):264-275. http://dx.doi.org/10.4168/aair.2016.8.3.264AAIR http://e-aair.org   271these data suggest that there is significant therapeutic effect of  CpG-ODN in cockroach allergen-induced asthma model.,Non-OADS,/arxiv_data1/oa_pdf/bb/5d/aair-8-264.PMC4773215.pdf
"2016 May;8(3):264-275. http://dx.doi.org/10.4168/aair.2016.8.3.264Volume 8, Number 3, May 2016 272  http://e-aair.orgFoxp3+ regulatory T cells (Fig.",Non-OADS,/arxiv_data1/oa_pdf/bb/5d/aair-8-264.PMC4773215.pdf
"2016 May;8(3):264-275. http://dx.doi.org/10.4168/aair.2016.8.3.264AAIR http://e-aair.org   273that IFN-γ is a critical factor for the immune modulatory func - tion of CpG-ODN.40 However, repeated CpG-ODN treatment  partially ameliorated eosinophilic inflammation and Th2 cyto - kine production in IFN- γ and IL-12 KO mice, suggesting that  there could be alternative mechanisms.41 Recently, pDCs acti - vated by CpG-ODN were shown to be involved in the genera - tion of CD4+CD25+ regulatory T cells and to induce IDO expres - sion under inflammatory conditions.16,17 In addition, CpG-ODN  demonstrated anti-inflammatory function in pDC in a PD-1/ PD-L1 dependent manner.42 More recently, increased Foxp3  mRNA levels were measured in CD4 T cells with high doses of  CpG-ODN treatment.",Non-OADS,/arxiv_data1/oa_pdf/bb/5d/aair-8-264.PMC4773215.pdf
"2016 May;8(3):264-275. http://dx.doi.org/10.4168/aair.2016.8.3.264Volume 8, Number 3, May 2016 274  http://e-aair.org10.",Non-OADS,/arxiv_data1/oa_pdf/bb/5d/aair-8-264.PMC4773215.pdf
2016 May;8(3):264-275. http://dx.doi.org/10.4168/aair.2016.8.3.264AAIR http://e-aair.org   27544.,Non-OADS,/arxiv_data1/oa_pdf/bb/5d/aair-8-264.PMC4773215.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 276  http://e-aair.orgINTRODUCTION Leukotriene receptor antagonists (LTRAs) selectively block the  binding of cysteinyl leukotrienes, which play a key role in the  pathogenesis of various types of acute and chronic inflammato - ry disorders, to their receptors on target cells.",Non-OADS,/arxiv_data1/oa_pdf/6e/3a/aair-8-276.PMC4773216.pdf
"She underwent pituitary surgery for acromeg - aly 2 years ago and was on rosuvastatin for dyslipidemia for 2 A Case of Pranlukast-Induced Anaphylactic Shock  Sujeong Kim, Jong-Myung Lee* Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/3a/aair-8-276.PMC4773216.pdf
2016 May;8(3):276-278. http://dx.doi.org/10.4168/aair.2016.8.3.276 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/6e/3a/aair-8-276.PMC4773216.pdf
2016 May;8(3):276-278. http://dx.doi.org/10.4168/aair.2016.8.3.276AAIR http://e-aair.org   277years thereafter.,Non-OADS,/arxiv_data1/oa_pdf/6e/3a/aair-8-276.PMC4773216.pdf
"2016 May;8(3):276-278. http://dx.doi.org/10.4168/aair.2016.8.3.276Volume 8, Number 3, May 2016 278  http://e-aair.orgfunction abnormalities.9,11 We could find only 2 cases sugges - tive of pranlukast-induced immediate-type hypersensitivity re - actions in the literature.12 Interestingly, both patients were diag - nosed with aspirin-induced urticaria (AIU) and pranlukast-in - duced generalized urticaria, accompanied by angioedema and  severe dizziness in 1 patient, within 1 hour after ingestion.",Non-OADS,/arxiv_data1/oa_pdf/6e/3a/aair-8-276.PMC4773216.pdf
Available from http://www.e-search.ne.jp/~jpr/PDF/ ONO04.PDF .,Non-OADS,/arxiv_data1/oa_pdf/6e/3a/aair-8-276.PMC4773216.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.3.203 www.annlabmed.org  203Ann Lab Med 2016;36:203-208 http://dx.doi.org/10.3343/alm.2016.36.3.203Review Article Diagnostic Genetics Korean Society for Laboratory Medicine Practice  Guidelines for the Molecular Diagnosis of Middle East  Respiratory Syndrome During an Outbreak in Korea in  2015 Chang-Seok Ki, M.D.1,*, Hyukmin Lee, M.D.2,*, Heungsup Sung, M.D.3, Sinyoung Kim, M.D.4, Moon-Woo Seong, M.D.5,  Dongeun Yong, M.D.4, Jae-Seok Kim, M.D.6, Mi-Kyung Lee, M.D.7, Mi-Na Kim, M.D.3, Jong-Rak Choi, M.D.4,   Jeong-Ho Kim, M.D.4, and The Korean Society for Laboratory Medicine MERS-CoV Laboratory Response Task Force Department of Laboratory Medicine and Genetics1, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; Department of  Laboratory Medicine2, Catholic Kwandong University College of Medicine, Incheon; Department of Laboratory Medicine3, University of Ulsan College of  Medicine and Asan Medical Center, Seoul; Department of Laboratory Medicine4, Yonsei University College of Medicine, Seoul; Department of Laboratory  Medicine5, Seoul National University College of Medicine, Seoul; Department of Laboratory Medicine6, Kangdong Sacred Heart Hospital, Hallym University  College of Medicine, Seoul; Department of Laboratory Medicine7, Chung-Ang University College of Medicine, Seoul, Korea For two months between May and July 2015, a nationwide outbreak of Middle East respi - ratory syndrome coronavirus (MERS-CoV) occurred in Korea.",Non-OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
Guidelines for the molecular diagnosis of MERS-CoV 204  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.203MERS case was identified in a 68-yr-old man returning from the  Middle East.,Non-OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
"Guidelines for the molecular diagnosis of MERS-CoV http://dx.doi.org/10.3343/alm.2016.36.3.203 www.annlabmed.org  205gens such as influenza viruses, parainfluenza viruses, and respi - ratory syncytial virus, but emphasizes that there should not be  any delay in testing for MERS-CoV because of those testing [4].",Non-OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
Guidelines for the molecular diagnosis of MERS-CoV 206  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.203forced ventilation duct system) can be used.,Non-OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
Guidelines for the molecular diagnosis of MERS-CoV http://dx.doi.org/10.3343/alm.2016.36.3.203 www.annlabmed.org  207quires either a positive rRT-PCR result for at least two specific  genomic targets or a single positive target with sequencing of a  second target.,Non-OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
Guidelines for the molecular diagnosis of MERS-CoV 208  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.203Acknowledgments  This work contained valuable feedback from many laboratory  physicians who participated in molecular detection of MERS- CoV during MERS outbreak in Korea in 2015.,Non-OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
http://www.mers.,Non-OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
"3. WHO, MERS-CoV in Republic of Korea at a glance as of 29 July 2015.  http://www.wpro.who.int/outbreaks_emergencies/wpro_coronavirus/en/.",Non-OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
http://www.who.int/csr/disease/coronavirus_in - fections/mers-laboratory-testing/en/.,Non-OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
http://www.moh.gov.sa/en/CCC/Regulations/ Case%20Definition.pdf (Updated on Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
http://www.cdc.gov/coro - navirus/mers/case-def.html (Updated on Dec 2015).,OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
"Centers for Disease Control and Prevention, Interim guidelines for col - lecting, handling, and testing clinical specimens from patients under in - vestigation (PUIs) for Middle East Respiratory Syndrome Coronavirus  (MERS-CoV) – Version 2.1 http://www.cdc.gov/coronavirus/mers/guide - lines-clinical-specimens.html (Updated on Jun 16, 2015).",Non-OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
http://www.cdc.go.kr/ CDC/contents/CdcKrContentView.jsp?cid=26529&menuIds=HOME001- MNU1133-MNU1161-MNU1517 (Updated in 2015).,OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
http://www.who.int/csr/disease/coronavirus_infec - tions/NovelCoronavirus2012_InterimRecommendationsLaboratoryBior - isk/en/.,Non-OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
http://www.cdc.go.kr/ CDC/notice/CdcKrTogether0302.jsp?menuIds=HOME001-MNU1154- MNU0004-MNU0088&cid=26027 (Updated on Apr 2014).,OADS,/arxiv_data1/oa_pdf/67/93/alm-36-203.PMC4773259.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.3.209 www.annlabmed.org  209Ann Lab Med 2016;36:209-214 http://dx.doi.org/10.3343/alm.2016.36.3.209Original Article Diagnostic Hematology Usefulness of Flow Cytometric Analysis for Detecting  Leptomeningeal Diseases in Non-Hodgkin Lymphoma Sang-Yong Shin, M.D.1,2, Seung-Tae Lee, M.D.2,3, Hee-Jin Kim, M.D.2, Young Lyun Oh, M.D.4, Seok Jin Kim, M.D.5,   Won Seog Kim, M.D.5, and Sun-Hee Kim, M.D.2 Department of Laboratory Medicine1, Gyeongsang National University School of Medicine, Jinju; Departments of Laboratory Medicine & Genetics2, Patholgy4  and Medicine5, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; Department of Laboratory Medicine3, Yonsei University  College of Medicine, Seoul, Korea Background:  The clinical usefulness of flow cytometry (FCM) for the diagnosis of lepto - meningeal diseases (LMD) in non-Hodgkin lymphomas has been suggested in previous  studies but needs to be further validated.",Non-OADS,/arxiv_data1/oa_pdf/26/61/alm-36-209.PMC4773260.pdf
Flow cytometry for leptomeningeal diseases 210  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.209tions should be further validated in various clinical settings.,Non-OADS,/arxiv_data1/oa_pdf/26/61/alm-36-209.PMC4773260.pdf
Flow cytometry for leptomeningeal diseases http://dx.doi.org/10.3343/alm.2016.36.3.209 www.annlabmed.org  211negative or equivocal by cytomorphology (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/26/61/alm-36-209.PMC4773260.pdf
Flow cytometry for leptomeningeal diseases 212  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.209Table 3.,Non-OADS,/arxiv_data1/oa_pdf/26/61/alm-36-209.PMC4773260.pdf
"Flow cytometry for leptomeningeal diseases http://dx.doi.org/10.3343/alm.2016.36.3.209 www.annlabmed.org  213detect subclinical CNS at diagnosis, such as using flow cytome - try, and to develop better treatment strategies for patients with  subclinical CNS.",Non-OADS,/arxiv_data1/oa_pdf/26/61/alm-36-209.PMC4773260.pdf
Flow cytometry for leptomeningeal diseases 214  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.20912.,Non-OADS,/arxiv_data1/oa_pdf/26/61/alm-36-209.PMC4773260.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.3.215 www.annlabmed.org  215Ann Lab Med 2016;36:215-222 http://dx.doi.org/10.3343/alm.2016.36.3.215Original Article Diagnostic Hematology Potential Risk Factors Associated With Vascular  Diseases in Patients Receiving Treatment for  Hypertension  Hyunjung Kim, M.D.1, Joonhong Park, M.D.1,2, Hyojin Chae, M.D.1,2, Gun Dong Lee, M.T.1,2, Sang Yoon Lee, M.T.1,2,   Jong Min Lee, M.D.3, Yong-Seog Oh, M.D.3, Myungshin Kim, M.D.1,2, and Yonggoo Kim, M.D.1,2 Department of Laboratory Medicine1, Catholic Genetic Laboratory Center2 and Division of Cardiology3, Department of Internal Medicine, College of Medicine,  The Catholic University of Korea, Seoul, Korea Background:  Currently, the hypertension (HTN) patients undergo appropriate medical  treatment, and traditional risk factors are highly controlled.",Non-OADS,/arxiv_data1/oa_pdf/4f/98/alm-36-215.PMC4773261.pdf
"Risk factors for vascular diseases in hypertension 216  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.215are necessary, particularly for patients being treated for HTN.",Non-OADS,/arxiv_data1/oa_pdf/4f/98/alm-36-215.PMC4773261.pdf
"Risk factors for vascular diseases in hypertension http://dx.doi.org/10.3343/alm.2016.36.3.215 www.annlabmed.org  217tively), and MBGNFQ (quencher dye) as fluorescence markers.",Non-OADS,/arxiv_data1/oa_pdf/4f/98/alm-36-215.PMC4773261.pdf
Risk factors for vascular diseases in hypertension 218  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.2151).,Non-OADS,/arxiv_data1/oa_pdf/4f/98/alm-36-215.PMC4773261.pdf
"Risk factors for vascular diseases in hypertension http://dx.doi.org/10.3343/alm.2016.36.3.215 www.annlabmed.org  219The thrombophilic polymorphisms, Factor V  G1691A and  prothrombin  G20210A could not be analyzed since they were  not detected in any patients.",Non-OADS,/arxiv_data1/oa_pdf/4f/98/alm-36-215.PMC4773261.pdf
"Risk factors for vascular diseases in hypertension 220  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.215otype is associated with cardiovascular diseases including MI,  venous thrombosis, and peripheral arterial thrombosis [12, 21].",Non-OADS,/arxiv_data1/oa_pdf/4f/98/alm-36-215.PMC4773261.pdf
Risk factors for vascular diseases in hypertension http://dx.doi.org/10.3343/alm.2016.36.3.215 www.annlabmed.org  2214.,Non-OADS,/arxiv_data1/oa_pdf/4f/98/alm-36-215.PMC4773261.pdf
Risk factors for vascular diseases in hypertension 222  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.21538.,Non-OADS,/arxiv_data1/oa_pdf/4f/98/alm-36-215.PMC4773261.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.3.223 www.annlabmed.org  223Ann Lab Med 2016;36:223-229 http://dx.doi.org/10.3343/alm.2016.36.3.223Original Article Clinical Chemistry Plasma Levels and Diagnostic Utility of Macrophage  Colony-Stimulating Factor, Matrix Metalloproteinase-9,  and Tissue Inhibitor of Metalloproteinases-1 as New  Biomarkers of Breast Cancer Sławomir Ławicki, M.D.1, Edyta Katarzyna Gła żewska, M.S.2, Monika Sobolewska, M.S.1, Grażyna Ewa B ędkowska, Ph.D.3,   and Maciej Szmitkowski, M.D.1 Department of Biochemical Diagnostics1, Laboratory of Esthetic Medicine2, Department of HaematologicalDiagnostics3, Medical University, Białystok, Poland Background:  Macrophage colony-stimulating factor (M-CSF), matrix metalloproteinase-9  (MMP-9), and its specific tissue inhibitor - tissue inhibitor of metalloproteinases-1 (TIMP- 1) may play an important role in the pathogenesis and spread of cancer.",OADS,/arxiv_data1/oa_pdf/cb/74/alm-36-223.PMC4773262.pdf
"M-CSF, MMP-9, and TIMP-1 in breast cancer 224  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.223stage of breast cancer.",OADS,/arxiv_data1/oa_pdf/cb/74/alm-36-223.PMC4773262.pdf
"M-CSF, MMP-9, and TIMP-1 in breast cancer http://dx.doi.org/10.3343/alm.2016.36.3.223 www.annlabmed.org  225opsy of mammary tumor or after surgery.",Non-OADS,/arxiv_data1/oa_pdf/cb/74/alm-36-223.PMC4773262.pdf
"M-CSF, MMP-9, and TIMP-1 in breast cancer 226  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.223every stage of cancer (with the exception of stage III-equal to M- CSF-and stage IV- the highest value of M-CSF).",Non-OADS,/arxiv_data1/oa_pdf/cb/74/alm-36-223.PMC4773262.pdf
"M-CSF, MMP-9, and TIMP-1 in breast cancer http://dx.doi.org/10.3343/alm.2016.36.3.223 www.annlabmed.org  227Table 3.",Non-OADS,/arxiv_data1/oa_pdf/cb/74/alm-36-223.PMC4773262.pdf
"M-CSF, MMP-9, and TIMP-1 in breast cancer 228  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.223small-cell lung cancer [17].",Non-OADS,/arxiv_data1/oa_pdf/cb/74/alm-36-223.PMC4773262.pdf
"M-CSF, MMP-9, and TIMP-1 in breast cancer http://dx.doi.org/10.3343/alm.2016.36.3.223 www.annlabmed.org  229REFERENCES 1.",OADS,/arxiv_data1/oa_pdf/cb/74/alm-36-223.PMC4773262.pdf
"ISSN 2234-3806 • eISSN 2234-3814  230  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.230Ann Lab Med 2016;36:230-234 http://dx.doi.org/10.3343/alm.2016.36.3.230Original Article Clinical Microbiology External Quality Assessment of MERS-CoV Molecular  Diagnostics During the 2015 Korean Outbreak Moon-Woo Seong, M.D.1, Seung Jun Lee, M.D.1, Sung Im Cho, M.S.1, Kyungphil Ko, M.T.1, Mi-Na Kim, M.D.2,   Heungsub Sung, M.D.2, Jae-Seok Kim, M.D.3, Ji Soo Ahn, M.T.1, Byung Su Yu, M.T.1, Taek Soo Kim, M.D.1,   Eui Chong Kim, M.D.1, and Sung Sup Park, M.D.1  Department of Laboratory Medicine1, Seoul National University College of Medicine, Seoul National University Hospital; Department of Laboratory Medicine2,  University of Ulsan College of Medicine, Asan Medical Center; Department of Laboratory Medicine3, Kangdong Sacred Heart Hospital, Hallym University  College of Medicine, Seoul, Korea  Background:  The largest outbreak of Middle East respiratory syndrome coronavirus  (MERS-CoV) infection outside Middle East Asia in 2015 has necessitated the rapid expan - sion of laboratories that conduct MERS-CoV molecular testing in Korea, together with ex - ternal quality assessment (EQA) to evaluate the assays used.",Non-OADS,/arxiv_data1/oa_pdf/a6/62/alm-36-230.PMC4773263.pdf
"EQA of MERS-CoV molecular diagnostics http://dx.doi.org/10.3343/alm.2016.36.3.230 www.annlabmed.org  231The first case of MERS-CoV infection in Korea was identified  recently, in a 68-yr-old man who had travelled to the Middle  East two weeks prior to his diagnosis [6].",Non-OADS,/arxiv_data1/oa_pdf/a6/62/alm-36-230.PMC4773263.pdf
"EQA of MERS-CoV molecular diagnostics 232  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.230ever, in the case of ORF1a, it was significant only at 1,000 and  100 copies/μL but not at 10 copies/μL ( P=0.0007, 0.0263, and  1.0000, respectively).",OADS,/arxiv_data1/oa_pdf/a6/62/alm-36-230.PMC4773263.pdf
"EQA of MERS-CoV molecular diagnostics http://dx.doi.org/10.3343/alm.2016.36.3.230 www.annlabmed.org  233ORF1a, but these were also not statistically significant (Table 3).",OADS,/arxiv_data1/oa_pdf/a6/62/alm-36-230.PMC4773263.pdf
EQA of MERS-CoV molecular diagnostics 234  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.230could be produced depending on the kit used.,Non-OADS,/arxiv_data1/oa_pdf/a6/62/alm-36-230.PMC4773263.pdf
http://www.who.int/csr/dis - ease/coronavirus_infections/WHO_interim_recommendations_lab_de - tection_MERSCoV_092014.pdf (Updated on Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/a6/62/alm-36-230.PMC4773263.pdf
http://www.who.int/csr/don/25-october-2015-mers-ko - rea/en/ (Accessed on Nov 2015) 8.,Non-OADS,/arxiv_data1/oa_pdf/a6/62/alm-36-230.PMC4773263.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.3.235 www.annlabmed.org  235Ann Lab Med 2016;36:235-243 http://dx.doi.org/10.3343/alm.2016.36.3.235Original Article Clinical Microbiology Prevalence and Clinical Impact of Heterogeneous  Vancomycin-Intermediate Staphylococcus aureus   Isolated From Hospitalized Patients Young Rae Koh, M.D.1, Kye-Hyung Kim, M.D.2, Chulhun L. Chang, M.D.1, and Jongyoun Yi, M.D.1,3,4 Department of Laboratory Medicine1, Pusan National University School of Medicine, Busan; Department of Internal Medicine2, Pusan National University  Hospital, Busan; Research Institute for Convergence of Biomedical Science and Technology3, Pusan National University Yangsan Hospital, Yangsan;  Biomedical Research Institute4, Pusan National University Hospital, Busan, Korea Background:  We estimated the prevalence and clinical impact of heterogeneous vanco - mycin-intermediate Staphylococcus aureus  (hVISA).",OADS,/arxiv_data1/oa_pdf/98/5c/alm-36-235.PMC4773264.pdf
Prevalence and clinical impact of hVISA 236  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.235ported in 2000 [9].,OADS,/arxiv_data1/oa_pdf/98/5c/alm-36-235.PMC4773264.pdf
Prevalence and clinical impact of hVISA http://dx.doi.org/10.3343/alm.2016.36.3.235 www.annlabmed.org  237cubated at 35ºC for 48 hr.,OADS,/arxiv_data1/oa_pdf/98/5c/alm-36-235.PMC4773264.pdf
Prevalence and clinical impact of hVISA 238  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.2357.,Non-OADS,/arxiv_data1/oa_pdf/98/5c/alm-36-235.PMC4773264.pdf
Prevalence and clinical impact of hVISA http://dx.doi.org/10.3343/alm.2016.36.3.235 www.annlabmed.org  239Table 3.,Non-OADS,/arxiv_data1/oa_pdf/98/5c/alm-36-235.PMC4773264.pdf
"Prevalence and clinical impact of hVISA 240  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.235[CI], 2.172-23.792) was independently associated with 30-day  mortality.",Non-OADS,/arxiv_data1/oa_pdf/98/5c/alm-36-235.PMC4773264.pdf
Prevalence and clinical impact of hVISA http://dx.doi.org/10.3343/alm.2016.36.3.235 www.annlabmed.org  241(P=0.0391) was significantly associated with 30-day mortality.,Non-OADS,/arxiv_data1/oa_pdf/98/5c/alm-36-235.PMC4773264.pdf
Prevalence and clinical impact of hVISA 242  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.235MRSA bacteremia.,Non-OADS,/arxiv_data1/oa_pdf/98/5c/alm-36-235.PMC4773264.pdf
Prevalence and clinical impact of hVISA http://dx.doi.org/10.3343/alm.2016.36.3.235 www.annlabmed.org  243Prospective comparison of the clinical impacts of heterogeneous vanco - mycin-intermediate methicillin-resistant Staphylococcus aureus  (MRSA)  and vancomycin-susceptible MRSA.,OADS,/arxiv_data1/oa_pdf/98/5c/alm-36-235.PMC4773264.pdf
"ISSN 2234-3806 • eISSN 2234-3814  244  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.244Ann Lab Med 2016;36:244-249 http://dx.doi.org/10.3343/alm.2016.36.3.244Brief Communication Diagnostic Hematology Establishment of Age- and Gender-Specific Reference  Ranges for 36 Routine and 57 Cell Population Data  Items in a New Automated Blood Cell Analyzer,  Sysmex XN-2000 Sang Hyuk Park, M.D.1,2, Chan-Jeoung Park, M.D.1, Bo-Ra Lee, B.S.1, Mi-Jeong Kim, B.S.1, Min-Young Han, B.S.1,   Young-Uk Cho, M.D.1, and Seongsoo Jang, M.D.1 Department of Laboratory Medicine1, University of Ulsan College of Medicine and Asan Medical Center, Seoul; Department of Laboratory Medicine2, Pusan  National University School of Medicine, Pusan National University Hospital, Busan; Biomedical Research Institute, Pusan National University Hospital,  Busan, Korea We established age- and gender-specific reference ranges for the 36 routine complete  blood cell (CBC) and 57 cell population data (CPD) items in the Sysmex XN-2000 (Sys - mex, Japan).",OADS,/arxiv_data1/oa_pdf/2d/e3/alm-36-244.PMC4773265.pdf
Age/gender-specific reference ranges in XN-2000 http://dx.doi.org/10.3343/alm.2016.36.3.244 www.annlabmed.org  245tablishment of age- and gender-specific reference ranges for all  36 routine and 57 CPD items in the new XN-2000 analyzer has  not been performed.,OADS,/arxiv_data1/oa_pdf/2d/e3/alm-36-244.PMC4773265.pdf
"Age/gender-specific reference ranges in XN-2000 246  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.244Items Need of Stratification*Reference ranges** Male (N = 144) Female (N = 136) (1) Age 20-40  (N = 43)(2) Age 41-60  (N = 50)(3) Age > 60  (N = 51)(1) Age 20-40  (N = 52)(2) Age 41-60  (N = 44)(3) Age > 60  (N = 40) WBC ( × 109/L) No 3.89-9.23 RBC ( × 1012/L) A (0.001), G ( < 0.001) 4.30-5.57 4.24-5.65 3.74-5.31 3.83-4.86 3.66-4.76 3.61-5.00 Hb (g/dL) A (0.046), G ( < 0.001) 13.85-16.67 13.19-16.87 11.83-16.57 12.13-14.87 11.85-14.20 11.50-14.10 HCT (%) A (0.049), G ( < 0.001) 39.15-51.65 39.06-51.27 35.89-50.64 34.79-44.27 34.26-43.45 34.04-42.48 MCV (fL) A ( < 0.001) 81.30-100.12 (1)/86.50-101.79 (2)/88.05-104.07 (3) MCH (pg) A ( < 0.001) 26.04-33.56 (1)/27.23-33.60 (2)/27.75-34.52 (3) MCHC (g/dL) G ( < 0.001) 31.45-34.74 (M)/30.59-33.76 (F) PLT-F ( × 109/L) A ( < 0.001), G (0.028) 156.8-402.5 146.6-420.8 141.3-389.7 167.6-389.4 157.8-389.0 143.5-354.2 RDW-SD (fL) A ( < 0.001) 35.26-48.70 (1)/38.30-51.62 (2)/38.56-50.28 (3) RDW-CV (%) A (0.011) 11.22-15.56 (1)/11.40-15.29 (2)/11.43-13.90 (3) PDW (fL) No 9.30-16.70 MPV (fL) No 9.10-12.60 P-LCR (%) No 17.21-46.29 PCT (%) A ( < 0.001), G (0.019) 0.12-0.35 0.16-0.39 0.14-0.34 0.19-0.38 0.21-0.39 0.16-0.33 NRBC ( × 1012/L) No 0.00-0.03 NRBC (%) No 0.00-0.50 NEUT ( × 109/L) No 1.78-6.04 NEUT (%) No 40.80-70.39 LYMPH ( × 109/L) A (0.032) 1.39-3.15 (1)/1.24-3.05 (2)/1.01-2.75 (3) LYMPH (%) No 20.11-46.79 MONO ( × 109/L) G ( < 0.001) 0.29-0.72 (M)/0.24-0.72 (F) MONO (%) A (0.021), G (0.011) 4.17-11.37 4.91-10.38 4.26-11.08 4.03-10.57 4.83-11.15 4.41-10.60 EOSINO ( × 109/L) G ( < 0.001) 0.04-0.58 (M)/0.01-0.59 (F) EOSINO (%) G (0.002) 0.73-8.86 (M)/0.24-10.24 (F) BASO ( × 109/L) No 0.01-0.09 BASO (%) No 0.20-1.50 IG ( × 109/L) No 0.00-0.04 IG (%) No 0.00-0.50 RET ( × 1012/L) A (0.003) 0.86-2.55 (1)/0.99-2.11 (2)/0.97-2.72 (3) RET (%) G ( < 0.001) 0.04-0.12 (M)/0.04-0.11 (F) IRF (%) A (0.016) 2.88-15.14 (1)/2.74-15.04 (2)/3.45-18.87 (3) LFR (%) A (0.012) 84.86-97.12 (1)/84.96-97.26 (2)/81.03-96.55 (3) MFR (%) A (0.009) 2.60-12.38 (1)/2.55-12.60 (2)/3.19-13.84 (3) HFR (%) A (0.049) 0.00-3.12 (1)/0.00-2.65 (2)/0.00-6.31 (3) RET-Hb (pg) A ( < 0.001), G ( < 0.001) 31.12-36.24 31.61-36.38 31.30-37.39 25.69-34.77 28.36-35.68 29.81-36.50 IPF (%) No 1.00-8.99 TNC ( × 109/L) G (0.012) 4.13-9.73 (M)/3.76-8.10 (F) WBC-N ( × 109/L) G (0.011) 4.13-9.73 (M)/3.76-8.10 (F) TNC-N ( × 109/L) G (0.012) 4.13-9.73 (M)/3.76-8.10 (F)Table 1.",Non-OADS,/arxiv_data1/oa_pdf/2d/e3/alm-36-244.PMC4773265.pdf
"Age/gender-specific reference ranges in XN-2000 http://dx.doi.org/10.3343/alm.2016.36.3.244 www.annlabmed.org  247Items Need of Stratification*Reference ranges** Male (N = 144) Female (N = 136) (1) Age 20-40  (N = 43)(2) Age 41-60  (N = 50)(3) Age > 60  (N = 51)(1) Age 20-40  (N = 52)(2) Age 41-60  (N = 44)(3) Age > 60  (N = 40) BASO-N ( × 109/L) No 0.02-0.09 BASO-N (%) No 0.30-1.50 WBC-D ( × 109/L) G (0.010) 4.08-9.67 (M)/3.70-8.08 (F) TNC-D ( × 109/L) G (0.010) 4.08-9.67 (M)/3.70-8.08 (F) Delta NEUT ( × 109/L) No 1.77-5.79 Delta NEUT (%) No 40.60-70.30 Delta LYMPH ( × 109/L) A (0.041) 1.19-2.90 (1)/1.15-3.04 (2)/1.01-2.74 (3) Delta LYMPH (%) No 19.70-46.60 HFLC ( × 109/L) A ( < 0.001) 0.00-0.08 (1)/0.00-0.02 (2)/0.00-0.02 (3) HFLC (%) A ( < 0.001) 0.00-0.91 (1)/0.00-0.36 (2)/0.00-0.34 (3) BASO-D ( × 109/L) No 0.01-0.08 BASO-D (%) No 0.20-1.40 WBC-P ( × 109/L) G (0.015) 3.79-9.36 (M)/3.65-7.95 (F) TNC-P ( × 109/L) G (0.015) 3.79-9.36 (M)/3.65-7.95 (F) NE-SFL (ch) G (0.001) 41.82-51.20 (M)/42.10-53.49 (F) NE-SSC (ch) No 143.10-157.30 NE-FSC (ch) No 82.30-98.10 LY-X (ch) A ( < 0.001) 76.33-83.55 (1)/77.86-85.29 (2)/77.63-84.48 (3) LY-Y (ch) A ( < 0.001), G ( < 0.001) 61.42-72.25 58.54-85.43 60.33-72.15 45.99-73.30 63.14-74.79 59.92-71.96 LY-Z (ch) A (0.042), G ( < 0.001) 49.19-60.39 57.38-75.57 57.10-61.07 57.60-61.90 57.85-61.69 28.65-61.77 MO-X (ch) G ( < 0.001) 116.36-124.28 (M)/118.14-124.79 (F) MO-Y (ch) A ( < 0.001), G ( < 0.001)   96.92-121.66   94.14-116.84   91.60-121.53 103.62-134.26   98.71-121.53   93.97-126.89 MO-Z (ch) A (0.002), G ( < 0.001) 59.37-71.66 62.25-69.00 61.01-71.47 62.11-73.38 61.69-70.99 63.90-71.96 NE-WX A (0.039) 267.50-349.63 (1)/271.88-373.13 (2)/275.90-350.40 (3) NE-WY No 561.00-735.00 NE-WZ A, (0.020) G (0.031) 509.95-710.85  532.33-829.88 347.40-877.90  340.32-732.13  445.63-964.38 509.75-827.33 LY-WX A (0.001), G (0.002) 395.65-567.20  407.23-615.30 404.90-554.40  420.93-656.68  438.38-589.38 427.13-562.23 LY-WY A (0.033), G ( < 0.001) 719.93-948.40 761.43-1,001.70 697.90-989.80  735.00-1,032.25  797.63-1,009.25 740.28-996.00 LY-WZ A (0.004) 434.00-579.88 (1)/439.38-579.50 (2)/437.40-558.40 (3) MO-WX No 215.00-329.00 MO-WY G (0.001) 513.60-817.80 (M)/498.70-784.45 (F) MO-WZ A ( < 0.001) 419.00-729.88 (1)/444.50-832.88 (2)/409.60-783.90 (3) MicroR (%) A (0.001) 0.14-5.79 (1)/0.10-6.81 (2)/0.20-1.87 (3) MacroR (%) A ( < 0.001), G ( < 0.001) 3.30-5.56 3.63-7.83 3.13-8.84 1.31-8.48 3.20-8.02 3.20-6.77 RBC-O ( × 1012/L) A ( < 0.001), G ( < 0.001) 4.29-5.72 4.23-5.64 2.36-5.49 3.78-5.01 3.72-4.81 3.81-4.99 Hb-O (g/dL) G ( < 0.001) 12.80-17.00 (M)/10.67-14.80 (F) PLT-O ( × 109/L) A ( < 0.001), G (0.043) 162.8-398.5 152.2-387.0 125.2-347.0 158.1-371.7 157.4-351.9 135.4-326.1 RBC-He (pg) A ( < 0.001), G ( < 0.001) 27.94-32.96 28.83-53.66 28.69-33.64 23.32-32.75 24.15-32.39 27.20-33.09 (Continued to the next page)Table 1.",Non-OADS,/arxiv_data1/oa_pdf/2d/e3/alm-36-244.PMC4773265.pdf
"Age/gender-specific reference ranges in XN-2000 248  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.244Items Need of Stratification*Reference ranges** Male (N = 144) Female (N = 136) (1) Age 20-40  (N = 43)(2) Age 41-60  (N = 50)(3) Age > 60  (N = 51)(1) Age 20-40  (N = 52)(2) Age 41-60  (N = 44)(3) Age > 60  (N = 40) Delta-He (pg) No 1.70-4.40 RET-Y (ch) A ( < 0.001), G ( < 0.001) 174.75-190.37 176.56-191.07 175.32-193.57 155.09-186.12 165.40-188.81 170.53-191.09 RET-RBC-Y (ch) A ( < 0.001), G ( < 0.001) 163.75-180.56 166.96-180.67 166.50-182.82 145.29-179.95 149.08-178.86 161.20-180.98 IRF-Y (ch) A (0.005), G ( < 0.001) 173.48-193.62 174.68-191.85 176.18-195.05 151.85-189.68 160.66-190.66 169.07-191.90 FRC ( × 1012/L) A (0.050), G ( < 0.001) 0.00-0.00 0.00-0.00 0.00-0.02 0.00-0.19 0.00-0.03 0.00-0.02 FRC (%) G ( < 0.001) 0.00-0.14 (M)/0.00-0.45 (F) HYPO-He (%) A (0.003), G ( < 0.001) 0.01-0.29 0.00-0.20 0.10-0.44 0.10-0.90 0.01-0.78 0.00-0.40 HYPER-He (%) A ( < 0.001), G ( < 0.001) 0.41-0.80 0.50-0.80 0.43-0.87 0.07-0.70 0.20-0.70 0.40-0.70 RPI G ( < 0.001) 0.70-3.00 (M)/0.60-1.86 (F) RET-UPP G (0.009) 0.00-18.00 (M)/0.00-14.00 (F) RET-TNC A (0.010), G (0.013) 36.00-91.40 29.00-93.45 9.90-95.40 32.33-84.73 28.13-78.38 31.08-78.98 PLT-F ( × 109/L) A ( < 0.001), G (0.027) 161.7-403.7 180.7-390.9 130.7-389.7 167.6-389.4 157.8-389.0 143.9-354.2 PLT-F2 ( × 109/L) A ( < 0.001), G (0.022) 154.9-403.7 171.3-401.4 131.3-380.5 168.4-389.9 158.4-389.3 143.9-354.3 H-IPF (%) No 0.20-3.50 IPF ( × 109/L) A (0.005) 2.93-17.80 (1)/2.60-16.15 (2)/2.53-17.74 (3) PLT-I ( × 109/L) A ( < 0.001), G (0.019) 165.0-396.2 161.2-387.1 125.3-359.0 158.1-387.1 153.4-370.9 138.8-344.2 All reference ranges were established according to CLSI guideline EP28-A3c [6] and 2.5th-97.5th percentile of each item was determined as a reference  range because all subgroups of each item showed no normal distribution by the Kolmogorov-Smirnov test.",Non-OADS,/arxiv_data1/oa_pdf/2d/e3/alm-36-244.PMC4773265.pdf
Age/gender-specific reference ranges in XN-2000 http://dx.doi.org/10.3343/alm.2016.36.3.244 www.annlabmed.org  249Authors’ Disclosures of Potential Conflicts of  Interest No potential conflicts of interest relevant to this article were re - ported.,Non-OADS,/arxiv_data1/oa_pdf/2d/e3/alm-36-244.PMC4773265.pdf
"ISSN 2234-3806 • eISSN 2234-3814  250  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.250Ann Lab Med 2016;36:250-254 http://dx.doi.org/10.3343/alm.2016.36.3.250Brief Communication Clinical Microbiology Antimicrobial Resistance and Molecular Characteristics  of Nasal Staphylococcus aureus Isolates From Newly  Admitted Inpatients Xu Chen, M.S.1,*, Kangde Sun, M.S.1,*, Danfeng Dong, M.S.2, Qingqiong Luo, M.S.1, Yibing Peng, M.D.2,   and Fuxiang Chen, M.D.1 Department of Laboratory Medicine1, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine (SJTUSM), Shanghai; Department  of Laboratory Medicine2, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (SJTUSM), Shanghai, China Staphylococcus aureus , or methicillin-resistant S. aureus  (MRSA), is a significant patho - gen in both nosocomial and community infections.",Non-OADS,/arxiv_data1/oa_pdf/e2/b0/alm-36-250.PMC4773266.pdf
Resistance and characteristics of nasal S. aureus http://dx.doi.org/10.3343/alm.2016.36.3.250 www.annlabmed.org  251settings worldwide.,Non-OADS,/arxiv_data1/oa_pdf/e2/b0/alm-36-250.PMC4773266.pdf
Resistance and characteristics of nasal S. aureus 252  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.250was explored.,Non-OADS,/arxiv_data1/oa_pdf/e2/b0/alm-36-250.PMC4773266.pdf
"Resistance and characteristics of nasal S. aureus http://dx.doi.org/10.3343/alm.2016.36.3.250 www.annlabmed.org  253lyadmitted inpatients, and the results revealed that 62 out of  292 (20.5%) inpatients carried S. aureus  in the nose.",Non-OADS,/arxiv_data1/oa_pdf/e2/b0/alm-36-250.PMC4773266.pdf
Resistance and characteristics of nasal S. aureus 254  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.250against erythromycin was detected.,Non-OADS,/arxiv_data1/oa_pdf/e2/b0/alm-36-250.PMC4773266.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.3.255 www.annlabmed.org  255Ann Lab Med 2016;36:255-258 http://dx.doi.org/10.3343/alm.2016.36.3.255Brief Communication   Clinical Microbiology Genotyping Influenza Virus by Next-Generation Deep  Sequencing in Clinical Specimens  Moon-Woo Seong, M.D., Sung Im Cho, M.S., Hyunwoong Park, M.D., Soo Hyun Seo, M.D., Seung Jun Lee, M.D.,   Eui-Chong Kim, M.D., and Sung Sup Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/30/35/alm-36-255.PMC4773267.pdf
"Genotyping influenza virus by deep sequencing  256  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.255by using QIAamp Viral RNA Mini kit (Qiagen, Hilden, Germany).",OADS,/arxiv_data1/oa_pdf/30/35/alm-36-255.PMC4773267.pdf
"Third, the assembled contigs (≥500 bp) were compared  against the nucleotide database of the National Center for Bio - technology Information (http://www.ncbi.nlm.nih.gov) by using  the BLAST algorithm (http://blast.ncbi.nlm.nih.gov/).",OADS,/arxiv_data1/oa_pdf/30/35/alm-36-255.PMC4773267.pdf
"Finally, as - sembled contigs and candidate viral reference genome se - quences were aligned in ClustalW (http://www.clustal.org), and  phylogenetic analysis was performed by using the maximum  likelihood method.",OADS,/arxiv_data1/oa_pdf/30/35/alm-36-255.PMC4773267.pdf
"Genotyping influenza virus by deep sequencing  http://dx.doi.org/10.3343/alm.2016.36.3.255 www.annlabmed.org  257Phylogenetic analysis of the HA and NA genes included vari - ous influenza A strains like A/Korea/01/2009(H1N1), A/ Korea/426/68(H2N2), A/New York/392/2004(H3N2).",Non-OADS,/arxiv_data1/oa_pdf/30/35/alm-36-255.PMC4773267.pdf
Genotyping influenza virus by deep sequencing  258  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.255Authors’ Disclosures of Potential Conflicts of  Interest No potential conflicts of interest relevant to this article were re - ported.,Non-OADS,/arxiv_data1/oa_pdf/30/35/alm-36-255.PMC4773267.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.3.259 www.annlabmed.org  259Ann Lab Med 2016;36:259-262 http://dx.doi.org/10.3343/alm.2016.36.3.259Case Report Diagnostic Genetics  The First Korean Family With Hereditary Gelsolin  Amyloidosis Caused by p.D214Y Mutation in the GSN  Gene Kyoung-Jin Park, M.D.1, Jong-Ho Park, B.S.1, June-Hee Park, B.S.2, Eun Bin Cho, M.D.3, Byoung Joon Kim, M.D.3,   and Jong-Won Kim, M.D.1,4 Department of Health Sciences and Technology1, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University; Samsung  Biomedical Research Institute2, Samsung Medical Center; Department of Neurology3, Samsung Medical Center, Sungkyunkwan University School of  Medicine; Department of Laboratory Medicine & Genetics4, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Hereditary gelsolin amyloidosis (HGA) is an autosomal dominant hereditary disease char - acterized by corneal lattice dystrophy, peripheral neuropathy, and cutis laxa.",Non-OADS,/arxiv_data1/oa_pdf/92/7a/alm-36-259.PMC4773268.pdf
"The first Korean family with gelsolin amyloidosis 260  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.259[5, 6, 11, 12, 14].",Non-OADS,/arxiv_data1/oa_pdf/92/7a/alm-36-259.PMC4773268.pdf
"The first Korean family with gelsolin amyloidosis http://dx.doi.org/10.3343/alm.2016.36.3.259 www.annlabmed.org  261A trinucleotide repeat expansion analysis yielded no remark - able findings, excluding Kennedy disease.",Non-OADS,/arxiv_data1/oa_pdf/92/7a/alm-36-259.PMC4773268.pdf
The first Korean family with gelsolin amyloidosis 262  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.259and electrophysiological presentation.,Non-OADS,/arxiv_data1/oa_pdf/92/7a/alm-36-259.PMC4773268.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.3.263 www.annlabmed.org  263Ann Lab Med 2016;36:263-265 http://dx.doi.org/10.3343/alm.2016.36.3.263Letter to the Editor  Diagnostic Hematology Minor BCR-ABL1 -Positive Acute Myeloid Leukemia  Associated With the NPM1  Mutation and FLT3 Internal  Tandem Duplication Moon Jung Kim, M.D.1, Sunhyun Ahn, M.D.2,3, Seong-hyun Jeong, M.D.4, Ja-Hyun Jang, M.D.5, Jae Ho Han, M.D.6,   Jong Rak Choi, M.D.7, and Sung Ran Cho, M.D.2 Department of Laboratory Medicine1, Seonam University College of Medicine, Goyang; Departments of Laboratory Medicine2 and Hematology-Oncology4,  Ajou University School of Medicine, Suwon; SQ Laboratory3, Yongin; Green Cross Laboratories5, Yongin; Department of Pathology6, Ajou University School of  Medicine, Suwon; Department of Laboratory Medicine7, Yonsei University College of Medicine, Seoul, Korea Dear Editor, Philadelphia chromosome-positive (Ph+) or BCR-ABL1 -positive  AML accounts for <1% of newly diagnosed AML cases [1].",Non-OADS,/arxiv_data1/oa_pdf/ee/fd/alm-36-263.PMC4773269.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/fd/alm-36-263.PMC4773269.pdf
"BCR-ABL1  (+) AML with NPM1  mutation and FLT3 ITD 264  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.263dual-color, dual-fusion translocation probe set (Abbott Molecu - lar/Vysis, Des Plaines, IL, USA).",OADS,/arxiv_data1/oa_pdf/ee/fd/alm-36-263.PMC4773269.pdf
BCR-ABL1  (+) AML with NPM1  mutation and FLT3 ITD http://dx.doi.org/10.3343/alm.2016.36.3.263 www.annlabmed.org  265patient had type A mutations of NPM1  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ee/fd/alm-36-263.PMC4773269.pdf
"ISSN 2234-3806 • eISSN 2234-3814  266  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.266Ann Lab Med 2016;36:266-267 http://dx.doi.org/10.3343/alm.2016.36.3.266Letter to the Editor  Diagnostic Hematology Bone Marrow Oxalosis in a Patient With Pancytopenia  Following Bilateral Nephrectomy  Moon Jin Kim, M.D.1, Pil-Whan Park, M.D.1, Yiel-Hea Seo, M.D.1, Kyung-Hee Kim, M.D.1, Ja Young Seo, M.D.1,   Ji-Hun Jeong, M.D.1, Hwan Tae Lee, M.D.1, Jungsuk An, M.D.2, and Jeong-Yeal Ahn, M.D.1 Departments of Laboratory Medicine1 and Pathology2, Gachon University Gil Medical Center, Incheon, Korea Dear Editor, Bone marrow (BM) oxalosis is a type of systemic oxalosis  wherein oxalate is deposited in BM.",Non-OADS,/arxiv_data1/oa_pdf/cf/7a/alm-36-266.PMC4773270.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/7a/alm-36-266.PMC4773270.pdf
Bone marrow oxalosis  http://dx.doi.org/10.3343/alm.2016.36.3.266 www.annlabmed.org  267osteolytic lesions in multiple sites that resulted in a spontaneous  fracture in his elbow.,Non-OADS,/arxiv_data1/oa_pdf/cf/7a/alm-36-266.PMC4773270.pdf
"ISSN 2234-3806 • eISSN 2234-3814  268  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.268Ann Lab Med 2016;36:268-270 http://dx.doi.org/10.3343/alm.2016.36.3.268Letter to the Editor  Diagnostic Hematology Marked Increase of Circulating Double-Negative γδ T  Cells in a Patient With Hydroa Vacciniforme-Like  Lymphoma Sang-Yong Shin, M.D., Chang-Hun Park, M.D., Duck Cho, M.D., Hee-Jin Kim, M.D., and Sun-Hee Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/67/9e/alm-36-268.PMC4773271.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/9e/alm-36-268.PMC4773271.pdf
"γδ T cells in HVLL http://dx.doi.org/10.3343/alm.2016.36.3.268 www.annlabmed.org  269Absolute lymphocytosis is unusual in hydroa vacciniforme-like  lymphoproliferative disease [3, 6].",Non-OADS,/arxiv_data1/oa_pdf/67/9e/alm-36-268.PMC4773271.pdf
"γδ T cells in HVLL 270  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.268McKinster C, Ruiz-Maldonado R, et al.",OADS,/arxiv_data1/oa_pdf/67/9e/alm-36-268.PMC4773271.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.3.271 www.annlabmed.org  271Ann Lab Med 2016;36:271-274 http://dx.doi.org/10.3343/alm.2016.36.3.271Letter to the Editor  Clinical Chemistry Influence of Vitamin C and Maltose on the Accuracy of  Three Models of Glucose Meters Jooyoung Cho, M.D.1, Sunyoung Ahn, M.D.1, Jisook Yim, M.D.1, Younjung Cheon, M.T.2, Seok Hoon Jeong, M.D.2,   Sang-Guk Lee, M.D.1, and Jeong-Ho Kim, M.D.1 Department of Laboratory Medicine1, Severance Hospital, Yonsei University College of Medicine, Seoul; Department of Laboratory Medicine2, Gangnam  Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Dear Editor, Glucose meters are increasingly used in hospitals and home  settings.",Non-OADS,/arxiv_data1/oa_pdf/c4/57/alm-36-271.PMC4773272.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/57/alm-36-271.PMC4773272.pdf
"Possible interferents on glucose meter 272  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.271Accuchek Inform glucose level readings at all concentrations  were subject to significant positive interference (>10% devia - tion from control sample levels) from vitamin C presence at con -centrations of 15 and 30 mg/dL, whereas no significant positive  interference was observed for Barozen H plus and Starstrip  models (Fig.",Non-OADS,/arxiv_data1/oa_pdf/c4/57/alm-36-271.PMC4773272.pdf
Possible interferents on glucose meter http://dx.doi.org/10.3343/alm.2016.36.3.271 www.annlabmed.org  273Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c4/57/alm-36-271.PMC4773272.pdf
Possible interferents on glucose meter 274  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.271Am J Clin Pathol 2000;113:75-86.,OADS,/arxiv_data1/oa_pdf/c4/57/alm-36-271.PMC4773272.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.3.275 www.annlabmed.org  275Ann Lab Med 2016;36:275-277 http://dx.doi.org/10.3343/alm.2016.36.3.275Letter to the Editor  Clinical Microbiology Septicemia Caused by Neisseria meningitidis  With  Decreased Ciprofloxacin Susceptibility: The First Case  Report in Korea Ji Yeon Ahn, M.D.1, Joon Ki Min, M.D.1, Myeong Hee Kim, M.D.2, Soo-youn Moon, M.D.1, Ki-Ho Park, M.D.1,   Mi Suk Lee, M.D.1, and Jun Seong Son, M.D.1 Division of Infectious Diseases1, Department of Internal Medicine, Kyung Hee University School of Medicine; Department of Laboratory Medicine2, Kyung  Hee University School of Medicine, Seoul, Korea Dear Editor, Several antibiotics are currently used for meningococcal pro - phylaxis, including ciprofloxacin, rifampin, and ceftriaxone.",Non-OADS,/arxiv_data1/oa_pdf/d6/bf/alm-36-275.PMC4773273.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/bf/alm-36-275.PMC4773273.pdf
"Meningococcus  with reduced susceptibility 276  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.275the siaD gene (serogroups B, C, Y, and W135) were used for  serogroup prediction.",OADS,/arxiv_data1/oa_pdf/d6/bf/alm-36-275.PMC4773273.pdf
Meningococcus  with reduced susceptibility http://dx.doi.org/10.3343/alm.2016.36.3.275 www.annlabmed.org  277REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d6/bf/alm-36-275.PMC4773273.pdf
"ISSN 2234-3806 • eISSN 2234-3814  278  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.278Ann Lab Med 2016;36:278-280 http://dx.doi.org/10.3343/alm.2016.36.3.278Letter to the Editor  Clinical Microbiology First Case Report of Human Infection With  Ochrobactrum tritici Causing Bacteremia and  Cholecystitis Duck Jin Hong, M.D.1,2, Keon-Han Kim, M.T.3, Jung Ok Kim, B.S.2, Jun Sung Hong, B.S.4, Seok Hoon Jeong, M.D.2,3,   and Kyungwon Lee, M.D.2 Department of Laboratory Medicine1, Eone Reference Laboratory, Incheon; Department of Laboratory Medicine and Research Institute of Bacterial  Resistance2, Yonsei University College of Medicine, Seoul; Department of Laboratory Medicine3, Gangnam Severance Hospital, Yonsei University College of  Medicine, Seoul; Brain Korea 21 PLUS Project for Medical Science4, Yonsei University College of Medicine, Seoul, Korea  Dear Editor, Herein, we report the first case of human infection with Ochro - bactrum tritici , primarily isolated from environmental sources  and not previously known to infect humans.",Non-OADS,/arxiv_data1/oa_pdf/18/e1/alm-36-278.PMC4773274.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/e1/alm-36-278.PMC4773274.pdf
"First case report of O. tritici  infection in human http://dx.doi.org/10.3343/alm.2016.36.3.278 www.annlabmed.org  279quences of both isolates were 100% identical to those of strain  CCUG 47104T, the O. tritici  type strain.",Non-OADS,/arxiv_data1/oa_pdf/18/e1/alm-36-278.PMC4773274.pdf
First case report of O. tritici  infection in human 280  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.278Acknowledgments This work was supported by a grant from the Research Program  funded by the Korea Center for Disease Control and Prevention  (#2014E4700201).,Non-OADS,/arxiv_data1/oa_pdf/18/e1/alm-36-278.PMC4773274.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.3.281 www.annlabmed.org  281Ann Lab Med 2016;36:281-283 http://dx.doi.org/10.3343/alm.2016.36.3.281Letter to the Editor  Clinical Microbiology Two Cases of Clostridium tertium  Infection and  Successful Identification of the Organism by Matrix- Assisted Laser Desorption-Ionization Time-of-Flight  Mass Spectrometry Analysis Yumiko Joichi, A.D.1,2, Shizuo Kayama, D.D.S.1, Ikue Hayashi, Ph.D.1,3, Makoto Onodera, B.S.E.1,2, Maki Furushimo, A.D.2,  Yumiko Koba, M.S.1,2, Michiya Yokozaki, M.D.1,4, Hiroki Ohge, M.D.1,5, and Motoyuki Sugai, D.D.S.1 Project Research Center for Nosocomial Infectious Diseases1, Hiroshima University; Section of Infection Diseases2, Laboratory Division of Clinical Support,  Hiroshima University Hospital; Research Facility3, Hiroshima University Faculty of Dentistry; Division of Laboratory Medicine4, Hiroshima University Hospital;  Department of Infectious Diseases5, Hiroshima University Hospital, Hiroshima, Japan  Dear Editor, Clostridium tertium  is an endospore-forming anaerobic gram– positive bacillus.",Non-OADS,/arxiv_data1/oa_pdf/e1/e3/alm-36-281.PMC4773275.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/e3/alm-36-281.PMC4773275.pdf
Identification of Clostridium tertium  by TOF-MS analysis  282  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.281Case 2.,Non-OADS,/arxiv_data1/oa_pdf/e1/e3/alm-36-281.PMC4773275.pdf
Identification of Clostridium tertium  by TOF-MS analysis  http://dx.doi.org/10.3343/alm.2016.36.3.281 www.annlabmed.org  283REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/e1/e3/alm-36-281.PMC4773275.pdf
"ISSN 2234-3806 • eISSN 2234-3814  284  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.284Ann Lab Med 2016;36:284-286 http://dx.doi.org/10.3343/alm.2016.36.3.284Letter to the Editor  Transfusion Medicine Anti-H Antibody Showing Agglutination in the Anti- Human Globulin Phase in a Korean Patient Young Eun Koh, M.D., Geun Young Ryu, M.D., Yoon-ho Kim, M.T., Mi-Ae Jang, M.D., Soo-young Yoon, M.D.,   and Chae Seung Lim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/b4/3c/alm-36-284.PMC4773276.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/3c/alm-36-284.PMC4773276.pdf
Anti-H antibody with a wide thermal range http://dx.doi.org/10.3343/alm.2016.36.3.284 www.annlabmed.org  285with A 1 cells that lacked H antigens.,Non-OADS,/arxiv_data1/oa_pdf/b4/3c/alm-36-284.PMC4773276.pdf
Anti-H antibody with a wide thermal range 286  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.28418:738-42.,Non-OADS,/arxiv_data1/oa_pdf/b4/3c/alm-36-284.PMC4773276.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.3.287 www.annlabmed.org  287Ann Lab Med 2016;36:287-289 http://dx.doi.org/10.3343/alm.2016.36.3.287Letter to the Editor  Diagnostic Genetics Chronic Myeloid Leukemia With Rare Variant b2a3  (e13a3) BCR-ABL1  Fusion Jihye Ha, M.D.1, June-Won Cheong, M.D.2, Saeam Shin, M.D.1, Seung-Tae Lee, M.D.1, and Jong Rak Choi, M.D.1 Departments of Laboratory Medicine1 and Internal Medicine2, Yonsei University College of Medicine, Seoul, Korea Dear Editor, CML is characterized by reciprocal t(9;22)(q34;q11) transloca - tion, which generates the BCR/ABL1 protein; that protein plays  a critical role in the pathogenesis of CML.",Non-OADS,/arxiv_data1/oa_pdf/61/1b/alm-36-287.PMC4773277.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/1b/alm-36-287.PMC4773277.pdf
CML with b2a3-type fusion 288  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.3.287 b2a3-type fusion CML seems to be sensitive to tyrosine kinase  inhibitor (TKI) therapy.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/alm-36-287.PMC4773277.pdf
"CML with b2a3-type fusion http://dx.doi.org/10.3343/alm.2016.36.3.287 www.annlabmed.org  289of the ABL1  gene, PCR using primers that bind to sequences in  the ABL1  exon 2 may fail to amplify target fusion transcripts.",Non-OADS,/arxiv_data1/oa_pdf/61/1b/alm-36-287.PMC4773277.pdf
]Available from ULR:http://www.iarc.fr/en/publications/books/sp161/index.php 4 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/63/48/TCA-7-238.PMC4773295.pdf
Available from URL:http://www.who.int/mediacent re/factsheets/fs297/en 18 World Health Organization (WHO).,Non-OADS,/arxiv_data1/oa_pdf/63/48/TCA-7-238.PMC4773295.pdf
Available from URL: http://www.scmp.com/news/china/article/1843735/chinas-ability-tackle-air-pollution-doubtful-says-vetern-us-policymakerB.,Non-OADS,/arxiv_data1/oa_pdf/63/48/TCA-7-238.PMC4773295.pdf
"abovementioned technique, which improves exposure to the left paratracheobronchial region with the use of the tractionof the proximal mesoesophagus, “mesoesophagus suspen-sion”(Video 1 Download link: http://c91.yunpan.360.cn/ ID:13365910827, Password: 83481010).",Non-OADS,/arxiv_data1/oa_pdf/30/17/TCA-7-199.PMC4773297.pdf
[Cited 14 July2013] Available from URL: http://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf.,Non-OADS,/arxiv_data1/oa_pdf/30/17/TCA-7-199.PMC4773297.pdf
Available fromURL: http://data.stats.gov.cn.,OADS,/arxiv_data1/oa_pdf/52/16/TCA-7-232.PMC4773307.pdf
"Available from URL:http://seer.cancer.gov/csr/1975_2011/; based on November2013 SEER data submission, posted to the SEER web site,April 2014.",OADS,/arxiv_data1/oa_pdf/52/16/TCA-7-232.PMC4773307.pdf
Available from URL:http://globocan.iarc.fr/factsheets/cancers/lung.asp.,Non-OADS,/arxiv_data1/oa_pdf/d3/ac/TCA-7-207.PMC4773308.pdf
"Available from URL:http://www.cancer.org/research/cancerfactsstatistics/cancerfactsﬁgures2015/.3 Molina JR, Y ang P, Cassivi SD, Schild SE, Adjei AA.",Non-OADS,/arxiv_data1/oa_pdf/d3/ac/TCA-7-207.PMC4773308.pdf
&2015 Published by Elsevier Inc. Speci ﬁcations Table Subject area Mechanical Engineering More speci ﬁc sub- ject areaMaterial Science/Mechanics of Composite MaterialsContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/dibData in Brief http://dx.doi.org/10.1016/j.dib.2015.09.054 2352-3409/ &2015 Published by Elsevier Inc.DOI of original article: http://dx.doi.org/10.1016/j.matdes.2015.07.127 nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/0a/7a/main.PMC4773369.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/7a/main.PMC4773369.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/9b/main.PMC4773379.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.02.008 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/9b/main.PMC4773379.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.amsu.2016.02.008 .,OADS,/arxiv_data1/oa_pdf/b7/9b/main.PMC4773379.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Klinefelter syndrome Brain activation Motor cortexAuditory cortex 1.,Non-OADS,/arxiv_data1/oa_pdf/15/d5/main.PMC4773384.pdf
http://dx.doi.org/10.1016/j.nicl.2016.02.002 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/15/d5/main.PMC4773384.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/d5/main.PMC4773384.pdf
"Procedure Stimuli were presented and responses obtained using Cogent 2000 (http://www.vislab.ucl.ac.uk/cogent_2000.php ), executed in MATLAB.",OADS,/arxiv_data1/oa_pdf/15/d5/main.PMC4773384.pdf
http://dx.doi.org/10.1016/j.nicl.2016.1001.1005 .,OADS,/arxiv_data1/oa_pdf/15/d5/main.PMC4773384.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: EmotionMotivation Depression AmygdalaNeurofeedbackReal-time fMRIEEG–fMRI Frontal EEG asymmetryApproachAvoidance 1.,Non-OADS,/arxiv_data1/oa_pdf/13/5f/main.PMC4773387.pdf
http://dx.doi.org/10.1016/j.nicl.2016.02.003 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/13/5f/main.PMC4773387.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/5f/main.PMC4773387.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/be/main.PMC4773392.pdf
"Steroidal ointments often contain propylene glycol (PG) as a solvent because corticosteroids are poorly soluble in white pet- rolatum, which is used as a base, and the solubilized concentration of steroids is often lower than the displayed concentration [1,3].I n addition to PG, non-ionic surfactants are added to such ointments to uniformly disperse PG within the white petrolatum base and increase the solubility of the steroids, although the amounts of PGand surfactants added seem to be small compared with those usedContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/rinphsResults in Pharma Sciences http://dx.doi.org/10.1016/j.rinphs.2016.02.001 2211-2863/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0c/be/main.PMC4773392.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: PG, propylene glycol; POE, polyoxyethylene; HLB, hydrophilic – lipophilic balance nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/0c/be/main.PMC4773392.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.01.011,Non-OADS,/arxiv_data1/oa_pdf/f8/0b/main.PMC4773451.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 3 2–141 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f8/0b/main.PMC4773451.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 3 2–141 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f8/0b/main.PMC4773451.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 3 2–141 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f8/0b/main.PMC4773451.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 3 2–141 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f8/0b/main.PMC4773451.pdf
"Genome- to-Genome Distance Calculator (GGDC) analysis was also performed using the GGDC Web server ( http://ggdc.dsmz.de )as previously reported [40,41] .",OADS,/arxiv_data1/oa_pdf/f8/0b/main.PMC4773451.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 3 2–141 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f8/0b/main.PMC4773451.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 3 2–141 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f8/0b/main.PMC4773451.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 3 2–141 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f8/0b/main.PMC4773451.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 3 2–141 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f8/0b/main.PMC4773451.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 3 2–141 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f8/0b/main.PMC4773451.pdf
" Annals of Surgical Treatment and Research 117pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.3.117 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Long-term results of oncoplastic breast surgery with  latissimus dorsi flap reconstruction: a pilot study of the objective cosmetic results and patient reported outcome Kyeong-Deok Kim*, Zisun Kim*, Jung Cheol Kuk, Jaehong Jeong, Kyu Sung Choi, Sung Mo Hur, Gui Ae Jeong,  Jun Chul Chung, Gyu Seok Cho, Eung Jin Shin, Hyung Chul Kim, Sang-Gue Kang1, Min Hyuk Lee2,   Cheol Wan Lim Department of Surgery, Soonchunhyang University Bucheon Hospital, Bucheon, 1Department of Plastic and Reconstructive  Surgery, Soonchunhyang University Seoul Hospital, Seoul, 2Department of Surgery, Soonchunhyang University Seoul Hospital,  Seoul, Korea INTRODUCTION The primary goal in the surgical management of breast  cancer is to achieve local control.",Non-OADS,/arxiv_data1/oa_pdf/b5/46/astr-90-117.PMC4773455.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/46/astr-90-117.PMC4773455.pdf
"124pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.3.124 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Validation of international consensus guideline 2012 for  intraductal papillary mucinous neoplasm of pancreas Dong Hyeon Han, Huisong Lee, Jin Young Park, Wooil Kwon, Jin Seok Heo, Seong Ho Choi, Dong Wook Choi Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea INTRODUCTION Noninflammatory cystic lesions of the pancreas are more  common than previously recognized and being diagnosed with  increasing frequency [1].",Non-OADS,/arxiv_data1/oa_pdf/7a/3b/astr-90-124.PMC4773456.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/3b/astr-90-124.PMC4773456.pdf
 Annals of Surgical Treatment and Research 131pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.3.131 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Incidental gallbladder cancer after routine  cholecystectomy: when should we suspect it preoperatively and what are predictors of patient survival?,Non-OADS,/arxiv_data1/oa_pdf/a4/e4/astr-90-131.PMC4773457.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/e4/astr-90-131.PMC4773457.pdf
" Annals of Surgical Treatment and Research 139pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.3.139 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Surgical treatment for hepatocellular carcinoma with bile  duct invasion Xu-guang Hu*, Wei Mao*, Sung Yeon Hong, Bong-Wan Kim, Wei-guang Xu, Hee-Jung Wang Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Ajou University School of Medicine, Suwon,  Korea INTRODUCTION Jaundice is present in 19% to 40% of patients with hepato - c ellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/ed/85/astr-90-139.PMC4773458.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/85/astr-90-139.PMC4773458.pdf
" Annals of Surgical Treatment and Research 147pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.3.147 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Intraoperative radiofrequency ablation for hepatocellular  carcinoma in 112 patients with cirrhosis: a surgeon's view Jung Yeon Lee, Young Hoon Kim, Young Hoon Roh, Kyung Bin Roh, Kwan Woo Kim, Sung Hwa Kang,   Yang Hyun Baek1, Sung Wook Lee1, Sang Young Han1, Hee Jin Kwon2, Jin Han Cho2 Departments of Surgery, 1Internal Medicine, and 2Radiology, Dong-A University College of Medicine, Pusan, Korea INTRODUCTION Hepatocellular carcinoma (HCC) commonly develops in pa - t ients with cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/de/c0/astr-90-147.PMC4773459.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/c0/astr-90-147.PMC4773459.pdf
" Annals of Surgical Treatment and Research 157pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.3.157 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Duodenal stump fistula after gastrectomy for gastric  cancer: risk factors, prevention, and management Hyun-June Paik*, Si-Hak Lee*, Chang-In Choi, Dae-Hwan Kim, Tae-Yong Jeon1, Dong-Heon Kim1,   Ung-Bae Jeon2, Cheol-Woong Choi3, Sun-Hwi Hwang Department of Surgery, Pusan National University Yangsan Hospital, Yangsan, 1Department of Surgery, Pusan National University  School of Medicine, Busan, Departments of 2Radiology and 3Internal Medicine, Pusan National University Yangsan Hospital,  Yangsan, Korea INTRODUCTION A duodenal stump fistula (DSF) forming after a gastrectomy  for gastric cancer is a life-threatening complication.",Non-OADS,/arxiv_data1/oa_pdf/98/6b/astr-90-157.PMC4773460.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/6b/astr-90-157.PMC4773460.pdf
"164pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.3.164 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE The feasibility of single-port laparoscopic appendectomy  using a solo approach: a comparative study Say-June Kim, Byung-Jo Choi, Wonjun Jeong, Sang Chul Lee Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea INTRODUCTION Solo surgery is a concept of an operation driven by a single  surgeon without human assistant(s).",Non-OADS,/arxiv_data1/oa_pdf/f7/43/astr-90-164.PMC4773461.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/43/astr-90-164.PMC4773461.pdf
" Annals of Surgical Treatment and Research 171pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.3.171 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Frequency of concomitant ischemic heart disease and  risk factor analysis for an early postoperative myocardial infarction after elective abdominal aortic aneurysm repair Seung Rim Han, Young-Wook Kim, Seon-Hee Heo, Shin-Young Woo, Yang Jin Park, Dong Ik Kim,   Jeonghoon Yang1, Seung-Hyuk Choi1, Duk-Kyung Kim1 Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine,  Seoul, 1Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine,  Seoul, Korea INTRODUCTION Ischemic heart disease (IHD) is prevalent in patients with  abdominal aortic aneurysm (AAA) and is known to be a major  cause of early and late death following elective AAA repair.",Non-OADS,/arxiv_data1/oa_pdf/8c/36/astr-90-171.PMC4773462.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/36/astr-90-171.PMC4773462.pdf
" Annals of Surgical Treatment and Research 179pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.3.179 Annals of Surgical Treatment and ResearchCASE REPORT Acute hyperammonemic encephalopathy after  5-fluorouracil based chemotherapy Hee Jung Yi, Kyung Sook Hong, Nara Moon, Soon Sup Chung, Ryung-Ah Lee, Kwang Ho Kim Department of Surgery, Ewha Womans University School of Medicine, Seoul, Korea INTRODUCTION Colon cancer is the second most common malignancy except  for the thyroid cancer in Korea is the one of the leading cause  of cancer related mortality.",Non-OADS,/arxiv_data1/oa_pdf/9a/ab/astr-90-179.PMC4773463.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/ab/astr-90-179.PMC4773463.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.01.013,Non-OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC4773480.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 4 2 –150 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC4773480.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 4 2 –150 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC4773480.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 4 2 –150 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC4773480.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 4 2 –150 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC4773480.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 4 2 –150 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC4773480.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 4 2 –150 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC4773480.pdf
The habitat of this microorganism is the human digestive tract.Acknowledgements The authors thank the Xegen Company ( http://www.xegen.fr/ ) for automating the genomic annotation process.,Non-OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC4773480.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 4 2 –150 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC4773480.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,1 4 2 –150 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC4773480.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/dibData in Brief http://dx.doi.org/10.1016/j.dib.2016.02.016 2352-3409/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/60/a7/main.PMC4773481.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/a7/main.PMC4773481.pdf
"Data source location1- Monash University; Australia 2- University of Oxford; United Kingdom 3- Spanish National Biotechnology Center; Spain 4- ETH-Zurich, Switzerland Data accessibility /C15Mass spectrometry discovery peptidomics data have been deposited to the ProteomeXchange Consortium ( http://proteomecentral.proteomexchange.",OADS,/arxiv_data1/oa_pdf/60/a7/main.PMC4773481.pdf
are described and available in Supplementary ﬁle 1 (see http://elifesciences.org/content/4/e07661/ DC8) and Source Code 1 (see http://elifesciences.org/content/4/e07661/DC9 ) of the original eLife paper [13].,OADS,/arxiv_data1/oa_pdf/60/a7/main.PMC4773481.pdf
Exact meaning of each parameter can be found in the following link: http://tools.proteomecenter.org/wiki/index.php?title ¼Software:SpectraST .,OADS,/arxiv_data1/oa_pdf/60/a7/main.PMC4773481.pdf
"Below are the command lines that were used to build the standardized HLA allele-speci ﬁc peptide spectral and assay libraries, which were deposited in the SWATHAtlas database ( http://www.swa thatlas.org/ ): /C15spectrast -cNSpecLib_celltype_allele_fdr_iRT -cICID-QTOF -cTReference_celltype_allele_fdr.txt -cP0.7 -c_IRTiRT.txt -c_IRR iprophet.pep.xml /C15A consensus library was then generated: spectrast -cNSpecLib_cons_celltype_allele_fdr_iRT -cICID-QTOF -cAC SpecLib_celltype_allele_fdr_iRT.splib /C15Optionally, HLA-allele speci ﬁc consensus libraries were merged: spectrast -cNSpecLib_cons_cellty- pe_alleles_fdr_iRT -cJU -cAC SpecLib_celltype_allele1_fdr_iRT.splib SpecLib_celltype_allele2_f- dr_iRT.splib SpecLib_celltype_allele3_fdr_iRT.splib SpecLib_celltype_allele4_fdr_iRT.splib /C15The script spectrast2tsv.py (msproteomicstools 0.2.2; https://pypi.python.org/pypi/msproteomic stools ) was then used to generate the HLA-allele speci ﬁc peptide assay library with the following recommended settings: spectrast2tsv.py -l 350,2000 -s b,y -x 1,2 -o 6 -n 6 -p 0.05 -d -e -w swaths.",OADS,/arxiv_data1/oa_pdf/60/a7/main.PMC4773481.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/a7/main.PMC4773481.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/40/main.PMC4773482.pdf
http://dx.doi.org/10.1016/j.ebcr.2015.10.001 2213-3232/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/40/main.PMC4773482.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/40/main.PMC4773482.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.01.003,Non-OADS,/arxiv_data1/oa_pdf/1d/36/main.PMC4773506.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,1–5 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/1d/36/main.PMC4773506.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,1–5 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/1d/36/main.PMC4773506.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,1–5 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/1d/36/main.PMC4773506.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,1–5 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/1d/36/main.PMC4773506.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: EEG Source priors Volumetric priorsBayesian model selectionInterictal spikesECDLORETA 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/main.PMC4773507.pdf
http://dx.doi.org/10.1016/j.nicl.2016.01.0172213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/main.PMC4773507.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/37/main.PMC4773507.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/30/main.PMC4773508.pdf
http://dx.doi.org/10.1016/j.nicl.2016.02.005 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/76/30/main.PMC4773508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/30/main.PMC4773508.pdf
"This dataset (denoted by CoRR-29) is obtainedfrom the Consortium for Reliability and Reproducibility (CoRR) data- base ( Zuo et al., 2014 ), speci ﬁcally the HNU dataset (Hangzhou Normal University) ( http://dx.doi.org/10.15387/fcp_indi.corr.hnu1 ).",OADS,/arxiv_data1/oa_pdf/76/30/main.PMC4773508.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/8b/main.PMC4773569.pdf
"However, the patientContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2016.02.002 2211-7539/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d1/8b/main.PMC4773569.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/8b/main.PMC4773569.pdf
Keywords Influenza; Live vaccine; Reassortants generation This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/7c/nihms762726.PMC4773654.pdf
"The  preferable method approved by WHO for seasonal LAIV seed viruses candidates  preparation is reassortment in eggs, due to intellectual property issues currently present for  reverse genetics generated LAIV vaccines, the production of such vaccines could be costly,  which is a concern for developing countries manufacturers ( http://www.who.int/phi/ Day1_Session3_PATH_Marks.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/33/7c/nihms762726.PMC4773654.pdf
The sequences of HA and NA genes were deposited in the  influenza sequence EpiFlu Database of GISAID ( http://platform.gisaid.org ).,OADS,/arxiv_data1/oa_pdf/33/7c/nihms762726.PMC4773654.pdf
All candidate vaccine  reassortants listed on WHO web site as recommended for use in the current influenza season  (http://www.who.int/influenza/vaccines/virus/en/ ) passed the two-way HI test.,Non-OADS,/arxiv_data1/oa_pdf/33/7c/nihms762726.PMC4773654.pdf
2 March 2016 207ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Shanghai diabetes scoring system,Non-OADS,/arxiv_data1/oa_pdf/57/b6/JDI-7-206.PMC4773660.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/57/b6/JDI-7-206.PMC4773660.pdf
2 March 2016 209ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Shanghai diabetes scoring system,Non-OADS,/arxiv_data1/oa_pdf/57/b6/JDI-7-206.PMC4773660.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/57/b6/JDI-7-206.PMC4773660.pdf
2 March 2016 211ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Shanghai diabetes scoring system,Non-OADS,/arxiv_data1/oa_pdf/57/b6/JDI-7-206.PMC4773660.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Ma http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
2 March 2016 141REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Genetics of diabetic complications,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Ma http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
2 March 2016 143REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Genetics of diabetic complications,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Ma http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
2 March 2016 145REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Genetics of diabetic complications,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Ma http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
2 March 2016 147REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Genetics of diabetic complications,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Ma http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
2 March 2016 149REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Genetics of diabetic complications,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Ma http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
2 March 2016 151REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Genetics of diabetic complications,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Ma http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
2 March 2016 153REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Genetics of diabetic complications,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
Available from: http://www.imi.europa.eu/content/summit.,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Ma http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/86/d0/JDI-7-139.PMC4773661.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/32/b8/JDI-7-241.PMC4773663.pdf
2 March 2016 243ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi HbA1c and arterial stiffness,Non-OADS,/arxiv_data1/oa_pdf/32/b8/JDI-7-241.PMC4773663.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/32/b8/JDI-7-241.PMC4773663.pdf
2 March 2016 245ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi HbA1c and arterial stiffness,Non-OADS,/arxiv_data1/oa_pdf/32/b8/JDI-7-241.PMC4773663.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/32/b8/JDI-7-241.PMC4773663.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/56/89/JDI-7-179.PMC4773664.pdf
2 March 2016 181ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi UCP2-/-mice on high-fat diet,Non-OADS,/arxiv_data1/oa_pdf/56/89/JDI-7-179.PMC4773664.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/56/89/JDI-7-179.PMC4773664.pdf
2 March 2016 183ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi UCP2-/-mice on high-fat diet,Non-OADS,/arxiv_data1/oa_pdf/56/89/JDI-7-179.PMC4773664.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/56/89/JDI-7-179.PMC4773664.pdf
2 March 2016 185ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi UCP2-/-mice on high-fat diet,Non-OADS,/arxiv_data1/oa_pdf/56/89/JDI-7-179.PMC4773664.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/56/89/JDI-7-179.PMC4773664.pdf
2 March 2016 187ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi UCP2-/-mice on high-fat diet,Non-OADS,/arxiv_data1/oa_pdf/56/89/JDI-7-179.PMC4773664.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/56/89/JDI-7-179.PMC4773664.pdf
2 March 2016 189ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi UCP2-/-mice on high-fat diet,Non-OADS,/arxiv_data1/oa_pdf/56/89/JDI-7-179.PMC4773664.pdf
2 March 2016 167COMMENTARY http://onlinelibrary.wiley.com/journal/jdi The effect of NOTCH inhibitor on L cell,Non-OADS,/arxiv_data1/oa_pdf/dd/ed/JDI-7-166.PMC4773665.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdCOMMENTARY Yamane and Inagaki http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/dd/ed/JDI-7-166.PMC4773665.pdf
2 March 2016 191ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi A2MG in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/76/2f/JDI-7-190.PMC4773666.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/76/2f/JDI-7-190.PMC4773666.pdf
2 March 2016 193ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi A2MG in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/76/2f/JDI-7-190.PMC4773666.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/76/2f/JDI-7-190.PMC4773666.pdf
2 March 2016 195ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi A2MG in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/76/2f/JDI-7-190.PMC4773666.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/76/2f/JDI-7-190.PMC4773666.pdf
2 March 2016 277CASE REPORT http://onlinelibrary.wiley.com/journal/jdi Fournier ’s gangrene,Non-OADS,/arxiv_data1/oa_pdf/c9/62/JDI-7-276.PMC4773667.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c9/62/JDI-7-276.PMC4773667.pdf
"2 March 2016 227ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi 25(OH)D 3, insulin resistance and b-cells",Non-OADS,/arxiv_data1/oa_pdf/61/b0/JDI-7-226.PMC4773668.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/61/b0/JDI-7-226.PMC4773668.pdf
"2 March 2016 229ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi 25(OH)D 3, insulin resistance and b-cells",Non-OADS,/arxiv_data1/oa_pdf/61/b0/JDI-7-226.PMC4773668.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/61/b0/JDI-7-226.PMC4773668.pdf
"2 March 2016 231ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi 25(OH)D 3, insulin resistance and b-cells",Non-OADS,/arxiv_data1/oa_pdf/61/b0/JDI-7-226.PMC4773668.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/61/b0/JDI-7-226.PMC4773668.pdf
theﬁrst drug in this class) through 6 June 2014 and that ‘glu- cose levels were only mildly elevated at less than 200 mg/dL insome reports ’(http://www.fda.gov/Drug s/DrugSafety/ucm4468 45.htm).,Non-OADS,/arxiv_data1/oa_pdf/77/5c/JDI-7-135.PMC4773669.pdf
"The information described is available on the foll owing websites (in Japanese): ipragliflozin, http://med2.astellas.jp /med/jp/basic/details /SGL/shihan- chosa/shchosa-sgl07.pdf; dapagliflozin, http ://med2.astrazeneca.co.jp/pr oduct/fxg_report201506.pdf and https://www.ononavi1717.jp/c ontents/pdf/dia- betes/forxiga/report12.pdf; tof ogliflozin, http://e-mr.sanofi.co.j p/di/information/apw_interim.pd f?date=201506220 94749 and http://w ww.kowa- souyaku.co.jp/file/1506se_dbt.pdf; luseoglif lozin; http://medical.n ikkeibp.co.jp/all/special2/lusefi/pdf/survey_lusg_01.pdf; canag liflozin, http://medical.mt- pharma.co.jp/intro /can/pdfs/sideeffect_1 50716.pdf; and empagliflo zin, http://www.bij-kusuri.jp/info rmation/jad_t_info_201507.pdf.",Non-OADS,/arxiv_data1/oa_pdf/77/5c/JDI-7-135.PMC4773669.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdEDITORIAL Ogawa and Sakaguchi http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/77/5c/JDI-7-135.PMC4773669.pdf
2 March 2016 137EDITORIAL http://onlinelibrary.wiley.com/journal/jdi Ogawa and Sakaguchi,Non-OADS,/arxiv_data1/oa_pdf/77/5c/JDI-7-135.PMC4773669.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdEDITORIAL Ogawa and Sakaguchi http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/77/5c/JDI-7-135.PMC4773669.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdCOMMENTARY Jung http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/4a/1a/JDI-7-169.PMC4773670.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/6e/7d/JDI-7-247.PMC4773671.pdf
2 March 2016 249ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Serum visfatin in women with GDM,Non-OADS,/arxiv_data1/oa_pdf/6e/7d/JDI-7-247.PMC4773671.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/6e/7d/JDI-7-247.PMC4773671.pdf
2 March 2016 251ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Serum visfatin in women with GDM,Non-OADS,/arxiv_data1/oa_pdf/6e/7d/JDI-7-247.PMC4773671.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/6e/7d/JDI-7-247.PMC4773671.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/0f/JDI-7-197.PMC4773672.pdf
2 March 2016 199ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Atherosclerotic factors and hs-CRP,Non-OADS,/arxiv_data1/oa_pdf/a3/0f/JDI-7-197.PMC4773672.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/0f/JDI-7-197.PMC4773672.pdf
2 March 2016 201ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Atherosclerotic factors and hs-CRP,Non-OADS,/arxiv_data1/oa_pdf/a3/0f/JDI-7-197.PMC4773672.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/0f/JDI-7-197.PMC4773672.pdf
2 March 2016 203ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Atherosclerotic factors and hs-CRP,Non-OADS,/arxiv_data1/oa_pdf/a3/0f/JDI-7-197.PMC4773672.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/0f/JDI-7-197.PMC4773672.pdf
2 March 2016 205ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Atherosclerotic factors and hs-CRP,Non-OADS,/arxiv_data1/oa_pdf/a3/0f/JDI-7-197.PMC4773672.pdf
2 March 2016 213ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Chemokine and diabetic complications,Non-OADS,/arxiv_data1/oa_pdf/c0/e2/JDI-7-212.PMC4773673.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c0/e2/JDI-7-212.PMC4773673.pdf
2 March 2016 215ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Chemokine and diabetic complications,Non-OADS,/arxiv_data1/oa_pdf/c0/e2/JDI-7-212.PMC4773673.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c0/e2/JDI-7-212.PMC4773673.pdf
2 March 2016 217ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Chemokine and diabetic complications,Non-OADS,/arxiv_data1/oa_pdf/c0/e2/JDI-7-212.PMC4773673.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c0/e2/JDI-7-212.PMC4773673.pdf
2 March 2016 271CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi PK/PD of IDeg in Japanese T1DM patients,Non-OADS,/arxiv_data1/oa_pdf/6c/a5/JDI-7-270.PMC4773674.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/6c/a5/JDI-7-270.PMC4773674.pdf
2 March 2016 273CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi PK/PD of IDeg in Japanese T1DM patients,Non-OADS,/arxiv_data1/oa_pdf/6c/a5/JDI-7-270.PMC4773674.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/6c/a5/JDI-7-270.PMC4773674.pdf
2 March 2016 275CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi PK/PD of IDeg in Japanese T1DM patients,Non-OADS,/arxiv_data1/oa_pdf/6c/a5/JDI-7-270.PMC4773674.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/32/5a/JDI-7-253.PMC4773675.pdf
2 March 2016 255CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combined repaglinide-sitagliptin therapy,Non-OADS,/arxiv_data1/oa_pdf/32/5a/JDI-7-253.PMC4773675.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/32/5a/JDI-7-253.PMC4773675.pdf
2 March 2016 257CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combined repaglinide-sitagliptin therapy,Non-OADS,/arxiv_data1/oa_pdf/32/5a/JDI-7-253.PMC4773675.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/32/5a/JDI-7-253.PMC4773675.pdf
2 March 2016 259CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combined repaglinide-sitagliptin therapy,Non-OADS,/arxiv_data1/oa_pdf/32/5a/JDI-7-253.PMC4773675.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/70/13/JDI-7-171.PMC4773676.pdf
2 March 2016 173ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Src regulates glucokinase activity,Non-OADS,/arxiv_data1/oa_pdf/70/13/JDI-7-171.PMC4773676.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/70/13/JDI-7-171.PMC4773676.pdf
2 March 2016 175ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Src regulates glucokinase activity,Non-OADS,/arxiv_data1/oa_pdf/70/13/JDI-7-171.PMC4773676.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/70/13/JDI-7-171.PMC4773676.pdf
2 March 2016 177ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Src regulates glucokinase activity,Non-OADS,/arxiv_data1/oa_pdf/70/13/JDI-7-171.PMC4773676.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/70/13/JDI-7-171.PMC4773676.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a6/e6/JDI-7-155.PMC4773678.pdf
2 March 2016 157REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Islet pathology in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/a6/e6/JDI-7-155.PMC4773678.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a6/e6/JDI-7-155.PMC4773678.pdf
2 March 2016 159REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Islet pathology in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/a6/e6/JDI-7-155.PMC4773678.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a6/e6/JDI-7-155.PMC4773678.pdf
2 March 2016 161REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Islet pathology in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/a6/e6/JDI-7-155.PMC4773678.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a6/e6/JDI-7-155.PMC4773678.pdf
2 March 2016 163REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Islet pathology in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/a6/e6/JDI-7-155.PMC4773678.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a6/e6/JDI-7-155.PMC4773678.pdf
2 March 2016 165REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Islet pathology in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/a6/e6/JDI-7-155.PMC4773678.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/1d/b2/JDI-7-233.PMC4773679.pdf
2 March 2016 235ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Sarcopenia in elderly-onset diabetes,Non-OADS,/arxiv_data1/oa_pdf/1d/b2/JDI-7-233.PMC4773679.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/1d/b2/JDI-7-233.PMC4773679.pdf
2 March 2016 237ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Sarcopenia in elderly-onset diabetes,Non-OADS,/arxiv_data1/oa_pdf/1d/b2/JDI-7-233.PMC4773679.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/1d/b2/JDI-7-233.PMC4773679.pdf
2 March 2016 239ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Sarcopenia in elderly-onset diabetes,Non-OADS,/arxiv_data1/oa_pdf/1d/b2/JDI-7-233.PMC4773679.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/1d/b2/JDI-7-233.PMC4773679.pdf
2 March 2016 261ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Antidiabetic prescription by specialists,Non-OADS,/arxiv_data1/oa_pdf/12/6b/JDI-7-260.PMC4773680.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/12/6b/JDI-7-260.PMC4773680.pdf
2 March 2016 263ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Antidiabetic prescription by specialists,Non-OADS,/arxiv_data1/oa_pdf/12/6b/JDI-7-260.PMC4773680.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/12/6b/JDI-7-260.PMC4773680.pdf
2 March 2016 265ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Antidiabetic prescription by specialists,Non-OADS,/arxiv_data1/oa_pdf/12/6b/JDI-7-260.PMC4773680.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/12/6b/JDI-7-260.PMC4773680.pdf
2 March 2016 267ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Antidiabetic prescription by specialists,Non-OADS,/arxiv_data1/oa_pdf/12/6b/JDI-7-260.PMC4773680.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/12/6b/JDI-7-260.PMC4773680.pdf
2 March 2016 269ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Antidiabetic prescription by specialists,Non-OADS,/arxiv_data1/oa_pdf/12/6b/JDI-7-260.PMC4773680.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a9/2e/JDI-7-219.PMC4773681.pdf
2 March 2016 221ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Diabetes mellitus and fasting incretins,Non-OADS,/arxiv_data1/oa_pdf/a9/2e/JDI-7-219.PMC4773681.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a9/2e/JDI-7-219.PMC4773681.pdf
2 March 2016 223ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Diabetes mellitus and fasting incretins,Non-OADS,/arxiv_data1/oa_pdf/a9/2e/JDI-7-219.PMC4773681.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a9/2e/JDI-7-219.PMC4773681.pdf
2 March 2016 225ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Diabetes mellitus and fasting incretins,Non-OADS,/arxiv_data1/oa_pdf/a9/2e/JDI-7-219.PMC4773681.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:260-266 http://dx.doi.org/10.3904/kjim.2014.077INTRODUCTION A colonoscopy is uncomfortable for the patient because  of its long duration and the use of a larger-diameter en -doscope that is routinely used for upper gastrointestinal  endoscopy [1].",Non-OADS,/arxiv_data1/oa_pdf/c4/58/kjim-2014-077.PMC4773707.pdf
The effects of BIS monitoring in moderate sedative colonoscopy www.kjim.org http://dx.doi.org/10.3904/kjim.2014.077patient tolerance and compliance during the colonos - copy procedure [2].,Non-OADS,/arxiv_data1/oa_pdf/c4/58/kjim-2014-077.PMC4773707.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.077oxygen saturation was < 80% for > 15 seconds with oxy - gen supplementation.",Non-OADS,/arxiv_data1/oa_pdf/c4/58/kjim-2014-077.PMC4773707.pdf
The effects of BIS monitoring in moderate sedative colonoscopy www.kjim.org http://dx.doi.org/10.3904/kjim.2014.077Propofol titration dose and BIS value The mean BIS value throughout the procedure (from  insertion to removal of the endoscope) was 74.3 ± 6.7 for  all 141 patients in the BIS group.,Non-OADS,/arxiv_data1/oa_pdf/c4/58/kjim-2014-077.PMC4773707.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.077ing endoscopy, no significant differences in propofol  dose or recovery time were found between the BIS and  MOAA/S groups [ 5,6].",Non-OADS,/arxiv_data1/oa_pdf/c4/58/kjim-2014-077.PMC4773707.pdf
The effects of BIS monitoring in moderate sedative colonoscopy www.kjim.org http://dx.doi.org/10.3904/kjim.2014.077the cost of nonsedative colonoscopy [20].,Non-OADS,/arxiv_data1/oa_pdf/c4/58/kjim-2014-077.PMC4773707.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.077ture on bispectral index and plasma beta-endorphin  in patients undergoing colonoscopy.",Non-OADS,/arxiv_data1/oa_pdf/c4/58/kjim-2014-077.PMC4773707.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:305-312 http://dx.doi.org/10.3904/kjim.2014.1221Division of Pulmonary, Allergy  and Critical Care Medicine, Hallym  University Kangdong Sacred  Heart Hospital and Lung Research  Institute, Hallym University College  of Medicine, Seoul; 2Division  of Pulmonary and Critical Care  Medicine, Department of Internal  Medicine and Lung Institute,  Seoul National University College  of Medicine, Seoul; 3Division  of Pulmonary and Critical Care  Medicine, Department of Internal  Medicine, Chung-Ang University  College of Medicine, Seoul; 4Division  of Pulmonary Medicine, Samsung  Medical Center, Sungkyunkwan  University School of Medicine, Seoul;  5Department of Pulmonary and  Critical Care Medicine, Asan Medical  Center, University of Ulsan College  of Medicine, Seoul; 6Department  of Internal Medicine, Hanyang  University College of Medicine,  Seoul; 7Department of Internal  Medicine, College of Medicine,  St. Paul’s Hospital, The Catholic  University of Korea, Seoul, Korea  Received : April 30, 2014 Revised : August 4, 2014 Accepted : April 28, 2015Correspondence to Yong Bum Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/df/39/kjim-2014-122.PMC4773708.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.122INTRODUCTION Chronic thromboembolic pulmonary hypertension  (CTEPH) is one of the leading causes of severe pulmo - nary hypertension (PH) and is associated with consider - able mortality [1].",Non-OADS,/arxiv_data1/oa_pdf/df/39/kjim-2014-122.PMC4773708.pdf
"Epidemiology of CTEPH in Korea www.kjim.org http://dx.doi.org/10.3904/kjim.2014.122The diagnosis of CTEPH was also established by trans - thoracic and transesophageal echocardiography using  Doppler, pulmonary function tests including diffu - sion capacity for carbon monoxide (DLCO), right heart  catheterization, pulmonary angiography, and a ventila - tion-perfusion lung scan.",Non-OADS,/arxiv_data1/oa_pdf/df/39/kjim-2014-122.PMC4773708.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.122Table 2.",Non-OADS,/arxiv_data1/oa_pdf/df/39/kjim-2014-122.PMC4773708.pdf
"Epidemiology of CTEPH in Korea www.kjim.org http://dx.doi.org/10.3904/kjim.2014.122distal: 105 patients (78.4%) belonged to the proximal  CTEPH group, while 29 (21.6%) belonged to the dis - tal CTEPH group.",Non-OADS,/arxiv_data1/oa_pdf/df/39/kjim-2014-122.PMC4773708.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.122DISCUSSION This was the first national study of Korean patients with  CTEPH.",Non-OADS,/arxiv_data1/oa_pdf/df/39/kjim-2014-122.PMC4773708.pdf
Epidemiology of CTEPH in Korea www.kjim.org http://dx.doi.org/10.3904/kjim.2014.122sults with a worldwide in-hospital mortality rate of 4.4%  to 10% [25].,Non-OADS,/arxiv_data1/oa_pdf/df/39/kjim-2014-122.PMC4773708.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.122bolic pulmonary hypertension.",Non-OADS,/arxiv_data1/oa_pdf/df/39/kjim-2014-122.PMC4773708.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:288-295 http://dx.doi.org/10.3904/kjim.2014.152INTRODUCTION Liver cirrhosis (LC) is a major health problem world - wide, and cirrhotic patients are subject to critical events  leading to Intensive Care Unit (ICU) admission.",Non-OADS,/arxiv_data1/oa_pdf/07/99/kjim-2014-152.PMC4773709.pdf
Bleeding complications in LC www.kjim.org http://dx.doi.org/10.3904/kjim.2014.152venous thromboembolism (VTE) prophylaxis in critical - ly ill patients with LC [6-8].,Non-OADS,/arxiv_data1/oa_pdf/07/99/kjim-2014-152.PMC4773709.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.152etiologic agent, accounting for the majority of LC cas - es (112/205, 54.6%), followed by alcohol and hepatitis C,  accounting for 33 cases (16.1%) and 29 cases (14.1%), re - spectively.",Non-OADS,/arxiv_data1/oa_pdf/07/99/kjim-2014-152.PMC4773709.pdf
"Bleeding complications in LC www.kjim.org http://dx.doi.org/10.3904/kjim.2014.152Three patients (3/25, 12.0%) with bilateral pupil dila - tation and an absence of light reflexes were diagnosed  with intracranial bleeding by brain CT. All of these pa - tients had intracerebral hemorrhages.",Non-OADS,/arxiv_data1/oa_pdf/07/99/kjim-2014-152.PMC4773709.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.152Table 3.",Non-OADS,/arxiv_data1/oa_pdf/07/99/kjim-2014-152.PMC4773709.pdf
"Bleeding complications in LC www.kjim.org http://dx.doi.org/10.3904/kjim.2014.152common site of bleeding was gastrointestinal (16/25,  64.0%).",Non-OADS,/arxiv_data1/oa_pdf/07/99/kjim-2014-152.PMC4773709.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.152There are limitations associated with our study.",Non-OADS,/arxiv_data1/oa_pdf/07/99/kjim-2014-152.PMC4773709.pdf
Bleeding complications in LC www.kjim.org http://dx.doi.org/10.3904/kjim.2014.152liver disease.,Non-OADS,/arxiv_data1/oa_pdf/07/99/kjim-2014-152.PMC4773709.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:253-259 http://dx.doi.org/10.3904/kjim.2014.182INTRODUCTION The incidence of synchronous second primary cancers  (SPC) in patients with squamous esophageal cancer (EC) is reported to be 5% to 10% [1-4].",Non-OADS,/arxiv_data1/oa_pdf/0a/d2/kjim-2014-182.PMC4773710.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.182from exposure to common carcinogenic agents such as  tobacco smoke [5,6].",Non-OADS,/arxiv_data1/oa_pdf/0a/d2/kjim-2014-182.PMC4773710.pdf
Synchronous cancers in esophageal cancer www.kjim.org http://dx.doi.org/10.3904/kjim.2014.182to 70) and 95.0% of the patients were male (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/0a/d2/kjim-2014-182.PMC4773710.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.182tients (38.1%): pancreatobiliary cancer (five patients), co - lon cancer (two patients), and hepatocellular cancer (one  patient).",Non-OADS,/arxiv_data1/oa_pdf/0a/d2/kjim-2014-182.PMC4773710.pdf
Synchronous cancers in esophageal cancer www.kjim.org http://dx.doi.org/10.3904/kjim.2014.182Table 3.,Non-OADS,/arxiv_data1/oa_pdf/0a/d2/kjim-2014-182.PMC4773710.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.182it was found that approximately one-third of SPC were  detected in the first six months after diagnosis of squa - mous EC [5].",OADS,/arxiv_data1/oa_pdf/0a/d2/kjim-2014-182.PMC4773710.pdf
Synchronous cancers in esophageal cancer www.kjim.org http://dx.doi.org/10.3904/kjim.2014.182Conflict of interest No potential conflict of interest relevant to this article  was reported.,Non-OADS,/arxiv_data1/oa_pdf/0a/d2/kjim-2014-182.PMC4773710.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:296-304 http://dx.doi.org/10.3904/kjim.2014.256INTRODUCTION The incidence of nursing home-acquired pneumonia  (NHAP) is increasing, and it is now the leading cause of  death among nursing home residents in Korea [1].",Non-OADS,/arxiv_data1/oa_pdf/27/aa/kjim-2014-256.PMC4773711.pdf
"Facility characteristics in NHAP prognosis www.kjim.org http://dx.doi.org/10.3904/kjim.2014.256site are associated with decreased hospitalization rates  in acute care centers [7,8], few studies have examined  outcomes after hospitalization.",Non-OADS,/arxiv_data1/oa_pdf/27/aa/kjim-2014-256.PMC4773711.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.256The Kaplan-Meier method was used to compare 90- day mortality among the three groups, and mortality  rates were assessed by log-rank test.",OADS,/arxiv_data1/oa_pdf/27/aa/kjim-2014-256.PMC4773711.pdf
"Facility characteristics in NHAP prognosis www.kjim.org http://dx.doi.org/10.3904/kjim.2014.256urea, respira tory rate and blood pressure) scores ≥ 3  points and pneumonia severity index (PSI) scores > 130  (class 5).",Non-OADS,/arxiv_data1/oa_pdf/27/aa/kjim-2014-256.PMC4773711.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.256Table 2.",Non-OADS,/arxiv_data1/oa_pdf/27/aa/kjim-2014-256.PMC4773711.pdf
Facility characteristics in NHAP prognosis www.kjim.org http://dx.doi.org/10.3904/kjim.2014.256risk factors for mortality.,Non-OADS,/arxiv_data1/oa_pdf/27/aa/kjim-2014-256.PMC4773711.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.256chronic kidney diseases (adjusted odds ratio [OR], 4.30;  95% CI, 1.08 to 17.05;  p = 0.038) and bed-ridden status  (adjusted OR, 6.68; 95% CI, 2.74 to 16.26; p < 0.001) were  significantly associated with DRP infection.",Non-OADS,/arxiv_data1/oa_pdf/27/aa/kjim-2014-256.PMC4773711.pdf
Facility characteristics in NHAP prognosis www.kjim.org http://dx.doi.org/10.3904/kjim.2014.256ations with mortality.,Non-OADS,/arxiv_data1/oa_pdf/27/aa/kjim-2014-256.PMC4773711.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.256homes as acute care providers: a pilot study of incentives  to reduce hospitalizations.",Non-OADS,/arxiv_data1/oa_pdf/27/aa/kjim-2014-256.PMC4773711.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:335-343 http://dx.doi.org/10.3904/kjim.2014.2661Division of Nephrology, Department  of Internal Medicine, Konkuk University  Medical Center, Seoul; 2BK-21, Konkuk  University School of Medicine, Seoul;  3Division of Nephrology, Department  of Internal Medicine, Kyung Hee  University Hospital at Gangdong,  Seoul; 4Division of Nephrology,  Department of Internal Medicine,  Hanyang University Guri Hospital, Guri;  5Division of Nephrology, Department  of Internal Medicine, CHA Bundang  Medical Center, CHA University,  Seongnam; 6Division of Nephrology,  Department of Internal Medicine,  Gangnam Severance Hospital, Yonsei  University College of Medicine, Seoul;  7Department of Pathology, Konkuk  University Medical Center, Seoul;  8Department of Pathology, 9Division  of Nephrology, Department of Internal  Medicine, National Health Insurance  Corporation Ilsan Hospital, Goyang,  Korea  Received : September  2, 2014 Revised : September  30, 2014 Accepted : October  20, 2014 Correspondence to Sug-Kyun Shin, M.D.",Non-OADS,/arxiv_data1/oa_pdf/86/2b/kjim-2014-266.PMC4773712.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.266INTRODUCTION Immunoglobulin A nephropathy (IgAN), the most prev - alent primary glomerular disease worldwide, is an im - portant cause of end-stage renal disease (ESRD) [1].",Non-OADS,/arxiv_data1/oa_pdf/86/2b/kjim-2014-266.PMC4773712.pdf
Low dose valsartan in IgA nephropathy www.kjim.org http://dx.doi.org/10.3904/kjim.2014.266of enrollment) with ACE-I or ARB.,Non-OADS,/arxiv_data1/oa_pdf/86/2b/kjim-2014-266.PMC4773712.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.266reduction in UPCR ( p < 0.001).",OADS,/arxiv_data1/oa_pdf/86/2b/kjim-2014-266.PMC4773712.pdf
"Low dose valsartan in IgA nephropathy www.kjim.org http://dx.doi.org/10.3904/kjim.2014.266Effects on blood pressure and other parameters  BP in the low-dose group did not change significant - ly in the 24-week period, with the exception of week 8  (systolic BP/diastolic BP, 121.8 ± 12.7 mmHg/74.9 ± 10.1  mmHg at baseline; 115.6 ± 11.1 mmHg/68.9 ± 10.4 mmHg  at week 8, p < 0.05) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/86/2b/kjim-2014-266.PMC4773712.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.266come when time-averaged urinary protein excretion was  reduced to less than 1.0 g/day.",OADS,/arxiv_data1/oa_pdf/86/2b/kjim-2014-266.PMC4773712.pdf
Low dose valsartan in IgA nephropathy www.kjim.org http://dx.doi.org/10.3904/kjim.2014.266risk of progression of kidney disease during antihyper - tensive therapy with or without ACE-I in patients with  nondiabetic kidney disease [14].,Non-OADS,/arxiv_data1/oa_pdf/86/2b/kjim-2014-266.PMC4773712.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.266Conflict of interest No potential conflict of interest relevant to this article  was reported.",Non-OADS,/arxiv_data1/oa_pdf/86/2b/kjim-2014-266.PMC4773712.pdf
Low dose valsartan in IgA nephropathy www.kjim.org http://dx.doi.org/10.3904/kjim.2014.266E.,Non-OADS,/arxiv_data1/oa_pdf/86/2b/kjim-2014-266.PMC4773712.pdf
Available from: http://www.uptodate.com/.,Non-OADS,/arxiv_data1/oa_pdf/86/2b/kjim-2014-266.PMC4773712.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:267-276 http://dx.doi.org/10.3904/kjim.2014.268INTRODUCTION The use of angiotensin-converting enzyme inhibitors  (ACEIs) is known to reduce myocardial infarction (MI)  size and the risk for subsequent acute myocardial infarc - tion (AMI), and to improve survival in post-MI patients  with congestive heart failure and asymptomatic left ven -tricular (LV) systolic dysfunction [1-3].",Non-OADS,/arxiv_data1/oa_pdf/e4/62/kjim-2014-268.PMC4773713.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.268Angiotensin II type 1 receptor blockers (ARBs) also in - hibit the renin-angiotensin system (RAS), in a manner  that is different than ACEIs, via selective inhibition of  the angiotensin II type 1 receptor [7].",Non-OADS,/arxiv_data1/oa_pdf/e4/62/kjim-2014-268.PMC4773713.pdf
"RAS inhibition after myocardial infarction www.kjim.org http://dx.doi.org/10.3904/kjim.2014.268RESULTS Baseline characteristics and use of medications before  and after PS matching are shown in Tables 1 and 2, re - spectively.",Non-OADS,/arxiv_data1/oa_pdf/e4/62/kjim-2014-268.PMC4773713.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.2680.684; 95% CI, 0.467 to 1.002; p = 0.051).",OADS,/arxiv_data1/oa_pdf/e4/62/kjim-2014-268.PMC4773713.pdf
RAS inhibition after myocardial infarction www.kjim.org http://dx.doi.org/10.3904/kjim.2014.268Table 1.,Non-OADS,/arxiv_data1/oa_pdf/e4/62/kjim-2014-268.PMC4773713.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.268this study suggests that it would be worth conducting  RCTs to compare ARBs and ACEIs as first choice RAS  blockades in AMI patients without heart failure and/or  LV dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/e4/62/kjim-2014-268.PMC4773713.pdf
"RAS inhibition after myocardial infarction www.kjim.org http://dx.doi.org/10.3904/kjim.2014.268compared with those who received pre-randomization  ACEIs in VALIANT have not yet been published [9,10].",Non-OADS,/arxiv_data1/oa_pdf/e4/62/kjim-2014-268.PMC4773713.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.268ACEIs or ARBs after the onset of MI were not obtained  from the patients or their physicians.",Non-OADS,/arxiv_data1/oa_pdf/e4/62/kjim-2014-268.PMC4773713.pdf
"RAS inhibition after myocardial infarction www.kjim.org http://dx.doi.org/10.3904/kjim.2014.268Seung, Kyoo-Rok Han, Kyoung-Tae Jeong, Moo-Hyun  Kim, Myeong-Chan Cho, Myung-Ho Jeong, Myoung- Yong Lee, Nae-Hee Lee, Seok-Kyu Oh, Seong-Wook  Park, Seong-Woon Rha, Seung-Ho Hur, Seung-Jae Joo,  Seung-Jea Tahk, Seung-Jung Park, Shung-Chull Chae,  Soo-Joong Kim, Tae-Hoon Ahn, Taek-Jong Hong,  Yang-Soo Jang, Young-Jo Kim, Young-Keun Ahn,  Young-Youp Koh, and Wook-Sung Chung.",Non-OADS,/arxiv_data1/oa_pdf/e4/62/kjim-2014-268.PMC4773713.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.26818.",Non-OADS,/arxiv_data1/oa_pdf/e4/62/kjim-2014-268.PMC4773713.pdf
"LETTER TO THE EDITOR pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:399-402 http://dx.doi.org/10.3904/kjim.2014.283 Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Departments of 1Internal Medicine,  2Pathology, and 3Surgery, College of  Medicine, The Catholic University of  Korea, Seoul, Korea Painful immunoglobulin G4-related thyroiditis  treated by total thyroidectomy Ihn Suk Lee1, Jung Uee Lee2, Kwan-Ju Lee3, Yi Sun Jang1, Jong Min Lee1, and Hye Soo Kim1 Received : September  17, 2014 Revised : December 1, 2014 Accepted : December 15, 2014 Correspondence to Hye Soo Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/3a/3a/kjim-2014-283.PMC4773714.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.283and her white blood cell count and erythrocyte sedimen - tation rate were 10,100/mm3 and 18 mm/hr, respectively.",OADS,/arxiv_data1/oa_pdf/3a/3a/kjim-2014-283.PMC4773714.pdf
"Painful IgG4-related thyroiditis http://dx.doi.org/10.3904/kjim.2014.283onset, lower female to male ratio, more rapid and ag - gressive disease course, and higher levels of circulating  thyroid autoantibodies compared with non-IgG4-related  thyroiditis [1].",Non-OADS,/arxiv_data1/oa_pdf/3a/3a/kjim-2014-283.PMC4773714.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.283immunoglobulin G subclasses of anti-thyroid peroxi - dase antibody in sera from patients with Hashimoto’s  thyroiditis with different thyroid functional status.",Non-OADS,/arxiv_data1/oa_pdf/3a/3a/kjim-2014-283.PMC4773714.pdf
"LETTER TO THE EDITOR Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:392-395 http://dx.doi.org/10.3904/kjim.2014.338Departments of 1Internal Medicine,  2Surgery, and 3Pathology,  Wonkwang University Hospital,  Iksan, KoreaLarge Brunner’s gland hamartoma with annular  stricture causing gastric outlet obstruction  In Tae Hwang1, Young Bum Cho1, Dong Eun Park2, Keum Ha Choi3, and Tae Hyeon Kim1 Received : November  4, 2014 Revised : May  17, 2015 Accepted : May  26, 2015 Correspondence to Tae Hyeon Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/e6/d8/kjim-2014-338.PMC4773715.pdf
"Large Brunner’s gland hamartoma http://dx.doi.org/10.3904/kjim.2014.338During this episode, the patient complained of further  aggravation of his symptoms.",Non-OADS,/arxiv_data1/oa_pdf/e6/d8/kjim-2014-338.PMC4773715.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.338cretion of pepsinogen, urogastrone, and alkaline-based  mucus in response to the acidic gastric contents passed  from the stomach, to protect the duodenal mucosa.",Non-OADS,/arxiv_data1/oa_pdf/e6/d8/kjim-2014-338.PMC4773715.pdf
Large Brunner’s gland hamartoma http://dx.doi.org/10.3904/kjim.2014.338by histopathological examination.,Non-OADS,/arxiv_data1/oa_pdf/e6/d8/kjim-2014-338.PMC4773715.pdf
"LETTER TO THE EDITOR Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:406-408 http://dx.doi.org/10.3904/kjim.2014.3531Division of Hematology/Oncology,  Department of Internal Medicine,  2Department of Laboratory  Medicine, Inje University Busan Paik  Hospital, Busan, KoreaMixed-phenotype acute leukemia treated with  decitabine Ji-Young Lee1, Sang-min Lee1, Ja-Young Lee2, Ki-Hyang Kim1, Moon-Young Choi1, and Won-Sik Lee1 Received : November 18, 2014 Revised : March 5, 2015 Accepted : April 4, 2015 Correspondence to  Won-Sik Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/36/35/kjim-2014-353.PMC4773716.pdf
"Mixed-phenotype acute leukemia treated with decitabine http://dx.doi.org/10.3904/kjim.2014.353formance status, which was characterized by general  overall weakness.",Non-OADS,/arxiv_data1/oa_pdf/36/35/kjim-2014-353.PMC4773716.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.353dysplastic syndrome and AML in older patients.",Non-OADS,/arxiv_data1/oa_pdf/36/35/kjim-2014-353.PMC4773716.pdf
"LETTER TO THE EDITOR Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:403-405 http://dx.doi.org/10.3904/kjim.2014.3551Division of Nephrology,  Department of Internal Medicine,  Presbyterian Medical Center, Jeonju;  2Department of Pathology, College  of Medicine, Seoul St. Mary’s  Hospital, The Catholic University of  Korea, Seoul, Korea Microscopic polyangiitis with crescentic   glomerulonephritis initially presenting as acute  pancreatitis A Young Cho1, Byeong Gwan Kim1, Sang Sun Kim1, Seong Hee Lee1, Hong Shik Shin1, Yeong Jin Choi2,  and In O Sun1 Received : November  20, 2014 Revised : December 19, 2014 Accepted : February 17, 2015 Correspondence to In O Sun, M.D.",Non-OADS,/arxiv_data1/oa_pdf/5c/14/kjim-2014-355.PMC4773717.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.355complement C3 and C4 levels were 0.78 g/L (normal, 0.76  to 1.39) and 0.14 g/L (normal, 0.12 to 0.37), respectively.",OADS,/arxiv_data1/oa_pdf/5c/14/kjim-2014-355.PMC4773717.pdf
MPA with acute pancreatitis http://dx.doi.org/10.3904/kjim.2014.355tis in patients with MPA have been reported.,Non-OADS,/arxiv_data1/oa_pdf/5c/14/kjim-2014-355.PMC4773717.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:313-322 http://dx.doi.org/10.3904/kjim.2014.363INTRODUCTION Recently, there has been a marked increase in the inci - dence of small-sized thyroid cancer [1-3], and an accurate  determination of the necessary extent of surgery has be - come a matter of concern.",Non-OADS,/arxiv_data1/oa_pdf/89/49/kjim-2014-363.PMC4773718.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.363the absence of extrathyroidal extension [4,5].",Non-OADS,/arxiv_data1/oa_pdf/89/49/kjim-2014-363.PMC4773718.pdf
Extrathyroid extension on three-dimensional ultrasonography www.kjim.org http://dx.doi.org/10.3904/kjim.2014.363TUI-rendered 3D US images to determine the contact  and protrusion of the nodules.,OADS,/arxiv_data1/oa_pdf/89/49/kjim-2014-363.PMC4773718.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.363RESULTS  The demographic and clinicopathological characteris - tics of the 61 patients included in this study are present - ed (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/89/49/kjim-2014-363.PMC4773718.pdf
Extrathyroid extension on three-dimensional ultrasonography www.kjim.org http://dx.doi.org/10.3904/kjim.2014.363t test ( p = 0.483).,Non-OADS,/arxiv_data1/oa_pdf/89/49/kjim-2014-363.PMC4773718.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.363Subgroup analyses of micropapillary thyroid carci - nomas The present study identified 55 micropapillary thyroid  carcinomas (78.6%) among the patients, and extrathyroi - dal extension was present in 12 cases (21.8%).",Non-OADS,/arxiv_data1/oa_pdf/89/49/kjim-2014-363.PMC4773718.pdf
"Extrathyroid extension on three-dimensional ultrasonography www.kjim.org http://dx.doi.org/10.3904/kjim.2014.363DISCUSSION  The preoperative staging of thyroid cancer is important  in order in determining the extent of surgery required  [4,5], especially in the case of small-sized thyroid cancer.",Non-OADS,/arxiv_data1/oa_pdf/89/49/kjim-2014-363.PMC4773718.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.363tension on both the 2D and 3D findings.",Non-OADS,/arxiv_data1/oa_pdf/89/49/kjim-2014-363.PMC4773718.pdf
Extrathyroid extension on three-dimensional ultrasonography www.kjim.org http://dx.doi.org/10.3904/kjim.2014.363the assessment of thyroid cancer as well [20].,Non-OADS,/arxiv_data1/oa_pdf/89/49/kjim-2014-363.PMC4773718.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.363graphic tumor characteristics as a predictive factor of  tumor stage in papillary thyroid carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/89/49/kjim-2014-363.PMC4773718.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:375-385 http://dx.doi.org/10.3904/kjim.2014.390INTRODUCTION Asthma is a chronic airway inflammatory disease char - acterized by airflow obstruction and bronchial hyperre - sponsiveness [ 1,2].",Non-OADS,/arxiv_data1/oa_pdf/1a/ed/kjim-2014-390.PMC4773719.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.390endotypes [ 6].",OADS,/arxiv_data1/oa_pdf/1a/ed/kjim-2014-390.PMC4773719.pdf
ATG gene polymorphisms in asthma www.kjim.org http://dx.doi.org/10.3904/kjim.2014.390The reaction was stopped by added phosphate buffer  saline (PBS) in a volume equal to the sputum plus DTT  solution.,Non-OADS,/arxiv_data1/oa_pdf/1a/ed/kjim-2014-390.PMC4773719.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.390and the 5’ ends contain 15-16 bases homologous to each  end of the linear pGL3-basic vector (Promega, Madison,  WI, USA).",OADS,/arxiv_data1/oa_pdf/1a/ed/kjim-2014-390.PMC4773719.pdf
"ATG gene polymorphisms in asthma www.kjim.org http://dx.doi.org/10.3904/kjim.2014.390gistic regression analysis with codominant, dominant  and recessive models after accounting for age and sex  as covariates.",Non-OADS,/arxiv_data1/oa_pdf/1a/ed/kjim-2014-390.PMC4773719.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.390noted according to severity of asthma (Tables 6 and 7).",Non-OADS,/arxiv_data1/oa_pdf/1a/ed/kjim-2014-390.PMC4773719.pdf
"ATG gene polymorphisms in asthma www.kjim.org http://dx.doi.org/10.3904/kjim.2014.390matics carrying CC/CT genotype at ATG 5 8830C>T had  significantly lower FEV1% predicted values compared  to the carriers of TT genotype (83.3% ± 22.1% vs. 92.3%  ± 19.2%, p = 0.021).",Non-OADS,/arxiv_data1/oa_pdf/1a/ed/kjim-2014-390.PMC4773719.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.390[AC] haplotype had a significantly higher sputum neu - trophil count compared to non-carriers (58.9% ± 33.6%  vs. 39.6% ± 35.5%, p = 0.037); while asthmatic carriers of  HT3 [GC] haplotype had a slightly but significantly low - er sputum neutrophil count compared to non-carriers  (43.5% ± 35.1% vs. 60.1% ± 33.6%, p = 0.049).",Non-OADS,/arxiv_data1/oa_pdf/1a/ed/kjim-2014-390.PMC4773719.pdf
"ATG gene polymorphisms in asthma www.kjim.org http://dx.doi.org/10.3904/kjim.2014.390but not ATG 7, polymorphisms with asthma susceptibil - ity and lung function [ 13,14].",Non-OADS,/arxiv_data1/oa_pdf/1a/ed/kjim-2014-390.PMC4773719.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2014.390volved in inflammatory and immune responses [ 10,26- 28].",Non-OADS,/arxiv_data1/oa_pdf/1a/ed/kjim-2014-390.PMC4773719.pdf
ATG gene polymorphisms in asthma www.kjim.org http://dx.doi.org/10.3904/kjim.2014.390nol 2011;127:1267-1276.e6.,Non-OADS,/arxiv_data1/oa_pdf/1a/ed/kjim-2014-390.PMC4773719.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:323-334 http://dx.doi.org/10.3904/kjim.2015.004INTRODUCTION Toll-like receptors (TLRs) recognize endogenous dan - ger molecules such as hyaluronan fragments that have  been altered from their native state or accumulated in  non-physiologic sites or amounts during cellular injury [1-5].",Non-OADS,/arxiv_data1/oa_pdf/d2/09/kjim-2015-004.PMC4773720.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.004[10] reported that unilateral ureteral obstruction (UUO)  increases renal expression of TLR2.",Non-OADS,/arxiv_data1/oa_pdf/d2/09/kjim-2015-004.PMC4773720.pdf
"TLR2 and RAS in UUO www.kjim.org http://dx.doi.org/10.3904/kjim.2015.004less than 75%; and grade 5, 75% or greater involved.",Non-OADS,/arxiv_data1/oa_pdf/d2/09/kjim-2015-004.PMC4773720.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.004cycle (Ct) method: 2–ΔΔCt = 2 – [(Ct of target gene – Ct of  GAPDH in treated mice) – (Ct of target gene – Ct of GAP - DH in sham mouse)].",Non-OADS,/arxiv_data1/oa_pdf/d2/09/kjim-2015-004.PMC4773720.pdf
TLR2 and RAS in UUO www.kjim.org http://dx.doi.org/10.3904/kjim.2015.00430 2010 0 aab Renin (38 kDa) β-ActinRenin S TLR2-KO-SUUO TLR2-KO-UUO3 210 S TLR2-KO-SUUO TLR2-KO-UUOS TLR2-KO-SUUO TLR2-KO-UUO Relative abundance (TLR2/β-actin)2-∆∆Ct TLR2 a b25 201510 502-∆∆Ct SA-SUUOA-UUO TLR2 TLR2 β-Actina1.5 1.00.5 0 WT TLR2-KO Wild TLR2-KO Relative abundance (TLR2/β-actin) 2.0 1.51.00.5 0TLR2 TLR2 β-ActinSaline Ang Ⅱa1.5 1.00.5 0 Saline SalineAng Ⅱ Ang ⅡRelative abundance (TLR2/β-actin) 2-∆∆Ct6 420 aab b AT1R AT1R (43 kDa) β-Actin S TLR2-KO-SUUO TLR2-KO-UUO4 3210 S TLR2-KO-SUUO TLR2-KOO-UUOS TLR2-KO-SUUO TLR2-KO-UUO Relative abundance (AT1R/β-actin) 2-∆∆Ct Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/d2/09/kjim-2015-004.PMC4773720.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.00420 15 10 5 0MCP-1 UUO TLR2-KO-UUO15 10 5 0OPN TGF-β UUO TLR2-KO-UUO30 20 10 0 UUO TLR2-KO-UUO2-∆∆Ct 2-∆∆Ct 2-∆∆Ct 5 4321025 201510 508 6420Tubulointerstitial injury score Area of MT stainUUOH&E MT TGF-β TLR2-KO UUO Area of TGF- β  UUO TLR2-KO-UUO UUO TLR2-KO-UUO UUO TLR2-KO-UUO Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/d2/09/kjim-2015-004.PMC4773720.pdf
TLR2 and RAS in UUO www.kjim.org http://dx.doi.org/10.3904/kjim.2015.0045 432 1 0a cb UUOS A-TLR2-KO-UUOA-UUOTubulointerstitial injury score Figure 3.,OADS,/arxiv_data1/oa_pdf/d2/09/kjim-2015-004.PMC4773720.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.00425 20 15 10 5 0a cb UUOS A-TLR2-KO-UUOA-UUOArea of MT stain 8 6420a cb UUOS A-TLR2-KO-UUOA-UUOArea of TGF-β TGF-β 25 201510 5 0a cb UUOS A-TLR2-KO-UUOA-UUO 2-∆∆Ct Renin β-Actin2.5 2.01.51.00.5 0a UUOS A-TLR2-KO-UUOA-UUO S UUO A-UUO A-TLR2-KO-UUORelative acundance (Renin/β-actin)Aa cb d a cbe e f d B C",Non-OADS,/arxiv_data1/oa_pdf/d2/09/kjim-2015-004.PMC4773720.pdf
TLR2 and RAS in UUO www.kjim.org http://dx.doi.org/10.3904/kjim.2015.004pression in WT UUO kidneys compared with untreated  UUO kidneys ( p < 0.05) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d2/09/kjim-2015-004.PMC4773720.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.004The renin and AT1R mRNA expression levels are in - creased in UUO kidneys [14,18,19].",Non-OADS,/arxiv_data1/oa_pdf/d2/09/kjim-2015-004.PMC4773720.pdf
TLR2 and RAS in UUO www.kjim.org http://dx.doi.org/10.3904/kjim.2015.004danger signals by cell  surface Toll-like receptors.,OADS,/arxiv_data1/oa_pdf/d2/09/kjim-2015-004.PMC4773720.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.00431.",Non-OADS,/arxiv_data1/oa_pdf/d2/09/kjim-2015-004.PMC4773720.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:357-366 http://dx.doi.org/10.3904/kjim.2015.024INTRODUCTION  Chronic myeloid leukemia (CML) is a myeloprolifera - tive neoplasm characterized by the clonal expansion of  hematopoietic stem cells with a reciprocal translocation  between chromosomes 9 and 22.",Non-OADS,/arxiv_data1/oa_pdf/c1/f8/kjim-2015-024.PMC4773721.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.024Bcr-Abl TKIs.",Non-OADS,/arxiv_data1/oa_pdf/c1/f8/kjim-2015-024.PMC4773721.pdf
"Treatment with deferasirox in CML cells www.kjim.org http://dx.doi.org/10.3904/kjim.2015.024Cell viability assay Cell viability was evaluated by a colorimetric assay  (Ez-cytox Kit, High Sensitive Water Soluble Tetrazoli - um).",Non-OADS,/arxiv_data1/oa_pdf/c1/f8/kjim-2015-024.PMC4773721.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.024Imatinib and deferasirox both produced a dose- and  time-dependent reduction of cell viability of both K562  and KU812 cells (Fig.",Non-OADS,/arxiv_data1/oa_pdf/c1/f8/kjim-2015-024.PMC4773721.pdf
Treatment with deferasirox in CML cells www.kjim.org http://dx.doi.org/10.3904/kjim.2015.024100 90 80 70 60 50 40 30 20 10 0 Concentration (µ M)KU812 (48 hr) K562 (48 hr) Control DFS20 M1 M5 M10 DFS20 +IM1DFS20 +IM5DFS20 +IM10 Cell viability (%)100 90 80 70 60 50 40 30 20 10 0 Concentration (µ M)C0ntrol DFS20 M1 M5 M10 DFS20 +IM1DFS20 +IM5DFS20 +IM10 Cell viability (%)a a a a a Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/c1/f8/kjim-2015-024.PMC4773721.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.024Co-treatment with deferasirox and imatinib induces  apoptosis and significantly down-regulates the Bcr- Abl down-stream  pathway of human CML cells To determine the effects of deferasirox on apoptosis  and protein expression after treatment with deferasirox  or imatinib, singly or in combination, we measured  the expression levels of proteins by using Western blot  analysis.",Non-OADS,/arxiv_data1/oa_pdf/c1/f8/kjim-2015-024.PMC4773721.pdf
Treatment with deferasirox in CML cells www.kjim.org http://dx.doi.org/10.3904/kjim.2015.024assay.,Non-OADS,/arxiv_data1/oa_pdf/c1/f8/kjim-2015-024.PMC4773721.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.024not only imatinib-sensitive cells but also imatinib-resis - tant cells.",Non-OADS,/arxiv_data1/oa_pdf/c1/f8/kjim-2015-024.PMC4773721.pdf
Treatment with deferasirox in CML cells www.kjim.org http://dx.doi.org/10.3904/kjim.2015.024Conflict of interest No potential conflict of interest relevant to this article  was reported.,Non-OADS,/arxiv_data1/oa_pdf/c1/f8/kjim-2015-024.PMC4773721.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.024Res 2010;70:440-446.",Non-OADS,/arxiv_data1/oa_pdf/c1/f8/kjim-2015-024.PMC4773721.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:386-391 http://dx.doi.org/10.3904/kjim.2015.039INTRODUCTION Familial Mediterranean fever (FMF) is  an autosomal recessive disorder char - acterized by attacks of fever and diffuse  abdominal pain.",Non-OADS,/arxiv_data1/oa_pdf/b2/21/kjim-2015-039.PMC4773722.pdf
Neutrophil lymphocyte ratio in FMF www.kjim.org http://dx.doi.org/10.3904/kjim.2015.039within clinically critical time interval.,Non-OADS,/arxiv_data1/oa_pdf/b2/21/kjim-2015-039.PMC4773722.pdf
      388  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.039The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/b2/21/kjim-2015-039.PMC4773722.pdf
"Neutrophil lymphocyte ratio in FMF www.kjim.org http://dx.doi.org/10.3904/kjim.2015.039with various cancers [13-15], liver cirrhosis [16], chron - ic kidney disease [17], and cardiac disease [18,19], NLR  could predict adverse clinical outcomes independent of  major established risk factors.",Non-OADS,/arxiv_data1/oa_pdf/b2/21/kjim-2015-039.PMC4773722.pdf
      390  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.039The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/b2/21/kjim-2015-039.PMC4773722.pdf
Neutrophil lymphocyte ratio in FMF www.kjim.org http://dx.doi.org/10.3904/kjim.2015.039tients: how can we use procalcitonin?,Non-OADS,/arxiv_data1/oa_pdf/b2/21/kjim-2015-039.PMC4773722.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:277-287 http://dx.doi.org/10.3904/kjim.2015.0431Department of Internal Medicine,  Seoul National University Hospital,  Seoul; 2Department of Internal  Medicine, Gachon University  Gil Medical Center, Incheon;  3Department of Internal Medicine,  College of Medicine, Uijeongbu  St. Mary’s Hospital, The Catholic  University of Korea, Uijeongbu;  4Department of Internal Medicine,  Korea University Guro Hospital,  Seoul; 5Department of Internal  Medicine, Seoul National University  Bundang Hospital, Seongnam;  6Department of Medicine, Samsung  Medical Center, Sungkyunkwan  University School of Medicine, Seoul;  7Department of Internal Medicine,  Asan Medical Center, University  of Ulsan College of Medicine,  Seoul; 8Department of Internal  Medicine, Ajou University Hospital,  Suwon; 9Department of Internal  Medicine, Severance Hospital, Yonsei  University College of Medicine,  Seoul; 10Department of  Clinical  Pharmacy, College of Pharmacy, The  Catholic University of Korea, Seoul;  11Department of Internal Medicine,  College of Medicine, Seoul St. Mary’s  Hospital, The Catholic University of  Korea, Seoul, Korea Received : February 22, 2015 Revised : August 17, 2015 Accepted : December 11, 2015Correspondence to Sang Hong Baek, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ca/c1/kjim-2015-043.PMC4773723.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.043INTRODUCTION Pharmacogenomic effects continue to draw medical  attention because they can substantially influence the  therapeutic response.",Non-OADS,/arxiv_data1/oa_pdf/ca/c1/kjim-2015-043.PMC4773723.pdf
Pharmacogenomics of bisoprolol in heart failure www.kjim.org http://dx.doi.org/10.3904/kjim.2015.043and concomitant medications for various medical con - ditions were allowed at the investigator’s discretion.,Non-OADS,/arxiv_data1/oa_pdf/ca/c1/kjim-2015-043.PMC4773723.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.043± 12.6 mmHg, and baseline HR was 80.8 ± 14.3 bpm.",OADS,/arxiv_data1/oa_pdf/ca/c1/kjim-2015-043.PMC4773723.pdf
Pharmacogenomics of bisoprolol in heart failure www.kjim.org http://dx.doi.org/10.3904/kjim.2015.04379.5 ± 41.3 mL ( p < 0.0001).,Non-OADS,/arxiv_data1/oa_pdf/ca/c1/kjim-2015-043.PMC4773723.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.043Short-term and long-term functional improvement  according to genotype Following 24 weeks of bisoprolol therapy, exercise ca - pacity evaluated by 6-minute walk test was significantly  improved from 401 ± 160 to 416 ± 138 m ( p < 0.001) (Ta - ble 2).",Non-OADS,/arxiv_data1/oa_pdf/ca/c1/kjim-2015-043.PMC4773723.pdf
Pharmacogenomics of bisoprolol in heart failure www.kjim.org http://dx.doi.org/10.3904/kjim.2015.043dy-Weinberg equilibrium.,Non-OADS,/arxiv_data1/oa_pdf/ca/c1/kjim-2015-043.PMC4773723.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.043ADRB1 is encoded by an intron-less gene located  on chromosome 10q24-26, consisting of a short 5’ un - translated region of 86 base pairs (bp), an open reading  frame that encodes a protein of 477 amino acids, and a  3’ untranslated region of about 900 bp [24].",Non-OADS,/arxiv_data1/oa_pdf/ca/c1/kjim-2015-043.PMC4773723.pdf
Pharmacogenomics of bisoprolol in heart failure www.kjim.org http://dx.doi.org/10.3904/kjim.2015.043tive β-1 adrenergic receptor in the Arg389Arg genotype.,Non-OADS,/arxiv_data1/oa_pdf/ca/c1/kjim-2015-043.PMC4773723.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.0439.",Non-OADS,/arxiv_data1/oa_pdf/ca/c1/kjim-2015-043.PMC4773723.pdf
Pharmacogenomics of bisoprolol in heart failure www.kjim.org http://dx.doi.org/10.3904/kjim.2015.043heart failure.,Non-OADS,/arxiv_data1/oa_pdf/ca/c1/kjim-2015-043.PMC4773723.pdf
"Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgIMAGE OF INTEREST Korean J Intern Med 2016;31:409-410 http://dx.doi.org/10.3904/kjim.2015.055A 52-year-old woman presented with fa - cial rigidity and jerky movements of all  four limbs.",Non-OADS,/arxiv_data1/oa_pdf/c8/8e/kjim-2015-055.PMC4773724.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.055plements, and a vitamin D analog, the patient’s symp - toms improved gradually.",Non-OADS,/arxiv_data1/oa_pdf/c8/8e/kjim-2015-055.PMC4773724.pdf
"Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgIMAGE OF INTEREST Korean J Intern Med 2016;31:411-412 http://dx.doi.org/10.3904/kjim.2015.081The patient was a 26-years-old female  with a history of lumbosacral menin - gomyelocele with paraplegia.",Non-OADS,/arxiv_data1/oa_pdf/34/97/kjim-2015-081.PMC4773725.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.081Conflict of interest No potential conflict of interest relevant to this article was reported.Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/34/97/kjim-2015-081.PMC4773725.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:242-252 http://dx.doi.org/10.3904/kjim.2015.1121Department of Internal Medicine,  College of Medicine, The Catholic  University of Korea, Seoul;  2Department of Internal Medicine,  Inje University Ilsan Paik Hospital,  Goyang, Korea Received : April 26, 2014 Revised : August 13, 2014 Accepted : November  18, 2015 Correspondence to Chan Ran You, M.D.",Non-OADS,/arxiv_data1/oa_pdf/42/87/kjim-2015-112.PMC4773726.pdf
"Efficacy of combination treatment www.kjim.org http://dx.doi.org/10.3904/kjim.2015.112INTRODUCTION Hepatocellular carcinoma (HCC) is the sixth most com - mon cancer and third leading cause of cancer-related  death with increasing incidence worldwide [ 1,2].",Non-OADS,/arxiv_data1/oa_pdf/42/87/kjim-2015-112.PMC4773726.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.112ly flexible coaxial microcatheter passed through a 5-Fr  Yashiro catheter (Terumo, Tokyo, Japan), which was  previously placed approximately in the hepatic artery.",Non-OADS,/arxiv_data1/oa_pdf/42/87/kjim-2015-112.PMC4773726.pdf
Efficacy of combination treatment www.kjim.org http://dx.doi.org/10.3904/kjim.2015.112serum.,Non-OADS,/arxiv_data1/oa_pdf/42/87/kjim-2015-112.PMC4773726.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.112were diagnosed with early-stage HCC according to the  BCLC staging classification.",Non-OADS,/arxiv_data1/oa_pdf/42/87/kjim-2015-112.PMC4773726.pdf
"Efficacy of combination treatment www.kjim.org http://dx.doi.org/10.3904/kjim.2015.1120.309; 95% CI, 0.130 to 0.736; p = 0.008 and HR, 0.352; 95%  CI, 0.158 to 0.787; p = 0.011, respectively) (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/42/87/kjim-2015-112.PMC4773726.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.112and p = 0.004, respectively).",OADS,/arxiv_data1/oa_pdf/42/87/kjim-2015-112.PMC4773726.pdf
"Efficacy of combination treatment www.kjim.org http://dx.doi.org/10.3904/kjim.2015.112therapy could be expanded to patients with resectable  HCC and transplant candidates [26,27 ].",Non-OADS,/arxiv_data1/oa_pdf/42/87/kjim-2015-112.PMC4773726.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.112HCC using a propensity score model.",OADS,/arxiv_data1/oa_pdf/42/87/kjim-2015-112.PMC4773726.pdf
Efficacy of combination treatment www.kjim.org http://dx.doi.org/10.3904/kjim.2015.112Conflict of interest No potential conflict of interest relevant to this article  was reported.,Non-OADS,/arxiv_data1/oa_pdf/42/87/kjim-2015-112.PMC4773726.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.112Hepatology 2011;53:1580-1589.",Non-OADS,/arxiv_data1/oa_pdf/42/87/kjim-2015-112.PMC4773726.pdf
"LETTER TO THE EDITOR Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:396-398 http://dx.doi.org/10.3904/kjim.2015.1311Division of Cardiology, Department  of Internal Medicine, SM Christianity  Hospital, Pohang; 2Division of  Cardiology, Department of Internal  Medicine, Keimyung University  Dongsan Medical Center, Daegu,  Korea Received : May  1, 2015 Revised : May  26, 2015 Accepted : June  15, 2015 Correspondence to Seongwook Han, M.D.",Non-OADS,/arxiv_data1/oa_pdf/97/14/kjim-2015-131.PMC4773727.pdf
"397 www.kjim.org Lee SH and Han S. Resolved LAA thrombi with apixaban http://dx.doi.org/10.3904/kjim.2015.131Another patient was a 79-year-old woman, who pre - sented with aggravated dyspnea on exertion (DOE).",Non-OADS,/arxiv_data1/oa_pdf/97/14/kjim-2015-131.PMC4773727.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.131(Fig.",Non-OADS,/arxiv_data1/oa_pdf/97/14/kjim-2015-131.PMC4773727.pdf
"Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org REVIEW Korean J Intern Med 2016;31:219-236 http://dx.doi.org/10.3904/kjim.2015.134INTRODUCTION In view of new developments in the approach to the  management of rheumatoid arthritis (RA), with more  successful remission rates, it is important for all medi - cal specialists to be updated with the new knowledge.",Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.134population [1].",Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
The physician’s approach to RA in SA www.kjim.org http://dx.doi.org/10.3904/kjim.2015.134the capture of patients later in the disease course.,Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.134a narrow window of opportunity exists where early ag - gressive therapy of RA can suppress inflammation be - fore irreversible joint destruction has occurred [14-16].",Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
"The physician’s approach to RA in SA www.kjim.org http://dx.doi.org/10.3904/kjim.2015.134strategy results in lower disease activity, better physical  function and less structural damage, particularly when  commenced in early disease [25].",Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.134DMARD and the cornerstone of RA treatment.",OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
The physician’s approach to RA in SA www.kjim.org http://dx.doi.org/10.3904/kjim.2015.134patient [42].,Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.134factors for NSAID-induced gastrointestinal tract events.",Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
"The physician’s approach to RA in SA www.kjim.org http://dx.doi.org/10.3904/kjim.2015.134patient education and support, with positive effects on  adherence to therapy and on health-related quality of life  [46].",Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.134monoclonal rather than soluble anti-TNF drugs seem  to confer a higher risk for TB [53,64,65].",Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
The physician’s approach to RA in SA www.kjim.org http://dx.doi.org/10.3904/kjim.2015.134DMARD or biologic therapy for optimal efficacy.,Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.134many experts feel that these drugs can be safely con - tinued during conception and the first 2 trimesters of  pregnancy [89].",Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
The physician’s approach to RA in SA www.kjim.org http://dx.doi.org/10.3904/kjim.2015.134count for this.,Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.134CONCLUSIONS  It is important for specialist physicians to adopt the  new classification criteria for RA in order for early de - tection of RA.",Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
The physician’s approach to RA in SA www.kjim.org http://dx.doi.org/10.3904/kjim.2015.134date.,Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
Available from: http://www.arthritiscare.org.uk/AboutAr - thritis/HaveyougottheSfactor.,Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.134netic resonance imaging in early rheumatoid arthritis.",Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
The physician’s approach to RA in SA www.kjim.org http://dx.doi.org/10.3904/kjim.2015.134tent tuberculosis infection.,Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
Available from: http://www.who.int/tb/data.,OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.134hepatitis in the biologic era.",Non-OADS,/arxiv_data1/oa_pdf/f6/27/kjim-2015-134.PMC4773728.pdf
"pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org REVIEW Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Intern Med 2016;31:210-218 http://dx.doi.org/10.3904/kjim.2015.137INTRODUCTION Rheumatoid arthritis (RA) is a representative systemic  autoimmune disease characterized with chronic and  destructive inflammatory synovitis and multiple organ  manifestations that causes severe disability and mortal - ity.",Non-OADS,/arxiv_data1/oa_pdf/19/e5/kjim-2015-137.PMC4773729.pdf
Management of RA www.kjim.org http://dx.doi.org/10.3904/kjim.2015.137novial inflammation is apparent in the early stage of the  disease.,Non-OADS,/arxiv_data1/oa_pdf/19/e5/kjim-2015-137.PMC4773729.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.137and appropriate induction of remission is prerequisite  to halt joint damage and functional disabilities, which  revealed improved outcomes with strategic therapeutic  approaches.",Non-OADS,/arxiv_data1/oa_pdf/19/e5/kjim-2015-137.PMC4773729.pdf
"Management of RA www.kjim.org http://dx.doi.org/10.3904/kjim.2015.137Among members of a JAK family, the expression of JAK3  is limited to lymphocytes and constitutively binds to the  common γchain which is a common receptor subunit  for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 [11].",Non-OADS,/arxiv_data1/oa_pdf/19/e5/kjim-2015-137.PMC4773729.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.137(HuRAg) mice, an RA animal model utilizing SCID  mice implanted with synovium and cartilage from pa - tients with RA and tofacitinib was continuously given  to the mice by the osmotic mini-pump [27].",Non-OADS,/arxiv_data1/oa_pdf/19/e5/kjim-2015-137.PMC4773729.pdf
Management of RA www.kjim.org http://dx.doi.org/10.3904/kjim.2015.137[6].,OADS,/arxiv_data1/oa_pdf/19/e5/kjim-2015-137.PMC4773729.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.137ab-free remission of 1.98, indicating that “deep remis - sion” would be a key for successful discontinuation of  adalimumab in established patients with RA.",Non-OADS,/arxiv_data1/oa_pdf/19/e5/kjim-2015-137.PMC4773729.pdf
"Management of RA www.kjim.org http://dx.doi.org/10.3904/kjim.2015.137We also need to create the therapeutic strategies for  the long-term maintenance after obtaining remission  in order to keep structural remission, functional remis - sion, social remission and comprehensive remission.",Non-OADS,/arxiv_data1/oa_pdf/19/e5/kjim-2015-137.PMC4773729.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.137nol Rev 2008;223:132-142.",Non-OADS,/arxiv_data1/oa_pdf/19/e5/kjim-2015-137.PMC4773729.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:367-374 http://dx.doi.org/10.3904/kjim.2015.178INTRODUCTION Acinetobacter baumannii  has emerged as a major nosoco - mial pathogen that causes ventilator-associated pneu - monia, bacteremia, secondary meningitis, skin and soft  tissue infection, and urinary tract infection in Intensive Care Units (ICUs) [1,2].",Non-OADS,/arxiv_data1/oa_pdf/e9/bc/kjim-2015-178.PMC4773730.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.178trum antibiotics, has led to increased isolation rates of  multidrug-resistant (MDR) A. baumannii in many hos - pitals [5,6].",Non-OADS,/arxiv_data1/oa_pdf/e9/bc/kjim-2015-178.PMC4773730.pdf
"Control of endemic MDR A. baumannii www.kjim.org http://dx.doi.org/10.3904/kjim.2015.178ventilator tubes, suctioning equipment, surrounding  curtains, bedrails, bedside tables, computer keyboards,  and monitors, blood pressure cuffs, infusion pumps,  stethoscopes, and washbasins.",Non-OADS,/arxiv_data1/oa_pdf/e9/bc/kjim-2015-178.PMC4773730.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.1781:100 diluted bleach or quaternary ammonium chloride  wipes (NewGenn Science, Roudham, UK).",OADS,/arxiv_data1/oa_pdf/e9/bc/kjim-2015-178.PMC4773730.pdf
"Control of endemic MDR A. baumannii www.kjim.org http://dx.doi.org/10.3904/kjim.2015.178patient-days, although this decrease was not statistically  significant ( p = 0.157).",Non-OADS,/arxiv_data1/oa_pdf/e9/bc/kjim-2015-178.PMC4773730.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.178This study highlights the importance of restricting  carbapenem usage in the control of endemic MDR A.  baumannii .",Non-OADS,/arxiv_data1/oa_pdf/e9/bc/kjim-2015-178.PMC4773730.pdf
"Control of endemic MDR A. baumannii www.kjim.org http://dx.doi.org/10.3904/kjim.2015.178ing hospital staff education and performing active sur - veillance cultures, contact precautions isolation, environ - mental cleaning, and hand hygiene promotion.",Non-OADS,/arxiv_data1/oa_pdf/e9/bc/kjim-2015-178.PMC4773730.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.178for metrics for multidrug-resistant organisms in health - care settings: SHEA/HICPAC position paper.",OADS,/arxiv_data1/oa_pdf/e9/bc/kjim-2015-178.PMC4773730.pdf
"ORIGINAL ARTICLE Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:344-356 http://dx.doi.org/10.3904/kjim.2015.227INTRODUCTION Chronic kidney disease (CKD) has become a global public  health challenge due to various adverse outcomes, includ - ing accelerated cardiovascular events, all-cause mortality,  and increased healthcare costs [1-3].",Non-OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
"Korean coefficient for MDRD equation www.kjim.org http://dx.doi.org/10.3904/kjim.2015.227graphic factors such as age, sex, and body size [5,6].",OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.227The HPLC system had a delivery system, an auto injec - tor, and an ultraviolet detector (Gilson model 305/306  HPLC pumps, 234 auto injector, and 118 UV detector;  Gilson, Villiers Le Bel, France).",OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
"Statistical analyses All analyses and calculations were performed using the  R version 2.15.1 (The Comprehensive R Archive Network:  http://cran.r-project.org) and SAS version 9.1 (SAS Insti - tute, Cary, NC, USA) software packages.",OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
"Korean coefficient for MDRD equation www.kjim.org http://dx.doi.org/10.3904/kjim.2015.2271, and 0.95540 (Korean coefficient) × 6v IDMS MDRD  Study equation was designated equation 2.",OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.227the 6v equation showed the opposite result with a great - er median difference in the modified equation (equation  2) than that in the IDMS MDRD Study equation.",OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
Korean coefficient for MDRD equation www.kjim.org http://dx.doi.org/10.3904/kjim.2015.227equations.,OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.227 Table 3.",OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
"Korean coefficient for MDRD equation www.kjim.org http://dx.doi.org/10.3904/kjim.2015.227equation (55.2 vs. 52.8, p = 0.023).",OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.227investigators have attempted to identify a method to  more accurately estimate GFR by modifying the original  MDRD Study equations, and ethnic coefficients from  several Asian countries have been reported [11,13-15,21].",OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
Korean coefficient for MDRD equation www.kjim.org http://dx.doi.org/10.3904/kjim.2015.227from the renal clearance of 125I-iothalamate used in the  MDRD Study.,OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.227cients were derived from patients diagnosed with CKD,  but the present study included healthy volunteers with - out CKD.",Non-OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
Korean coefficient for MDRD equation www.kjim.org http://dx.doi.org/10.3904/kjim.2015.227REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2015.227mal sampling strategies to assess inulin clearance in chil - dren by the inulin single-injection method.",Non-OADS,/arxiv_data1/oa_pdf/9b/82/kjim-2015-227.PMC4773731.pdf
"Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org REVIEW Korean J Intern Med 2016;31:201-209 http://dx.doi.org/10.3904/kjim.2016.021INTRODUCTION Gastric cancer remains one of the most challenging ma - lignant diseases worldwide.",Non-OADS,/arxiv_data1/oa_pdf/7b/7c/kjim-2016-021.PMC4773732.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2016.021Currently, however, adenoma and dysplasia are used in - discriminately by most clinicians.",Non-OADS,/arxiv_data1/oa_pdf/7b/7c/kjim-2016-021.PMC4773732.pdf
"Gastric dysplasia www.kjim.org http://dx.doi.org/10.3904/kjim.2016.021classification; however, the term “dysplasia” is used syn - onymously with “intraepithelial neoplasia/dysplasia”  [10].",Non-OADS,/arxiv_data1/oa_pdf/7b/7c/kjim-2016-021.PMC4773732.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2016.021gies to improve diagnostic accuracy have limitations in  terms of clinical application.",Non-OADS,/arxiv_data1/oa_pdf/7b/7c/kjim-2016-021.PMC4773732.pdf
"Gastric dysplasia www.kjim.org http://dx.doi.org/10.3904/kjim.2016.021include depressed macroscopic type, surface erythema,  surface unevenness (nodularity), and erosion or ulcer - ation [31,32,34-39].",Non-OADS,/arxiv_data1/oa_pdf/7b/7c/kjim-2016-021.PMC4773732.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2016.021development of metachronous cancer after endoscopic  resection of early gastric cancer (EGC).",Non-OADS,/arxiv_data1/oa_pdf/7b/7c/kjim-2016-021.PMC4773732.pdf
Gastric dysplasia www.kjim.org http://dx.doi.org/10.3904/kjim.2016.021tion in patients with gastric dysplasia.,Non-OADS,/arxiv_data1/oa_pdf/7b/7c/kjim-2016-021.PMC4773732.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2016.02127.",Non-OADS,/arxiv_data1/oa_pdf/7b/7c/kjim-2016-021.PMC4773732.pdf
Gastric dysplasia www.kjim.org http://dx.doi.org/10.3904/kjim.2016.021ment of Helicobacter pylori infection: the Maastricht IV/  Florence Consensus Report.,Non-OADS,/arxiv_data1/oa_pdf/7b/7c/kjim-2016-021.PMC4773732.pdf
"EDITORIAL Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2016;31:237-241 http://dx.doi.org/10.3904/kjim.2016.026Angiotensin converting enzyme inhibitors remain  the first treatment of choice Pyung Chun Oh1,2, Ichiro Sakuma3, Toshio Hayashi4, and Kwang Kon Koh1,2 1Division of Cardiology,  Department of Internal Medicine,  Heart Center, Gachon University  Gil Medical Center, Incheon;  2Gachon Cardiovascular Research  Institute, Incheon, Korea;  3Cardiovascular Medicine,  Hokko Memorial Clinic, Sapporo;  4Department of Geriatrics,  Nagoya University Graduate  School of Medicine, Nagoya,  Japan Received : February 8, 2016 Accepted: February 19, 2016 Correspondence to  Kwang Kon Koh, M.D.",Non-OADS,/arxiv_data1/oa_pdf/98/f3/kjim-2016-026.PMC4773733.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2016.026treatment of acute MI.",Non-OADS,/arxiv_data1/oa_pdf/98/f3/kjim-2016-026.PMC4773733.pdf
"http://dx.doi.org/10.3904/kjim.2016.026ly, ACE inhibition could reduce the intracellular pro - duction of superoxide anions via the reduced activity of  angiotensin II-dependent nicotinamide adenine dinu - cleotide/nicotinamide adenine dinucleotide phosphate  oxidase systems within the endothelium [7,8].",Non-OADS,/arxiv_data1/oa_pdf/98/f3/kjim-2016-026.PMC4773733.pdf
"2, March 2016 http://dx.doi.org/10.3904/kjim.2016.026valsartan therapy improved flow-mediated vasodilation,  reduced the level of C-reactive protein, a biomarker of in - flammation, increased plasma adiponectin, lowered fast - ing insulin levels, and improved insulin sensitivity in an  additive manner compared to monotherapy alone in an  hypertensive population (Fig.",Non-OADS,/arxiv_data1/oa_pdf/98/f3/kjim-2016-026.PMC4773733.pdf
http://dx.doi.org/10.3904/kjim.2016.02617.,OADS,/arxiv_data1/oa_pdf/98/f3/kjim-2016-026.PMC4773733.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/e5/omw005.PMC4773848.pdf
Nature http://dx.doi.org/10.1038/nature14878 (2015).,Non-OADS,/arxiv_data1/oa_pdf/c5/9e/41586_2015_Article_BFnature14962.PMC4773891.pdf
http://dx.doi.org/10.1093/ bioinformatics/btv491 (2015).,Non-OADS,/arxiv_data1/oa_pdf/c5/9e/41586_2015_Article_BFnature14962.PMC4773891.pdf
"Author Information Data access form is available at http://www.uk10k.org/data_ access.html, raw and processed data files at https://www.ebi.ac.uk/ega/, imputation panel at https://www.ebi.ac.uk/ega/, UK10K Genome Browser at http://www.uk10k.org/dalliance.html, single-marker loci navigator at http://fathmm.biocompute.org.uk/ UK10K_Browser/ and dynamic power calculator at http:// fathmm.biocompute.org.uk/UK10K_Browser/Power.htm.",OADS,/arxiv_data1/oa_pdf/c5/9e/41586_2015_Article_BFnature14962.PMC4773891.pdf
"phenotype data were deposited to the European Genome-Phenome archive (EGA, https://www.ebi.ac.uk/ega/), with accession numbers EGAD00001000740, EGAD00001000789, EGAD00001000741, EGAD00001000790, EGAD00001000776, EGAD00001000433, EGAD00001000434, EGAD00001000435, EGAD00001000436, EGAD00001000613, EGAD00001000614, EGAD00001000437, EGAD00001000438, EGAD00001000615, EGAD00001000439,EGAD00001000440, EGAD00001000441, EGAD00001000442, EGAD00001000443, EGAD00001000430, EGAD00001000431, EGAD00001000432, EGAD00001000429, EGAD00001000413, EGAD00001000414, EGAD00001000415, EGAD00001000416,EGAD00001000417, EGAD00001000418, EGAD00001000419 and EGAD00001000420.",OADS,/arxiv_data1/oa_pdf/c5/9e/41586_2015_Article_BFnature14962.PMC4773891.pdf
Human genome version  GRCh 37:Feb 2009 (hg 19) ( http://genome.ucsc.,Non-OADS,/arxiv_data1/oa_pdf/1f/e3/IJMR-142-699.PMC4774067.pdf
No gene was definitely associated with mental  retardation/ developmental disability or other related  disorders (UCSC genome browser hg19 version   http://genome.ucsc.edu/cgi-bin/hgGateway?db=hg19 ).,Non-OADS,/arxiv_data1/oa_pdf/1f/e3/IJMR-142-699.PMC4774067.pdf
In DECIPHER ( https://decipher.sanger.ac.uk ) a few  entries have been described in overlapping region  associated with mental retardation.,Non-OADS,/arxiv_data1/oa_pdf/1f/e3/IJMR-142-699.PMC4774067.pdf
"Double segment imbalances in three patients with global developmental delay S. No Age/gender Clinical features Involved  chromosomal  regionsCMA report (GRCh37/hg19 genome  browser) 1 7 yr/M Global developmental delay, facial  dysmorphism, brachydactyly, congenital heart  disease, mother had 6 first trimester abortion3p26.3-p24.1  (26.8 Mb gain),  18p11.32- 11.21(14.4 Mb  loss)arr3p26.3p24.1(81668-26977225)X3, 18p11.32p11.21(60739-14540632)X1 2 3 months/ F Global developmental delay, facial  dysmorphism, corpus callosal agenesis, 2 first  cousins also had developmental delay7q36.1 (9.3 Mb  loss),11q24.1-25  (13 Mb gain)arr7q36.1q36.3(49770238-159118443) X1, 11q24.1-25(121769912-134926021) X3 3 1 yr/M Global developmental delay, hypotonia, mild  cerebral atrophy9p24.3-p23  (10.8Mb loss) 20q  (12.1 Mb gain)arr9p24.3p23(209111-11073967)X1,  20q13.2q13.33(50724046-62917655) X3 Source: http://genome.ucsc.edu/cgi-bin/hgGateway?db=hg19 Of the 15 patients with single definite pathogenic  variant, nine were also having possibly pathogenic  VUS or possibly VUS at unrelated parts of genomes.",Non-OADS,/arxiv_data1/oa_pdf/1f/e3/IJMR-142-699.PMC4774067.pdf
"DD, developmental delay; DECIPHER, database of genomic variation and phenotype in humans using ensemobl resources ( https://decipher.sanger.ac.uk/ ); OMIM,  mendelian inheritance in man ( http://omim.org /); DGV , database of genomic variants ( http://dgv.tcag.ca/dgv/app/home ); UCSC, genome browser ( https://genome.ucsc.",Non-OADS,/arxiv_data1/oa_pdf/1f/e3/IJMR-142-699.PMC4774067.pdf
"Autosomal  recessive(omim) 23 yr/M DD Gain 16p11.2 33016127 33420084 403 LOC729355, TP53TG3,  LOC729355, TP53TG3Region of 16p11.2  duplication syndrome,  autism susceptibility  locus 1 yr/M DD with facial  dysmorphismGain 6q16.1 92296817 93008151 711 No genes Spinocerebellar  ataxia, schizophrenia  susceptibility locus DD, developmental delay; OMIM, mendelian inheritance in man ( http://omim.org /); DECIPHER, database of genomic variation and phenotype in humans using ensemobl  resources ( https://decipher.sanger.ac.uk/) ; MR, mental retardation; UCSC, genome browser ( https://genome.ucsc.edu/ )710  INDIAN J MED RES, DECEMBER 2015",Non-OADS,/arxiv_data1/oa_pdf/1f/e3/IJMR-142-699.PMC4774067.pdf
Recurrent benign copy number variants Type of CNV Chromosome position  (GRCh37/hg19  genome browser)Start nucleotide End nucleotide Size of the CNV  (kb)Number of patients  having CNV Gain 6q27 168879957 169369190 489 3 Gain 14q32.33 105466939 106033135 566 4 Loss 17q12 33357810 33658959 301 3 Gain Xq21.3 90634737 91313584 678 4 Gain Xq21.3 89241618 90168748 927 5 Source : http://genome.ucsc.edu/cgi-bin/hgGateway?db=hg19 our study an d 63 vs 36% in their study).,Non-OADS,/arxiv_data1/oa_pdf/1f/e3/IJMR-142-699.PMC4774067.pdf
"p.T789A (rs1063856) and p.Y795Y  (rs1063857) were found to be in strong linkage  disequilibrium with each other (r2=1.0), each showing  8 per cent heterozygosity, which also showed moderate  degree of linkage disequilibrium with c.2282-42C>A  (rs216293) (r2=0.656) ( http://www.broadinstitute.org/ mpg/snap/ldsearchpw.php ).",OADS,/arxiv_data1/oa_pdf/4b/46/IJMR-142-759.PMC4774073.pdf
Available from: http://www.vwf.group.shef.ac.uk/genomicvwf.,Non-OADS,/arxiv_data1/oa_pdf/4b/46/IJMR-142-759.PMC4774073.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a2/0d/hepatmon-15-12-32707.PMC4774144.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowAbstract Background:  Intracranial tumors with heterogeneous histopathology are a  well‑described pathologic entity.",Non-OADS,/arxiv_data1/oa_pdf/52/9a/SNI-7-21.PMC4774166.pdf
"Surg Neurol Int 2016;7:21. http://surgicalneurologyint.com/A-rare-intracranial-tumor-consisting-of-malignant- anaplastic-and-papillary-meningioma-subtypes/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/52/9a/SNI-7-21.PMC4774166.pdf
"Surgical Neurology International 2016, 7:21  http://www.surgicalneurologyint.com/content/7/1/21was remarkable for a left homonymous hemianopia as  well as mild left‑sided hemiparesis.",Non-OADS,/arxiv_data1/oa_pdf/52/9a/SNI-7-21.PMC4774166.pdf
"Surgical Neurology International 2016, 7:21  http://www.surgicalneurologyint.com/content/7/1/21disease fluid protein 15 (GCDFP‑15) positivity.",Non-OADS,/arxiv_data1/oa_pdf/52/9a/SNI-7-21.PMC4774166.pdf
"Surgical Neurology International 2016, 7:21  http://www.surgicalneurologyint.com/content/7/1/21common intracranial tumor to collide with another, but  all other reported cases have been in conjunction with  an entirely different tumor (astrocytoma, metastatic  tumor).",Non-OADS,/arxiv_data1/oa_pdf/52/9a/SNI-7-21.PMC4774166.pdf
"Surgical Neurology International 2016, 7:21  http://www.surgicalneurologyint.com/content/7/1/2110.",Non-OADS,/arxiv_data1/oa_pdf/52/9a/SNI-7-21.PMC4774166.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowAbstract Background:  Glasgow Co ma Scale has been a long sought model to classify  patients with head injury.",Non-OADS,/arxiv_data1/oa_pdf/80/72/SNI-7-23.PMC4774167.pdf
"Surg Neurol Int 2016;7:23. http://surgicalneurologyint.com/Role-of-computed-tomography-scores-and-findings-to-predict-early-death-in-patients-with-traumatic-brain-injury:-A-reappraisal-in-a-major- tertiary-care-hospital-in-Nepal/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/80/72/SNI-7-23.PMC4774167.pdf
"Surgical Neurology International 2016, 7:23  http://www.surgicalneurologyint.com/content/7/1/23INTRODUCTION Traumatic brain injury (TBI) is a silent epidemic that  has paramount short‑ and long‑term consequences.",Non-OADS,/arxiv_data1/oa_pdf/80/72/SNI-7-23.PMC4774167.pdf
"Surgical Neurology International 2016, 7:23  http://www.surgicalneurologyint.com/content/7/1/23the context of a rural medical infrastructure, the proper  prehospital management via a rapid response ambulance  and paramedical team are still lacking.",Non-OADS,/arxiv_data1/oa_pdf/80/72/SNI-7-23.PMC4774167.pdf
"Surgical Neurology International 2016, 7:23  http://www.surgicalneurologyint.com/content/7/1/23compressed cisterns, MLS and nonevacuated hematomas  of >25 ml blood.",Non-OADS,/arxiv_data1/oa_pdf/80/72/SNI-7-23.PMC4774167.pdf
"Surgical Neurology International 2016, 7:23  http://www.surgicalneurologyint.com/content/7/1/23studies for correct assessment of the outcome.",Non-OADS,/arxiv_data1/oa_pdf/80/72/SNI-7-23.PMC4774167.pdf
"Surgical Neurology International 2016, 7:23  http://www.surgicalneurologyint.com/content/7/1/23of 437 cases.",Non-OADS,/arxiv_data1/oa_pdf/80/72/SNI-7-23.PMC4774167.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowSurgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSir, Behavioral manifestations constitute major burden of patients  suffering from brain tumors.",Non-OADS,/arxiv_data1/oa_pdf/df/68/SNI-7-20.PMC4774168.pdf
Surg  Neurol Int 2016;7:20. http://surgicalneurologyint.com/Frontal-lobe-signs-after-posterior-fossa-surgery:-Is- hypoperfusion-ignored?/,Non-OADS,/arxiv_data1/oa_pdf/df/68/SNI-7-20.PMC4774168.pdf
"Surgical Neurology International 2016, 7:20  http://www.surgicalneurologyint.com/content/7/1/20Financial support and sponsorship Nil.",Non-OADS,/arxiv_data1/oa_pdf/df/68/SNI-7-20.PMC4774168.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowAbstract Background:  To investigate the clinical outcome at 101 patients undergoing  decompressive craniectomy (DC) after severe traumatic brain injury (TBI).",Non-OADS,/arxiv_data1/oa_pdf/fc/63/SNI-7-19.PMC4774169.pdf
"Surg Neurol Int 2016;7:19. http://surgicalneurologyint.com/According-to-which-factors-in-severe-traumatic- brain-injury-craniectomy-could-be-beneficial/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/fc/63/SNI-7-19.PMC4774169.pdf
"Surgical Neurology International 2016, 7:19  http://www.surgicalneurologyint.com/content/7/1/19the three intracranial components was further supported  by Kellie.",Non-OADS,/arxiv_data1/oa_pdf/fc/63/SNI-7-19.PMC4774169.pdf
"Surgical Neurology International 2016, 7:19  http://www.surgicalneurologyint.com/content/7/1/19The most common complications during surgery  were hemodynamic instability (15 cases – 15%) and  hemorrhagic diathesis (10 cases – 10%).",Non-OADS,/arxiv_data1/oa_pdf/fc/63/SNI-7-19.PMC4774169.pdf
"Surgical Neurology International 2016, 7:19  http://www.surgicalneurologyint.com/content/7/1/19Table 2: Baseline characteristics of participants Sex Age ICP preoperative GSC preoperative Bone flap size GOS 6 months GOS 12 months Complications A 22 20 5 130 4 5 Hemorrhagic diathesis A 56 18 7 135 2 2 Rebleeding A 64 15 5 130 5 5 A 64 25 3 120 1 1 Hypovolemic shock, death A 38 20 4 124 4 5 A 63 20 4 125 2 2 A 32 20 5 134 3 4 Hemodynamic instability A 71 17 7 130 5 5 Θ 16 25 3 136 2 4 A 33 20 6 128 5 5 A 27 20 5 137 2 4 A 27 20 5 115 3 4 Θ 54 25 3 130 2 3 Θ 6 25 3 105 2 4 A 72 25 3 110 2 2 Hemodynamic instability A 52 25 4 135 2 3 A 32 25 5 120 3 5 A 7 25 5 135 3 4 A 75 20 6 122 5 5 A 12 50 3 138 2 3 Hemodynamic instability A 12 20 6 116 4 4 A 12 20 5 128 4 4 A 12 25 3 137 2 3 A 25 30 3 136 2 4 Hemodynamic instability A 70 15 7 138 4 4 A 25 30 6 130 4 5 A 30 20 6 132 4 5 A 18 10 8 122 5 5 A 41 25 3 136 2 3 A 30 20 5 130 4 5 A 67 20 6 139 4 4 A 33 20 6 119 4 5 A 75 25 5 120 3 3 A 71 15 7 132 5 5 A 43 40 3 139 3 3 A 49 50 3 110 2 3 A 35 30 3 140 2 3 A 56 20 5 131 4 5 Hypertension, seizure A 69 30 6 130 5 5 A 72 40 3 135 2 2 Hemorrhagic diathesis Θ 70 20 5 120 3 4 Hemodynamic instability A 22 10 8 136 5 5 A 41 12 8 122 5 5 A 54 15 7 138 5 5 Θ 65 20 6 110 4 4 Θ 14 20 5 114 4 5 Hypotension A 28 30 5 132 4 4 Hemodynamic instability A 37 40 4 138 2 3 Θ 32 30 3 110 2 3 Hemodynamic instability A 56 20 7 127 5 5 Θ 44 25 4 137 2 4 Bradycardia Contd...",Non-OADS,/arxiv_data1/oa_pdf/fc/63/SNI-7-19.PMC4774169.pdf
"Surgical Neurology International 2016, 7:19  http://www.surgicalneurologyint.com/content/7/1/19Table 2: Contd..",Non-OADS,/arxiv_data1/oa_pdf/fc/63/SNI-7-19.PMC4774169.pdf
"Surgical Neurology International 2016, 7:19  http://www.surgicalneurologyint.com/content/7/1/19There are many prognostic factors affecting the outcome  in severe TBI after DC such as age, lowest recorded  GCS, presence of cranial fracture, absence of pupillary  response/brainstem reflexes, respiratory insufficiency,  refractory rise in ICP and the status of the basal cisterns  or third ventricle on CT scan, the volume and location of  the lesion, and the timing of surgery.",Non-OADS,/arxiv_data1/oa_pdf/fc/63/SNI-7-19.PMC4774169.pdf
"Surgical Neurology International 2016, 7:19  http://www.surgicalneurologyint.com/content/7/1/1911.",Non-OADS,/arxiv_data1/oa_pdf/fc/63/SNI-7-19.PMC4774169.pdf
"Surgical Neurology International 2016, 7:19  http://www.surgicalneurologyint.com/content/7/1/19Commentary This paper continues a concept that is common in  medicine that chronological age is a marker to be used  in treatment.",Non-OADS,/arxiv_data1/oa_pdf/fc/63/SNI-7-19.PMC4774169.pdf
"The primers  were designed using Primer Premier 5 (Gen-Script Real-time  PCR Primer Design, https://www.genscript.com/ssl-bin/ app/primer) and shown in T able 1 , and DNAStar software  (DNAStar company, Madison, WI, USA), and subjected to  BLAST analysis (NCBI).",OADS,/arxiv_data1/oa_pdf/7e/e2/NRR-11-101.PMC4774200.pdf
"Materials and Methods Subjects and imagi ng data Data used in thi s study were obtained from the human  connectome project (HCP) database (http://www.human - connectome.org/) (Van Essen et al., 2013).",OADS,/arxiv_data1/oa_pdf/6e/54/NRR-11-119.PMC4774203.pdf
"Accepted:  2015-12-20 orcid: 0000-0002-6654-302X  (Hyeok Gyu Kwon)    doi: 10.4103/1673-5374.175058          http://www.nrronline.org/ How to cite this article:  Jang SH, Kwon HG (2016) Traumatic ax - onal injury of the medial lemniscus pathway in a patient with trau - matic brain injury: validation by diffusion tensor tractography.",Non-OADS,/arxiv_data1/oa_pdf/10/85/NRR-11-130.PMC4774205.pdf
Available  at: http://dx.doi.org/10.1016/B978-0-444-59544-7.00013-5.,OADS,/arxiv_data1/oa_pdf/89/b1/NRR-11-144.PMC4774208.pdf
NextProt (http://www.nextprot.org/db/) was used to  identify domains and regions of the human SCYL proteins.,OADS,/arxiv_data1/oa_pdf/6c/1a/NRR-11-42.PMC4774220.pdf
Please visit the symposium web - site (http://www.inrs-nrr.org/) for a detailed program.,Non-OADS,/arxiv_data1/oa_pdf/bc/6b/NRR-11-5.PMC4774223.pdf
"Sincerely, Editors-in-chief of NRR Kwok-fai So and Xiao-ming Xu doi: 10.4103/1673-5374.175037       http://www.nrronline.org/    How to cite this article: So KF, Xu XM (2016) Letter from the Edi - tors-in-Chief.",Non-OADS,/arxiv_data1/oa_pdf/bc/6b/NRR-11-5.PMC4774223.pdf
"Accepted:  2015-10-12 doi: 10.4103/1673-5374.169634          http://www.nrronline.org/ How to cite this article: Fischer I, Haas C, Raghupathi R, Jin Y (2016)  Spinal cord concussion: studying the potential risks of repetitive inju - ry.",Non-OADS,/arxiv_data1/oa_pdf/94/64/NRR-11-58.PMC4774225.pdf
"Accepted:  2015-10-10 orcid: 0000-0002-9647-8417 (Zhifeng Kou) 0000-0002-3837-7319 (Dong Sun)    doi: 10.4103/1673-5374.169600          http://www.nrronline.org/ How to cite this article: Kou Z, Sun D (2016) New era of treatment and evalu - ation of traumatic brain injury and spinal cord injury.",Non-OADS,/arxiv_data1/oa_pdf/3c/65/NRR-11-6.PMC4774226.pdf
"Accepted:  2015-12-02 orcid: 0000-0001-5756-3718  (Jana Glumm)    doi: 10.4103/1673-5374.175043          http://www.nrronline.org/ How to cite this article:  Neubert J, Glumm J (2016) Promoting neu - ronal regeneration using extracellular vesicles loaded with superpara - magnetic iron oxide nanoparticles.",Non-OADS,/arxiv_data1/oa_pdf/10/d5/NRR-11-61.PMC4774227.pdf
"White)    doi: 10.4103/1673-5374.175044          http://www.nrronline.org/ How to cite this article: White RB, Thomas MG (2016) Developmental tran - scription factors in age-related CNS disease: a phoenix rising from the ashes?",Non-OADS,/arxiv_data1/oa_pdf/d4/71/NRR-11-64.PMC4774228.pdf
Accepted:  2015-08-26 orcid: 0000-0001-9234-1053  (Laura A. Smith Callahan)    doi: 10.4103/1673-5374.165303          http://www.nrronline.org/ How to cite this article: Smith Callahan LA (2016) The concentra - tion game: differential effects of bioactive signaling in 2D and 3D cul - ture.,Non-OADS,/arxiv_data1/oa_pdf/d7/71/NRR-11-66.PMC4774229.pdf
"Accepted:  2015-09-25 orcid: 0000-0003-0097-8984  (Richard K. Shields)    doi: 10.4103/1673-5374.169623          http://www.nrronline.org/ How to cite this article: Zhorne R, Dudley-Javoroski S, Shields RK (2016) Skel - etal muscle activity and CNS neuro-plasticity.",OADS,/arxiv_data1/oa_pdf/64/61/NRR-11-69.PMC4774230.pdf
"Accepted:  2015-08-19 orcid: 0000-0002-8899-3443  (Hassan Al-Ali)   0000-0003-1633-5318  (John L. Bixby)  0000-0003-1568-5965  (Vance P. Lemmon)  doi: 10.4103/1673-5374.169614          http://www.nrronline.org/ How to cite this article: Al-Ali H, Bixby JL, Lemmon VP (2016) Exploiting  kinase polypharmacology for nerve regeneration.",Non-OADS,/arxiv_data1/oa_pdf/b2/55/NRR-11-71.PMC4774232.pdf
"Accepted:  2016-01-04 orcid: 0000-0002-6884-4897  (Marlan R. Hansen)    doi: 10.4103/1673-5374.175045          http://www.nrronline.org/ How to cite this article: Cheng E, Hansen MR (2016) Schwannomas pro - vide insight into the role of p75NTR and merlin in Schwann cells following  nerve injury and during regeneration.",Non-OADS,/arxiv_data1/oa_pdf/4b/33/NRR-11-73.PMC4774233.pdf
"Accepted:  2015-10-19 doi: 10.4103/1673-5374.169630          http://www.nrronline.org/ How to cite this article: Belousov AB, Fontes JD (2016) Role of neu - ronal gap junctions in NMDA receptor-mediated excitotoxicity and  ischemic neuronal death.",Non-OADS,/arxiv_data1/oa_pdf/f0/8b/NRR-11-75.PMC4774234.pdf
"Accepted:  2015-10-28 doi: 10.4103/1673-5374.175046          http://www.nrronline.org/ How to cite this article: Harrison JL, Rowe RK, Lifshitz J (2016) Lipid  mediators of inflammation in neurological injury: shifting the balance  toward resolution.",Non-OADS,/arxiv_data1/oa_pdf/9f/81/NRR-11-77.PMC4774235.pdf
Accepted:  2015-10-15 orcid: 0000-0002-9809-0299  (Kyoko Koshibu)    doi: 10.4103/1673-5374.169635          http://www.nrronline.org/ How to cite this article: Koshibu K (2016) Nootropics with potential to  (re)build neuroarchitecture.,Non-OADS,/arxiv_data1/oa_pdf/b4/57/NRR-11-79.PMC4774236.pdf
"Diana Ama ntea* Department of Pharmacy, Health and Nutritional Sciences, University of  Calabria, I-87036 Rende (CS), Italy *Corres pondence to:  Diana Amantea, Ph.D., diana.amantea@unical.it.Accepted:  2015-10-26 orcid: 0000-0002-7513-3495  (Diana Amantea)    doi: 10.4103/1673-5374.169633          http://www.nrronline.org/ How to cite this article: Amantea D (2016) Polarizing the immune system towards  neuroprotection in brain ischemia.",Non-OADS,/arxiv_data1/oa_pdf/52/83/NRR-11-81.PMC4774237.pdf
"For example, the Interna - tional Society for Stem Cell Research (ISSCR) provides a pa - tient handbook including questions that patients may review  on a patient education page (http://www.closerlookatstem - cells.org).",Non-OADS,/arxiv_data1/oa_pdf/4d/fe/NRR-11-83.PMC4774238.pdf
"The critical need for a truly informed  consent, with independent regulatory review and oversight  to maximize respect for patient autonomy and minimize po - tential impacts of conflicts of interest for researchers, is high - lighted by the ISSCR “Guidelines for the Clinical Translation  of Stem Cells” (2008, accessed at http://www.isscr.org/docs/ default-source/clin-trans-guidelines/isscrglclinicaltrans.",Non-OADS,/arxiv_data1/oa_pdf/4d/fe/NRR-11-83.PMC4774238.pdf
"Accepted:  2015-10-15 orcid: 0000-0002-0899-3030  (Claire Henchcliffe)    doi: 10.4103/1673-5374.169632          http://www.nrronline.org/ How to cite this article: Hellmers N, Obeng-Aduasare Y, de Me - lo-Martín I, Henchcliffe C (2016) Future needs for informed consent  in stem cell clinical trials in neurodegenerative diseases.",Non-OADS,/arxiv_data1/oa_pdf/4d/fe/NRR-11-83.PMC4774238.pdf
"Accepted:   2015-10-30 orcid: 0000-0002-0926-5473  (Francesca Fernandez-Enright)    0000-0003-2449-8002 (Jessica L. Andrews)   doi: 10.4103/1673-5374.175048          http://www.nrronline.org/ How to cite this article: Fernandez-Enright F, Andrews JL (2016) Lingo-1: a novel  target in therapy for Alzheimer ’s disease?",Non-OADS,/arxiv_data1/oa_pdf/9c/80/NRR-11-88.PMC4774240.pdf
"Accepted:  2015-11-06 doi: 10.4103/1673-5374.175050         http://www.nrronline.org/ How to cite this article:  Salinas Tejedor L, Skripuletz T, Stangel M,  Gudi V (2016) Mesenchymal stem cells require the peripheral immune  system for immunomodulating effects in animal models of multiple  sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/ef/2e/NRR-11-90.PMC4774241.pdf
"Accepted:  2015-12-18 doi: 10.4103/1673-5374.175051          http://www.nrronline.org/How to cite this article: Prins CA, Almeida FM, Martinez AMB (2016) Absence of  galectin-3 attenuates neuroinflammation improving functional recovery after spinal  cord injury.",Non-OADS,/arxiv_data1/oa_pdf/79/79/NRR-11-92.PMC4774242.pdf
Available at: http://exac.broadinstitute.org (accessed April 2015).,OADS,/arxiv_data1/oa_pdf/46/37/ACN3-3-226.PMC4774259.pdf
Automated segmentation of white matter lesions was performedusing the Lesion Segmentation Tool (LST) implementedin SPM8 (http://www.applied-statistics.de/lst.html); thisgenerated a total white matter lesion volume (mL) foreach individual.,OADS,/arxiv_data1/oa_pdf/67/78/ACN3-3-154.PMC4774260.pdf
Available at: http://volbrain.upv.es (accessed December 2014).,Non-OADS,/arxiv_data1/oa_pdf/67/78/ACN3-3-154.PMC4774260.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowFor decades, warfarin, a Vitamin K antagonist, was the only  oral anticoagulant available to physicians.",Non-OADS,/arxiv_data1/oa_pdf/2a/77/SNI-7-22.PMC4774265.pdf
Surg Neurol Int 2016;7:22. http://surgicalneurologyint.com/The-new-era-of-anticoagulation/,Non-OADS,/arxiv_data1/oa_pdf/2a/77/SNI-7-22.PMC4774265.pdf
"Surgical Neurology International 2016, 7:22  http://www.surgicalneurologyint.com/content/7/1/22at high risk for bleeding or with mild renal impairment.",Non-OADS,/arxiv_data1/oa_pdf/2a/77/SNI-7-22.PMC4774265.pdf
"Surgical Neurology International 2016, 7:22  http://www.surgicalneurologyint.com/content/7/1/22tranexamic acid and epsilon‑aminocaproic acid have been  suggested for reversal.",Non-OADS,/arxiv_data1/oa_pdf/2a/77/SNI-7-22.PMC4774265.pdf
"Surgical Neurology International 2016, 7:22  http://www.surgicalneurologyint.com/content/7/1/22Dabigatran versus warfarin in the treatment of acute venous thromboembolism.",Non-OADS,/arxiv_data1/oa_pdf/2a/77/SNI-7-22.PMC4774265.pdf
Available online 25 August 2015; http://dx.doi.org/10.1016/j.simyco.2015.07.001 .,OADS,/arxiv_data1/oa_pdf/b1/0f/main.PMC4774270.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 82: 1 –21.,Non-OADS,/arxiv_data1/oa_pdf/b1/0f/main.PMC4774270.pdf
Duplicated reads were identi ﬁed and marked using Picard tools ( http://broadinstitute.github.io/picard ).,OADS,/arxiv_data1/oa_pdf/b1/0f/main.PMC4774270.pdf
"39.128 = CBS 102605Alternaria – 33.9 – 2.7 96.7 – A. citriarbusti (now A. alternata ) CBS 102598 Alternaria Ion Torrent 34.8 38× 1.7 98.1 1.4 A. gaisen CBS 118488 Alternaria Illumina 35.2 182× 1.8 96.7 2.8 A. tenuissima (now A. alternata ) CBS 918.96 Alternaria Illumina 33.5 260× 1.4 98.2 1.5 A. alternantherae CBS 124392 Alternantherae Illumina 35.0 210× 16.5 89.3 8.0 A. solani CBS 109157 Porri Ion Torrent 32.6 50× 1.5 87.9 9.0 A. avenicola CBS 121459 Panax Illumina 39.1 200× 11.9 87.2 9.5 A. infectoria CBS 210.86 Infectoriae Illumina 36.5 200× 5.3 85.1 10.3 A. papaveraceae CBS 116607 Crivellia Illumina 33.8 220× 5.3 85.8 10.3 A. brassicicola1ATCC 96836= CBS 118699Brassicicola – 32.0 – 7.1 86.6 – 1Publicly available genomes; A. arborescens downloaded from NCBI, A. brassisicola downloaded from JGI ( http://genome.jgi-psf.org/Altbr1/Altbr1.home.html ).",Non-OADS,/arxiv_data1/oa_pdf/b1/0f/main.PMC4774270.pdf
"Phylogenetic analyses Multiple sequence alignments of individual data partitions were generated with MAFFT v. 7 ( http://mafft.cbrc.jp/alignment/server/ index.html ), and manually adjusted.",OADS,/arxiv_data1/oa_pdf/b1/0f/main.PMC4774270.pdf
The best nucleotide sub- stitution model for each partition was determined withFindmodel ( http://www.hiv.lanl.gov/content/sequence/ ﬁndmodel/ ﬁndmodel.html ).,OADS,/arxiv_data1/oa_pdf/b1/0f/main.PMC4774270.pdf
"The resulting trees wereprinted with TreeView v. 1.6.6 ( Page 1996 ) and, together with the alignments, deposited into TreeBASE ( http://www.treebase.",OADS,/arxiv_data1/oa_pdf/b1/0f/main.PMC4774270.pdf
Fungal Diversity .http://dx.doi.org/10.1007/ s13225-015-0320-2 .,OADS,/arxiv_data1/oa_pdf/b1/0f/main.PMC4774270.pdf
Available from: http://tree.bio.,OADS,/arxiv_data1/oa_pdf/b1/0f/main.PMC4774270.pdf
Available from: http://www.repeatmasker.org .,Non-OADS,/arxiv_data1/oa_pdf/b1/0f/main.PMC4774270.pdf
Available from: http://www.repeatmasker.org .,Non-OADS,/arxiv_data1/oa_pdf/b1/0f/main.PMC4774270.pdf
Available online 18 November 2015; http://dx.doi.org/10.1016/j.simyco.2015.10.001 .,OADS,/arxiv_data1/oa_pdf/68/b1/main.PMC4774271.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 82: 23 –74.,Non-OADS,/arxiv_data1/oa_pdf/68/b1/main.PMC4774271.pdf
New insights into the biodiversity and ecology of the indoor mycobiota .http://microbe.net/wp-content/uploads/2014/10/Samson-Sloan- Berkeley-Rob-PC3_v2.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/b1/main.PMC4774271.pdf
Available online 18 November 2015; http://dx.doi.org/10.1016/j.simyco.2015.10.002 .,OADS,/arxiv_data1/oa_pdf/9f/89/main.PMC4774272.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 82: 75 –136.,Non-OADS,/arxiv_data1/oa_pdf/9f/89/main.PMC4774272.pdf
The alignments used were deposited in Tree-BASE ( http://www.treebase.org ).,OADS,/arxiv_data1/oa_pdf/9f/89/main.PMC4774272.pdf
"More than 360 species are recorded as Microdiplodia (MycoBank, http://www.mycobank.org ), but the validity of this genus is unknown due to lack of phylogeneticinformation regarding the lectotype species, M. conigena (Clements & Shear 1931 ).",Non-OADS,/arxiv_data1/oa_pdf/9f/89/main.PMC4774272.pdf
"Notes : The genus Paraphaeosphaeria was established by Eriksson (1967) as a generic segregate from Leptosphaeria .T o date, about 35 taxa have been described as species withinParaphaeosphaeria (http://www.indexfungorum.org , Aug. 2015), of which nine species have been transferred to Neo- phaeosphaeria (Coniothyriaceae orLeptosphaeriaceae )o r Phaeosphaeriopsis (Phaeosphaeriaceae ) based on ascospore and conidial morphology, as well as sequence data from SSUand ITS nrDNA ( C^amara et al.",OADS,/arxiv_data1/oa_pdf/9f/89/main.PMC4774272.pdf
"Notes : To date, 50 species have been described as Keissleriella (orTrichometasphaeria ; MycoBank, http://www.mycobank.org , April 2015), but K. breviasca can be distinguished from all known species by its short asci with consistently four asco-spores ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/main.PMC4774272.pdf
"Notes : Although more than 700 taxa have been described as species within Helminthosporium (http://www.indexfungorum.org , Aug. 2015), the genus has been quite heterogeneous.",OADS,/arxiv_data1/oa_pdf/9f/89/main.PMC4774272.pdf
"Notes : Since establishment of the genus ( Saccardo 1883 ), more than 176 taxa have been described within Massarina (Index Fungorum; http://www.indexfungorum.org , Aug. 2015), but the heterogeneity of the genus has been continuously suggested.Several taxonomic reassessments of many species withinMassarina have been attempted based on morphology ( Bose 1961, Barr 1992, Hyde 1995, Aptroot 1998, Hyde et al.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/main.PMC4774272.pdf
"Notes : Among more than 185 taxa described as Periconia (http://www.indexfungorum.org , Aug. 2015), only two species have been reported to have sexual morphs.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/main.PMC4774272.pdf
"Notes : There are more than 500 names in Camarosporium (http://www.indexfungorum.org , Aug. 2015).",Non-OADS,/arxiv_data1/oa_pdf/9f/89/main.PMC4774272.pdf
"Notes : Although more than 200 species have been assigned to Trematosphaeria (http://www.indexfungorum.org , Aug. 2015), most of these species have not had their generic placementsveriﬁed by molecular evidence.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/main.PMC4774272.pdf
"Notes : More than 60 species have been described in Monodictys (http://www.indexfungorum.org , Aug. 2015), but their phylogenetic placements are mostly unknown.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/main.PMC4774272.pdf
Available at: http://www.tree ﬁnder.de .,Non-OADS,/arxiv_data1/oa_pdf/9f/89/main.PMC4774272.pdf
Available online 26 November 2015; http://dx.doi.org/10.1016/j.simyco.2015.10.003 .,OADS,/arxiv_data1/oa_pdf/0a/c3/main.PMC4774273.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 82: 137 –217.,Non-OADS,/arxiv_data1/oa_pdf/0a/c3/main.PMC4774273.pdf
"Alignments of all consensus sequences, as well as the reference sequences were generated with MAFFT v. 7 ( http://mafft.cbrc.jp/alignment/ server/index.html ;Katoh & Standley 2013 ), and were improved manually when necessary.",OADS,/arxiv_data1/oa_pdf/0a/c3/main.PMC4774273.pdf
http://nt.ars-grin.gov/fungaldatabases/ .,OADS,/arxiv_data1/oa_pdf/0a/c3/main.PMC4774273.pdf
Available from:  http://www.sakura-americas.com/wp-content/uploads/00_nov.,Non-OADS,/arxiv_data1/oa_pdf/3a/1c/JOMFP-19-306.PMC4774282.pdf
Available from:  http://www.sakura-americas.com/wp-content/uploads/06_may.,Non-OADS,/arxiv_data1/oa_pdf/3a/1c/JOMFP-19-306.PMC4774282.pdf
Available from:  http://www.sakura-americas.com/wp-content/uploads/96_sept.pdf [Last cited on 2015 Dec 12].,Non-OADS,/arxiv_data1/oa_pdf/3a/1c/JOMFP-19-306.PMC4774282.pdf
Available from: http://www.ihcworld.com/_ histologic/pdf/82_july.pdf [Last cited on 2015 Dec 12].,OADS,/arxiv_data1/oa_pdf/3a/1c/JOMFP-19-306.PMC4774282.pdf
"Briefly, 3 µg RNA samples were labeled with the Exiqon  Hy3/Hy5 power labeling kit (Exiqon, Vedbaek, Denmark)  and hybridized on the miRCURY LNA™ array (version 18.0;  Exiqon), which contains 3,100 capture probes, covering  all human miRNAs annotated in the miRBase database  (http://www.mirbase.org/) .",OADS,/arxiv_data1/oa_pdf/2e/29/etm-11-03-0811.PMC4774313.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/98/24/hepatmon-15-12-30300.PMC4774338.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ea/08/hepatmon-15-12-32498.PMC4774339.pdf
"Global Initiative for Chronic Obstructive Lung Disease (GOLD):  Global Strategy for the Diagnosis, Management and Prevention  of COPD, 2013. http://www.goldcopd.org/.",Non-OADS,/arxiv_data1/oa_pdf/7a/54/etm-11-03-0723.PMC4774341.pdf
"Global Initiative for asthma (GINA): Global Strategy for Asthma  Management and Prevention, 2012. http://www.ginasthma.org/.",Non-OADS,/arxiv_data1/oa_pdf/7a/54/etm-11-03-0723.PMC4774341.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/25/31/hepatmon-15-12-33073.PMC4774342.pdf
The gene expression profile GSE12486  was obtained from the Gene Expression Omnibus database  (GEO; http://www.ncbi.nlm.nih.gov/geo/) (9).,OADS,/arxiv_data1/oa_pdf/14/3f/etm-11-03-0864.PMC4774345.pdf
"Refai  Showkathali Senior  Consultant  Interventional  Cardiologist, MIOT  International  Hospital,  Chennai,  India E-mail  address:  refais@gmail.com Available  online  11  January  2016 http://dx.doi.org/10.1016/j.ihj.2015.10.373 0019-4832/ #  2015  Cardiological  Society  of  India.",Non-OADS,/arxiv_data1/oa_pdf/be/5e/main.PMC4774350.pdf
"This is an open access article licensed under the terms of the (https://creativecommons.org/licenses/by/4.0/legalcode), which p ermits unrestricted, non- commercial use, distribution and reproduction in a ny medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/a9/TOBEJ-9-310.PMC4774379.pdf
"This is an open access article licensed under the terms of the (https://creativecommons.org/licenses/by/4.0/legalcode), which p ermits unrestricted, non- commercial use, distribution and reproduction in a ny medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/eb/TOBEJ-9-292.PMC4774380.pdf
"This is an open access article licensed under the terms of the (https://creativecommons.org/licenses/by/4.0/legalcode), which p ermits unrestricted, non- commercial use, distribution and reproduction in a ny medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/a1/TOBEJ-9-282.PMC4774381.pdf
"This is an open access article licens ed under the terms of the (https://creativecommons.org/licenses/by/4.0/legalcode), which permits unr estricted, non - commercial use, distribution and reproduction in any medium, pr ovided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/d2/TOBEJ-9-288.PMC4774382.pdf
"This is an open access article licensed under the terms of the (https://creativecommons.org/licenses/by/4.0/legalcode), which p ermits unrestricted, non- commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/c4/TOBEJ-9-314.PMC4774383.pdf
"This is an open access article licensed under the terms of the (https://creativecommons.org/licenses/by/4.0/legalcode), which p ermits unrestricted, non- commercial use, distribution and reproduction in a ny medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/56/TOBEJ-9-322.PMC4774384.pdf
"This is an open access article licensed under the terms of the (https://creativecommons.org/licenses/by/4.0/legalcode), which p ermits unrestricted, non- commercial use, distribution and reproduction in a ny medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/9d/TOBEJ-9-305.PMC4774390.pdf
"This is an open access article licensed under the terms of the (https://creativecommons.org/licenses/by/4.0/legalcode), which p ermits unrestricted, non- commercial use, distribution and reproduction in a ny medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/3d/TOBEJ-9-301.PMC4774392.pdf
"This is an open access article licensed under the terms of the (https://creativecommons.org/licenses/by/4.0/legalcode), which p ermits unrestricted, non- commercial use, distribution and reproduction in a ny medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/a9/TOBEJ-9-318.PMC4774396.pdf
"This is an open access article licensed under the terms of the (https://creativecommons.org/licenses/by/4.0/legalcode), which p ermits unrestricted, non- commercial use, distribution and reproduction in a ny medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/b0/TOBEJ-9-296.PMC4774397.pdf
"org/), PicTar (http://pictar.mdc -berlin.de/) and miRDB (http:// www.mirdb.org/miRDB/), the 3' -UTR of BCL9 containing a  sequence motif mat ching with the ‘seed’ sequence of miR -30c  was identified (Fig.",OADS,/arxiv_data1/oa_pdf/25/e7/ol-11-03-2001.PMC4774446.pdf
2010. http://www.who.int/classifications/icd/ ICD10Volume2_en_2010.pdf.,OADS,/arxiv_data1/oa_pdf/25/e7/ol-11-03-2001.PMC4774446.pdf
"Key Words:  iRhom1, iRhom2, TNF-a, TACE, EGFRAbstract Copyright  © 2016 The Korean Society of Applied Pharmacology*Corresponding Authors E-mail: namk@kribb.re.kr (Nam KH), kchoi@cbu.ac.kr (Choi KC) Tel: +82-43-240-6561 (Nam KH), +82-43-261-3664 (Choi KC)Fax: +82-43-240-6569 (Nam KH), +82-43-249-1745 (Choi KC)*Two authors contributed equally as corresponding authors.Received  Sep 14, 2015  Revised  Nov 3, 2015  Accepted  Nov 6, 2015 Published Online  Mar 1, 2016http://dx.doi.org/10.4062/biomolther.2015.149 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/9b/bt-24-109.PMC4774490.pdf
"110 http://dx.doi.org/10.4062/biomolther.2015.149al., 2001; Urban et al., 2002; Lemberg et al., 2005; Urban and  Wolfe, 2005).",OADS,/arxiv_data1/oa_pdf/10/9b/bt-24-109.PMC4774490.pdf
"112 http://dx.doi.org/10.4062/biomolther.2015.149et al., 2011), similar to the phenotype observed in increased  activation of the EGFR pathway (Foltenyi et al., 2007).",Non-OADS,/arxiv_data1/oa_pdf/10/9b/bt-24-109.PMC4774490.pdf
114 http://dx.doi.org/10.4062/biomolther.2015.149implications of enhanced genomic analysis of rhomboid intramem- brane proteases.,OADS,/arxiv_data1/oa_pdf/10/9b/bt-24-109.PMC4774490.pdf
"MT (5-methoxy N-acetyltryptamine) is a neurohormone with   a tryptamine structure that binds to G-protein-coupled recep- *Corresponding Author E-mail: jang@skku.edu Tel: +82-31-290-7780, Fax: +82-31-292-8800Received  Jul 8, 2015  Revised  Dec 4, 2015  Accepted  Jan 4, 2016 Published Online  Mar 1, 2016http://dx.doi.org/10.4062/biomolther.2015.097 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/f0/bt-24-115.PMC4774491.pdf
"116 http://dx.doi.org/10.4062/biomolther.2015.097Biomol  Ther 24(2), 115-122 (2016) tors MT 1 and MT 2.",OADS,/arxiv_data1/oa_pdf/1e/f0/bt-24-115.PMC4774491.pdf
"118 http://dx.doi.org/10.4062/biomolther.2015.097Biomol  Ther 24(2), 115-122 (2016) the hypnotic effect of MT.",Non-OADS,/arxiv_data1/oa_pdf/1e/f0/bt-24-115.PMC4774491.pdf
"120 http://dx.doi.org/10.4062/biomolther.2015.097Biomol  Ther 24(2), 115-122 (2016) We investigated phosphorylation of ERK1/2, p38 MAPK,  PKA, and PKC in mice treated with the combination of quin - pirole, MT, and pentobarbital.",Non-OADS,/arxiv_data1/oa_pdf/1e/f0/bt-24-115.PMC4774491.pdf
"122 http://dx.doi.org/10.4062/biomolther.2015.097Biomol  Ther 24(2), 115-122 (2016) 22, 314-320.",Non-OADS,/arxiv_data1/oa_pdf/1e/f0/bt-24-115.PMC4774491.pdf
"Aloin, an anthraquinone glycoside, also known as barbaloin, is a bitter, yellow-brown  colored compound with clinically proven pharmacological ac- tions including anti-tumor, anti-inflammatory, anti-oxidant and Original Article *Corresponding Author E-mail: masugi@med.miyazaki-u.ac.jp Tel: +81-985 851785, Fax: +81-985 857932Received  Jul 20, 2015  Revised  Sep 10, 2015  Accepted  Oct 21, 2015 Published Online  Mar 1, 2016http://dx.doi.org/10.4062/biomolther.2015.106 Copyright  © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/cd/bt-24-123.PMC4774492.pdf
"124 http://dx.doi.org/10.4062/biomolther.2015.106anti-colitis properties (Park et al., 2011; Cui et al., 2014; Esmat  et al., 2015).",OADS,/arxiv_data1/oa_pdf/5c/cd/bt-24-123.PMC4774492.pdf
"126 http://dx.doi.org/10.4062/biomolther.2015.106Biomol  Ther 24(2), 123-131 (2016)  Fig.",Non-OADS,/arxiv_data1/oa_pdf/5c/cd/bt-24-123.PMC4774492.pdf
"128 http://dx.doi.org/10.4062/biomolther.2015.106RESUL TS Preliminary studies were conducted to assess the effect  of aloin on cell viability, proliferation, and toxicity.",OADS,/arxiv_data1/oa_pdf/5c/cd/bt-24-123.PMC4774492.pdf
"130 http://dx.doi.org/10.4062/biomolther.2015.106DISCUSSION Many research groups are currently attempting to identify  molecules that stimulate osteoblast differentiation, for the de- velopment of drugs to treat osteoporosis.",Non-OADS,/arxiv_data1/oa_pdf/5c/cd/bt-24-123.PMC4774492.pdf
"Previous studies (Zeisberg et  al., 2007) have shown that the EndMT process, which is re-garded as an important mechanism for CAF recruitment to the Original Article *Corresponding Author E-mail: 475625278@qq.com Tel: +514 87373006, Fax: +514 87373006 †The first two authors contributed equally to this work.Received  Jul 1, 2015  Revised  Oct 4, 2015  Accepted  Nov 12, 2015 Published Online  Mar 1, 2016http://dx.doi.org/10.4062/biomolther.2015.088 Copyright  © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/1a/bt-24-132.PMC4774493.pdf
"134 http://dx.doi.org/10.4062/biomolther.2015.088Biomol  Ther 24(2), 132-139 (2016)  F-actin filaments staining was performed with phalloidin-FITC  diluted in 3% BSA in PBS for 60 min followed by staining with  Actin-Trakcer Green.",Non-OADS,/arxiv_data1/oa_pdf/14/1a/bt-24-132.PMC4774493.pdf
"136 http://dx.doi.org/10.4062/biomolther.2015.088Biomol  Ther 24(2), 132-139 (2016)  DISCUSSION Endothelial-to-Mesenchymal Transition (EndMT) is a form  of the more widely known and studied Epithelial-to-Mesenchy - mal Transition (EMT).",Non-OADS,/arxiv_data1/oa_pdf/14/1a/bt-24-132.PMC4774493.pdf
"138 http://dx.doi.org/10.4062/biomolther.2015.088Biomol  Ther 24(2), 132-139 (2016)  to Smurfs in the nucleus and translocates into the cytoplasm  in response to TGF- β and recruits the ubiquitin ligases to the  activated type I receptors, leading to the degradation of the re-ceptor through the proteasomal pathway (Ng et al., 2005; Yan  et al., 2009).",Non-OADS,/arxiv_data1/oa_pdf/14/1a/bt-24-132.PMC4774493.pdf
"In this study, we tested the effect of ATF3 on NAR-mediat - ed apoptosis in human colon cancer and we report that NAR Original Article Biomol  Ther 24(2), 140-146 (2016) *Corresponding Author E-mail: jjb0403@anu.ac.kr Tel: +82-54-820-7757, Fax: +82-54-820-6252Received  Jul 23, 2015  Revised  Oct 5, 2015  Accepted  Oct 26, 2015 Published Online  Mar 1, 2016http://dx.doi.org/10.4062/biomolther.2015.109 Copyright  © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/e4/bt-24-140.PMC4774494.pdf
"142Biomol  Ther 24(2), 140-146 (2016) http://dx.doi.org/10.4062/biomolther.2015.109tures containing 1 μg of ATF3 promoter linked to luciferase  and 0.1 μg of pRL-null vector were transfected for 24 h. The  transfected cells were cultured in the absence or presence of NAR for 24.",Non-OADS,/arxiv_data1/oa_pdf/2d/e4/bt-24-140.PMC4774494.pdf
"144Biomol  Ther 24(2), 140-146 (2016) http://dx.doi.org/10.4062/biomolther.2015.109hibition by SB203580 blocked PARP cleavage by NAR (Fig.",Non-OADS,/arxiv_data1/oa_pdf/2d/e4/bt-24-140.PMC4774494.pdf
"146Biomol  Ther 24(2), 140-146 (2016) http://dx.doi.org/10.4062/biomolther.2015.109genesis 27, 972-981.",Non-OADS,/arxiv_data1/oa_pdf/2d/e4/bt-24-140.PMC4774494.pdf
"Key Words:  Cytotoxic, Apoptosis, Mitochondrial pathway, K562 cellAbstract Copyright  © 2016 The Korean Society of Applied Pharmacology*Corresponding Authors E-mail: luyanhua@ecust.edu.cn  (Lu Y), rxtan@nju.edu.cn (Tan R) Tel: +86-21-64251185 (Lu Y), +86-25-83592945 (Tan R)Fax: +86-21-64251185 (Lu Y), +86-25-83592945 (Tan R)Received  Jul 6, 2015  Revised  Nov 30, 2015  Accepted  Jan 7, 2016 Published Online  Mar 1, 2016http://dx.doi.org/10.4062/biomolther.2015.093 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/53/bt-24-147.PMC4774495.pdf
"148 http://dx.doi.org/10.4062/biomolther.2015.093Biomol  Ther 24(2), 147-155 (2016) submerged liquid culture of the marine endophytic fungus  Aspergillus fumigatus CY018 (Lu et al., 2014).",OADS,/arxiv_data1/oa_pdf/27/53/bt-24-147.PMC4774495.pdf
"150 http://dx.doi.org/10.4062/biomolther.2015.093Biomol  Ther 24(2), 147-155 (2016) RESUL TS Cytotoxic effects of chaetominine on K562 cells  The effect of chaetominine on the growth of the human leu- kemia K562 cell line was tested using the MTT assay with  5-FU as a positive control.",Non-OADS,/arxiv_data1/oa_pdf/27/53/bt-24-147.PMC4774495.pdf
"152 http://dx.doi.org/10.4062/biomolther.2015.093Biomol  Ther 24(2), 147-155 (2016) Cytotoxic effect of chaetominine on primary human   peripheral blood cells  The cytotoxicity of chaetominine on HPBMCs was evalu - ated by the MTT assay.",OADS,/arxiv_data1/oa_pdf/27/53/bt-24-147.PMC4774495.pdf
"154 http://dx.doi.org/10.4062/biomolther.2015.093Biomol  Ther 24(2), 147-155 (2016) apoptotic effect.",Non-OADS,/arxiv_data1/oa_pdf/27/53/bt-24-147.PMC4774495.pdf
"In the absence of a reliable liver protective drug  in the modern system of medicine, natural extracts from me-Original Article Biomol  Ther 24(2), 156-162 (2016) Copyright  © 2016 The Korean Society of Applied Pharmacology*Corresponding Authors E-mail: zhanghhx@vip.sina.com (Zhang H), chenyang197732@hotmail.com (Chen Y) Tel: +86-028-85503037 (Zhang H), +86-0756-7637616 (Chen Y) Fax: +86-028-85503037 (Zhang H), +86-0756-7637616 (Chen Y)Received  Jul 6, 2015  Revised  Aug 28, 2015  Accepted  Dec 29, 2015 Published Online  Mar 1, 2016http://dx.doi.org/10.4062/biomolther.2015.094 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/d1/bt-24-156.PMC4774496.pdf
"158Biomol  Ther 24(2), 156-162 (2016) http://dx.doi.org/10.4062/biomolther.2015.094tion 1 h before.",Non-OADS,/arxiv_data1/oa_pdf/63/d1/bt-24-156.PMC4774496.pdf
"160Biomol  Ther 24(2), 156-162 (2016) http://dx.doi.org/10.4062/biomolther.2015.094Effect of chemicals on the animal vital signs and tissue  index After the administration of carbon tetrachloride, there was  no death case in normal control group and the therapies  groups, while three deaths occurred in model control group.",Non-OADS,/arxiv_data1/oa_pdf/63/d1/bt-24-156.PMC4774496.pdf
"162Biomol  Ther 24(2), 156-162 (2016) http://dx.doi.org/10.4062/biomolther.2015.094paratively beneficial effects on CCl 4-induced liver damage via  induction of antioxidant defense and these biological effects  were further confirmed by histological observations.",Non-OADS,/arxiv_data1/oa_pdf/63/d1/bt-24-156.PMC4774496.pdf
"Key Words:  Apigenin, Chondrocyte, Metalloproteinase, Osteoarthritis Abstract Copyright  © 2016 The Korean Society of Applied Pharmacology*Corresponding Authors E-mail: LCJ123@cnu.ac.kr (Lee CJ), hscspine@hanmail.net (Hwang SC) Tel: +82-42-580-8255 (Lee CJ), +82-55-750-8102 (Hwang SC)Fax: +82-42-585-6627 (Lee CJ), +82-55-750-8104 (Hwang SC) †The first two authors contributed equally to this work.Received  Dec 30, 2015  Revised  Jan 17, 2016  Accepted  Jan 22, 2016 Published Online  Mar 1, 2016http://dx.doi.org/10.4062/biomolther.2015.217 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/73/bt-24-163.PMC4774497.pdf
"164 http://dx.doi.org/10.4062/biomolther.2015.217Biomol  Ther 24(2), 163-170 (2016)  tellariae Radix, a medicinal plant used for controlling the in- flammatory diseases in folk medicine, showed the various  biological activities including anti-inflammatory and anti-MMP  effects (Durigova et al., 2008; Hwang et al., 2011; Palmieri  et al., 2012; Du et al., 2015; Patil et al., 2015).",OADS,/arxiv_data1/oa_pdf/da/73/bt-24-163.PMC4774497.pdf
"166 http://dx.doi.org/10.4062/biomolther.2015.217Biomol  Ther 24(2), 163-170 (2016)  sure protein concentrations in culture media to ensure consis- tency across samples.",Non-OADS,/arxiv_data1/oa_pdf/da/73/bt-24-163.PMC4774497.pdf
"168 http://dx.doi.org/10.4062/biomolther.2015.217Biomol  Ther 24(2), 163-170 (2016)  IL-1β plus apigenin 50 μM, and IL-1β plus apigenin 100 μM,  respectively.",Non-OADS,/arxiv_data1/oa_pdf/da/73/bt-24-163.PMC4774497.pdf
"170 http://dx.doi.org/10.4062/biomolther.2015.217Biomol  Ther 24(2), 163-170 (2016)  Palmieri, D., Perego, P. and Palombo, D. (2012) Apigenin inhibits the  TNF-α-induced expression of eNOS and MMP-9 via modulating  Akt signalling through oestrogen receptor engagement.",Non-OADS,/arxiv_data1/oa_pdf/da/73/bt-24-163.PMC4774497.pdf
"Most re- cently, a clinical study with thirty-two patients (15 women, 7  men) treated for hyperlipidemia with statin showed that CoQ 10  *Corresponding Author E-mail: sychoung@khu.ac.kr Tel: +82-2-961-9198, Fax: +82-2-961-0372Received  Jul 1, 2015  Revised  Sep 18, 2015  Accepted  Sep 24, 2015 Published Online  Mar 1, 2016http://dx.doi.org/10.4062/biomolther.2015.089 Copyright  © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/74/bt-24-171.PMC4774498.pdf
"172 http://dx.doi.org/10.4062/biomolther.2015.089Biomol  Ther 24(2), 171-177 (2016) supplementation may decrease myopathic symptoms caused  by statin treatment (Caso et al., 2007).",Non-OADS,/arxiv_data1/oa_pdf/86/74/bt-24-171.PMC4774498.pdf
"174 http://dx.doi.org/10.4062/biomolther.2015.089Biomol  Ther 24(2), 171-177 (2016) heart weights were decreased to as low as the normal diet  group (N: 1.32 ± 0.02 g).",Non-OADS,/arxiv_data1/oa_pdf/86/74/bt-24-171.PMC4774498.pdf
"176 http://dx.doi.org/10.4062/biomolther.2015.089Biomol  Ther 24(2), 171-177 (2016) the generation of adenosine triphosphate (ATP) (Siciliano et  al., 2007).",Non-OADS,/arxiv_data1/oa_pdf/86/74/bt-24-171.PMC4774498.pdf
"Esculetin has also recently been Original Article Biomol  Ther 24(2), 178-183 (2016) *Corresponding Author E-mail: jskim@kiom.re.kr Tel: +82-42-868-9465, Fax: +82-42-868-9471Received  Jul 13, 2015  Revised  Oct 24, 2015  Accepted  Nov 20, 2015 Published Online  Mar 1, 2016http://dx.doi.org/10.4062/biomolther.2015.101 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/4d/bt-24-178.PMC4774499.pdf
"180Biomol  Ther 24(2), 178-183 (2016) http://dx.doi.org/10.4062/biomolther.2015.101lens opacification (Fig.",Non-OADS,/arxiv_data1/oa_pdf/3d/4d/bt-24-178.PMC4774499.pdf
"182Biomol  Ther 24(2), 178-183 (2016) http://dx.doi.org/10.4062/biomolther.2015.101posterior cortical regions.",OADS,/arxiv_data1/oa_pdf/3d/4d/bt-24-178.PMC4774499.pdf
"In eastern Asia,  Rosa rugosa is a traditional herbal medicine for treating ill-nesses such as stomach aches, diarrhoea, menoxenia, dia- betes mellitus, pain and chronic inflammatory disease (Gu et  *Corresponding Author E-mail: haji@ms.xjb.ac.cn Tel: +86-991-3835-679, Fax: +86-991-3838-957 †The first two authors contributed equally to this work.Received  Jul 2, 2015  Revised  Sep 10, 2015  Accepted  Sep 24, 2015 Published Online  Mar 1, 2016http://dx.doi.org/10.4062/biomolther.2015.090 Copyright  © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/d9/bt-24-184.PMC4774500.pdf
"186 http://dx.doi.org/10.4062/biomolther.2015.090Biomol  Ther 24(2), 184-190 (2016) with primary antibody at 4°C overnight, and subsequently in- cubated with secondary antibody for 1 h. Membranes were  washed three times with PBST for 10 min each step.",Non-OADS,/arxiv_data1/oa_pdf/d5/d9/bt-24-184.PMC4774500.pdf
"188 http://dx.doi.org/10.4062/biomolther.2015.090Biomol  Ther 24(2), 184-190 (2016) wide range of pathogenic stimuli and performs a key role in  the pathogenesis of chronic inflammatory diseases.",OADS,/arxiv_data1/oa_pdf/d5/d9/bt-24-184.PMC4774500.pdf
"190 http://dx.doi.org/10.4062/biomolther.2015.090Biomol  Ther 24(2), 184-190 (2016) lia in lipopolysaccharide-induced macrophages is associated with  its anti-inflammatory effect.",Non-OADS,/arxiv_data1/oa_pdf/d5/d9/bt-24-184.PMC4774500.pdf
"Key Words:  VDR, Quercetin, Fluorescence, STD-NMR, Molecular dynamics simulationAbstract Copyright  © 2016 The Korean Society of Applied Pharmacology*Corresponding Authors E-mail: mdseo@ajou.ac.kr (Seo MD), hjmaeng@gachon.ac.kr (Maeng HJ) Tel: +82-31-219-3450 (Seo MD), +82-32-899-6580 (Maeng HJ)Fax: +82-31-219-3435 (Seo MD), +82-32-899-6118 (Maeng HJ)Received  Aug 7, 2015  Revised  Aug 26, 2015  Accepted  Sep 9, 2015 Published Online  Mar 1, 2016http://dx.doi.org/10.4062/biomolther.2015.122 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/34/bt-24-191.PMC4774501.pdf
"192 http://dx.doi.org/10.4062/biomolther.2015.122Biomol  Ther 24(2), 191-198 (2016)  their active states.",OADS,/arxiv_data1/oa_pdf/b0/34/bt-24-191.PMC4774501.pdf
"194 http://dx.doi.org/10.4062/biomolther.2015.122Biomol  Ther 24(2), 191-198 (2016)  STD-NMR detection of quercetin subsites for VDR binding As quercetin binds to the VDR-LBD with relatively low affin- ity (K d in the micromolar range), we employed highly sensitive  STD-NMR spectroscopy to analyze the interaction between  quercetin and the VDR-LBD.",Non-OADS,/arxiv_data1/oa_pdf/b0/34/bt-24-191.PMC4774501.pdf
"196 http://dx.doi.org/10.4062/biomolther.2015.122Biomol  Ther 24(2), 191-198 (2016)  molecular contacts with the VDR-LBD than 1,25(OH) 2D3, and  consequently has a relatively high degree of freedom, with re- laxed binding specificity inside the ligand binding pocket (Fig.",Non-OADS,/arxiv_data1/oa_pdf/b0/34/bt-24-191.PMC4774501.pdf
"198 http://dx.doi.org/10.4062/biomolther.2015.122Biomol  Ther 24(2), 191-198 (2016)  REFERENCES Bartik, L., Whitfield, G. K., Kaczmarska, M., Lowmiller, C. L., Moffet, E.  W., Furmick, J. K., Hernandez, Z., Haussler, C. A., Haussler, M. R.  and Jurutka, P. W. (2010) Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.",Non-OADS,/arxiv_data1/oa_pdf/b0/34/bt-24-191.PMC4774501.pdf
"Since the plasma lactate  level induced by biguanide was correlated with the function of OCT1 (Wang et al., 2003), the difference in OCT1-mediated  transport may explain the variation in lactic acidosis incidence  *Corresponding Author E-mail: songimsook1@gmail.com Tel: +82-53-950-8575, Fax: +82-53-950-8557Received  Jul 1, 2015  Revised  Aug 19, 2015  Accepted  Aug 20, 2015 Published Online  Mar 1, 2016http://dx.doi.org/10.4062/biomolther.2015.087 Copyright  © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/b7/bt-24-199.PMC4774502.pdf
"200 http://dx.doi.org/10.4062/biomolther.2015.087Biomol  Ther 24(2), 199-205 (2016) between metformin and phenformin.",Non-OADS,/arxiv_data1/oa_pdf/a4/b7/bt-24-199.PMC4774502.pdf
"202 http://dx.doi.org/10.4062/biomolther.2015.087Biomol  Ther 24(2), 199-205 (2016) on the transport rate of digoxin in LLC-PK1-Pgp cells.",OADS,/arxiv_data1/oa_pdf/a4/b7/bt-24-199.PMC4774502.pdf
"204 http://dx.doi.org/10.4062/biomolther.2015.087Biomol  Ther 24(2), 199-205 (2016) plasma samples from rats administered phenformin (single  oral dose, 100 mg/kg) with and without verapamil (2.5 mg/kg/ hr infusion for 10 h and 1.5 mg/kg loading injection).",Non-OADS,/arxiv_data1/oa_pdf/a4/b7/bt-24-199.PMC4774502.pdf
"Laccase [benzenediol:oxygen oxidoreductase, enzyme  commission number,  1.10.3.2 (http://www.kegg.jp/dbget-bin/ www_bget?ec:1.10.3.2); LAC] is part of the largest subgroup  of blue multicopper oxidases, and exhibits the distinctive redox  ability of copper ions, since it is capable of catalyzing the  oxidation of an extensive range of aromatic substrates concom - itantly with the reduction of molecular oxygen to water (9,10).",Non-OADS,/arxiv_data1/oa_pdf/e8/48/ol-11-03-2009.PMC4774592.pdf
"Firstly, the dimerization interface of the HexA α -subunit  was identified from a PISA analysis (http://www.ebi.ac.uk/pdbe/prot_int/ pistart.html)42 of the HexA crystal structure.3 The identified interface was  then replaced with residues comprising the more stable homodimeric β-subunit:β -subunit interface found in human HexB, which was identified by  a PISA analysis of the human HexB 2 crystal structure.",OADS,/arxiv_data1/oa_pdf/9f/a2/mtm201557.PMC4774620.pdf
"https://www.addgene.org/41824/, Addgene, Cambridge, MA) via Round-the-horn site-directed mutagenesis  http:// openwetware.org/wiki/’Round-the-horn_site-directed_mutagenesis using Platinum Taq polymerase (Life Technologies, Grand Island, NY) in place of the Q5 polymerase in the Q5 Site-directed mutagenesis kit (New England Biolabs, Ipswich, MA).",Non-OADS,/arxiv_data1/oa_pdf/9f/a2/mtm201557.PMC4774620.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/9f/a2/mtm201557.PMC4774620.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/  Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/2f/a2/mtm20161.PMC4774621.pdf
Several randomized trials have been registered on http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/d9/b7/CCR-11-328.PMC4774638.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/73/d8/mtm20169.PMC4774642.pdf
"The miRNA-10b sponge was designed according to a previous design principle (7,11), and the hsa-miRNA-10b-5P sequence was provided by miRNABase database (http://www.mirbase.org), and was synthesized by Shanghai Integrated Biotech Solutions Co., Ltd.",OADS,/arxiv_data1/oa_pdf/41/60/or-35-04-1950.PMC4774667.pdf
"The EuroSCORE II and STS   risk score were calculated with free online calculators available at http://www.euroscore.org and http://209.220.160.181/   STSWebRiskCalc261/de.aspx, respectively.",OADS,/arxiv_data1/oa_pdf/15/90/HI-9-2-53.PMC4774933.pdf
http://creativecommons.org/ licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/2c/6c/txd-1-e41.PMC4775084.pdf
"Within each age group (pediatric and adult), we used nearest-neighbor Mahalanobis metric matching (http://www.stata.",Non-OADS,/arxiv_data1/oa_pdf/2c/6c/txd-1-e41.PMC4775084.pdf
"Historical trends in acute rejection by transplant year, donor type, and recipient age are shown in Figure S2a-S2b ( SDC, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/2c/6c/txd-1-e41.PMC4775084.pdf
"Currently, there is an observational, noninter- ventional, multicenter registry focusing on pediatric and adultaHUS patients who were treated with eculizumab (a human- ized anti-C5 monoclonal antibody that inhibits terminal com- plement activation) therapy (http://clinicaltrials.gov/show/NCT01522183).",Non-OADS,/arxiv_data1/oa_pdf/2c/6c/txd-1-e41.PMC4775084.pdf
"Keywords Activities; Participation; Physical activity Introduction Staying active and socially engaged is important as we age.1 The activity theory of aging  proposes that higher levels of participation in social and leisure activities, and role  replacement when circumstances require, are essential to the well-being of older adults2,3  also endorsed engagement as one of three domains of ‘successful aging.’ According to their  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
http://dx.doi.org/10.1080/01924780903552246 .,Non-OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
http://dx.doi.org/10.1080/01924788.2012.702306 .,Non-OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00005 .,Non-OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
http://dx.doi.org/10.1001/jama.,Non-OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
http://dx.doi.org/10.1093/aje/ kws125 .,Non-OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
http://dx.doi.org/10.1007/s12160-010-9172-x .,Non-OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
http://dx.doi.org/10.1093/ije/dyq104 .,OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
http://dx.doi.org/10.1016/j.pmr.2009.12.006 .,OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00260 .,Non-OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
http://dx.doi.org/10.1207/s15324796abm3002_6 .,Non-OADS,/arxiv_data1/oa_pdf/3b/d6/nihms761500.PMC4775165.pdf
"4–6 Multiple allelic variants in the CYP2C19 gene have been described, with over 69 reported to date (http://www.cypalleles.",Non-OADS,/arxiv_data1/oa_pdf/8a/23/tpj201558a.PMC4775436.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website (http://www.nature.com/tpj)Effect of gene diplotype on CYP2C19 activity Y Shirasaka et al 387 © 2016 Macmillan Publishers Limited The Pharmacogenomics Journal (2016), 375 –387",Non-OADS,/arxiv_data1/oa_pdf/8a/23/tpj201558a.PMC4775436.pdf
235Original  articleDOI: http://dx.doi.org/10.1590/1413-785220152305148842 All the authors declare that there is no potential conflict of interest referring to this article.,Non-OADS,/arxiv_data1/oa_pdf/ba/8f/1413-7852-aob-23-05-00235.PMC4775472.pdf
"Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To determine the prevalence of low back pain in  children and its relationship with gender, age, exercise practi - ce and sedentary activities (time on TV and on computer and/or video game).",Non-OADS,/arxiv_data1/oa_pdf/ba/8f/1413-7852-aob-23-05-00235.PMC4775472.pdf
239Original  articleDOI: http://dx.doi.org/10.1590/1413-785220152305138774 All the authors declare that there is no potential conflict of interest referring to this article.,Non-OADS,/arxiv_data1/oa_pdf/57/c0/1413-7852-aob-23-05-00239.PMC4775473.pdf
"Available from URL: http://www.scielo.br/aob.ABSTRACT Objectives: To identify and compare the rate of success of the - rapeutic modalities applied in surgeries for the treatment of in - fections associated with total knee arthroplasty (TKA), and to  evaluate the functional outcome and pain in different therapeutic  modalities by means of quality of life scores.",Non-OADS,/arxiv_data1/oa_pdf/57/c0/1413-7852-aob-23-05-00239.PMC4775473.pdf
244Original  articleDOI: http://dx.doi.org/10.1590/1413-785220152305145784 All the authors declare that there is no potential conflict of interest referring to this article.,Non-OADS,/arxiv_data1/oa_pdf/03/14/1413-7852-aob-23-05-00244.PMC4775474.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To report clinical and epidemiological characteristics and  risk factors of patients with Carpal Tunnel Syndrome (CTS) on sick  leave admitted in a University Hospital.,Non-OADS,/arxiv_data1/oa_pdf/03/14/1413-7852-aob-23-05-00244.PMC4775474.pdf
247Original  articleDOI: http://dx.doi.org/10.1590/1413-785220152305142211 All the authors declare that there is no potential conflict of interest referring to this article.,Non-OADS,/arxiv_data1/oa_pdf/51/43/1413-7852-aob-23-05-00247.PMC4775475.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To evaluate the low energy extracorporeal shock  waves therapy (ESWT) associated with physical therapy in the treatment of chronic muscle injuries classified as grades 2 and 3 in the lower limbs of amateur athletes.,Non-OADS,/arxiv_data1/oa_pdf/51/43/1413-7852-aob-23-05-00247.PMC4775475.pdf
251Original  articleDOI: http://dx.doi.org/10.1590/1413-785220152305119821 All the authors declare that there is no potential conflict of interest referring to this article.,Non-OADS,/arxiv_data1/oa_pdf/b0/da/1413-7852-aob-23-05-00251.PMC4775476.pdf
"Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To evaluate the fatty infiltration and atrophy of the  supraespinatus in the pre- and postoperative of a rotator cuff lesion (RCL), by MRI.",Non-OADS,/arxiv_data1/oa_pdf/b0/da/1413-7852-aob-23-05-00251.PMC4775476.pdf
255Original  articleDOI: http://dx.doi.org/10.1590/1413-785220152305145030 All the authors declare that there is no potential conflict of interest referring to this article.,Non-OADS,/arxiv_data1/oa_pdf/2c/44/1413-7852-aob-23-05-00255.PMC4775477.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To evaluate the effectiveness of intramedullary fixa - tion using the Kirschner-wire (K-wire) compared to the titanium  elastic nail (TEN) in pediatric femoral shaft fractures.,Non-OADS,/arxiv_data1/oa_pdf/2c/44/1413-7852-aob-23-05-00255.PMC4775477.pdf
259Original  articleDOI: http://dx.doi.org/10.1590/1413-785220152305142813 All the authors declare that there is no potential conflict of interest referring to this article.,Non-OADS,/arxiv_data1/oa_pdf/8b/3c/1413-7852-aob-23-05-00259.PMC4775478.pdf
"Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To evaluate the distribution of SP (substance P) and  S-100 peptide immunoreactivity, as well as the vascular supply  of tissues commonly used as grafts for anterior cruciate ligament (ACL) reconstruction.",Non-OADS,/arxiv_data1/oa_pdf/8b/3c/1413-7852-aob-23-05-00259.PMC4775478.pdf
263Original  articleDOI: http://dx.doi.org/10.1590/1413-785220152305121124 All the authors declare that there is no potential conflict of interest referring to this article.,Non-OADS,/arxiv_data1/oa_pdf/31/6d/1413-7852-aob-23-05-00263.PMC4775479.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To compare the functional results of ankle frac - tures treated with metallic and absorbable plates.,Non-OADS,/arxiv_data1/oa_pdf/31/6d/1413-7852-aob-23-05-00263.PMC4775479.pdf
268Original  articleDOI: http://dx.doi.org/10.1590/1413-785220152305138846 All the authors declare that there is no potential conflict of interest referring to this article.,Non-OADS,/arxiv_data1/oa_pdf/a4/8c/1413-7852-aob-23-05-00268.PMC4775480.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To evaluate the bleeding of the femoral head on hip  osteoarthritis in patients who underwent total hip arthroplasty.,Non-OADS,/arxiv_data1/oa_pdf/a4/8c/1413-7852-aob-23-05-00268.PMC4775480.pdf
271Original  articleDOI: http://dx.doi.org/10.1590/1413-785220152305143730 All the authors declare that there is no potential conflict of interest referring to this article.,Non-OADS,/arxiv_data1/oa_pdf/3e/60/1413-7852-aob-23-05-00271.PMC4775481.pdf
"Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To analyze the epidemiological aspects of proximal  humerus fractures and describe the profile of patients with pro - ximal humerus fractures hospitalized and treated at Hospital São Paulo, between 2008 and 2013.",Non-OADS,/arxiv_data1/oa_pdf/3e/60/1413-7852-aob-23-05-00271.PMC4775481.pdf
http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.chathamhouse.org/sites/ ﬁles/chathamhouse/public/Research/Global %20Health/0214SustainableAntibiotics.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.who.int/drugresistance/global_action_plan/ongoing_activities/en.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.nd4bb.eu.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://drive-ab.eu.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://amr-review.org/sites/default/ ﬁles/Report-52.15.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
https://www.whitehouse.gov/sites/default/ ﬁles/docs/national_action_plan_for_- combating_antibotic-resistant_bacteria.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
https://www.ohe.org/publications/ new-drugs-tackle-antimicrobial-resistance-analysis-eu-policy-options.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://who.int/phi/implementation/9_current_who_-model_for_development_preservation_new_antibiotics.pdf?ua =1.,OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.who.int/phi/Incentive strategies for development of antibiotics MJ Renwick et al 86 The Journal of Antibiotics,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.idsociety.org/2012_lpad_proposal_backing.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.reactgroup.org/uploads/publications/react-publications/Exploring-Responses-to-the-need-for-new-antibiotics.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.cgdev.org/doc/books/ vaccine/MakingMarkets-complete.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.who.int/phi/implementation/7_summary_EN.,OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.aei.org/wp-content/ uploads/2013/07/-gottlieb-pdf_092004305764.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
https://www.congress.gov/113/bills/hr4187/BILLS-113hr4187ih.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.cnas.org/ ﬁles/documents/ publications/CNAS_RenewingTheProjectBioShieldAct_Kadlec.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://energycommerce.house.gov/sites/ republicans.energycommerce.house.gov/ ﬁles/114/Analysis/Cures/20150127-Cures-Dis- cussion-Document.pdf.,OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.pewtrusts.org/ ~ /media/Assets/2014/06/25/A-New- Pathway-for-Antibiotic-Innovation/RADARSPEWPresentation13113updatedpdf.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.who.int/phi/ implementation/establishing_drug_discovery_platform_antibiotics_public_goods.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.who.int/phi/ implementation/6_infobrief_delinking_roi_from_sales_volumes.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.rand.org/ content/dam/rand/pubs/reports/2006/R3055.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.businesswire.com/news/home/ 20031113005437/en/FDAs-Fast-Track-Initiative-Cut-Total-Drug#.VR3YYRPF_7c.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.who.int/intellectualproperty/studies/A.Towse.pdf.Accessed on 1 April 2015.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://papers.ssrn.com/sol3/papers.cfm?,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.oecd.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://antibiotics-theperfectstorm.blogspot.co.uk/2011/04/public- private-partnerships-for.html.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.ip-watch.org/2011/09/26/ health-impact-fund-%E2%80%93-raising-issues-of-distribution-ip-rights-and-alliances/.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.cddep.org/blog/posts/can_new_regulatory_pathways_expedite_antibiotic_development_while_assuring_appropriate.,Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
http://www.idsociety.org/uploadedFiles/IDSA/News_and_Publications/IDSA_News_Releases/2012/LPAD%20FAQs.pdf.,OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Incentive strategies for development of antibiotics MJ Renwick et al 88 The Journal of Antibiotics",Non-OADS,/arxiv_data1/oa_pdf/4f/68/ja201598a.PMC4775540.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):1-13 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.1 Received April 8, 2015; Accepted August 7, 2015Corresponding author: Eun Kyoung KangDepartment of Rehabilitation Medicine, Kangwon National University Hospital, 156 Baengnyeong-ro, Chuncheon 24289, KoreaTel: +82-33-258-9205, Fax: +82-33-258-2146, E-mail: stewardofgod@gmail.com  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/7e/arm-40-1.PMC4775741.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):102-110 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.102 Received June 2, 2015; Accepted July 22, 2015Corresponding author: Jun Sang ParkDepartment of Physical Medicine and Rehabilitation, Kyung Hee University Medical Center, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, KoreaTel: +82-2-958-8565, Fax: +82-2-958-8560, E-mail: leadernadakkk@hanmail.net  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/2e/arm-40-102.PMC4775742.pdf
"SNP selection and genotyping We selected four, single nucleotide polymorphisms  (SNPs) with greater than 0.1 heterozygosity among SNPs  located in the coding regions or 3’-untranslated region (UTR) of the  NOS1  gene which were searched at the  dbSNP database (http://www.ncbi.nlm.nih.gov/SNP; dbSNP Build 131) [11,12].",OADS,/arxiv_data1/oa_pdf/6f/2e/arm-40-102.PMC4775742.pdf
"SNPAnalyzer-Pro (ISTECH, Goyang, Korea), HelixTree (Golden Helix, Bozeman, United States), and SNPStats (http://bioinfo.iconcologia.net/index.php?module=Snpstats) were used to analyze genetic data.",OADS,/arxiv_data1/oa_pdf/6f/2e/arm-40-102.PMC4775742.pdf
"For the statistical power, the required case size in each SNP was calculated using the genetic power calculator (http://pngu.mgh.harvard.edu/~purcell/gpc/cc2.html).",OADS,/arxiv_data1/oa_pdf/6f/2e/arm-40-102.PMC4775742.pdf
"Our results suggest that the coding SNP (rs2293054, exon 16, 734th amino acid of NOS1 protein) (http://www.uniprot.org/uniprot/P29475) in the  NOS1  gene contributes to the susceptibil- ity to the clinical phenotype such as NIHSS and MBI in IS patients (Tables 3, 4).",Non-OADS,/arxiv_data1/oa_pdf/6f/2e/arm-40-102.PMC4775742.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):111-119 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.111 Received April 16, 2015; Accepted August 3, 2015Corresponding author: Han-Young JungDepartment of Physical and Rehabilitation Medicine, Inha University School of Medicine, 27 Inhang-ro, Jung-gu, Incheon 22332, KoreaTel: +82-32-890-2486, Fax: +82-32-890-2486, E-mail: rmjung@inha.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/6b/arm-40-111.PMC4775743.pdf
"This is because vitamin D receptors Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):120-125 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.120 Received April 14, 2015; Accepted August 4, 2015Corresponding author: Dong Suk KimDepartment of Physical Medicine and Rehabilitation, 170 Jomaru-ro, Wonmi-gu, Bucheon 14584, KoreaTel: +82-32-621-5114, Fax: +82-32-621-5662, E-mail: nickel0050@gmail.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/c6/47/arm-40-120.PMC4775744.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):126-134 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.126 Received March 30, 2015; Accepted August 6, 2015Corresponding author: Kyung Jae YoonDepartment of Physical and Rehabilitation Medicine, Kangbuk Samsung Hospital, 29 Saemunan-ro, Jongno-gu, Seoul 03181, KoreaTel: +82-2-2001-2284, Fax: +82-2-2001-2176, E-mail: kint99@gmail.com  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/2c/arm-40-126.PMC4775745.pdf
"People with brain injury due to stroke, traumatic brain injury, hypoxia or infec - tion commonly experience significant damage to central Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):135-141 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.135 Received April 29, 2015; Accepted August 7, 2015Corresponding author: Min Ho ChunDepartment of Physical Medicine and Rehabilitation, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, KoreaTel: +82-2-3010-3800, Fax: +82-2-3010-6964, E-mail: mhchun@amc.seoul.kr  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/59/49/arm-40-135.PMC4775746.pdf
"Spinal stenosis can result in the compression of nerves Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):14-20 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.14 Received May 21, 2015; Accepted July 17, 2015Corresponding author: Bum Sun KwonDepartment of Physical Medicine and Rehabilitation, Dongguk Uni­versity College of Medicine, 27 Dongguk ­ro, Ilsandong­gu, Goyang 10326,  KoreaTel: +82­31­961­7460, Fax: +82­31­961­7488, E­mail: bskwon@dumc.or.kr  This is an open­access article distributed under the terms of the Creative  Commons Attribution Non­Commercial License (http://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/ab/e2/arm-40-14.PMC4775747.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):142-151 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.142 Received January 12, 2015; Accepted August 7, 2015Corresponding author: Min Ho ChunDepartment of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, KoreaTel: +82-2-3010-3800, Fax: +82-2-3010-6964, E-mail: mhchun@amc.seoul.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/79/arm-40-142.PMC4775748.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):152-161 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.152 Received June 29, 2015; Accepted August 12, 2015Corresponding author: Kun Jai Lee Department of Rehabilitation Medicine, Kangwon National University Hospital, Kangwon National University College of Medicine, 156 Baengnyeong-ro, Chuncheon 24289, KoreaTel: +82-33-258-9100, Fax: +82-33-258-2146, E-mail: kjleerh@kangwon.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/d7/arm-40-152.PMC4775749.pdf
"Third, Pearson correlation coefficients were calculated to evaluate the association between dif - ferences of subscores of the K-WAB and MMSE-K. Com-parisons between Pearson correlation coefficients were performed using an on-line calculator for the differences between 2 independent correlation coefficients (http://www.quantpsy.org/corrtest/corrtest.htm) [26]: first, each correlation coefficient is converted into a z-score us - ing Fisher r-to-z transformation, then making use of the sample size employed to obtain each coefficient, these z-scores are compared using formula 2.8.5 from Cohen et al.",OADS,/arxiv_data1/oa_pdf/e7/d7/arm-40-152.PMC4775749.pdf
Available from: http://www.quantpsy.org/corrtest/corrtest.htm.,OADS,/arxiv_data1/oa_pdf/e7/d7/arm-40-152.PMC4775749.pdf
"Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016;40(1):162-167 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.162 Received April 3, 2015; Accepted May 26, 2015Corresponding author: Sung-Hee ParkDepartment of Physical Medicine and Rehabilitation, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju 54896, KoreaTel: +82-63-250-2299, Fax: +82-63-254-4145, E-mail: shpark0130@chonbuk.ac.kr  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/dd/c5/arm-40-162.PMC4775750.pdf
"He was transferred to the neu-Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016;40(1):168-171 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.168 Received April 20, 2015; Accepted June 3, 2015Corresponding author: Sung Joon ChungDepartment of Rehabilitation Medicine, Kyung Hee University, 892 Dongnam-ro, Gangdong-gu, Seoul 05278, KoreaTel: +82-2-440-7246, Fax: +82-2-440-7260, E-mail: sungjoon.chung@gmail.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/b7/7e/arm-40-168.PMC4775751.pdf
"She had Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016;40(1):172-176 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.172 Received February 26, 2015; Accepted July 7, 2015Corresponding author: Seung-A HaDepartment of Rehabilitation Medicine, Bundang Jesaeng General Hospital, 20 Seohyeon-ro 180beon-gil, Bundang-gu, Seongnam 13590, KoreaTel: +82-31-779-0063, Fax: +82-31-779-0635, E-mail: hsa12345@hanmail.net  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/3d/9c/arm-40-172.PMC4775752.pdf
"Improvement of cerebral state monitor and Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016;40(1):177-181 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.177 Received June 1, 2015; Accepted July 29, 2015Corresponding author: Bum Sun KwonDepartment of Physical Medicine and Rehabilitation, Dongguk University College of Medicine, 27 Dongguk-ro, Ilsandong-gu, Goyang 10326, KoreaTel: +82-31-961-7460, Fax: +82-31-961-7488, E-mail: bskwon@dumc.or.kr  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/b7/b6/arm-40-177.PMC4775753.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):21-27 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.21 Received June 15, 2015; Accepted July 20, 2015Corresponding author: Keewon KimDepartment of Rehabilitation Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-2072-2619, Fax: +82-2-743-7473, E-mail: keewonkimm.d@gmail.com  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/48/arm-40-21.PMC4775754.pdf
"In Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):28-33 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.28 Received May 7, 2015; Accepted July 29, 2015Corresponding author: Zee Ihn LeeDepartment of Rehabilitation Medicine, Daegu Fatima Hospital, 99 Ayang-ro, Dong-gu, Daegu 41199, KoreaTel: +82-53-940-7823, Fax: +82-53-954-7417, E-mail: zilee@hanmail.net  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/6f/8f/arm-40-28.PMC4775755.pdf
"CMT is defined as a thickening and/or tightness of the unilateral sterno-cleidomastoid muscle (SCM) characterized by fibrosis, resulting in a shortening of the SCM and consequent lim-Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):34-42 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.34 Received April 27, 2015; Accepted July 31, 2015Corresponding author: Shin-Young YimThe Center for Torticollis, Department of Physical Medicine and Rehabilitation, Ajou University School of Medicine, 164 Worldcup-ro, Yeongtong-gu, Suwon 16499, KoreaTel: +82-31-219-5284, Fax: +82-31-219-5209, E-mail: syyim@ajou.ac.kr  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/8b/48/arm-40-34.PMC4775756.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):43-49 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.43 Received April 30, 2015; Accepted July 20, 2015Corresponding author: Hee Kyu KwonDepartment of Physical Medicine and Rehabilitation, Korea University Anam Hospital, Korea University School of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, KoreaTel: +82-2-920-6471, Fax: +82-2-929-9951, E-mail: hkkwon@korea.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/07/arm-40-43.PMC4775757.pdf
"General measurements are made by sensory nerve conduction at the index and middle finger, and by mo-tor conduction from the abductor pollicis brevis (APB) Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):50-55 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.50 Received May 15, 2015; Accepted July 22, 2015Corresponding author: Dong-Sik ParkDepartment of Rehabilitation Medicine, Hallym University Kangdong Sacred Heart Hospital, Hallym University College of Medicine, 150 Seongan-ro, Gangdong-gu, Seoul 05355, KoreaTel: +82-2-2224-2660, Fax: +82-2-2225-2789, E-mail: don@hallym.or.kr  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/92/5b/arm-40-50.PMC4775758.pdf
"Till date, the inadequate regulation of blood glucose  and the duration of the disease have a high correlation Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):56-65 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.56 Received April 30, 2015; Accepted July 27, 2015Corresponding author: Sung-Bom PyunDepartment of Physical Medicine and Rehabilitation, Korea University Anam Hospital, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Korea.",Non-OADS,/arxiv_data1/oa_pdf/25/f2/arm-40-56.PMC4775759.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):66-73 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.66 Received May 29, 2015; Accepted July 27, 2015Corresponding author: Young Sook ParkDepartment of Physical Medicine and Rehabilitation, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, 158 Paryong-ro, Masanhoewon-gu, Changwon 51353, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e8/46/arm-40-66.PMC4775760.pdf
"Tel: +82-55-290-6390, Fax: +82-55-290-6588, E-mail: jijibaeheiwon@hanmail.net  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/46/arm-40-66.PMC4775760.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):74-80 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.74 Received March 16, 2015; Accepted July 31, 2015Corresponding author: Kil Chan LeeDepartment of Rehabilitation Medicine and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, KoreaTel: +82-2-2227-2994, Fax: +82-2-363-2795, E-mail: iskil98@naver.com  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/20/arm-40-74.PMC4775761.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):81-87 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.81 Received June 2, 2015; Accepted August 7, 2015Corresponding author: Won Hyuk ChangDepartment of Physical and Rehabilitation Medicine, Center for Prevention and Rehabilitation, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, KoreaTel: +82-2-3410-6068, Fax: +82-2-3410-0052, E-mail: wh.chang@samsung.com  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/a2/arm-40-81.PMC4775762.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):88-94 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.88 Received February 3, 2015; Accepted July 20, 2015Corresponding author: Youngsun KimCommunication Sciences and Disorders, School of Rehabilitation and Communication Sciences, College of Health Sciences and Professions, Ohio University, W233 Grover Center, Athens, OH 45701-2979, USATel: +1-740-597-1286, Fax: +1-740-593-0287, E-mail: kimy2@ohio.edu  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/57/arm-40-88.PMC4775763.pdf
"This condition is commonly caused by various diseases, including central nervous system (CNS) disorders, neurodegenerative diseases, peripheral nervous system disorders, neuromuscular junction disor - ders, myopathies, local anatomical lesions, and psycho -Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(1):95-101 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.1.95 Received June 2, 2015; Accepted August 7, 2015Corresponding author: Han Gil SeoDepartment of Rehabilitation Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, KoreaTel: +82-2-2072-1659, Fax: +82-2-743-7473, E-mail: hgseo80@gmail.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/92/5e/arm-40-95.PMC4775764.pdf
Statistical analyses were performed using R statistical software(http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/df/49/JMRS-63-41.PMC4775825.pdf
A CTmyelogram can be fused with the treatment planning CTto facilitate delineation of the spinal cord in the scenariowhere the artifacts from metallic spinal hardware obscurethe visualisation of the contents of the spinal canal.Contouring atlases for OARs are available through theRadiation Therapy Oncology Group (RTOG) website (https://www.rtog.org/CoreLab/ContouringAtlases.aspx).,Non-OADS,/arxiv_data1/oa_pdf/a2/b0/JMRS-63-05.PMC4775826.pdf
Anderson Cancer Center has included a list ofapproved treatment planning algorithms for lung targetsand they are approved for use in RTOG SABR trialsfor lung tumours (http://rpc.mdanderson.org/RPC/home.htm).,Non-OADS,/arxiv_data1/oa_pdf/a2/b0/JMRS-63-05.PMC4775826.pdf
Available from: http://www.safeworkaustralia.gov.au/sites/swa/about/ publications/pages/sr200807handandwristinjuries.,Non-OADS,/arxiv_data1/oa_pdf/ea/6d/JMRS-63-09.PMC4775832.pdf
from: http://www.aihw.gov.au/WorkArea/ DownloadAsset.aspx?id=6442459567.,OADS,/arxiv_data1/oa_pdf/ea/6d/JMRS-63-09.PMC4775832.pdf
Statistical analyses were performed using R statistical software (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/c6/ee/JMRS-63-23.PMC4775834.pdf
Available at http://www.rtog.org/ClinicalTrials/ ProtocolTable/StudyDetails.aspx?study=1021 (accessed 1 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/c6/ee/JMRS-63-23.PMC4775834.pdf
Statistical methodology Statistical analyses was performed using R statistical software (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/a2/e0/JMRS-63-31.PMC4775835.pdf
Available from: http://www.rtog.org/ClinicalTrials/ProtocolTable/ StudyDetails.aspx?study=0915.,Non-OADS,/arxiv_data1/oa_pdf/a2/e0/JMRS-63-31.PMC4775835.pdf
Available from: http://www.rtog.org/ClinicalTrials/ProtocolTable/ StudyDetails.aspx?study=1021.,Non-OADS,/arxiv_data1/oa_pdf/a2/e0/JMRS-63-31.PMC4775835.pdf
Editor: Andreas Engel./C2112016 The Authors 0006-3495/16/02/0840/10 http://dx.doi.org/10.1016/j.bpj.2015.09.029 840 Biophysical Journal Volume 110 February 2016 840–849,Non-OADS,/arxiv_data1/oa_pdf/5e/60/main.PMC4775837.pdf
"This is an open access article, published  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0).",Non-OADS,/arxiv_data1/oa_pdf/71/4c/JVR-07-01.PMC4776021.pdf
"This is an open access article, published  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0).",Non-OADS,/arxiv_data1/oa_pdf/cc/10/JVR-06-19.PMC4776022.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/da/omw006.PMC4776050.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/a2/omw007.PMC4776051.pdf
"http://www.ncbi.nlm.nih.gov/htbin-post/Omim/ dispmim?530000 (7 April 2009, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/36/a2/omw007.PMC4776051.pdf
"http://www.ncbi.nlm.nih.gov/books/NBK1203/ (1 April 2009, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/36/a2/omw007.PMC4776051.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/d8/rjw024.PMC4776052.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/ac/ofw016.PMC4776053.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/d8/ofw018.PMC4776054.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/6d/ofw012.PMC4776055.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Posttraumatic stress disorderMental disordersDiffusion tensor imagingMagnetic resonance imagingNeuroimagingPsychoradiology 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/a8/main.PMC4776058.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.012 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/a8/main.PMC4776058.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/a8/main.PMC4776058.pdf
"Image Analysis DTI preprocessing, including skull stripping using the Brain Ex- traction Tool (BET, http://fsl.fmrib.ox.ac.uk/fsl/bet2/ ) and eddy cur- rent correction for distortions induced by the head movement and eddy currents, were performed using the FMRIB Software Library (FSL 4.1, Oxford, U.K., http://www.fmrib.ox.ac.uk/fsl/ ).",OADS,/arxiv_data1/oa_pdf/7b/a8/main.PMC4776058.pdf
aAnalyses of demographics and clinical data were performed in SPSS 20.0 software (http://www.spss.com ).,OADS,/arxiv_data1/oa_pdf/7b/a8/main.PMC4776058.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: EncephalitisMeningitis ADEM SurveillanceMobile healthData standards 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC4776059.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.008 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC4776059.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC4776059.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Antibiotic resistanceSusceptibility testsStaphylococcus aureusMultidrug resistant bacteria 1.,Non-OADS,/arxiv_data1/oa_pdf/65/18/main.PMC4776060.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.020 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/18/main.PMC4776060.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/18/main.PMC4776060.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Atrial ﬁbrillation Stroke preventionRisk strati ﬁcation Oral anticoagulationNon-vitamin K oral anticoagulantsNet clinical bene ﬁt Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.017 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"4 (1), 1. http://dx.doi.org/10.1186/1471-2369-4-1 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1093/europace/euu353 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.clinthera.2014.07.015 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1007/s11239-013-1048-z .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1111/jth.12177 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1160/TH13-07-0552 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.jacc.2012.10.010 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"http://dx.doi.org/10.1016/j.jacc.2012.10.010 .Apostolakis, S., Sullivan, R.M., Olshansky, B., Lip, G.Y.H., 2013d.",OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1378/chest.13-0054 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.ijcard.2012.12.093 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1093/eurjhf/hfs005 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1160/TH11- 11-0784 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.ijcard.2012.06.118 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.amjmed.2014.05.035 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/ 10.1056/NEJMoa1007903 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"Lancet 355 (9211), 1205 –1210 ( http://www.thelancet.com/newlancet/sub/issues/vol355no9211/menu_ NOD999.html ).",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"105 (2), 91 –99.http://dx.doi.org/10.1016/S0002-9343(98)00198-3 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.ijcard.2015.08.074 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"J. Med.326 (11), 733 –73 6. http://dx.doi.org/10.1056/NEJM199203123261103 .",OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1378/chest.14-2099 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1093/europace/eus305 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1093/eurheartj/ehv177 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1161/CIRCULATIONAHA.114.014113 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1056/NEJMoa1007432 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1161/STROKEAHA.106.480566 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/S0140- 6736(12)62177 –1.,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1161/CIRCULATIONAHA.113.006426 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/s1474-4422(10)70274-x .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1378/chest.11 –2298 (e326S - 50S).,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"Outcomes 4 (1), 14 –21.http://dx.doi.org/10.1161/CIRCOUTCOMES.110.958108 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/ 10.1016/j.jacc.2011.03.031 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.jacc.2013.,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"Assessment of female sex as a risk Factor in Atrial Fibrillation in Sweden: Nationwide Retrospective Cohort Study.BMJ 344, e3522 ( http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3365143&tool=pmcentrez&rendertype=abstract .",OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1161/CIRCULATIONAHA.111.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"Circula- tion 110, 2287– 2292. http://dx.doi.org/10.1161/01.CIR.0000145172.55640.93 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.ahj.2005.04.017 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1160/TH13-07-0556 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.amjmed.2014.05.023 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/ 10.1056/NEJMoa1107039 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1160/ TH14-11-0982 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1160/TH13-09-0741 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"131 (7), 492 –501 ( http://www.ncbi.nlm.nih.gov/pubmed/10507957 .A c c e s s e dS e p - tember 15, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"146 (12), 857 –867 ( http://www.ncbi.nlm.nih.gov/pubmed/17577005 .A c c e s s e d May 30, 2015).Hart, R.G., Eikelboom, J.W., Brimble, K.S., McMurtry, M.S., Ingram, A.J., 2013.",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.cjca.2013.04.005 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1161/CIRCULATIONAHA.111.038729 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/S0140-6736(09)61343-X .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"64 (1),1–12.http://dx.doi.org/10.1016/j.jacc.2014.04.029 .",OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"https://www.nice.org.uk/ resource/CG180/pdf/c/cg180-atrial- ﬁbrillation-nic-consensus-statement-on-the-use-of- noacs?id=gvyb3hjdqrcjtn6ytpwx3ydb64 (Accessed November 17, 2015) .",OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"Stroke 23 (9), 1237 –1241 (http://www.ncbi.nlm.nih.gov/pubmed/1519277 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/S1052-3057(10)80159 –4.,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.jacc.2014.03.021 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
vol 45. http://dx.doi.org/10.1161/STR.0000000000000024 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1160/TH11-07-0517 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"Neuroepidemiology 25 (1), 26–31.http://dx.doi.org/10.1159/000085310 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"2015, 876923. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1378/chest.11 –2302 (e601S - 36S).,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1159/000319048 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"137 (2), 263. http://dx.doi.org/10.1378/chest.09-1584 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1038/nrcardio.2011.112 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"Heart J., ehv431 http://dx.doi.org/10.1093/ eurheartj/ehv431 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
Heart J. http://dx.doi.org/10.1093/eurheartj/ehv415 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"313 (19), 1950. http://dx.doi.org/10.1001/jama.2015.4369 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1093/ europace/eur126 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1093/eurheartj/ehu298 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1160/TH15-07-0565 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"159 (7), 677 –685 ( http://www.ncbi.nlm.nih.gov/pubmed/10218746 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"12, 14. http://dx.doi.org/10.1186/1477-9560-12-14 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1161/STROKEAHA.114.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
1745 –1751 http://dx.doi.org/10.1111/j.1538 –7836.2012.04853.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1161/CIRCULATIONAHA.110.977546 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1161/ CIRCULATIONAHA.115.015735 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1160/TH11-05-0364 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"108 (1), 65 –73.http://dx.doi.org/10.1160/TH11-12-0827 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"111 (1), 14 –18.http://dx.doi.org/10.1160/TH13-08-0667 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/ 10.1056/NEJMoa1009638 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
Chest 1093-1100. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1253/circj.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1160/TH15-03-0192 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"373 (6), 511 –52 0.http://dx.doi.org/10.1056/NEJMoa1502000 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.beha.,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"116 (1), 6 –12 (http://www.ncbi.nlm.nih.gov/pubmed/1727097 .A c c e s s e d November 8, 2015).PubMed –NCBI, 2015a.",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"http://www.ncbi.nlm.nih.gov/pubmed/23415014 (Accessed Janu- ary 6, 2016) .",OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"http://www.ncbi.nlm.nih.gov/pubmed/26514352 (Accessed Janu- ary 6, 2016) .",OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.amjcard.2013.10.044 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.jacc.2013.08.1623 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.amjmed.2015.,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1160/ TH14-08-0681 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"147 (3), 259 –268 ( http://www.ncbi.nlm.nih.gov/pubmed/ 9482500 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1007/s11239-015-1216-4 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1038/ajg.2014.398 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.jacc.2007.01.098 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"278 (1), 1 –18.http://dx.doi.org/10.1111/joim.12360 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1161/JAHA.113.000250 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1160/TH14-02-0118 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.4244/EIJV8I6A105 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1161/ CIRCULATIONAHA.114.011777 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1059/0003 –4819-116-1-6 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"Stroke 32 (8), 1732 –1738 ( http://www.ncbi.nlm.nih.gov/ pubmed/11486098 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1016/j.cjca.2014.08.001 .,OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"QJM 107 (12), 955– 967. http://dx.doi.org/10.1093/ qjmed/hcu054 .",OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"Outcomes 1 (2), 84 –91.http://dx.doi.org/10.1161/CIRCOUTCOMES.",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1161/ STROKEAHA.115.009947 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1161/ STROKEAHA.111.636373 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
114(5) http://dx.doi.org/ 10.1160/TH15-03-0222 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/ 10.1001/jama.2012.6756 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
http://dx.doi.org/10.1378/chest.11 –2304 (e531S - 75S).,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
"31 (7), 1622 –1626 ( http://www.ncbi.nlm.nih.gov/pubmed/ 9626843 .",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/main.PMC4776061.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MacroeconomicModellingAlzheimer's DiseaseChina 1.,Non-OADS,/arxiv_data1/oa_pdf/00/5e/main.PMC4776062.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.12.019 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/00/5e/main.PMC4776062.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/5e/main.PMC4776062.pdf
"IMF Working Paper WP/13/26 (January, http://www.imf.org/ external/pubs/ft/wp/2013/wp1326.pdf (accessed June 24, 2015)) GTAP, 2014.",Non-OADS,/arxiv_data1/oa_pdf/00/5e/main.PMC4776062.pdf
10. http://dx.doi.org/10.1016/j.jalz.2014.04.4 .,OADS,/arxiv_data1/oa_pdf/00/5e/main.PMC4776062.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Trophoblastic tumorHydatidiform moleCell free DNACirculating tumor DNAMolecular genotyping Liquid biopsy 1.,Non-OADS,/arxiv_data1/oa_pdf/ae/a4/main.PMC4776063.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.12.022 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/a4/main.PMC4776063.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/a4/main.PMC4776063.pdf
"Ideally, the analyte would be stable at room temperature and during long-term storage, which would simplify NPC diagnostics, allowing clinicians from any- where in the world to send samples to clinical labs without need forEBioMedicine 4 (2016) 18 –19 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.12.018 .",Non-OADS,/arxiv_data1/oa_pdf/04/fa/main.PMC4776064.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.004 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/fa/main.PMC4776064.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/fa/main.PMC4776064.pdf
"Nonetheless, our results, including the predeceas- ing genome-wide association studies of smoking quantity and ﬁne mapping studies of lung cancer con ﬁrm the importance of the chromo- some 15q25.1 region (CHRNA3, CHRNA5, IREB2 and PSMA4) in lungEBioMedicine 4 (2016) 15 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.01.002 .",Non-OADS,/arxiv_data1/oa_pdf/93/83/main.PMC4776065.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.006 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/93/83/main.PMC4776065.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/83/main.PMC4776065.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: African-AmericansEnvironmentGeneticsLung Cancerrs2036527Single Nucleotide PolymorphismsSmoking 1.,Non-OADS,/arxiv_data1/oa_pdf/07/e3/main.PMC4776066.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.002 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/07/e3/main.PMC4776066.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/e3/main.PMC4776066.pdf
"R Foundation for Statistical Computing, Vienna, Austria ( http://www.R-project.org /) [computer program].",Non-OADS,/arxiv_data1/oa_pdf/07/e3/main.PMC4776066.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mesenchymal Stem Cells Mesenchymal Stromal CellsTwist1Interferon GammaFibroblast Growth FactorImmuno-suppressionAngiogenesisInﬂammation Lung Injury 1.,Non-OADS,/arxiv_data1/oa_pdf/a2/4f/main.PMC4776067.pdf
Introduction Mesenchymal stem cell (MSC)-based therapies are currently being evaluated in more than 500 clinical trials ( https://clinicaltrails.gov )f o r the treatment of various skeletal and non-skeletal related disorders.,Non-OADS,/arxiv_data1/oa_pdf/a2/4f/main.PMC4776067.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.12.020 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/4f/main.PMC4776067.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/4f/main.PMC4776067.pdf
These data have been de- posited in NCBI's Gene Expression Omnibus (GEO) and are accessible through GEO Series accession number GSE76158 (http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/a2/4f/main.PMC4776067.pdf
"The individual genes of these ﬁve cate- gories were then curated for enhanced accuracy by systematic search of the GeneCards Compendium ( http://www.genecards.org ), which vali- dated almost all of the initial genes.",OADS,/arxiv_data1/oa_pdf/a2/4f/main.PMC4776067.pdf
Mixed Lymphocyte Reactions Freshly isolated human peripheral blood mono-nuclear cells (PBMNCs) obtained from OneBlood Florida ( http://www.oneblood.,Non-OADS,/arxiv_data1/oa_pdf/a2/4f/main.PMC4776067.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Human T cellsTc e l ld i f f e r e n t i a t i o nAdoptive cell transfer therapyRapamycin 1.,Non-OADS,/arxiv_data1/oa_pdf/00/f2/main.PMC4776068.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.019 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/00/f2/main.PMC4776068.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/f2/main.PMC4776068.pdf
It would be also interesting to look forEBioMedicine 4 (2016) 11 –12 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.12.022 .,Non-OADS,/arxiv_data1/oa_pdf/91/2d/main.PMC4776069.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.013 2352-3964/Crown Copyright © 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/91/2d/main.PMC4776069.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/2d/main.PMC4776069.pdf
http://dx.doi.org/10.1200/JCO.2012.43.1817 .,OADS,/arxiv_data1/oa_pdf/91/2d/main.PMC4776069.pdf
http://dx.doi.org/10.1016/j.ajog.2015.09.083 .,OADS,/arxiv_data1/oa_pdf/91/2d/main.PMC4776069.pdf
http://dx.doi.org/10.1586/erm.09.51 .,Non-OADS,/arxiv_data1/oa_pdf/91/2d/main.PMC4776069.pdf
http://dx.doi.org/10.1016/j.mce.2006.02.019 .,OADS,/arxiv_data1/oa_pdf/91/2d/main.PMC4776069.pdf
http://dx.doi.org/10.1016/j.placenta.2013.11.014 .,OADS,/arxiv_data1/oa_pdf/91/2d/main.PMC4776069.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Chronic heart failure Preserved left ventricular function BiomarkersEndothelial progenitor cellsEndothelial cell-derived microvesicles 1.,Non-OADS,/arxiv_data1/oa_pdf/96/35/main.PMC4776070.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.018 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/96/35/main.PMC4776070.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/35/main.PMC4776070.pdf
http://dx.doi.org/ 10.17554/j.issn.2309 –6861.2015.02.77 .,Non-OADS,/arxiv_data1/oa_pdf/96/35/main.PMC4776070.pdf
http://dx.doi.org/10.1016/j.dsx.2015.04.003 .,OADS,/arxiv_data1/oa_pdf/96/35/main.PMC4776070.pdf
http://dx.doi.org/10.1007/s40618-015-0273-z .,Non-OADS,/arxiv_data1/oa_pdf/96/35/main.PMC4776070.pdf
http://dx.doi.org/10.1016/j.clinbiochem.2015.02.003 .,OADS,/arxiv_data1/oa_pdf/96/35/main.PMC4776070.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/96/35/main.PMC4776070.pdf
http://dx.doi.org/10.1002/0471142956.cy0103s32 (chapter 1: unit 1.3).,OADS,/arxiv_data1/oa_pdf/96/35/main.PMC4776070.pdf
http://dx.doi.org/10.1016/j.cardfail.2015.10.017 (Epub ahead of print).,OADS,/arxiv_data1/oa_pdf/96/35/main.PMC4776070.pdf
http://dx.doi.org/10.1007/s10741-011-9273-z .,Non-OADS,/arxiv_data1/oa_pdf/96/35/main.PMC4776070.pdf
http://dx.doi.org/10.1111/jth.12207 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/96/35/main.PMC4776070.pdf
This is an open access article under the CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/b5/main.PMC4776072.pdf
uncertain whether the same markers would have clinical utility when  http://dx.doi.org/10.1016/j.ebiom.2016.01.016  2352-3964/Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/40/b5/main.PMC4776072.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/b5/main.PMC4776072.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Pulmonary tuberculosisImmune modulation Phosphodiesterase inhibitor Lung ﬁbrosis Inﬂammation 1.,Non-OADS,/arxiv_data1/oa_pdf/87/05/main.PMC4776074.pdf
"Introduction Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) is a common infectious disease among humans, accounting for 9 million new cases and 1.5 million deaths in 2013 ( http://www.who.int/tb/ publications/factsheet_global.pdf?ua=1 ).",Non-OADS,/arxiv_data1/oa_pdf/87/05/main.PMC4776074.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.015 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/87/05/main.PMC4776074.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/05/main.PMC4776074.pdf
"Synthesis of cDNA, labeling, hybridiza- tion and post-hybridization washings were performed according to the established, standardized protocols of the Center for Applied Genomics ( http://www.cag.icph.org/index.htm ) of Rutgers University.",OADS,/arxiv_data1/oa_pdf/87/05/main.PMC4776074.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: BacteriophagesDiarrheaEscherichia coliStreptococcus Biﬁdobacterium ChildrenBangladesh 1.,Non-OADS,/arxiv_data1/oa_pdf/54/03/main.PMC4776075.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.12.023 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/03/main.PMC4776075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/03/main.PMC4776075.pdf
"At species level, the taxonomic as- signment was determined by BLAST ( Altschul et al., 1990 ) using thewebsite http://blast.ncbi.nlm.nih.gov with a 97% identity threshold.",OADS,/arxiv_data1/oa_pdf/54/03/main.PMC4776075.pdf
http://dx.doi.org/10.1111/1462-2920.13144 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/54/03/main.PMC4776075.pdf
http://answers.hhs.gov/ ohrp/categories/1569.,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/10.1177_1062860614557636.PMC4776220.pdf
"However, conclusions based on these experiments carry the major caveat that WNT signal transmis- sion is substantially maintained in double-de ﬁcient T cells ( JeannetEBioMedicine 4 (2016) 3 –4 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.01.019 .",OADS,/arxiv_data1/oa_pdf/59/ce/main.PMC4776221.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.02.019 2352-3964/Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/59/ce/main.PMC4776221.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/ce/main.PMC4776221.pdf
http://dx.doi.org/10.4161/auto.6.,Non-OADS,/arxiv_data1/oa_pdf/59/ce/main.PMC4776221.pdf
http://dx.doi.org/10.1038/nm.3445 (Epub 2014 Jan 12).,OADS,/arxiv_data1/oa_pdf/59/ce/main.PMC4776221.pdf
http://dx.doi.org/10.1038/nm.2446 .,OADS,/arxiv_data1/oa_pdf/59/ce/main.PMC4776221.pdf
http://dx.doi.org/10.1038/nm.1982 (Epub 2009 Jun 14).,OADS,/arxiv_data1/oa_pdf/59/ce/main.PMC4776221.pdf
http://dx.doi.org/10.4049/jimmunol.1101585 (Epub 2011 Oct 19).,Non-OADS,/arxiv_data1/oa_pdf/59/ce/main.PMC4776221.pdf
http://dx.doi.org/10.1182/blood-2014-10- 607465 (epub 2015 apr 6).,Non-OADS,/arxiv_data1/oa_pdf/59/ce/main.PMC4776221.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/21/main.PMC4776222.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/21/main.PMC4776222.pdf
http://dx.doi.org/10.1016/j.eucr.2015.12.005Urology Case Reports 5 (2016) 22 e24,Non-OADS,/arxiv_data1/oa_pdf/48/21/main.PMC4776222.pdf
http://www.uptodate.com/contents/priapism ; Accessed 25.11.14.,Non-OADS,/arxiv_data1/oa_pdf/48/21/main.PMC4776222.pdf
"John Gurdon, co-recipient of the Nobel prize with Yamanaka once said “It isEBioMedicine 4 (2016) 1 –2 http://dx.doi.org/10.1016/j.ebiom.2016.02.005 2352-3964/© 2016 Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/95/9f/main.PMC4776223.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/9f/main.PMC4776223.pdf
", ‘intermediate ’or Mon2 subset)DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.01.018 .",Non-OADS,/arxiv_data1/oa_pdf/03/47/main.PMC4776225.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.025 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/03/47/main.PMC4776225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/47/main.PMC4776225.pdf
"It would also enable us to pinpoint neural correlates of resil- ience, which might stimulate research into preventive interventions for subjects frequently exposed to traumatic stressors such as ﬁrst responders.EBioMedicine 4 (2016) 20 –21 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.01.012 .",Non-OADS,/arxiv_data1/oa_pdf/64/fb/main.PMC4776227.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.02.002 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/64/fb/main.PMC4776227.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/fb/main.PMC4776227.pdf
http://dx.doi.org/10.1002/da.22044 .,Non-OADS,/arxiv_data1/oa_pdf/64/fb/main.PMC4776227.pdf
"http://dx.doi.org/10.1002/dev.20494 .Kim, M.J., Lyoo, I.K., Kim, S.J., Sim, M., Kim, N., Choi, N., et al., 2005.",OADS,/arxiv_data1/oa_pdf/64/fb/main.PMC4776227.pdf
http://dx.doi.org/10.1016/j.neubiorev.2014.04.003 S0149- 7634(14)00087-6 [pii].,OADS,/arxiv_data1/oa_pdf/64/fb/main.PMC4776227.pdf
DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.01.016 .,OADS,/arxiv_data1/oa_pdf/b2/87/main.PMC4776228.pdf
Tel: +27 (0)21 650 6906; fax: +27 (021) 406 6796. http://dx.doi.org/10.1016/j.ebiom.2016.02.013 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/87/main.PMC4776228.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/87/main.PMC4776228.pdf
"While the ﬁndings relate speci ﬁcally to China, the implications DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.12.019 .",Non-OADS,/arxiv_data1/oa_pdf/d5/98/main.PMC4776229.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.02.018 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/98/main.PMC4776229.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/98/main.PMC4776229.pdf
"Ministry of Civil Affairs of People's Republic of China, Beijing (Available at:http://www.mca.gov.cn/article/sj/tjgb/201506/201506008324399.shtml .",Non-OADS,/arxiv_data1/oa_pdf/d5/98/main.PMC4776229.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/0e/main.PMC4776230.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/0e/main.PMC4776230.pdf
http://dx.doi.org/10.1016/j.eucr.2015.12.010Urology Case Reports 5 (2016) 27 e30,Non-OADS,/arxiv_data1/oa_pdf/73/0e/main.PMC4776230.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/4c/main.PMC4776232.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/4c/main.PMC4776232.pdf
http://dx.doi.org/10.1016/j.eucr.2015.12.006Urology Case Reports 5 (2016) 25 e26,Non-OADS,/arxiv_data1/oa_pdf/0e/4c/main.PMC4776232.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 0(0) 1–8 DOI: 10.1177/2054270415622776",Non-OADS,/arxiv_data1/oa_pdf/4f/54/10.1177_2054270415622776.PMC4776248.pdf
"The Sage encyclopedia of social science research methods.Social science research , 2004. http://books.google.",Non-OADS,/arxiv_data1/oa_pdf/4f/54/10.1177_2054270415622776.PMC4776248.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: HIVSIVGut barrier integrityMicrobial translocationInterleukin-7Interleukin-21 Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/14/6c/main.PMC4776249.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.028 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/6c/main.PMC4776249.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/6c/main.PMC4776249.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 0(0) 1–10 DOI: 10.1177/2054270415622602",Non-OADS,/arxiv_data1/oa_pdf/c6/20/10.1177_2054270415622602.PMC4776250.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 0(0) 1–8 DOI: 10.1177/2054270416632703",Non-OADS,/arxiv_data1/oa_pdf/a6/41/10.1177_2054270416632703.PMC4776251.pdf
"European Working Time Directive, http://bma.org.uk/practical-support-at-work/ewtd (accessed 8 June 2015).",Non-OADS,/arxiv_data1/oa_pdf/a6/41/10.1177_2054270416632703.PMC4776251.pdf
"Impact of doctor working time cap on patient safety and training getting worse, https://www.rcseng.ac.uk/news/impact-of-doctor-work- ing-time-cap-on-patient-safety-and-training-getting-worse-says-new-survey (accessed 25 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/a6/41/10.1177_2054270416632703.PMC4776251.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Human embryonic stem cells Pluripotent CardiomyocytesDifferentiationCardiomyogenesisDNA methylationLong non-coding RNAlncRNAEpigenetic Methylome TranscriptomeMesodermGood manufacturing practice, GMP, epigeneticmemory, WNT, hedgehog, transforming growthfactor, ROR2, PDGFR α, demethylation, TET, TDG, HOX, TBOX 1.",Non-OADS,/arxiv_data1/oa_pdf/68/ad/main.PMC4776252.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.021 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/68/ad/main.PMC4776252.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/ad/main.PMC4776252.pdf
Data generated from this study is available through NCBI's Gene Expression Omnibus (GEO) through  GEO series accession number GSE76525 ( https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE76525).,OADS,/arxiv_data1/oa_pdf/68/ad/main.PMC4776252.pdf
Several studiesDOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.01.008 .,OADS,/arxiv_data1/oa_pdf/de/3f/main.PMC4776259.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.02.009 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/de/3f/main.PMC4776259.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/3f/main.PMC4776259.pdf
"Science 350, 6263. http://dx.doi.org/ 10.1126/science.aab3897 .",Non-OADS,/arxiv_data1/oa_pdf/de/3f/main.PMC4776259.pdf
http://dx.doi.org/10.3390/jpm6010005 .,Non-OADS,/arxiv_data1/oa_pdf/de/3f/main.PMC4776259.pdf
"Consequently, the authors postulated that renalDOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.01.011 .",OADS,/arxiv_data1/oa_pdf/7f/e3/main.PMC4776260.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.01.026 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/7f/e3/main.PMC4776260.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/e3/main.PMC4776260.pdf
"263, 11033 –11036 (doi: http://www.jbc.org/content/263/23/11033.long ).",Non-OADS,/arxiv_data1/oa_pdf/7f/e3/main.PMC4776260.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7f/e3/main.PMC4776260.pdf
"13, 85.http://dx.doi.org/10.1186/1475-2840-13-85 (Apr 24).",Non-OADS,/arxiv_data1/oa_pdf/7f/e3/main.PMC4776260.pdf
"Rep. 5, 15272. http://dx.doi.org/10.1038/srep15272 .17 M. Epstein / EBioMedicine 4 (2016) 16 –17",Non-OADS,/arxiv_data1/oa_pdf/7f/e3/main.PMC4776260.pdf
"Osong Public Health Res Perspect 2016 7(1), 18 e25 http://dx.doi.org/10.1016/j.phrp.2015.11.007pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/main.PMC4776261.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/38/main.PMC4776261.pdf
"Osong Public Health Res Perspect 2016 7(1), 71 e74 http://dx.doi.org/10.1016/j.phrp.2015.12.001pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/94/2a/main.PMC4776262.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/2a/main.PMC4776262.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs117/ en/[accessed 29.08.14].,Non-OADS,/arxiv_data1/oa_pdf/94/2a/main.PMC4776262.pdf
Available from: http://idsc.nih.go.jp/idwr/ydata/report- Ea.html .,OADS,/arxiv_data1/oa_pdf/94/2a/main.PMC4776262.pdf
Available from: http://idsc.nih.go.jp/idwr/kanja/ idwr/idwr2011/idwr2011-22.pdf .,Non-OADS,/arxiv_data1/oa_pdf/94/2a/main.PMC4776262.pdf
Available from: http://kosis.kr .,Non-OADS,/arxiv_data1/oa_pdf/94/2a/main.PMC4776262.pdf
"Osong Public Health Res Perspect 2016 7(1), 26 e31 http://dx.doi.org/10.1016/j.phrp.2015.11.002pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/db/11/main.PMC4776263.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/11/main.PMC4776263.pdf
Available from: http://www.searo.who.int/publications/journals/seajph/ seajphv2n(3-4)p135.pdf [accessed 22.08.14].,Non-OADS,/arxiv_data1/oa_pdf/db/11/main.PMC4776263.pdf
Available from: http://www.npc.gov.np/new/uploadedFiles/allFiles/mdg-report- 2013.pdf [accessed 22.08.14].3.Department of Health Services (DoHS) (Nepal).,OADS,/arxiv_data1/oa_pdf/db/11/main.PMC4776263.pdf
Available from: http://www.pharmexec.com/free- market-economics [accessed 24.08.15].,Non-OADS,/arxiv_data1/oa_pdf/db/11/main.PMC4776263.pdf
http://dx.doi.org/10.1186/1478-7547-3-1 .,Non-OADS,/arxiv_data1/oa_pdf/db/11/main.PMC4776263.pdf
BMC Res Notes 2012 Jan;5. http://dx.doi.org/10.1186/1756-0500-5-30 .,Non-OADS,/arxiv_data1/oa_pdf/db/11/main.PMC4776263.pdf
Available from: http://www.hst.,Non-OADS,/arxiv_data1/oa_pdf/db/11/main.PMC4776263.pdf
BMC PregnancyChildbirth 2010 Jan;10. http://dx.doi.org/10.1186/1471-2393-10-2 .,Non-OADS,/arxiv_data1/oa_pdf/db/11/main.PMC4776263.pdf
http://dx.doi.org/10.4172/ 2167-0420.1000134 .Costs associated with free maternity services 31,Non-OADS,/arxiv_data1/oa_pdf/db/11/main.PMC4776263.pdf
"Osong Public Health Res Perspect 2016 7(1), 1 e2 http://dx.doi.org/10.1016/j.phrp.2016.02.001pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/06/d4/main.PMC4776264.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/d4/main.PMC4776264.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs117/en/ [accessed 28.12.15].,Non-OADS,/arxiv_data1/oa_pdf/06/d4/main.PMC4776264.pdf
"E-mail: tiana@cu.ac.kr (Y.-S. Choi).. Osong Public Health Res Perspect 2016 7(1), 12 e17 http://dx.doi.org/10.1016/j.phrp.2015.12.009pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/2c/34/main.PMC4776265.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/34/main.PMC4776265.pdf
"Osong Public Health Res Perspect 2016 7(1), 56 e62 http://dx.doi.org/10.1016/j.phrp.2015.10.015pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/9a/9b/main.PMC4776267.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/9b/main.PMC4776267.pdf
Avail-able from: http://www.khna.or.kr/ [accessed 28.06.10].,Non-OADS,/arxiv_data1/oa_pdf/9a/9b/main.PMC4776267.pdf
Available from:http://www.hira.or.kr/main.do [accessed 28.06.10].,Non-OADS,/arxiv_data1/oa_pdf/9a/9b/main.PMC4776267.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/7f/main.PMC4776268.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.02.003 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/7f/main.PMC4776268.pdf
"Osong Public Health Res Perspect 2016 7(1), 43 e48 http://dx.doi.org/10.1016/j.phrp.2015.12.012pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/e4/e4/main.PMC4776269.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/e4/main.PMC4776269.pdf
Available from: http://www.cdc.gov/vhf/ ebola/symptoms/index.html [accessed 14.11.25].,OADS,/arxiv_data1/oa_pdf/e4/e4/main.PMC4776269.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs103/ en/[accessed 14.11.25].,Non-OADS,/arxiv_data1/oa_pdf/e4/e4/main.PMC4776269.pdf
Available from:http://healthmap.org/site/diseasedaily/article/ebola-quarantine-or- not-quarantine-82514 [accessed 14.12.01].,Non-OADS,/arxiv_data1/oa_pdf/e4/e4/main.PMC4776269.pdf
"Osong Public Health Res Perspect 2016 7(1), 49 e55 http://dx.doi.org/10.1016/j.phrp.2016.01.001pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/e1/fb/main.PMC4776270.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/fb/main.PMC4776270.pdf
"Osong Public Health Res Perspect 2016 7(1), 63 e70 http://dx.doi.org/10.1016/j.phrp.2015.11.008pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/df/1b/main.PMC4776271.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/1b/main.PMC4776271.pdf
Available at:http://stacks.cdc.gov/view/cdc/6964 [accessed 03.12.15].,OADS,/arxiv_data1/oa_pdf/df/1b/main.PMC4776271.pdf
http://dx.doi.org/10.1002/14651858.CD001188.pub4 .,Non-OADS,/arxiv_data1/oa_pdf/df/1b/main.PMC4776271.pdf
"Osong Public Health Res Perspect 2016 7(1), 3 e11 http://dx.doi.org/10.1016/j.phrp.2015.11.012pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/07/80/main.PMC4776272.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/80/main.PMC4776272.pdf
"Osong Public Health Res Perspect 2016 7(1), 36 e42 http://dx.doi.org/10.1016/j.phrp.2015.10.005pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/75/bf/main.PMC4776273.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/bf/main.PMC4776273.pdf
Available from: http://www.ki.se/csp/who_safe_communities_ indicators_en.htm [accessed 15.01.13].,Non-OADS,/arxiv_data1/oa_pdf/75/bf/main.PMC4776273.pdf
"Osong Public Health Res Perspect 2016 7(1), 32 e35 http://dx.doi.org/10.1016/j.phrp.2015.10.010pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/a7/79/main.PMC4776274.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/79/main.PMC4776274.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/bb/main.PMC4776327.pdf
Cell culture and siRNA treatment The human non-small cell lung cancer cell (NSCLC) lines H1299 (KRAS-wild type) and H358 (KRASG12C (GGT to TGC)-mutant) were obtained from American Type Culture Collection (ATCC).Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2016.02.012 2405-5808/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/54/bb/main.PMC4776327.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/bb/main.PMC4776327.pdf
Appendix A. Transparency document Transparency document associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.,Non-OADS,/arxiv_data1/oa_pdf/54/bb/main.PMC4776327.pdf
Available  from: http://www.uptodate.com/contents/attention‑deficit‑ hyperactivity‑disorder ‑in‑children‑and‑adolescents‑ treatment‑with‑medications.,Non-OADS,/arxiv_data1/oa_pdf/d2/c7/JRPP-5-22.PMC4776543.pdf
URL: http://www.uptodate.,Non-OADS,/arxiv_data1/oa_pdf/d2/c7/JRPP-5-22.PMC4776543.pdf
Available from: http://www.ipmameded.org/ media/46347/adherence.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/cc/JRPP-5-52.PMC4776547.pdf
Available from: http://apps.who.int/ebola/ current‑situation/ebola‑situation‑report‑1‑july‑2015.,Non-OADS,/arxiv_data1/oa_pdf/a0/8b/IJNMR-21-105.PMC4776555.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs103/en/.,Non-OADS,/arxiv_data1/oa_pdf/a0/8b/IJNMR-21-105.PMC4776555.pdf
Available from: http://www.who.int/csr/ disease/Ebola/Ebola‑6‑months/west‑africa/en/.,Non-OADS,/arxiv_data1/oa_pdf/a0/8b/IJNMR-21-105.PMC4776555.pdf
Available from: http://www.who.int/csr/ disease/Ebola/Ebola‑6‑months/sierra‑leone/en/.,Non-OADS,/arxiv_data1/oa_pdf/a0/8b/IJNMR-21-105.PMC4776555.pdf
Available from: http://who.int/features/2014/ebola‑community‑care/en/.,Non-OADS,/arxiv_data1/oa_pdf/a0/8b/IJNMR-21-105.PMC4776555.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/a0/8b/IJNMR-21-105.PMC4776555.pdf
2012; Available from:  http://www.who.int/mediacentre/factsheets/fs317/en/.,Non-OADS,/arxiv_data1/oa_pdf/98/3b/IJNMR-21-14.PMC4776556.pdf
HYPERLINK  “http://www.ncbi.nlm.nih.gov/pubmed/?term=What+is+the +best+way+to+change+self‑efficacy+to+promote+lifest yle+and+recreational+physical+activity%3F+A+systemati c+review+with+meta‑analysis” \o “British journal of health  psychology.” Br J Health Psychol 2010;15:265‑88.,Non-OADS,/arxiv_data1/oa_pdf/05/b8/IJNMR-21-20.PMC4776557.pdf
Available from: http://www.applications.,OADS,/arxiv_data1/oa_pdf/6e/c9/IJNMR-21-29.PMC4776558.pdf
Available from:  http://www.unaids.org/sites/defaulty/files/en/dataanalysis/ knowyourresponse/countryprogressrepor.,OADS,/arxiv_data1/oa_pdf/6e/c9/IJNMR-21-29.PMC4776558.pdf
Available from: http://aidsinfo.nih.gov/ guideline.August 2012.,Non-OADS,/arxiv_data1/oa_pdf/6e/c9/IJNMR-21-29.PMC4776558.pdf
Available from: http://www.iiep.unesco.,Non-OADS,/arxiv_data1/oa_pdf/6e/c9/IJNMR-21-29.PMC4776558.pdf
Available  from: http://www.betsa.ir.,Non-OADS,/arxiv_data1/oa_pdf/58/75/IJNMR-21-38.PMC4776559.pdf
Available from: http://www.essential‑skills.com.,Non-OADS,/arxiv_data1/oa_pdf/58/75/IJNMR-21-38.PMC4776559.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/IJNMR-21-45.PMC4776560.pdf
Available from: http://www.en.ipo.ir.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/IJNMR-21-45.PMC4776560.pdf
Available  from: http://www.bristol.ac.uk/cmpo/publications/papers/2012/ wp282.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/IJNMR-21-45.PMC4776560.pdf
"Cremona SE, Antenatal Predictors of Maternal Bonding for  Adolescent Mother 2008, Victoria University Institional  Repository (VUIR); Available from: http://vuir.vu.edu.au/cgi/ oai2.",Non-OADS,/arxiv_data1/oa_pdf/98/e2/IJNMR-21-71.PMC4776563.pdf
Available from:  http://profdoc.um.ac.ir/paper‑ abstract‑1028502.html.,Non-OADS,/arxiv_data1/oa_pdf/51/9a/IJNMR-21-9.PMC4776567.pdf
HYPERLINK  “http://www.ncbi.nlm.nih.gov/pubmed/?term=Reddy+MS.+ Suicide+incidence+and+epidemiology” \o “Indian journal of  psychological medicine.” Indian J Psychol Med 2010;32:77‑82.,Non-OADS,/arxiv_data1/oa_pdf/09/78/IJNMR-21-93.PMC4776568.pdf
Available  from: http://www.nhp.gov.in/sites/default/files/pdf/ Bhore_Committee_Report_VOL‑1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/69/86/JFMPC-4-479.PMC4776595.pdf
Available from: http://www.pharmabiz.,Non-OADS,/arxiv_data1/oa_pdf/69/86/JFMPC-4-479.PMC4776595.pdf
Available from: http://www3.weforum.org/docs/WEF_ EconomicNonCommunicableDiseasesIndia_Report_2014.,Non-OADS,/arxiv_data1/oa_pdf/69/86/JFMPC-4-479.PMC4776595.pdf
Available from: http://www.communityhealth.,Non-OADS,/arxiv_data1/oa_pdf/69/86/JFMPC-4-479.PMC4776595.pdf
Available  from: http://www.knowledgecommissionarchive.nic.,Non-OADS,/arxiv_data1/oa_pdf/69/86/JFMPC-4-479.PMC4776595.pdf
Kumar: Healthcare is PrimaryJournal of Family Medicine and Primary Care 482 October 2015 : Volume 4 : Issue 4from: http://www.pib.nic.in/newsite/PrintRelease.,Non-OADS,/arxiv_data1/oa_pdf/69/86/JFMPC-4-479.PMC4776595.pdf
Available from: http://www.hindustantimes.com/ brunch/the‑family‑doctor‑is‑now‑extinct‑it‑s‑the‑ag e‑of‑the‑specialist‑who‑doesn‑t‑know‑your‑ name/ story‑yuGpCC65O71g5BK6sdmKaM.html.,Non-OADS,/arxiv_data1/oa_pdf/69/86/JFMPC-4-479.PMC4776595.pdf
Available from: http://www.mciindia.,Non-OADS,/arxiv_data1/oa_pdf/a6/3c/JFMPC-4-483.PMC4776596.pdf
Available from:http://www.mciindia.org/circulars/Circular‑ 03.09.2015‑TEQ ‑Promotion‑Publication.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/3c/JFMPC-4-483.PMC4776596.pdf
Index Copernicus International.http://en.indexcopernicus.,Non-OADS,/arxiv_data1/oa_pdf/a6/3c/JFMPC-4-483.PMC4776596.pdf
Available from: http://www.unicef.org/india/ National_Fact_Sheet_CES_2009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/ac/JFMPC-4-487.PMC4776597.pdf
Available from: http://www.rchiips.org/pdf/rch2/ National_Report_RCH‑II.pdf [Last accessed on 2014 Jul 14].,Non-OADS,/arxiv_data1/oa_pdf/2c/ac/JFMPC-4-487.PMC4776597.pdf
Available from: http://www.rchiips.org/pdf/ INDIA_REPORT_DLHS‑3.pdf  [Last accessed on 2014 Jul 14].,Non-OADS,/arxiv_data1/oa_pdf/2c/ac/JFMPC-4-487.PMC4776597.pdf
Available from: http://www.thehindu.com/news/national/ india‑launches‑vaccine‑to‑prevent‑japanese‑encephalitis/ article5201813.ece; [Last accessed on 2014 April  10 2014;21:30 IST].,Non-OADS,/arxiv_data1/oa_pdf/2c/ac/JFMPC-4-487.PMC4776597.pdf
Available from:  http://timesofindia.indiatimes.com/city/pune/ Serums‑polio‑vaccine‑likely‑in‑national‑plan/ articleshow/18856737.cms[Last accessed on 2013 Mar 8].,Non-OADS,/arxiv_data1/oa_pdf/2c/ac/JFMPC-4-487.PMC4776597.pdf
"WHO South‑east Asia regional  office, New Delhi; 2014; Available from: http://www.searo.",Non-OADS,/arxiv_data1/oa_pdf/2c/ac/JFMPC-4-487.PMC4776597.pdf
Available from: http://www.gavi.org/country‑documents/ IND_201304_Proposal_HSS.pdf[Last accessed on  2014 Mar 28 at 19:30 IST].,Non-OADS,/arxiv_data1/oa_pdf/2c/ac/JFMPC-4-487.PMC4776597.pdf
Available  from: http://www.mohfw.nic.in/WriteReadData/ l892s/1084811197NATIONAL%20VACCINE%20POLICY%20 BOOK.pdf [Last accessed 2014 Jul 14].,Non-OADS,/arxiv_data1/oa_pdf/2c/ac/JFMPC-4-487.PMC4776597.pdf
Available  from: http://www.gavi.org/country/india/documents/[last  accessed on 2014 Mar 28].,Non-OADS,/arxiv_data1/oa_pdf/2c/ac/JFMPC-4-487.PMC4776597.pdf
Available  from: https://www.mycii.in/KmResourceApplication/42087.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/JFMPC-4-495.PMC4776598.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/JFMPC-4-495.PMC4776598.pdf
Available from: http://www.afpionline.com/ documents/afpimembershipguide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/JFMPC-4-495.PMC4776598.pdf
Available from: http://www.apps.searo.who.int/pds_docs/ B3426.pdf.,OADS,/arxiv_data1/oa_pdf/6b/2f/JFMPC-4-495.PMC4776598.pdf
Available from: http://www.natboard.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/JFMPC-4-495.PMC4776598.pdf
Available from: http://www.web.tnmgrmu.ac.in/ regulations/familymedicine.pdf‑familymedicine.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/JFMPC-4-495.PMC4776598.pdf
Available  from: http://www.cfhospital.org/fcamsmdg.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/JFMPC-4-495.PMC4776598.pdf
Available from: http://www.emagister.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/JFMPC-4-495.PMC4776598.pdf
Available from: http://www.archive.financialexpress.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/JFMPC-4-495.PMC4776598.pdf
Available from: http://www.cmch‑vellore.edu/pdf/jobs/ prospectus%202013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/JFMPC-4-495.PMC4776598.pdf
Available from: http://www.mciindia.org/ RulesandRegulation/GME_REGULATIONS.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/JFMPC-4-495.PMC4776598.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs348/en/.,Non-OADS,/arxiv_data1/oa_pdf/ec/00/JFMPC-4-501.PMC4776599.pdf
Available from: http://www.who.int/neglected_diseases/ diseases/en/.,Non-OADS,/arxiv_data1/oa_pdf/51/6f/JFMPC-4-507.PMC4776600.pdf
Available from:  http://www.who.int/neglected_diseases/mediacentre/ WHA_66.12_Eng.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/51/6f/JFMPC-4-507.PMC4776600.pdf
Available from: http://www.apps.who.int/iris/ bitstream/10665/152781/1/9789241564861_eng.,OADS,/arxiv_data1/oa_pdf/51/6f/JFMPC-4-507.PMC4776600.pdf
Available from: http://www.viz.healthmetricsandevaluation.,Non-OADS,/arxiv_data1/oa_pdf/51/6f/JFMPC-4-507.PMC4776600.pdf
Available from: http://www.vizhub.healthdata.,Non-OADS,/arxiv_data1/oa_pdf/51/6f/JFMPC-4-507.PMC4776600.pdf
Available from: http://www.who.int/water_sanitation_health/dwq/ gdwqvol32ed.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/0c/JFMPC-4-514.PMC4776601.pdf
Available from:  http://www.elaws.gov.on.ca/html/statutes/english/elaws_ statutes_90o01_e.htm.,Non-OADS,/arxiv_data1/oa_pdf/b2/f3/JFMPC-4-519.PMC4776602.pdf
Available from: http://osha.europa.eu.,Non-OADS,/arxiv_data1/oa_pdf/b2/f3/JFMPC-4-519.PMC4776602.pdf
Available from: http://www.ehjournal.,Non-OADS,/arxiv_data1/oa_pdf/b2/f3/JFMPC-4-519.PMC4776602.pdf
Available from: http://www.census2011.co.in/census/ district/21‑chennai.html.,Non-OADS,/arxiv_data1/oa_pdf/b2/f3/JFMPC-4-519.PMC4776602.pdf
Available from: http://www.chennaicorporation.,Non-OADS,/arxiv_data1/oa_pdf/b2/f3/JFMPC-4-519.PMC4776602.pdf
Available  from: http://www.pppinindia.com/pdf/ppp_position_ paper_solid_waste_mgmt_112k9.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b2/f3/JFMPC-4-519.PMC4776602.pdf
Available from:  http://www.delhi.gov.in/wps/wcm/connect/doit_des/DES/ Our+Services/Statistical+Hand+Book/.,Non-OADS,/arxiv_data1/oa_pdf/94/c8/JFMPC-4-529.PMC4776604.pdf
Available from:  http://www.delhi.gov.in/wps/wcm/connect/DoIT_Health/ health/home/nrhm.,Non-OADS,/arxiv_data1/oa_pdf/94/c8/JFMPC-4-529.PMC4776604.pdf
Available from: https://www.health.qld.gov.au/psu/safetyandquality/ nsqhss‑audit‑tools.asp.,Non-OADS,/arxiv_data1/oa_pdf/94/c8/JFMPC-4-529.PMC4776604.pdf
Available from: http://www.nabh.co/Hospitals.,Non-OADS,/arxiv_data1/oa_pdf/94/c8/JFMPC-4-529.PMC4776604.pdf
Available from: http://www.euro.who.,Non-OADS,/arxiv_data1/oa_pdf/46/19/JFMPC-4-539.PMC4776606.pdf
Available from: http://www.kesehatanibu.depkes.go.id/ archives/7652014.,Non-OADS,/arxiv_data1/oa_pdf/29/61/JFMPC-4-551.PMC4776608.pdf
Available from: http://www.iarc.fr/en/publications/ pdfs‑online/epi/sp160/CI5vol9.pdf  [Last accessed on  2013 Nov 14].,Non-OADS,/arxiv_data1/oa_pdf/7c/b0/JFMPC-4-566.PMC4776610.pdf
Available from: http://www.measuredhs.,Non-OADS,/arxiv_data1/oa_pdf/7c/b0/JFMPC-4-566.PMC4776610.pdf
Available from: http://www.measuredhs.,Non-OADS,/arxiv_data1/oa_pdf/7c/b0/JFMPC-4-566.PMC4776610.pdf
"Measles Mortality Reduction, India Strategic Plan, 2005‑2010  Available from: http://www.childhealthindiainfo.com/ index.php?...measles‑mortality‑reduct.",Non-OADS,/arxiv_data1/oa_pdf/7c/b0/JFMPC-4-566.PMC4776610.pdf
Available from: http://www.who.int/vaccines‑documents/ DocsPDF‑IBI‑e/mod7_e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7c/b0/JFMPC-4-566.PMC4776610.pdf
Available  from: http://www.mohfw.nic.in/writereaddata/.../9457038 092annualreporthealth.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7c/b0/JFMPC-4-566.PMC4776610.pdf
Available from: http://www.who.int/ gpsc/5may/Hand_Hygiene_Knowledge_Questionnaire.,Non-OADS,/arxiv_data1/oa_pdf/0b/74/JFMPC-4-582.PMC4776613.pdf
Available from:  http://www.nhtsa.gov/nhtsa/Safety1nNum3ers/ 4.,Non-OADS,/arxiv_data1/oa_pdf/8a/79/JFMPC-4-587.PMC4776614.pdf
Available from: http://www.aidsinfo.nih.gov/ guidelines/html/5/pediatric ‑oi‑prevention‑and ‑treatment ‑ guidelines/402/giardiasis.,Non-OADS,/arxiv_data1/oa_pdf/22/70/JFMPC-4-596.PMC4776617.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/9b/afv197.PMC4776624.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/06/afv204.PMC4776625.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"Here we propose that in the complex matrix of human blood plasma supra-physiological [AscH/C0]o f3 –30 mM, achieved by IV administration [4], can be quanti ﬁed by direct UV spectroscopy.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.02.004 2213-2317/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
These trials were approved by The University of Iowa IRB and are listed on https://clinicaltrials.gov [4 –6].,Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"[2] Institute of Medicine (US) Panel on Dietary Antioxidants and Related Com- pounds, Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, andCarotenoids, National Academies Press (US), Washington (DC), 2000,PMID:25077263; 〈http://www.ncbi.nlm.nih.gov/books/NBK225483/ 〉.",Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"71 (3) (2013) 765 –775, http://dx.doi.org/ 10.1007/s00280-013-2070 /C08, PMCID: PMC3587047.",Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"Buatti (PI), B. Allen, C. Anderson, D. Berg, S. Bhatia, K. Bodeker, G. Beuttner, W. Rockey, M. Smith, W. Sun, B. Wagner, (Start date 04/2013; Active and Re-cruiting), A phase 1 trial of high dose ascorbate in glioblastoma multiforme atThe University of Iowa, (NCT01752491), 〈http://clinicaltrials.gov/ct2/show/ NCT01752491 〉.",Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"Allen, W. Rockey, D. Spitz, B. Wagner, S. Schroeder, R. Hohl, (Start date01/2014; active and recruiting), Gemcitabine, Ascorbate, and Radiation Ther-apy for Pancreatic Cancer, Phase 1, at The University of Iowa, (NCT01852890),〈http://clinicaltrials.gov/ct2/show/NCT01852890 〉.",Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"19 (2008) 1969 –1974, http://dx.doi.org/ 10.1093/annonc/mdn377 〈http://www.ncbi.nlm.nih.gov/pubmed/18544557 〉.",Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"Newberg, S. Deshmukh, M. Levine, Phase I evaluation of intravenous as-corbic acid in combination with gemcitabine and erlotinib in patients withmetastatic pancreatic cancer, PLoS One 7 (1) (2012) e29794, http://dx.doi.org/ 10.1371/journal.pone.0029794 , PMID: 22272248.",Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"426 (2) (2012) 109 –117, http://dx.doi.org/ 10.1016/j.ab.2012.04.014 , PMID: 22522059.",OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"365 (2007) 31 – 39,http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"32 (3)(2013) , http://dx.doi.org/10.1080/07315724.2013.791167 , PMID: 23885992.",Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"Methods16(1988) 27 –40,http://dx.doi.org/10.1016/0165-022X(88)90100-5 .",Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"61 (10) (2007) 1233 –1236, http://dx.doi.org/ 10.1038/sj.ejcn.1602655 , PMID: 17299479.",Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"23 (4) (1951) 636 –638, http://dx.doi.org/10.1021/ac60052a025 .",Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"82 (1) (1999) 35 –50,http://dx.doi.org/10.1016/S0301-4622(99)00104-0 , PMID:17030339.",Non-OADS,/arxiv_data1/oa_pdf/f4/f8/main.PMC4776628.pdf
"This is an  Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/4b/biu060.PMC4776677.pdf
"(28 March  2014; http://onlinelibrary.wiley.com/doi/10.1002/hyp.10083/abstract )  doi:10.1002/hyp.10083 Reed EB, Norton C. 1962.",Non-OADS,/arxiv_data1/oa_pdf/a8/4b/biu060.PMC4776677.pdf
"This is an  Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/2b/biu058.PMC4776678.pdf
The Online mendelian Inheritance  in man (O mIm) database catalogues more than   5000 human genetic diseases (http://www.omim.org/).,OADS,/arxiv_data1/oa_pdf/60/dd/ipsc-70-001.PMC4776682.pdf
Decipher (http://decipher.sanger.ac.uk/) and the Database  of genomic Variants (http://dgv.tcag.ca/dgv/app/home)  are interactive Web-based databases which incorporate a  suite of tools designed to aid the interpretation of genomic  variants.,OADS,/arxiv_data1/oa_pdf/60/dd/ipsc-70-001.PMC4776682.pdf
Two databases of genes associated with aSD  are updated regularly: autismKB (http://autismkb.cbi.pku.,Non-OADS,/arxiv_data1/oa_pdf/60/dd/ipsc-70-001.PMC4776682.pdf
edu.cn) and SF arI gene (https://gene.sfari.org) (36).,OADS,/arxiv_data1/oa_pdf/60/dd/ipsc-70-001.PMC4776682.pdf
T Bo u r g e r o n 6 tives of the allen Brain Institute (http://www.brain-map.,Non-OADS,/arxiv_data1/oa_pdf/60/dd/ipsc-70-001.PMC4776682.pdf
org) or the Sestan Laboratory (http://medicine.yale.edu/ lab/sestan/index.aspx) are impressive in their description  of human gene expression at very high resolution.,Non-OADS,/arxiv_data1/oa_pdf/60/dd/ipsc-70-001.PMC4776682.pdf
INCF  (http://www.incf.org/) develops collaborative neuroinfor - matics infrastructure and promotes the sharing of data  and computing resources to the international research  community.,OADS,/arxiv_data1/oa_pdf/60/dd/ipsc-70-001.PMC4776682.pdf
"For example, the uK National health  Service (N hS) initiative INVOL VE (http://www.invo.org.and biomarkers, all promise to provide important new  insights into the aetiology and classification of these disor - ders.",Non-OADS,/arxiv_data1/oa_pdf/60/dd/ipsc-70-001.PMC4776682.pdf
"The research   Domain Criteria ( rDoC) project has been launched by   the uS National Institute of mental health (NI mh), calling  for the development, for research purposes, of new ways of  classifying psychopathology based on dimensions of observ - able behaviour and neurobiological and genetic measures  (http://www.nimh.nih.gov/research-priorities/rdoc/nimh- research-domain-criteria-rdoc.shtml).",Non-OADS,/arxiv_data1/oa_pdf/60/dd/ipsc-70-001.PMC4776682.pdf
"There is also the James Lind alliance (http:// www.lindalliance.org), the Patient-Centered Outcomes  research Institute (PCO rI) (http://www.pcori.org) and  PatientsLike me (www.patientslikeme.org) initiatives for  patients who want to monitor their own health and  chronic illness.",Non-OADS,/arxiv_data1/oa_pdf/60/dd/ipsc-70-001.PMC4776682.pdf
another exam - ple is the initiative for cancer research at Sage Bionet - works (http://sagebase.org).,Non-OADS,/arxiv_data1/oa_pdf/60/dd/ipsc-70-001.PMC4776682.pdf
"For exam - ple, aspiritech, a non-profit organization based in high- land Park, Illinois, uSa, places people who have autism  (mainly asperger’ s syndrome) in jobs testing software  (http://www.aspiritech.org).",Non-OADS,/arxiv_data1/oa_pdf/60/dd/ipsc-70-001.PMC4776682.pdf
"http://informahealthcare.com/hth ISSN: 0265-6736 (print), 1464-5157 (electronic) Int J Hyperthermia, 2015; 31(8): 869–874 !2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/62/51/ihyt-31-869.PMC4776683.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-com-mercial re-use, distribution, and reproduction in any medium, providedthe original work is properly cited, and is not altered, transformed, orbuilt upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/62/51/ihyt-31-869.PMC4776683.pdf
"This study was registered with the identification number KCT 0001301 at the Clinical Research Information Service inRepublic of Korea (CRIS, http://cris.nih.go.kr).",Non-OADS,/arxiv_data1/oa_pdf/62/51/ihyt-31-869.PMC4776683.pdf
Available at http://www2.massgeneral.org/painrelief/ pain%20topics/heat_cold.pdf (accessed October 2012).,Non-OADS,/arxiv_data1/oa_pdf/62/51/ihyt-31-869.PMC4776683.pdf
"Retrieved from http://www.wma.net/en/30publications/10policies/b3/index.html (Ac-cessed 6 February, 2014).",Non-OADS,/arxiv_data1/oa_pdf/31/29/imhn-36-583.PMC4776684.pdf
"http://informahealthcare.com/gye ISSN: 0951-3590 (print), 1473-0766 (electronic) Gynecol Endocrinol, 2015; 31(7): 552–559 !2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/fb/5a/igye-31-552.PMC4776687.pdf
"Despite this, in general, low doses will confer moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non- commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited, and is not altered,transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/fb/5a/igye-31-552.PMC4776687.pdf
Availablefrom: http://www.emea.eu.int/pdfs/human/ewp/002197en.pdf [lastaccessed Oct 2014].DOI: 10.3109/09513590.2015.1019853 Parenteral HT microspheres 559,Non-OADS,/arxiv_data1/oa_pdf/fb/5a/igye-31-552.PMC4776687.pdf
"(2012) foundThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License(http://creativecommons.org/Licenses/by-nc-nd/4.0/), which permitsnon-commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited, and is not altered,transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/cf/4e/ijmh-25-001.PMC4776695.pdf
Available from: http://stakeholders.ofcom.org.uk/market-data-research/market-data/communications-market-reports/cmr14/uk/.,OADS,/arxiv_data1/oa_pdf/cf/4e/ijmh-25-001.PMC4776695.pdf
"Retrieved from http://lovdata.no/dokument/NL/lov/1999-07-02-63?q =pasientrettighetsloven Psykisk helsevernloven [The Mental Health Act] (1999, July).",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/imhn-36-209.PMC4776696.pdf
"Retrieved from http://lovdata.no/dokument/NL/lov/1999-07-02-62?q =psykisk +helsevern Ridley, J., & Hunter, S. (2013).",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/imhn-36-209.PMC4776696.pdf
Retrieved fromhttp://www.wma.net/en/30publications/10policies/b3/index.html,Non-OADS,/arxiv_data1/oa_pdf/8f/f1/imhn-36-209.PMC4776696.pdf
"Further, a research agenda identifies the practices the area of inquiry is interested in informing, and the types of study designs and analytic approaches amenable to carrying out the proposed work.ARTICLE HISTORY Received 6 October 2014 Revised 1 April 2015 Accepted 10 April 2015 KEYWORDS Health services research; interprofessional research; IPECP research agenda; research Introduction The National Center for Interprofessional Practice and Education at the University of Minnesota (hereafter the National Center) ( https://nexusipe.org/ ) is committed to nurturing and producing an evidence-base on the impact of interprofessional education and collaborative practice (IPECP) on both health-related and pre- and post-licensure education outcomes.",Non-OADS,/arxiv_data1/oa_pdf/6e/1d/ijic-30-007.PMC4776700.pdf
"1, 7 –14 http://dx.doi.org/10.3109/13561820.2015.1040875 © 2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/6e/1d/ijic-30-007.PMC4776700.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/6e/1d/ijic-30-007.PMC4776700.pdf
http://dx.doi.org/10.1002/14651858.,Non-OADS,/arxiv_data1/oa_pdf/6e/1d/ijic-30-007.PMC4776700.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/56/msv281.PMC4776705.pdf
"Brieﬂy, library adapter sequences were ﬁrst removed and overlapping read pairs mergedusing SeqPrep ( https://github.com/jstjohn/SeqPrep ,l a s t accessed December 10, 2015) with default settings.",Non-OADS,/arxiv_data1/oa_pdf/9c/56/msv281.PMC4776705.pdf
"Nonoverlapping reads were then quality trimmed to a Phred quality score threshold of 20 using Nesoni 0.128 (https://github.com/Victorian -Bioinformatics-Consortium/ nesoni , last accessed December 10, 2015).",Non-OADS,/arxiv_data1/oa_pdf/9c/56/msv281.PMC4776705.pdf
"These analyses were performed using ReﬁneM version 0.0.6 ( https://github.com/dparks1134/ReﬁneM ,l a s t accessed December 10, 2015).",OADS,/arxiv_data1/oa_pdf/9c/56/msv281.PMC4776705.pdf
"Average AAIs The average AAI between pairs of genomes was calculated from orthologous genes identi ﬁed through reciprocal best BLAST hits as implemented in CompareM version 0.0.5(https://github.com/dparks1134/CompareM , last accessed December 10, 2015).",OADS,/arxiv_data1/oa_pdf/9c/56/msv281.PMC4776705.pdf
"ATP/ADP Translocase Gene Phylogeny An ARB database containing chlamydial, rickettsial, and chlo-roplast ATP/ADP translocase protein sequences was down-loaded from http://www.microbial-ecology.net/download (last accessed December 10, 2015) (Schmitz-Esser et al.2004 ) and aligned de novo together with ATP/ADP translo- cases identiﬁed in the TM6 genomes using MAFFT-linsi ver- sion 6.864b (Katoh and Toh 2010 ).",OADS,/arxiv_data1/oa_pdf/9c/56/msv281.PMC4776705.pdf
Supplementary Material Supplementary ﬁgures S1–S6 and tables S1–S6 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/9c/56/msv281.PMC4776705.pdf
"Available from: http://www.R-project.org/ Rheims H, Rainey FA, Stackebrandt E. 1996.",Non-OADS,/arxiv_data1/oa_pdf/9c/56/msv281.PMC4776705.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/db/msv334.PMC4776707.pdf
"For some SNPs in APPBPP2, the differences of allele frequencies between Eurasiatic pop-ulation and sub-Saharan populations from Africa are of theorder of 90% ( http://popgen.uchicago.edu/ggv/ , last accessed December 2015) calling for a fur ther functional analysis.",Non-OADS,/arxiv_data1/oa_pdf/7a/db/msv334.PMC4776707.pdf
Supplementary Material Supplementary ﬁgures S1–S15 and tables S1–S9 Molecular Biology and Evolution online ( http://www.mbe.oxfordjour- nals.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/db/msv334.PMC4776707.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/83/msv341.PMC4776708.pdf
"Results and Discussion The “Vhica” Package The VHICA analysis is fully automated through the R package “vhica,” available in CRAN ( https://cran.r-project.org /).",OADS,/arxiv_data1/oa_pdf/1c/83/msv341.PMC4776708.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/0a/msv344.PMC4776709.pdf
"Evolutionary Rates and Relationships Rate matrices and branch lengths were obtained from http:// hgdownload.cse.ucsc.edu/goldenPath/hg19/multiz46way/ (last accessed January 3, 2016) and http://genomewiki.ucsc.",OADS,/arxiv_data1/oa_pdf/69/0a/msv344.PMC4776709.pdf
Supplementary Material Supplementary ﬁgures S1–S7 and tables S1–S6 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/69/0a/msv344.PMC4776709.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/d8/msv345.PMC4776710.pdf
"We also obtained WGBS methylation map of the psoas muscle from human from the NIH Roadmap project (GSM1010986, http://nihroadmap.nih.gov/epigenomics/ ,l a s t accessed December 2015).",OADS,/arxiv_data1/oa_pdf/51/d8/msv345.PMC4776710.pdf
"RNA-seq data for H. sapiens muscle and D. rerio 1,000-cell embryo were obtained from the Human Bodymap 2.0 project ( http://www.ebi.ac.uk/arrayexpress/ex- periments/E-MTAB-513/ , last accessed December 2015) and SRR748490 ( Jiang et al.",OADS,/arxiv_data1/oa_pdf/51/d8/msv345.PMC4776710.pdf
Supplementary Material Supplementary ﬁgures S1–S3 and tables S1–S5 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/51/d8/msv345.PMC4776710.pdf
Available from: http://www.repeatmasker.org .,Non-OADS,/arxiv_data1/oa_pdf/51/d8/msv345.PMC4776710.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/5e/msv346.PMC4776711.pdf
"We conducted a BLAST search of the T. belangeri (chi- nensis ) whole-genome sequence (European Nucleotide Archive; WGS Sequence S et: ALAR00000000.1) using human opsin gene sequences to identify sequences of OPN1SW andOPN1LW , which were used to design PCR pri- mers within introns (Primer3; http://primer3.sourceforge.net , last accessed January 16, 2016) ( table 2 ).",OADS,/arxiv_data1/oa_pdf/f7/5e/msv346.PMC4776711.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/13/msv349.PMC4776712.pdf
"2014 ) and is publicly available at https://github.com/grifﬁnp/GWAS_pipeline (last accessed January 13, 2016).",Non-OADS,/arxiv_data1/oa_pdf/26/13/msv349.PMC4776712.pdf
"The observed overlap wascompared with a simulated null distribution for both nodeand edge number, where n¼1,000 simulation iterations.Supplementary Material Supplementary ﬁgures S1–S4 and tables S1–S5 are available at Molecular Biology and Evolution online ( http://www.mbe.",OADS,/arxiv_data1/oa_pdf/26/13/msv349.PMC4776712.pdf
Available from: http://www.bioinformatics.,OADS,/arxiv_data1/oa_pdf/26/13/msv349.PMC4776712.pdf
"InterJournal, Complex Systems 1695 .A v a i l a b l e from: http://igraph.org .",Non-OADS,/arxiv_data1/oa_pdf/26/13/msv349.PMC4776712.pdf
Available from: http://broadinstitute.github.io/picard .,Non-OADS,/arxiv_data1/oa_pdf/26/13/msv349.PMC4776712.pdf
Available from: http://dx.doi.org/10.6084/ m9.ﬁgshare.895626 .,OADS,/arxiv_data1/oa_pdf/26/13/msv349.PMC4776712.pdf
Available from: http://www.repeatmasker.org .,Non-OADS,/arxiv_data1/oa_pdf/26/13/msv349.PMC4776712.pdf
Available from: http://CRAN.R-project.org/package ¼epiR .,Non-OADS,/arxiv_data1/oa_pdf/26/13/msv349.PMC4776712.pdf
"This is an  Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/b4/biu169.PMC4776715.pdf
(23 September 2014; http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/74/b4/biu169.PMC4776715.pdf
"This is an  Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/61/biv012.PMC4776716.pdf
"This is an  Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/ed/biu222.PMC4776717.pdf
"We produced this practical guide on  the basis of our experiences developing and participating in  the NSF Graduate K–12 Education program, CAMEOS (for  Coastal, Atmospheric, and Marine Environmental Observing  Studies; http://bml.ucdavis.edu/education/cameos ) at the  University of California, Davis’ , Bodega Marine Laboratory.",Non-OADS,/arxiv_data1/oa_pdf/d5/ed/biu222.PMC4776717.pdf
"At the recent  World Parks Congress, organized by the  International Union for Conservation  of Nature (IUCN) in Sydney, Australia,  12 innovative approaches were pro - moted as part of the “Promise of  Sydney” to help transform decision - making, policy, capacity, and financing  for protected areas in the next decade  (http://io.aibs.org/syd ).",Non-OADS,/arxiv_data1/oa_pdf/c8/f0/biv064.PMC4776719.pdf
"This is an  Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/77/biv083.PMC4776720.pdf
(11 December 2014; http://www.water.,Non-OADS,/arxiv_data1/oa_pdf/4f/77/biv083.PMC4776720.pdf
BOTEC Analysis Corp. (11  December 2014; http://lcb.wa.gov/publications/Marijuana/SEPA/ BOTEC_Whitepaper_Final.pdf ) [PF and CACP] Police Foundation and Colorado Association of Chiefs of  Police.,OADS,/arxiv_data1/oa_pdf/4f/77/biv083.PMC4776720.pdf
"http://informahealthcare.com/jas ISSN: 0277-0903 (print), 1532-4303 (electronic) J Asthma, 2015; 52(6): 630–637 !2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/d4/9d/ijas-52-630.PMC4776729.pdf
"Several of the health conditions which are associated with poorasthma control are common among survivors of the WTCterrorist attacks; these include gastroesophageal reflux dis-order (GERD) [2,18,19], obstructive sleep apnea (OSA)[20,21], obesity [22,23], post-traumatic stress disorder(PTSD) [1,2,24,25], depression [2,24,25] and anxiety [2,25].Previous studies have found close links between respiratory and mental illnesses among persons exposed to 9/11 [26–29], and a study performed six to nine months after 9/11 found an This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License(http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited, and is not altered,transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/d4/9d/ijas-52-630.PMC4776729.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/0e/iew007.PMC4776738.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/87/iew011.PMC4776739.pdf
"1 In the U.S., there are nearly 14 million cancer  survivors,2 many of whom face health-related quality of life (QOL) concerns (physical,  emotional, psychosocial, spiritual, and financial) associated with their diagnosis and  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) Address correspondence to: Angela R. Moore, MPH, Comprehensive Cancer Control Branch, Division of Cancer Prevention and  Control, CDC, 4770 Buford Highway, NE, MS F-76, Chamblee Georgia 30341. armoore@cdc.gov.",Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1089/jwh.2009.1666 .,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1158/1055-9965.EPI-12-1356 .,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
Report - recommendations for the framework  and format of Healthy People 2020. http://healthypeople.gov/2020/about/advisory/Reports.aspx 7.,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1177/109019818801500401 .,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
"http://s2.medicina.uady.mx/observatorio/ docs/eq/li/Eq_2007_Li_Dahlgren.pdf  [Accessed September 8, 2015] 12.",Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1007/s10900-010-9289-7 .,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1016/j.jadohealth.2012.08.009 .,OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1007/ s11764-013-0276-8 .,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
2011; 20(10):2093– 2098. http://dx.doi.org/10.1158/1055-9965.EPI-11-0652 .,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1146/ annurev.publhealth.28.021406.144145 .,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1007/s11764-015-0432-4 .,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1002/cncr.28157 .,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1002/cncr.28162 .,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1007/s10552-010-9664-9 .,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1089/jwh.2012.4239 .,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1634/theoncologist.,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1002/pon.1965 .,Non-OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
http://dx.doi.org/10.1016/S0140-6736(14)60648-6 .,OADS,/arxiv_data1/oa_pdf/84/31/nihms756846.PMC4776752.pdf
"This is an  Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/d6/biv109.PMC4777015.pdf
"Research is being performed along this transect by the Andes Biodiversity and Ecosystem  Group ( http://andesconservation.org ), with the primary goal to understand ecosystem ecology and biodiversity and their responses to  past and future climate change (Malhi et al.",Non-OADS,/arxiv_data1/oa_pdf/3e/d6/biv109.PMC4777015.pdf
1This clinical condition is classi ﬁed as early infantile epileptic encephalopathy 14 (MIM #614959) by the online database Mendelian inheritance in man (OMIM; http://www.omim.org/).,Non-OADS,/arxiv_data1/oa_pdf/c4/d7/hgv201427.PMC4777018.pdf
This alteration has not been previously reported and is not found in the single-nucleotide variation database (https://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/c4/d7/hgv201427.PMC4777018.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/c4/d7/hgv201427.PMC4777018.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/KCNT1 mutation with EIFMS S Shimada et al 3 © 2014 The Japan Society of Human Genetics Human Genome Variation (2014) 14027",Non-OADS,/arxiv_data1/oa_pdf/c4/d7/hgv201427.PMC4777018.pdf
"This is  an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/04/biv138.PMC4777060.pdf
"(9 September 2015; http://ec.europa.eu/research/science-society/ document_library/pdf_06/she-figures-2012_en.pdf ) Fine E, Sheridan J, Carnes M, Handelsman J, Pribbenow C, Savoy J, Wendt A.",Non-OADS,/arxiv_data1/oa_pdf/55/04/biv138.PMC4777060.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/2f/nlv024.PMC4777218.pdf
Kaplan –Meier survival analysis with significance tests and significance tests using Cox proportional hazards models was carried out using the R survival package (http://cran.r-project.org/web/packages/survival/ ).,OADS,/arxiv_data1/oa_pdf/17/c5/cmr-26-108.PMC4777222.pdf
Available at: http://cancergenome.nih.gov/ [Accessed 11 December 2015].,Non-OADS,/arxiv_data1/oa_pdf/17/c5/cmr-26-108.PMC4777222.pdf
"The relativerisk of HLA-DR9 in AIH with CZN was calculated to be3.72 (95% con ﬁdence interval; 1.35 –10.37) in a large- scale population study of healthy Japanese individuals by the HLA Laboratory (Kyoto, Japan) ( http://www.hla.or.jp/ ).",OADS,/arxiv_data1/oa_pdf/72/12/meg-28-391.PMC4777223.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/05/c9/ccid-9-055.PMC4777224.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical, Cosmetic and Investigational Dermatology 2016:9 55–62Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  55ClInIC al TrIal repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/CCID.S9889 0Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/05/c9/ccid-9-055.PMC4777224.pdf
"Or use: http://youtu.be/iRxyyg3UFD USoothing and anti-itch effect of quercetin  phytosome in human subjects: a single-blind study Giada Maramaldi1 Stefano T ogni1 Ivan pagin1 luca Giacomelli2 roberta Cattaneo3 roberto eggenhöffner2 Samuele e Burastero4 1Indena S.p.a, Milan, 2Department  of Surgical Sciences and Integrated  Diagnostics, School of Medicine,   Genova University, Genoa, 3abich  Srl, Verbania, 4San raffaele Scientific  Institute, Milan, Italy Correspondence: Giada Maramaldi   Indena S.p.a., Viale ortles 12, Milan,  20139 Italy   T el +39 02 5749 6249   Fax +39 02 5749 6374   email giada.maramaldi@indena.co mBackground:  We evaluated the ability of quercetin, a natural antioxidant formulated in a  specific delivery system, to reduce skin inflammation induced by a variety of stimuli, includ - ing UV radiation, stimulation with a histamine solution, or contact with chemical irritants.",Non-OADS,/arxiv_data1/oa_pdf/05/c9/ccid-9-055.PMC4777224.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/05/c9/ccid-9-055.PMC4777224.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/c9/ccid-9-055.PMC4777224.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/00/42/cia-11-245.PMC4777226.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 245–253Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  245OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S9815 1The prognostic value of the plasma n-terminal  pro-brain natriuretic peptide level on all-cause  death and major cardiovascular events in a  community-based population Qiwei Zhu1 Wenkai Xiao1,* Y ongyi Bai1,* Ping Ye1 leiming luo1 Peng gao1 hongmei Wu1 Jie Bai2 1Department of geriatric Cardiology,   2Department of Clinical Biochemistry,   Chinese P lA general hospital,   Beijing, People’s republic of China *These authors contributed equally  to this workBackground:  Despite growing evidence that N-terminal pro-brain natriuretic peptide  (NT-proBNP) has an important prognostic value for patients with cardiovascular disease, chronic  kidney disease, etc, the prognostic significance of NT-proBNP levels in the general population  has not been established.",Non-OADS,/arxiv_data1/oa_pdf/00/42/cia-11-245.PMC4777226.pdf
"Many studies have shown that BNP and NT-proBNP Correspondence: Ping Ye Department of geriatric Cardiology,  Chinese PlA general hospital, 28 Fuxing  road, haidian District, Beijing 100853,  People’s republic of China email yeping301@sina.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhu et al Running head recto: Prognostic value of the plasma NT-proBNP level DOI: http://dx.doi.org/10.2147/CIA.S98151",Non-OADS,/arxiv_data1/oa_pdf/00/42/cia-11-245.PMC4777226.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/00/42/cia-11-245.PMC4777226.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/00/42/cia-11-245.PMC4777226.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/ndt-12-445.PMC4777227.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2016:12 445–452Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  445OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9073 5Detection of hyperphosphorylated tau protein  and α-synuclein in spinal cord of patients with  alzheimer’s disease Yanjun guo1,2 luning Wang2 Mingwei Zhu2 honghong Zhang3 Yazhuo hu3 Zhitao han3 Jia liu4 Weiqin Zhao1 Dexin Wang1 1Department of Neurology, Beijing  Friendship hospital, capital Medical  University, 2Department of geriatric  Neurology, P la general hospital,   3institute of geriatrics, chinese P la  general hospital & chinese P la  Medical academy, 4Department of  Neurology, Xuanwu hospital, capital  Medical University, Beijing, People’s  republic of chinaAbstract:  The aim of this study was to investigate the neuropathological features of the  spinal cord in patients suffering with Alzheimer’s disease (AD).",Non-OADS,/arxiv_data1/oa_pdf/bb/a6/ndt-12-445.PMC4777227.pdf
"de Calignon et al2 studied a transgenic mouse model and found that  tau pathology progresses from transgene-expressing neurons in the entorhinal cortex  to neurons without detectable transgene expression, beginning with the neighboring  cells of entorhinal cortex and followed by propagation to neurons downstream in the correspondence: luning Wang Department of geriatric Neurology,  Pla general hospital, 28 Fuxing road,  haidian District, Beijing 100853, People’s  republic of china Tel +86 13 3311 38801 Fax +86 01 0631 39807 email lnw_301@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Guo et al Running head recto: AD spinal neuropathology DOI: http://dx.doi.org/10.2147/NDT.S90735",Non-OADS,/arxiv_data1/oa_pdf/bb/a6/ndt-12-445.PMC4777227.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/bb/a6/ndt-12-445.PMC4777227.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/ndt-12-445.PMC4777227.pdf
http://unitingtocombatntds.org/resource/london-declaration [accessed 4 December 2015].,Non-OADS,/arxiv_data1/oa_pdf/c3/84/ihv072.PMC4777228.pdf
Geneva: World Health Organization; 2012. http://www.who.int/neglected_diseases/ NTD_RoadMap_2012_Fullversion.pdf [accessed 4 December 2015].,Non-OADS,/arxiv_data1/oa_pdf/c3/84/ihv072.PMC4777228.pdf
Geneva: World Health Organization; 2012: p.5 –7.http://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf#page=9 [accessed 4 December 2015].,Non-OADS,/arxiv_data1/oa_pdf/c3/84/ihv072.PMC4777228.pdf
http://apps.who.int/iris/bitstream/ 10665/44440/1/9789241564090_eng.pdf [accessed 4 December 2015].,Non-OADS,/arxiv_data1/oa_pdf/c3/84/ihv072.PMC4777228.pdf
"Decatur, GA:Task Force for Global Health 2013. http://www.taskforce.org/press- room/press-releases/task-force-global-health-receives-new-funding-neglected-tropical-diseases- [accessed 4 December 2015].",Non-OADS,/arxiv_data1/oa_pdf/c3/84/ihv072.PMC4777228.pdf
http://www.ntdsupport.org/operational-research- eliminate-ntds [accessed 8 December 2015].,OADS,/arxiv_data1/oa_pdf/c3/84/ihv072.PMC4777228.pdf
"Decatur, Georgia: Neglected Tropical Diseases Support Center, 2014. http://www.ntdsupport.",Non-OADS,/arxiv_data1/oa_pdf/c3/84/ihv072.PMC4777228.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8e/0a/dmso-9-037.PMC4777230.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/8e/0a/dmso-9-037.PMC4777230.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 37–46submit your manuscript | www.dovepress.co m Dove press   http: //dx.doi.org/10.2147/DMSO.S8983 6Long-term weight loss maintenance for obesity:  a multidisciplinary approach Luca Montesi1 Marwan el Ghoch2 Lucia Brodosi1 Simona Calugi2 Giulio Marchesini1 Riccardo Dalle Grave2 1Unit of Metabolic Diseases, S Orsola- Malpighi Hospital, “Alma Mater  Studiorum” University, Bologna, italy;   2Department of eating and weight  Disorders, villa Garda Hospital,   verona, italy Correspondence: Giulio Marchesini   Unit of Metabolic Diseases, S Orsola- Malpighi Hospital, “Alma Mater  Studiorum” University, via Massarenti, 9,  i-40135 Bologna, italy   T el +39 05 1214 4889   Fax +39 05 1636 4502   email giulio.marchesini@unibo.i tAbstract:  The long-term weight management of obesity remains a very difficult task, associ - ated with a high risk of failure and weight regain.",Non-OADS,/arxiv_data1/oa_pdf/8e/0a/dmso-9-037.PMC4777230.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/8e/0a/dmso-9-037.PMC4777230.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/0a/dmso-9-037.PMC4777230.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/21/03/ndt-12-511.PMC4777231.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 511–516Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  511OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9141 1association between sociodemographic  characteristics and anxiety levels of violence- exposed patients admitted to emergency clinic hilal hocagil1 Filiz izci2 abdullah cüneyt hocagil1 ebru Findikli3 sevda Korkmaz4 Merve iris Koc5 1Department of emergency, school  of Medicine, Bulent ecevit University,   Zonguldak, 2Department of Psychiatry,   school of Medicine, istanbul Bilim  University, istanbul, 3Department of  Psychiatry, school of Medicine, sutcu  imam University, Kahramanmaras,   4Department of Psychiatry, school  of Medicine, Firat University, elazig,   5Department of Psychiatry, erenkoy  Training and research hospital  for Psychiatric and Neurological  Disorders, istanbul, T urkeyBackground:  Here we aimed to investigate sociodemographic characteristics, psychiatric  history, and association between sociodemographic characteristics and anxiety levels of violence- exposed patients admitted to emergency clinic.",Non-OADS,/arxiv_data1/oa_pdf/21/03/ndt-12-511.PMC4777231.pdf
"No 164, istanbul  34100, Turkey Tel +90 212 505 450 3013 email filizizci@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Hocagil et al Running head recto: Association between sociodemographic characteristics and anxiety levels DOI: http://dx.doi.org/10.2147/NDT.S91411",Non-OADS,/arxiv_data1/oa_pdf/21/03/ndt-12-511.PMC4777231.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/21/03/ndt-12-511.PMC4777231.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/03/ndt-12-511.PMC4777231.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d2/ea/ndt-12-501.PMC4777232.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 501–510submit your manuscript | www.dovepress.co m Dove press  501 http: //dx.doi.org/10.2147/NDT .S10115 5Dove press OrigiNal researchopen access to scientific and medical research Open access Full T ext article intelligence quotient discrepancy indicates levels  of motor competence in preschool children at  risk for developmental delays Tzu-Ying Yu1 Kuan-lin chen2,3 Willy chou4,5 shu-han Yang4 sheng-chun Kung4 Ya-chen lee2 li-chen T ung4,6,7 1Department of Occupational  Therapy, college of Medicine, i-shou  University, Kaohsiung, 2Department  of Occupational Therapy, college  of Medicine, National cheng Kung  University, Tainan, 3Department of  Physical Medicine and rehabilitation,   National cheng Kung University  hospital, college of Medicine,   National cheng Kung University,   Tainan, 4Department of Physical  Medicine and rehabilitation, chi-Mei  Medical center, Tainan, 5Department  of recreation and health care  Management, cha Nan University  of Pharmacy and science, Tainan,   6school of Medicine, Kaohsiung  Medical University, Kaohsiung, 7school  of Medicine, chung shan Medical  University, Taichung, TaiwanPurpose:  This study aimed to establish 1) whether a group difference exists in the motor  competence of preschool children at risk for developmental delays with intelligence quotient  discrepancy (IQD; refers to difference between verbal intelligence quotient [VIQ] and  performance intelligence quotient [PIQ]) and 2) whether an association exists between IQD  and motor competence.",Non-OADS,/arxiv_data1/oa_pdf/d2/ea/ndt-12-501.PMC4777232.pdf
"Keywords:  IQ discrepancy, motor competence, child Introduction Intelligence quotient discrepancy (IQD) refers to the difference between measured  verbal intelligence quotient (VIQ) and performance intelligence quotient (PIQ)  obtained from the Wechsler Intelligence Scale.1 Intelligence quotient (IQ) is defined  as the ability to understand complex ideas, adapt effectively to the environment, correspondence: li-chen Tung Department of Physical Medicine  and rehabilitation, chi-Mei Medical  center, Tainan, Taiwan, No 901,  Zhonghua road, Yongkang District,  Tainan city 710, Taiwan Tel +886 6 281 2811 ext 55005 email lidiatung@hotmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Yu et al Running head recto: IQ discrepancy indicates motor competence DOI: http://dx.doi.org/10.2147/NDT.S101155",Non-OADS,/arxiv_data1/oa_pdf/d2/ea/ndt-12-501.PMC4777232.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d2/ea/ndt-12-501.PMC4777232.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/ea/ndt-12-501.PMC4777232.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0f/47/ijn-11-729.PMC4777233.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 729–741International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  729OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9365 1Degradation of the electrospun silica nanofiber  in a biological medium for primary hippocampal  neuron – effect of surface modification Z Vivian Feng1,* Wen shuo chen2,* Khomson Keratithamkul1 Michael stoick1 Brittany Kapala3 Eryn Johnson3 an-chi huang2 Ting Yu chin4 Yui Whei chen-Yang2 Mong-lin Yang3 1Chemistry Department, Augsburg  college, Minneapolis, MN, Usa;   2Department of Chemistry, Center  for Nanotechnology, Center for  Biomedical T echnology, Chung  Yuan Christian University, Chung  Li, Taiwan, Republic of China;   3Department of science, concordia  University Saint Paul, Saint Paul, MN,   Usa; 4Department of Bioscience  Technology, Chung Yuan Christian  University, Chung Li, Taiwan, Republic  of china *These authors contributed equally  to this workAbstract:  In this work, silica nanofibers (SNFs) were prepared by an electrospinning method  and modified with poly- d-lysine (PDL) or (3-aminopropyl) trimethoxysilane (APTS) making  biocompatible and degradable substrates for neuronal growth.",Non-OADS,/arxiv_data1/oa_pdf/0f/47/ijn-11-729.PMC4777233.pdf
"Specifically, researchers have identified desirable properties for such scaffolds to  be three dimensional (3-D), bioactive, and biodegradable.4 In order to achieve the  ideal chemical and mechanical properties in vitro, the organic-based biomaterials,  such as a combination of gelatin and genipin, poly( ε-caprolactone), and poly(ortho- methoxyaniline), have been successfully synthesized and utilized for neuronal tissue  engineering.5–7 Although inorganic-based biomaterials have seen greater success in  sensors, adsorbents, and medicines,8–11 their applications in tissue engineering have  mainly focused on bone tissue engineering,11,12 utilizing their good mechanical strength  and biocompatibility for in vivo implantation, with limited progress in neuronal tissue  engineering.13 In our previous study,14 we have introduced a novel inorganic neuronal  tissue engineering substrate, the chemically modified silica nanofibers (SNFs), which  were electrospun to form biomimetic framework of the extracellular matrix and sol–gel correspondence: Mong-lin Yang Department of science, concordia  University Saint Paul, 1282 Concordia  Avenue, Saint Paul, MN 55104, USA Tel +1 651 641 8220 Fax +1 651 641 6291 email myang2@csp.ed u  Yui Whei chen-Yang Department of Chemistry, Center for  Nanotechnology, Center for Biomedical  Technology, Chung Yuan Christian  University, 200 Chung Pei Road, Chung  Li, Taiwan 32023, Republic of China Tel +866 3 265 3317 Fax +886 3 265 3399 email yuiwhei@cycu.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Feng et al Running head recto: Degradation of the electrospun silica nanofiber in a biological medium DOI: http://dx.doi.org/10.2147/IJN.S93651",Non-OADS,/arxiv_data1/oa_pdf/0f/47/ijn-11-729.PMC4777233.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0f/47/ijn-11-729.PMC4777233.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/ijn-11-729.PMC4777233.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/39/b3/rru-8-035.PMC4777234.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/39/b3/rru-8-035.PMC4777234.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Research and Reports in Urology 2016:8 35–39submit your manuscript | www.dovepress.co m Dove press  35 http: //dx.doi.org/10.2147/RRU.S10094 4a case report of laparoscopic ipsilateral  ureteroureterostomy in children with renal  duplex Yuen shan Wong Yuk Him Tam Kristine Kit Yi Pang Division of Paediatric surgery and  Paediatric Urology, Department of  surgery, Prince of Wales Hospital, The  Chinese University of Hong Kong,   shatin, NT, Hong Kong Correspondence: Yuk Him Tam   Division of Paediatric surgery and  Paediatric Urology, Department of  surgery, Prince of Wales Hospital, The  Chinese University of Hong Kong, shatin,  NT, Hong Kong   T el +852 2632 2953   email pyhtam@surgery.cuhk.edu.h kAbstract:  We report on two children aged 2 and 6 years, who underwent  laparoscopic ipsilateral  ureteroureterostomy for their renal duplex anomalies.",Non-OADS,/arxiv_data1/oa_pdf/39/b3/rru-8-035.PMC4777234.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/39/b3/rru-8-035.PMC4777234.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/b3/rru-8-035.PMC4777234.pdf
"Stimuli and apparatus Visual and auditory stimuli were controlled via a purpose-made ArduinoTMmicrocontroller (http:// arduino.cc , refresh rate 10 KHz) and driven by in- house experimental software (ExpyVR, http://lnco.epﬂ.",OADS,/arxiv_data1/oa_pdf/f4/41/i1534-7362-16-3-21.PMC4777235.pdf
"Journal of Neurophysiology ,76, 141–157, http://www.ncbi.nlm.nih.gov/pubmed/8836215 .",Non-OADS,/arxiv_data1/oa_pdf/f4/41/i1534-7362-16-3-21.PMC4777235.pdf
"Neuro- psychologia ,70, 358–366, http://dx.doi.org/10.1016/ j.neuropsychologia.2014.12.008 .",Non-OADS,/arxiv_data1/oa_pdf/f4/41/i1534-7362-16-3-21.PMC4777235.pdf
"Inﬂation and ﬂattening of the anatomical images was carried out using the Freesurfer image analysis suite, which is documented and freely available for downloadonline (http://surfer.nmr.mgh.harvard.edu ).",OADS,/arxiv_data1/oa_pdf/4b/6c/i1534-7362-16-3-26.PMC4777237.pdf
"Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7754376 Sperry, R. W. (1950).",OADS,/arxiv_data1/oa_pdf/4b/6c/i1534-7362-16-3-26.PMC4777237.pdf
Retrieved from http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/4b/6c/i1534-7362-16-3-26.PMC4777237.pdf
Retrieved from http://opencv.org/ .,Non-OADS,/arxiv_data1/oa_pdf/78/2e/i1534-7362-16-3-27.PMC4777240.pdf
"Retrieved from http://www.positivescience.com .Proudlock, F. A., Shekhar, H., & Gottlob, I.",OADS,/arxiv_data1/oa_pdf/78/2e/i1534-7362-16-3-27.PMC4777240.pdf
"Retrieved from http://www.vectornav.com/support/manuals .Journal of Vision (2016) 16(3):27, 1–15 Tomasi et al.",OADS,/arxiv_data1/oa_pdf/78/2e/i1534-7362-16-3-27.PMC4777240.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ott-9-949.PMC4777257.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy OncoTargets and Therapy 2016:9 949–958Dove press submit your manuscript | www.dovepress.co m Dove press  Original researchopen access to scientific and medical research Open access Full T ext article 949 http: //dx.doi.org/10.2147/OTT .S10097 9clinical utility of her2 assessed by  immunohistochemistry in patients undergoing  curative resection for gastric cancer Xuechao liu1,2,* Pengfei Xu1,3,* haibo Qiu1,2,* Jianjun liu1,2 shangxiang chen1,2 Dazhi Xu1,2 Wei li1,2 Y ouqing Zhan1,2 Yuanfang li1,2 Yingbo chen1,2 Zhiwei Zhou1,2 Xiaowei sun1,2 1sun Yat-sen University cancer center,   state Key laboratory of Oncology  in south china, collaborative  innovation center for cancer  Medicine, 2Department of gastric  and Pancreatic surgery, 3Department  of Thoracic surgery, sun Yat-sen  University cancer center, guangzhou,   People’s republic of china *These authors contributed equally  to this workPurpose:  We sought to determine whether human epidermal growth factor receptor 2 (HER2)  and vascular endothelial growth factor (VEGF) expression were independent prognostic factors  for gastric cancer (GC).",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ott-9-949.PMC4777257.pdf
"However, correspondence: Xiaowei sun Department of gastric and Pancreatic  surgery, sun Yat-sen University cancer  center, 651# east Dongfeng road,  guangzhou 510060, guangdong,  People’s republic of china Fax +86 20 8734 3123 email sunxw@sysucc.org.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: Clinical utility of HER2 for gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S100979",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ott-9-949.PMC4777257.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ott-9-949.PMC4777257.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/89/ott-9-949.PMC4777257.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/eb/imcrj-9-043.PMC4777258.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2016:9 43–46International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  43Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S8882 4peribulbar anesthesia causing bilateral orbital  hemorrhage Kyla Garft1,2 peter Burt1,2  Benjamin Burt1,3 1Bendigo eye Clinic, Victoria,   2ophthalmology education,   Monash University Rural Medical  school, Melbourne, 3occuloplastics  Department, Royal Victorian eye and  ear Hospital, Victoria, australia Correspondence: Kyla Garft   Bendigo eye Clinic, 144 arnold street,  Bendigo North, Victoria 3550, australia   email kylakrystal@gmail.co mAbstract:  We report a case of bilateral orbital hemorrhage as a complication of peribulbar  anesthesia in a 78 year old man.",Non-OADS,/arxiv_data1/oa_pdf/52/eb/imcrj-9-043.PMC4777258.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer­reviewed open ­access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/52/eb/imcrj-9-043.PMC4777258.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/eb/imcrj-9-043.PMC4777258.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/90/09/dddt-10-851.PMC4777259.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 851–859submit your manuscript | www.dovepress.co m Dove press  851 http: //dx.doi.org/10.2147/DDDT .S9738 0Dove press Original researchopen access to scientific and medical research Open access Full T ext article Papaverine inhibits lipopolysaccharide-induced  microglial activation by suppressing nF- kB  signaling pathway Yalong Dang1 Yalin Mu2 Kun Wang3 Ke Xu2 Jing Yang1 Yu Zhu1 Bin luo2,3 1Department of Ophthalmology, The  First affiliated hospital of Zhengzhou  University, Zhengzhou, People’s  republic of china; 2Department of  Ophthalmology, Yellow-river hospital,   sanmenxia city, People’s republic of  china; 3clinical laboratory, Yellow- river hospital, sanmenxia city,   People’s republic of chinaObjective:  To investigate the effects of papaverine (PAP) on lipopolysaccharide (LPS)-induced  microglial activation and its possible mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/90/09/dddt-10-851.PMC4777259.pdf
"This  is a common phenomenon also observed in many acute/chronic retinal degenerative  diseases, such as glaucoma,6 age-related macular degeneration,7 and ocular traumatic  injury.8 Therefore, inhibiting overactivated microglial responses and alleviating the correspondence: Yu Zhu Department of Ophthalmology, The  First Affiliated Hospital of Zhengzhou  University, east Jianshe road, 450001  Zhengzhou, People’s republic of china email asiadragon@163.co m  Bin luo Department of Ophthalmology, Yellow- river hospital, West heping road,   hubin District, 472000 sanmenxia city,  People’s republic of china email 13569610688@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Dang et al Running head recto: PAP inhibits microglial activation via NF- kB signaling pathway DOI: http://dx.doi.org/10.2147/DDDT.S97380",Non-OADS,/arxiv_data1/oa_pdf/90/09/dddt-10-851.PMC4777259.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/90/09/dddt-10-851.PMC4777259.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/09/dddt-10-851.PMC4777259.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2d/dc/btt-10-023.PMC4777272.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBiologics: Targets and Therapy 2016:10 23–31Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  23Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S6784 4Update on the management of Philadelphia  chromosome positive chronic myelogenous  leukemia: role of nilotinib Josephine emole1 Taiwo Talabi2 Javier Pinilla-ibarz1 1Department of Malignant  Hematology, 2Moffitt Program for  Outreach wellness education and  Resources, H Lee Moffitt Cancer  Center and Research institute, Tampa,   FL, USA Correspondence: Javier Pinilla-ibarz   Department of Malignant Hematology,   H Lee Moffitt Cancer Center and  Research institute, 12902 Magnolia Drive,  Tampa, FL 33612, USA   email javier.pinilla@moffitt.or gAbstract:  Chronic myelogenous leukemia (CML) is a pluripotent stem cell disease characterized  by the presence of the Philadelphia chromosome and the bcr-abl gene.",Non-OADS,/arxiv_data1/oa_pdf/2d/dc/btt-10-023.PMC4777272.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/2d/dc/btt-10-023.PMC4777272.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/2d/dc/btt-10-023.PMC4777272.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/35/da/copd-11-407.PMC4777273.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 407–415International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  407OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9111 8a cross-sectional study to assess inhalation device  handling and patient satisfaction in COPD Marc Miravitlles1 Jéssica Montero-Caballero2 Frank richard2 salud santos3 Juan luis garcia-rivero4 Francisco Ortega5 Xavier ribera6 1Pneumology Department, hospital  Universitari Vall d’hebron, Ciber  de enfermedades respiratorias  (CIBeres), Barcelona, spain;   2Boehringer Ingelheim Pharma  gmbh & Co K g, Ingelheim, germany;   3Pulmonology Department, hospital  Universitari de Bellvitge, IDIBell,   Universitat de Barcelona, Ciber  de enfermedades respiratorias  (CIBeres), Barcelona, spain;   4Pneumology Department, hospital de  laredo, Cantabria, spain; 5Pneumology  Department, hospital Virgen del  rocío, sevilla, spain; 6Boehringer  Ingelheim Pharma gmbh & Co K g,   Barcelona, spainAbstract:  Delivery of inhaled medications via an inhaler device underpins the effectiveness  of treatment for patients with chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/35/da/copd-11-407.PMC4777273.pdf
"Keywords:  COPD, Respimat®, Breezhaler®, inhaler, handling Introduction The cornerstone of treatment delivery for chronic obstructive pulmonary disease  (COPD) involves administration of medications through inhaler devices.1 Inhaler  choice and handling of inhalation devices are key factors for the effectiveness of  treatment.2–4 Therefore, patients should receive appropriate guidance on the correct  use of the inhaler with regular follow-up to ensure treatment compliance.3,5,6 Patient satisfaction with their inhaler is an acknowledged predictor of treatment  adherence.7–10 In a large, multinational, cross-sectional, real-world survey reported by  Chrystyn et al,10 patient satisfaction with their inhaler was closely linked to treatment  compliance and loosely associated with fewer exacerbations and lower utilization of  health-care resources.10 Reporting of patient satisfaction with inhalers is therefore  gaining increasing attention and is now recognized as an important patient-reported  outcome in clinical trials involving patients with COPD or asthma.1 Measurement of inhaler satisfaction requires the use of reliable and validated instru - ments such as the Patient Satisfaction and Preference Questionnaire (PASAPQ).11 Details Correspondence: Marc Miravitlles Pneumology Department, hospital  Universitari Vall d’hebron,  P Vall d’hebron 119–129, 08035  Barcelona, spain Tel +34 93 274 6157 Fax +34 93 274 6083 email mmiravitlles@vhebron.ne t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Miravitlles et al Running head recto: Device handling and patient satisfaction in COPD DOI: http://dx.doi.org/10.2147/COPD.S91118",Non-OADS,/arxiv_data1/oa_pdf/35/da/copd-11-407.PMC4777273.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/35/da/copd-11-407.PMC4777273.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/da/copd-11-407.PMC4777273.pdf
Mutations in rhodopsin cause autosomal dominant retinitis pigmentosa (ADRP) (http://www.retina-international.org/ﬁles/ sci-news/rhomut.htm [in the public domain]).,Non-OADS,/arxiv_data1/oa_pdf/55/c6/i1552-5783-57-3-787.PMC4777275.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/74/67/ijn-11-791.PMC4777276.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).international Journal of nanomedicine 2016:11 791–822submit your manuscript | www.dovepress.co m Dove press  791 http: //dx.doi.org/10.2147/IJN.S9747 6Targeted polyethylene glycol gold nanoparticles  for the treatment of pancreatic cancer: from  synthesis to proof-of-concept in vitro studies Jolanda spadavecchia1,2,* Dania Movia3,* caroline Moore3,4 ciaran Manus Maguire3,4 hanane Moustaoui2 sandra casale1 Yuri Volkov3,4 adriele Prina-Mello3,4 1laboratoire de réactivité de surface,   sorbonne Universités, UPM c Univ  Paris Vi, Paris, 2centre national de  la recherche française, UM r 7244,   csPB aT, laboratory of chemistry,   structures, and Properties of  Biomaterials and Therapeutic agents,   Université Paris 13, sorbonne Paris  cité, Bobigny, France; 3aMBer centre,   crann  institute, 4Department of  clinical Medicine, school of Medicine,   Trinity college, Dublin, ireland *These authors contributed equally  to this workAbstract:  The main objective of this study was to optimize and characterize a drug delivery  carrier for doxorubicin, intended to be intravenously administered, capable of improving the  therapeutic index of the chemotherapeutic agent itself, and aimed at the treatment of pancreatic  cancer.",Non-OADS,/arxiv_data1/oa_pdf/74/67/ijn-11-791.PMC4777276.pdf
"Despite regulatory issues and  technical/scientific challenges,4 cancer nanomedicine – for instance miniaturized  delivery systems – aiming at improving the therapeutic efficacy of currently available correspondence: adriele Prina-Mello lab 0.74, nanomedicine and Molecular  imaging lab, institute of Molecular  Medicine, Trinity centre for health  sciences, James’s street, Dublin 8, ireland email prinamea@tcd.i e; dmovia@tcd.i eJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Spadavecchia et al Running head recto: PEG-AuNPs for the treatment of PDAC DOI: http://dx.doi.org/10.2147/IJN.S97476",Non-OADS,/arxiv_data1/oa_pdf/74/67/ijn-11-791.PMC4777276.pdf
Available from: http://www.janssen.pt/sites/default/files/The-Future- Of-Healthcare-In-Europe.pd f. 2012.,Non-OADS,/arxiv_data1/oa_pdf/74/67/ijn-11-791.PMC4777276.pdf
Available from: http://www.cytimmune.com /.,Non-OADS,/arxiv_data1/oa_pdf/74/67/ijn-11-791.PMC4777276.pdf
ClinicalTrials.go v. Available from: https://clinicaltrials.gov /.,Non-OADS,/arxiv_data1/oa_pdf/74/67/ijn-11-791.PMC4777276.pdf
Available from: http://www.cytimmune.com/#pipelin e. Accessed  August 2015.,Non-OADS,/arxiv_data1/oa_pdf/74/67/ijn-11-791.PMC4777276.pdf
Available from: http://static.bdbiosciences.com/docu - ments/accuri/Accuri-TB-Guide-to-Absolute-Counting.pd f. Accessed  August 2015.,Non-OADS,/arxiv_data1/oa_pdf/74/67/ijn-11-791.PMC4777276.pdf
Available from: http://www.ecu.edu/cs-dhs/bsomresearchgrad - studies/CoreImagingCenter/upload/Colocalization_AIM_ZEN.pd f.  Accessed August 2015.,Non-OADS,/arxiv_data1/oa_pdf/74/67/ijn-11-791.PMC4777276.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/74/67/ijn-11-791.PMC4777276.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/67/ijn-11-791.PMC4777276.pdf
Avaible from: http://ispub.com/ IJNT/3/1/13197.,Non-OADS,/arxiv_data1/oa_pdf/82/cc/cm-89-128.PMC4777456.pdf
http://www.cti.gov.br/invesalius/).,Non-OADS,/arxiv_data1/oa_pdf/8e/a1/cm-89-137.PMC4777457.pdf
<http://profiles.nlm.nih.gov/ps/retrieve/ResourceMetadata/FJBBCP>.,OADS,/arxiv_data1/oa_pdf/c7/1f/cm-89-176.PMC4777462.pdf
Available from http://www.houston.va.gov/debakey.asp.20.,Non-OADS,/arxiv_data1/oa_pdf/c7/1f/cm-89-176.PMC4777462.pdf
Available from:  https://www.phe-culturecollections.org.uk/products/celllines/ generalcell/detail.jsp?refId=12122002&collection=ecacc_gc 66.,Non-OADS,/arxiv_data1/oa_pdf/f1/91/cm-89-38.PMC4777467.pdf
Image 2.A :Axial T1 C+ shows bilateral enhancing vestibular schwanommas bulging from IAC into  CPA cisterns in a patient with NF2 (cited from: http://www.massgeneral.org/cancer/news/newsarticle.,Non-OADS,/arxiv_data1/oa_pdf/f4/29/cm-89-56.PMC4777470.pdf
Available from: http://www.orpha.net/consor/cgi-bin/ Disease_Search.php?lng=EN&data_id=185&Disease_Disease_ Search_diseaseGroup=Neurofibromatosis-type-1&Disease_ Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20 diseases=Neurofibromatosis-type-1&title=Neurofibromatosis-type-1&search=Disease_Search_Simple 6.,OADS,/arxiv_data1/oa_pdf/f4/29/cm-89-56.PMC4777470.pdf
Available from: http://globocan.iarc.fr 2.,Non-OADS,/arxiv_data1/oa_pdf/43/c5/cm-89-89.PMC4777474.pdf
Images were analyzed using  CellProfiler 2.0 cell image analysis software (http://www.cellprofiler.org) (39).,OADS,/arxiv_data1/oa_pdf/e7/f2/ijo-48-04-1341.PMC4777600.pdf
2. http://globocan.iarc.fr/factsheet.asp   3.,Non-OADS,/arxiv_data1/oa_pdf/e7/f2/ijo-48-04-1341.PMC4777600.pdf
Clinical trial Registration number: NCT00753688; GSK study ID: VEG110727; http://www.gsk- clinicalstudyregister.com/study/VEG110727#ps.,Non-OADS,/arxiv_data1/oa_pdf/49/dc/hyv184.PMC4777611.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/dc/hyv184.PMC4777611.pdf
http://www.pmda.go.jp/files/000153553.pdf.,Non-OADS,/arxiv_data1/oa_pdf/49/dc/hyv184.PMC4777611.pdf
http://ctep.cancer.gov/protocolDevelopment/electronic_ applications/docs/ctcaev3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/49/dc/hyv184.PMC4777611.pdf
http://www.meddra.org/.,Non-OADS,/arxiv_data1/oa_pdf/49/dc/hyv184.PMC4777611.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/4e/hyv191.PMC4777612.pdf
"http://fmu-global.jp/survey/proceedings-of-the-18th-prefectural-oversight- committee-meeting-for-fukushima-health-management-survey/ (9 September 2015, date last accessed).",OADS,/arxiv_data1/oa_pdf/c5/4e/hyv191.PMC4777612.pdf
"http://fmu-global.jp/survey/proceedings- of-the-18th-prefectural-oversight-committee-meeting-for-fukushima-health- management-survey/ (9 September 2015, date last accessed).",OADS,/arxiv_data1/oa_pdf/c5/4e/hyv191.PMC4777612.pdf
"http://fmu-global.jp/s urvey/the-20th-prefectural-oversight- committee-meeting-for-fukushima-health-management-survey/ (9 September 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/c5/4e/hyv191.PMC4777612.pdf
"http://www.pref.fukushima.lg.jp/sec/21045b/kenkocyosa-kentoiinkai-b4.html (22 October 2015, date last accessed) [Ja- panese].",Non-OADS,/arxiv_data1/oa_pdf/c5/4e/hyv191.PMC4777612.pdf
"Study design and objectives As part of the ‘Systems Approach to Biomarker Research (SABRe) in Cardiovascular Disease (CVD) initiative ’(http://www.nih.gov/news/health/mar2009/nhlbi-12.htm —accessed December 22, 2014), a nested case –control study was designed with pairs of myocardial infarction cases and controls (Npairs = 135), which were matched using several baseline characteristics.",Non-OADS,/arxiv_data1/oa_pdf/e4/ba/SIM-35-1315.PMC4777663.pdf
"The resulting stacks were loaded into the open source software platform Fiji (Fiji/Image J http://imagej.nih.gov/ij/i, NIH).60 Individual neurons were traced in a 3D pane view and a Hessian-based analysis was applied utilizing Fiji ’s Simple Neurite Tracer plugin as previously described to create comparable volume reconstructions.28 Using the ‘ﬁt to volume ’feature, each neuron trace was ﬁlled out using the Dijkstra ’s algorithm at a set intensity of 0.005 (determined by taking the average of adjusted thresholds from each axon) for the axons in the ventral horn and an adjusted threshold for the axons in the CST to obtain the relative volume and length of each traced neuron segment.",OADS,/arxiv_data1/oa_pdf/63/4f/gt2015112a.PMC4777664.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Gene Therapy website (http://www.nature.com/gt)Selective CSMN transduction upon cortex injection JH Jara et al 282 Gene Therapy (2016) 272 –282 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/63/4f/gt2015112a.PMC4777664.pdf
Published online 2 October 2015; http://dx.doi.org/10.1016/j.simyco.2015.08.001 .,OADS,/arxiv_data1/oa_pdf/7b/87/main.PMC4777771.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 81: 1 –26.,Non-OADS,/arxiv_data1/oa_pdf/7b/87/main.PMC4777771.pdf
Lineage/clade Species Strain ITS (5.8S) D1D2 SSU RPB1 RPB2 TEF1 CYTB T. brassicae CBS 6382TAF444436 AF075521 AB001731 KF036541 KF036957 KF037218 AB175750 T. domesticum CBS 8280TAF444414 AF075512 AB001754 KF036550 KF036966 KF037226 AB175753 T. montevideense CBS 6721TAF444422 AF105397 AB001762 KF036563 KF036980 KF037239 AB175774 T. scarabaeorum CBS 5601TAF444446 AF444710 KF036719 KF036569 KF036986 KF037243 KF423349 haglerorum Cryptococcus arboriformis CBS 10441TAB260936 AB260936 KF036619 KF036347 KF036760 KF037032 KF423171 C. haglerorum CBS 8902TAY787857 AF407276 KF036634 KF036375 KF036787 KF037059 KF423197 porosum Trichosporon dehoogii CBS 8686TAF444476 AF444718 KF036714 KF036547 KF036963 KF037223 KF423341 T. gamsii CBS 8245TKF036602 AF444708 KF036716 KF036553 KF036969 KF037229 AB175780 T. lignicola CBS 219.34TAY370684 AY370685 DQ836003 KF036560 KF036977 KF037236 KF423346 T. porosum CBS 2040TAF414694 AF189833 AB051045 KF036568 KF036985 / KF423348 T. sporotrichoides CBS 8246TAF444470 AF189885 KF036721 KF036571 KF036988 KF037245 KF423351 T. wieringae CBS 8903TAY315667 AY315666 KF036725 KF036575 KF036992 KF037248 KF423354 Trichosporon T. aquatile CBS 5973TAF410475 AF075520 AB001730 KF036538 KF036954 KF037215 AB040664 T. asahii CBS 2479TAY055381 AF105393 AB001726 KF036539 KF036955 KF037216 AB175744 T. asteroids CBS 2481TAF444416 AF075513 AB001729 KF036540 KF036956 KF037217 AB175746 T. caseorum CBS 9052TAJ319758 AJ319757 AJ319754 KF036542 KF036958 / KF423338 T. coremiiforme CBS 2482TAF444434 AF139983 AB001727 KF036544 KF036960 KF037220 AB175751 T. dohaense CBS 10761TFJ228475 FJ228471 KF036715 KF036549 KF036965 KF037225 KF423343 T. faecal CBS 4828TAF444419 AF105395 AB001728 KF036552 KF036968 KF037228 AB175758 T. inkin CBS 5585TAF444420 AF105396 AB001757 KF036555 KF036971 KF037231 AB175764 T. insectorum CBS 10422TKF036603 AY520383 AY520254 KF036556 KF036972 / KF423344 T. japonicum CBS 8641TAF444473 AF308657 AB001749 KF036557 KF036973 KF037233 KF423345 T. lactis CBS 9051TAJ319759 AJ319756 AJ319755 KF036558 KF036975 // T. ovoides CBS 7556TAF444439 AF075523 AB001765 KF036567 KF036984 / AB175776 Vanrija Vanrija albida CBS 2839TAB035578 AB126584 AB039285 KF036399 KF036813 KF037084 KF423221 V. humicola CBS 571TAF410470 AF189836 AB032637 KF036378 DQ645517 DQ645519 AB176693 V. longa CBS 5920TAB035577 AB126589 AB035586 KF036382 KF036795 KF037067 KF423204 V. musci CBS 8899TAB035579 AB126586 AB039378 KF036387 KF036800 KF037072 KF423209 V. pseudolongus CBS 8297TAB051048 AB126587 AB051047 KF036397 KF036811 KF037082 KF423219 single species clade Cryptococcus curvatus CBS 570TAF410467 AF189834 AB032626 KF036359 KF036771 KF037044 KF423183 C. daszewskae CBS 5123TAB035580 AB126588 AB035582 KF036361 KF036773 KF037046 KF423185 C. fragicola CBS 8898TAB035588 AB126585 AB035588 KF036370 KF036782 KF037054 / C. marinus CBS 5235TKF036593 AF189846 AB032644 KF036384 KF036797 KF037069 KF423206 Cryptotrichosporon anacardii CBS 9551TAY549985 AY550002 DQ242636 KF036417 KF036830 KF037101 KF423237 Trichosporon chiarellii CBS 11177TGQ338074 EU030272 KF036711 KF036543 KF036959 KF037219 KF423339 T. guehoae CBS 8521TAF410476 AF105401 KF036717 / / / AB175763 Pucciniomycotina Leucosporidium scottii CBS 5930TAF444495 AF070419 KF036682 KF036499 KF036913 KF037176 KF423303 Sterigmatomyces halophilus CBS 4609TAF444556 AF177416 D64119 KF036521 KF036936 KF037198 KF423322 Ustilaginomycotina Ustilago maydis AY854090 AF453938 X62396 XM754917 AY485636 AY885160 AB040663 The asterisks indicate teleomorphic taxa; CBS database: sequences are available from the CBS database at http://www.cbs.knaw.nl/Collections/Biolomics.aspx?,Non-OADS,/arxiv_data1/oa_pdf/7b/87/main.PMC4777771.pdf
Available from: http://www.iapt-taxon.org/nomen/main.php .,OADS,/arxiv_data1/oa_pdf/7b/87/main.PMC4777771.pdf
Available from http://seer.cancer.gov/.,Non-OADS,/arxiv_data1/oa_pdf/9c/96/leu2015223a.PMC4777772.pdf
Available from http://cache.merchantcantos.com/webcast/webcaster/4000 /7464/16533/28919/Lobby/default.htm.,Non-OADS,/arxiv_data1/oa_pdf/9c/96/leu2015223a.PMC4777772.pdf
Available from http://www.m4.de/uploads/media/m4_Seminar_12112013_Endell_web.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9c/96/leu2015223a.PMC4777772.pdf
Available at: http://www.cancer.gov/cancertopics/pdq/treatment/CML/HealthProfessional/Page4#Section_271 (last assessed 21 February 2015).,Non-OADS,/arxiv_data1/oa_pdf/47/a3/leu2015281a.PMC4777774.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)The CML-study IIIA A Gratwohl et al 569 © 2016 Macmillan Publishers Limited Leukemia (2016) 562 –569",Non-OADS,/arxiv_data1/oa_pdf/47/a3/leu2015281a.PMC4777774.pdf
"Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) OPEN Distinct molecular abnormalities underlie unique clinical features of essential thrombocythemia in children Leukemia (2016) 30,746–749; doi:10.1038/leu.2015.167 Essential thrombocythemia (ET) is rare in children, with an annual incidence of ~ 100-fold lower than that in adults.1The rarity of the disease in children makes the clinical course and pathogenesis of childhood ET far less clear.",Non-OADS,/arxiv_data1/oa_pdf/a4/ed/leu2015167a.PMC4777775.pdf
English editing service was provided by Editage (http://www.editage.cn/).,Non-OADS,/arxiv_data1/oa_pdf/a4/ed/leu2015167a.PMC4777775.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) OPEN Gene dosage reductions of Trf1 and/or Tin2 induce telomere DNA damage and lymphoma formation in aging mice Leukemia (2016) 30,749–753; doi:10.1038/leu.2015.173 Telomeres are essential structures that cap the end of chromo- somes, which is required for maintenance of chromosomal stability, cell viability and the capacity of cells to proliferate.",Non-OADS,/arxiv_data1/oa_pdf/a4/ed/leu2015167a.PMC4777775.pdf
"RNA-seq data processing The transcriptome sequencing reads were mapped to the human reference (hg19) via TopHat and the RefSeq (March 2014) transcript levels(units of FPKM) were quanti ﬁed using Cuf ﬁnks, and differential expression was tested in CuffDiff according to a standard protocol (http://www.nature.com/nprot/journal/v7/n3/full/nprot.2012.016.html).",OADS,/arxiv_data1/oa_pdf/4a/56/leu2015285a.PMC4777778.pdf
25Heatmaps of select transcripts were then plotted with a red –black –green scale using the R package heatmap2 (https://cran.r-project.org/web/packages/gplots/index.html) from the RNA-seq expression data.,OADS,/arxiv_data1/oa_pdf/4a/56/leu2015285a.PMC4777778.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)EBV-miR-BRHF1-2 targets PRDM1 JM a et al 604 Leukemia (2016) 594 –604 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/4a/56/leu2015285a.PMC4777778.pdf
Published online 10 December 2015; http://dx.doi.org/10.1016/j.simyco.2015.10.004 .,OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4777779.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 81: 55 –83.,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4777779.pdf
RESULTS AND DISCUSSION Based on the sequences determined in this study and thoseretrieved from GenBank ( http://www.ncbi.nlm.nih.gov/genbank ) two datasets comprising concatenated sequences of the seven genes and of the four protein-coding genes solely were con- structed for the analysis of the phylogeny of yeast and repre-sentative teleomorphic taxa and to visually examine thetopological concordance of the trees generated using differentalgorithms.,OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4777779.pdf
Available at: http://www.iapt-taxon.org/nomen/main.php .WANG ET AL .,OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4777779.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 81: 149 –189.,Non-OADS,/arxiv_data1/oa_pdf/c7/16/main.PMC4777780.pdf
Published online 11 January 2016; http://dx.doi.org/10.1016/j.simyco.2015.12.002 .,OADS,/arxiv_data1/oa_pdf/c7/16/main.PMC4777780.pdf
FEMS Yeast Research 15.http://dx.doi.org/10.1093/femsyr/fov019 pii: fov019.,OADS,/arxiv_data1/oa_pdf/c7/16/main.PMC4777780.pdf
Available at: http://www.iapt-taxon.org/nomen/main.php .,Non-OADS,/arxiv_data1/oa_pdf/c7/16/main.PMC4777780.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 81: 85 –147.Studies in Mycology 85,Non-OADS,/arxiv_data1/oa_pdf/94/96/main.PMC4777781.pdf
Published online 8 January 2016; http://dx.doi.org/10.1016/j.simyco.2015.12.001 .,OADS,/arxiv_data1/oa_pdf/94/96/main.PMC4777781.pdf
"The NCBI GenBank database ( http://www.ncbi.nlm.nih.gov/ ) is the most widely used tool to identify these molecular reads, but the taxon namespresented in the results from GenBank searches are oftenconfusing because they refer to such non-monophyletic groupsor genera.",OADS,/arxiv_data1/oa_pdf/94/96/main.PMC4777781.pdf
"So far, approximately 190 new fungal species have been e-published in Index Fungorum since then(http://www.indexfungorum.org/ ).",OADS,/arxiv_data1/oa_pdf/94/96/main.PMC4777781.pdf
15: http://dx.doi.org/10.1093/femsyr/fov002 .,Non-OADS,/arxiv_data1/oa_pdf/94/96/main.PMC4777781.pdf
Available at: http://www.iapt-taxon.org/nomen/main.php .,Non-OADS,/arxiv_data1/oa_pdf/94/96/main.PMC4777781.pdf
R package version 4.1 –10.http://CRAN.R-project.org/ package=rpart .,Non-OADS,/arxiv_data1/oa_pdf/94/96/main.PMC4777781.pdf
Published online 2 October 2015; http://dx.doi.org/10.1016/j.simyco.2015.08.002 .,OADS,/arxiv_data1/oa_pdf/1f/4d/main.PMC4777782.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 81: 27 –53.,Non-OADS,/arxiv_data1/oa_pdf/1f/4d/main.PMC4777782.pdf
http://dx.doi.org/10.1093/femsyr/fov019 .,OADS,/arxiv_data1/oa_pdf/1f/4d/main.PMC4777782.pdf
Available at: http://www.iapt-taxon.org/nomen/main.php .,Non-OADS,/arxiv_data1/oa_pdf/1f/4d/main.PMC4777782.pdf
Available athttp://clinicaltrials.gov NCT01208766.,Non-OADS,/arxiv_data1/oa_pdf/72/29/bmt2015236a.PMC4777887.pdf
Available at http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/72/29/bmt2015236a.PMC4777887.pdf
Available at http://clinicaltrials.gov NCT02037256.,Non-OADS,/arxiv_data1/oa_pdf/72/29/bmt2015236a.PMC4777887.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on Bone Marrow Transplantation website (http://www.nature.com/bmt)Autologous stem cell mobilization in MM R Silvennoinen et al 376 Bone Marrow Transplantation (2016) 372 –376 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/72/29/bmt2015236a.PMC4777887.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on Bone Marrow Transplantation website (http://www.nature.com/bmt)Inﬂuence of glutathione S-transferase gene polymorphisms M Ansari et al 383 © 2016 Macmillan Publishers Limited Bone Marrow Transplantation (2016) 377 –383",Non-OADS,/arxiv_data1/oa_pdf/38/48/bmt2015321a.PMC4777888.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/56/ofw020.PMC4777900.pdf
aFrom Streptococcus pneumoniae MLST website ( http://pubmlst.org/spneumoniae/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/56/ofw020.PMC4777900.pdf
Acknowledgments We thank all the microbiologists of the Observatoires Régionaux du Pneumocoque network for their active contribution to the French surveil- lance of Streptococcus pneumoniae (list of the coordinators available at: http://www.sante-limousin.fr/public/observatoires/observatoire-des-pneu- mocoques/presentation/16e5496f74fa6e0319d340496390862b#bas).,Non-OADS,/arxiv_data1/oa_pdf/0b/56/ofw020.PMC4777900.pdf
Available at: http://www.eucast.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/ofw020.PMC4777900.pdf
Available at: http://ansm.sante.fr/var/ansm_site/ storage/original/application/28f39921e2a8d8368a1fbfcdc496bd88.pdf .A c c e s s e d 15 September 2015.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/ofw020.PMC4777900.pdf
Available at: http://ecdc.europa.eu/en/publications/ Publications/antimicrobial-consumption-europe-esac-net-2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0b/56/ofw020.PMC4777900.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/85/ofw022.PMC4777901.pdf
Available at: http://aidsinfo.nih.gov/content ﬁles/ AdultandAdolescentGL.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1a/85/ofw022.PMC4777901.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/2e/ofv214.PMC4777902.pdf
Viral Hepatitis Statistics and Surveillance 2013; http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/8a/2e/ofv214.PMC4777902.pdf
" Case Rep Nephrol Dial  2015;5:204 –212  DOI: 10.1159/000441715   Published online: December 15, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   2296‒9705/15/0053‒0204$39.50/0   www.karger.com/cnd   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/fd/12/cnd-0005-0204.PMC4777904.pdf
" Case Rep Dermatol 2015;7:352 –357  DOI: 10.1159/000442704   Published online: Decemb er 17, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒6567/15/0073‒0352$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/ Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/44/14/cde-0007-0352.PMC4777905.pdf
" Case Rep Dermatol  2015;7: 340–344  DOI: 10.1159/000441711   Published online: November 28, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6567/15/0073‒0340$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/25/87/cde-0007-0340.PMC4777906.pdf
" Case Rep Dermatol  2015;7:345 –351  DOI: 10.1159/000442380   Published online: December 3, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6567/15/0073‒0345$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/5d/cf/cde-0007-0345.PMC4777907.pdf
" Case Rep Dermatol 2015;7:358 –362  DOI: 10.1159/000442969   Published online: December 23, 2015  © 2015 The Author(s )  Published by S. Karger AG, Basel   1662‒6567/15/0073‒0358$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/c2/8e/cde-0007-0358.PMC4777908.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/30/main.PMC4777924.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.05.003 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/70/30/main.PMC4777924.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/30/main.PMC4777924.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.e lsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/70/30/main.PMC4777924.pdf
"Price, G. Caramori, F. Perros, C. Meng, N. Gambaryan, P. Dorfmuller, D. Montani, P. Casolari, et al., Nuclear factor k-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension, PLoS One 8 (2013) http://dx.doi.org/10.1371/journal.pone.0075415 e75415.",Non-OADS,/arxiv_data1/oa_pdf/70/30/main.PMC4777924.pdf
http://dx.doi.org/10.1136/bcr-2013200425 .,Non-OADS,/arxiv_data1/oa_pdf/70/30/main.PMC4777924.pdf
" Case Rep Ophthalmol  2015;6:443 –447  DOI: 10.1159/000442744   Published online: December 10, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/15/0063‒0443$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/4c/76/cop-0006-0443.PMC4777930.pdf
" Case Rep Neurol  2015;7:242 –246  DOI: 10.1159/000441892   Published online: December 24, 2015  © 2015 S. Karger AG, Basel   1662‒680X/15/0073‒0242$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/f2/96/crn-0007-0242.PMC4777931.pdf
" Case Rep Neurol  2015;7:238 –241  DOI: 10.1159/000442520   Published online: December 24, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒680X/15/0073‒0238$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/20/69/crn-0007-0238.PMC4777932.pdf
"© 2015 The Author(s) Published by S. Karger AG, Basel  Published online: December 18, 2015 EXTRA  Tarja-Brita Robins Wahlin   Department of Neurobiology, Care Sciences and Society   Karolinska Institutet, Novum, Floor 5   SE–141 86 Stockholm (Sweden)   E-Mail Tarja-Brita.Robins.Wahlin   @   ki.se www.karger.com/dee DOI: 10.1159/000441942  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/1e/ab/dee-0005-0517.PMC4777933.pdf
"© 2015 The Author(s) Published by S. Karger AG, Basel  Published online: December 17, 2015 EXTRA  Krista Lanctôt   Neuropsychopharmacology Research Group   Sunnybrook Health Sciences Centre   2075 Bayview Avenue, Suite FG08, Toronto, ON M4N 3M5 (Canada)   E-Mail krista.lanctot   @   sunnybrook.ca www.karger.com/dee DOI: 10.1159/000442383  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/54/b2/dee-0005-0492.PMC4777934.pdf
" Case Rep Ophthalmol 2015;6:427 –434  DOI: 10.1159/000441969   Published online: December 3, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1663‒2699/15/0063‒0427$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/e2/d1/cop-0006-0427.PMC4777935.pdf
" Case Rep Ophthalmol 2015;6:439 –442  DOI: 10.1159/000442519   Published online: Decem ber 10, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1663‒2699/15/0063‒0439$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/4f/d4/cop-0006-0439.PMC4777936.pdf
" Case Rep Ophthalmol  2015;6:453 –457  DOI: 10.1159/000442742   Published online: December 12, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/15/0063‒0453$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/e9/96/cop-0006-0453.PMC4777937.pdf
" Case Rep Ophthalmol 2015;6:477 –481  DOI: 10.1159/000442661   Published online: December 24, 2015  © 2015 S. Karger AG, Basel   1663‒2699/15/0063‒0477$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/26/40/cop-0006-0477.PMC4777938.pdf
" Case Rep Ophthalmol  2015;6:488 –494  DOI: 10.1159/000443264   Published online: December 24, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/15/0063‒0488$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/44/49/cop-0006-0488.PMC4777939.pdf
"© 2015 The Author(s) Published by S. Karger AG, Basel  Published online: December 19, 2015 EXTRA  Susumu Ookawara, MD, PhD   Division of Nephrology, First Department of Integrated Medicine   Saitama Medical Center, Jichi Medical University   1-847 Amanuma-cho, Omiya-ku, Saitama-City, Saitama 330-8503 (Japan)   E-Mail su-ooka   @   hb.tp1.jp www.karger.com/nne DOI: 10.1159/000442591  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/21/05/nne-0005-0100.PMC4777940.pdf
"Data were analyzed using  EZR (Saitama Medical Center, Jichi Medical University), a basic  statistics graphical user  interface for R  [12]  (EZR is a modified version of the R comm ander added to statistical func- tions that is commonly used in the medical field; http://www.ji chi.ac.jp/saitama-sct/ SaitamaHP.files/statmedEN.html).",OADS,/arxiv_data1/oa_pdf/21/05/nne-0005-0100.PMC4777940.pdf
" Case Rep Ophthalmol 2015;6:390 –393  DOI: 10.1159/000442175   Published online: November 27, 2015  © 2015 The Author(s)   Published by S. Kar ger AG, Basel   1663‒2699/15/0063‒0390$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/51/43/cop-0006-0390.PMC4777941.pdf
" Case Rep Ophthalmol  2015;6:448 –452  DOI: 10.1159/000442584   Published online: December 12, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/15/0063‒0448$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/ca/9c/cop-0006-0448.PMC4777942.pdf
" Case Rep Ophthalmol 2015;6:415 –419  DOI: 10.1159/000442660   Published online: December 2, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1663‒2699/15/0063‒0415$39.50/0   www.karger.com/cop   This article is licensed under t he Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/e8/7c/cop-0006-0415.PMC4777944.pdf
"Houston, TX 77030 (USA)   E-Mail mkunik   @   bcm.edu www.karger.com/dee DOI: 10.1159/000441717  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/05/3a/dee-0005-0470.PMC4777945.pdf
Trial registration (parent study): NCT01325714 in ClinicalTrials.gov (http://clinicaltrials.gov/ct2/results?,Non-OADS,/arxiv_data1/oa_pdf/05/3a/dee-0005-0470.PMC4777945.pdf
"2003. http://www.rand.org/pubs/rep rints/RP1354.html (accessed July 18,  2015).",Non-OADS,/arxiv_data1/oa_pdf/05/3a/dee-0005-0470.PMC4777945.pdf
"Washington,  Geriatrics and Extended Care Strategic Healthcare Group, Nation al Pain Management Coordinating Committee,  2000. http://www.va.gov/PAINMANAGEMENT/docs/TOOLKIT.pdf.",Non-OADS,/arxiv_data1/oa_pdf/05/3a/dee-0005-0470.PMC4777945.pdf
" Case Rep Neurol 2015;7:247 –252  DOI: 10.1159/000442410   Published online: December 24 , 2015  © 2015 S. Karger AG, Basel   1662‒680X/15/0073‒0247$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/dc/06/crn-0007-0247.PMC4777946.pdf
" Case Rep Ophthalmol 2015;6:482 –487  DOI: 10.1159/000443141   Published online: December 24, 2015  © 2015 S. Karger AG, Basel   1663‒2699/15/0063‒0482$39.50/0   www.karge r.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/7f/1b/cop-0006-0482.PMC4777947.pdf
" Case Rep Ophthalmol 2015;6:401 –407  DOI: 10.1159/000442345   Published online: December 1, 2015  © 2015 The Author(s)   Published by S. Kar ger AG, Basel   1663‒2699/15/0063‒0401$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/d8/48/cop-0006-0401.PMC4777948.pdf
"© 2015 The Author(s) Published by S. Karger AG, Basel  Published online: December 11, 2015 EXTRA  Henry Ndukwe   School of Pharmacy, University of Otago   PO Box 56   Dunedin 9054 (New Zealand)   E-Mail henry.ndukwe   @   otago.ac.nz www.karger.com/dee DOI: 10.1159/000441894  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/79/38/dee-0005-0482.PMC4777950.pdf
"2010.  http://www.pharmac.govt.nz/2010/08/13/Notification%20of%20donep ezil%20funding%20date.pdf  (accessed March 19, 2015).",Non-OADS,/arxiv_data1/oa_pdf/79/38/dee-0005-0482.PMC4777950.pdf
"2011. http://www.nice.org.uk/guidance/ ta217/chapter/2-Clinical-need-and-practice (accessed June 3, 20 15).",Non-OADS,/arxiv_data1/oa_pdf/79/38/dee-0005-0482.PMC4777950.pdf
2015. http://pathways.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/79/38/dee-0005-0482.PMC4777950.pdf
" Case Rep Ophthalmol 2015;6:385 –389  DOI: 10.1159/000441694   Published online: November 27, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1663‒2699/15/0063‒0385$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/b5/ef/cop-0006-0385.PMC4777951.pdf
" Case Rep Ophthalmol  2015;6:420 –426  DOI: 10.1159/000442461   Published online: December 2, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/15/0063‒0420$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/51/8a/cop-0006-0420.PMC4777952.pdf
" Case Rep Ophthalmol  2015;6:469 –476  DOI: 10.1159/000442970   Published online: December 19, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/15/0063‒0469$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/7a/e0/cop-0006-0469.PMC4777953.pdf
"Anticholinergic medicin es bind to the muscarinic  receptors, and the decreased cholinergic neurotransmission impa cts both peripheral and  Published online: January 6, 2016 EXTRA  Dr. Mohammed S. Salahudeen, PharmD, MBA   School of Pharmacy, University of Otago   PO Box 56   Dunedin 9054 (New Zealand)   E-Mail mohammed.salahudeen   @   otago.ac.nz www.karger.com/dee DOI: 10.1159/000441718  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/a0/3b/dee-0005-0530.PMC4777954.pdf
"http://www.health.govt.nz/nz-health-statistics/natio nal-collections-and-surveys/collections  (accessed April 9, 2015).",Non-OADS,/arxiv_data1/oa_pdf/a0/3b/dee-0005-0530.PMC4777954.pdf
"Effective  December 2010. http://www.PHARMAC.Govt.Nz/2010/11/18/su.Pdf (ac cessed April 9, 2015).",Non-OADS,/arxiv_data1/oa_pdf/a0/3b/dee-0005-0530.PMC4777954.pdf
" Case Rep  Neurol 2015;7:233 –237  DOI: 10.1159/000442085   Published online: November 27, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒680X/15/0073‒0233$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/df/cf/crn-0007-0233.PMC4777955.pdf
" Case Rep Ophthalmol 2015;6:458 –461  DOI: 10.1159/000442789   Published online: December 19, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1663‒2699/15/0063‒0458$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/8b/06/cop-0006-0458.PMC4777956.pdf
" Case Rep Op hthalmol  2015;6:435 –438  DOI: 10.1159/000442437   Published online: December 5, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/15/0063‒0435$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/62/63/cop-0006-0435.PMC4777958.pdf
" Case Rep Ophthalmol 2015;6:408 –414  DOI: 10.1159/000442346   Published online: December 1, 2015  © 2015 The Auth or(s)  Published by S. Karger AG, Basel   1663‒2699/15/0063‒0408$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/8c/96/cop-0006-0408.PMC4777959.pdf
"© 2015 The Author(s) Published by S. Karger AG, Basel  Published online: December 5, 2015 EXTRA  Daly Sebastian   Department of Speech Language Studies   Dr. SR Chandrasekhar Institute of Speech and Hearing   Lingarajapuram, Bangalore 560 084 (India)   E-Mail dalyaslp   @   gmail.com www.karger.com/dee DOI: 10.1159/000441183  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/4f/66/dee-0005-0459.PMC4777960.pdf
"The aim was  Published online: December 18, 2015 EXTRA  Claire Boutoleau-Bretonnière   Centre Mémoire Ressource et Recherche (CMRR), Département de Neurologie   CHU de Nantes, boulevard Jacques-Monod, Saint-Herblain   FR–44093 Nantes (France)   E-Mail claire.boutoleaubretonniere   @   chu-nantes.fr www.karger.com/dee DOI: 10.1159/000440859  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/39/b5/dee-0005-0503.PMC4777961.pdf
" Case Rep Ophthalmol 2015;6:462 –468  DOI: 10.1159/0004 42788   Published online: December 19, 2015  © 2015 S. Karger AG, Basel   1663‒2699/15/0063‒0462$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/bf/f4/cop-0006-0462.PMC4777962.pdf
" Case Rep Gastroenterol 2015;9:375 –380  DOI: 10.1159/000442462   Published online: December 12, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒0631/15/0093‒0375$39.50/0   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/fa/05/crg-0009-0375.PMC4777963.pdf
" Case Rep Ophthalmol  2015;6:394 –400  DOI: 10.1159/000442182   Published online: November 28, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/15/0063‒0394$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/a1/87/cop-0006-0394.PMC4777964.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/f5/main.PMC4777982.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.12.061 2049-0801/ ©2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/cc/f5/main.PMC4777982.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/95/main.PMC4777983.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.02.011 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/95/main.PMC4777983.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/03/main.PMC4777985.pdf
This early work laid the foundation for our current understanding that cell functions are greatly in ﬂuenced by the composition of their surrounding ECMContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.02.005 2213-2317/ &2016 Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/32/03/main.PMC4777985.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/03/main.PMC4777985.pdf
"245 (2016) 351 –360, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/32/03/main.PMC4777985.pdf
"97 (2016) 4 –27,http://dx.doi.org/ 10.1016/j.addr.2015.11.001 .",OADS,/arxiv_data1/oa_pdf/32/03/main.PMC4777985.pdf
"11 (2010) 31, http://dx.doi.org/10.1186/1465-9921-11-31 .",Non-OADS,/arxiv_data1/oa_pdf/32/03/main.PMC4777985.pdf
"12 (2010) 201, http://dx.doi.org/ 10.1186/ar2896 .",Non-OADS,/arxiv_data1/oa_pdf/32/03/main.PMC4777985.pdf
"(2015) , http://dx.doi.org/ 10.3402/ecrj.v2.26385 .",Non-OADS,/arxiv_data1/oa_pdf/32/03/main.PMC4777985.pdf
"6 (2012) 87 –95, http://dx.doi.org/10.2174/1874312901206010087 , Epub 2012 Jun 15.",Non-OADS,/arxiv_data1/oa_pdf/32/03/main.PMC4777985.pdf
Loss- of-function experiments confirmed their essential and stagespecific role in regulating MuSC  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/3c/nihms-757628.PMC4778082.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven figures, four tables, and two movies and can be  found with this article online at http://dx.doi.org/10.1016/j.celrep.2016.01.072 .",OADS,/arxiv_data1/oa_pdf/ad/3c/nihms-757628.PMC4778082.pdf
"Hospital outpatient services-mean and median expenses per per-son with expense and distribution of expenses by source  of payment: United States, 2012, http://meps.ahrq.gov/ mepsweb/data_stats/tables_compendia_hh_interactive.jsp?_SERVICE=MEPSSocket0&_PROGRAM=MEPSPGM.TC.SAS&File=HCFY2012&Table=HCFY2012_PLEXP_F&VAR 1=AGE&VAR2=SEX&VAR3=RACETH5C&VAR4=INSU RCOV&VAR5=POVCAT12&VAR6=MSA&VAR7=REGION&VAR8=HEALTH&VARO  5.",Non-OADS,/arxiv_data1/oa_pdf/8f/65/10.1177_2050312115626433.PMC4778083.pdf
"Health Expenditure and Financing, http://www.oecd.org/health/health-systems.",Non-OADS,/arxiv_data1/oa_pdf/6b/96/10.1177_2050312115623792.PMC4778086.pdf
"Results for Canada are converted to US$ based on OECD’s Purchasing Power Parity for consumption, http://stats.oecd.org/Index.aspx?datasetcode=SNA_TABLE4.OOP: out-of-pocket; LIS: Luxembourg Income Study; OECD: Organisation for Economic Co-operation and Development.All calculations are based on weighted observations.",OADS,/arxiv_data1/oa_pdf/6b/96/10.1177_2050312115623792.PMC4778086.pdf
"of observations 203,799 60,313 203,799 60,313   Source: Authors’ calculations are from 2010 LIS data (http://www.lisdatacenter.org).",OADS,/arxiv_data1/oa_pdf/6b/96/10.1177_2050312115623792.PMC4778086.pdf
(4/5) Elderly  Q1 41.2 26.9 1.5 27.1 11.8 2.3  Q2 36.6 31.3 1.2 19.2 8.9 2.2  Q3 33.3 26.0 1.3 14.6 6.0 2.5  Q4 26.9 17.7 1.5 9.2 5.0 1.9  Q5: 80–95 17.6 11.0 1.6 4.8 1.8 2.6  Top 5 10.0 4.8 2.1 2.6 0.5 4.9 Non-elderly  Q1 27.3 11.3 2.4 16.1 4.6 3.5  Q2 23.6 13.6 1.7 11.0 3.4 3.3  Q3 21.1 10.8 1.9 8.1 2.2 3.7  Q4 16.5 6.9 2.4 5.0 1.8 2.7  Q5: 80–95 10.3 4.1 2.5 2.5 0.7 3.8  Top 5 5.6 1.7 3.2 1.3 0.2 7.2 Source: Authors’ calculations are from 2010 LIS data (http://www.lisdatacenter.org).,Non-OADS,/arxiv_data1/oa_pdf/6b/96/10.1177_2050312115623792.PMC4778086.pdf
"Princeton, NJ: Robert Wood Johnson Foundation, http://www.rwjf.org/content/dam/farm/reports/issue_briefs/2010/rwjf402103/subassets/rwjf402103_1  14.",Non-OADS,/arxiv_data1/oa_pdf/6b/96/10.1177_2050312115623792.PMC4778086.pdf
"Commonwealth Fund, New York, November 2014, http://www.commonwealthfund.org/publications/issue-briefs/2014/ nov/out-of-pocket-health-care-costs  32.",Non-OADS,/arxiv_data1/oa_pdf/6b/96/10.1177_2050312115623792.PMC4778086.pdf
"Paris:  OECD Publishing, 2013, http://dx.doi.org/10.1787/health_ glance-2013-en  36.",Non-OADS,/arxiv_data1/oa_pdf/6b/96/10.1177_2050312115623792.PMC4778086.pdf
"Luxembourg: LIS, http://www.lisdatacenter.org/  42.",Non-OADS,/arxiv_data1/oa_pdf/6b/96/10.1177_2050312115623792.PMC4778086.pdf
"The New York Times, 7 February 2015, http://www.nytimes.com/2015/02/08/sunday- review/insured-but-not-covered.html",Non-OADS,/arxiv_data1/oa_pdf/6b/96/10.1177_2050312115623792.PMC4778086.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/ea/main.PMC4778089.pdf
http://dx.doi.org/10.1016/j.hrcr.2015.09.004,OADS,/arxiv_data1/oa_pdf/a5/ea/main.PMC4778089.pdf
"Methodology: Retrospective analysis of literature Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncom- mercial use, distribution, and reproduction in any medium, providedyou give appropriate credit to the ori ginal author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e5/93/330_2015_Article_3900.PMC4778143.pdf
Reference standardA comment to this article is available at http://dx.doi.org/10.1007/ s00330-015-3937-3.,Non-OADS,/arxiv_data1/oa_pdf/40/07/330_2015_Article_3918.PMC4778148.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncom-mercial use, distribution, and reproduction in any medium, providedyou give appropriate credit to the original author(s) and the source, pro- vide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/40/07/330_2015_Article_3918.PMC4778148.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommerc ial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium,provided you give appropriate credit to the original author(s) and thesource, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/53/70/330_2015_Article_3899.PMC4778155.pdf
"J Forensic Sci57:778 –782 35. http://handbook.cochrane.org/ - accessed on the 17th of July, 2013.36.",OADS,/arxiv_data1/oa_pdf/04/12/330_2015_Article_3908.PMC4778156.pdf
"This is an  Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/12/biu192.PMC4778170.pdf
"At the same time, general IBM platforms, such as  NetLogo ( http://ccl.northwestern.edu/netlogo ) have evolved  with the practice of IBE to allow even inexperienced pro - grammers to develop powerful software for IBMs rapidly  (Railsback and Grimm 2012).",Non-OADS,/arxiv_data1/oa_pdf/9f/12/biu192.PMC4778170.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/02/f9/JOS-5-1.PMC4778171.pdf
Available from: http://www.brookfieldengineering.com.,Non-OADS,/arxiv_data1/oa_pdf/99/67/IJPhS-77-675.PMC4778226.pdf
Available  from: http://www.who-umc.org/DynPage.aspx?id=97224&mn1=7347&m n2=7252&mn3=7257.,OADS,/arxiv_data1/oa_pdf/27/86/IJPhS-77-687.PMC4778228.pdf
Available from: http://www.thehindu.com/ news/diabetes-drug-maybe-i-erred-in-my-judgement/article4921604.ece.,Non-OADS,/arxiv_data1/oa_pdf/27/86/IJPhS-77-687.PMC4778228.pdf
Available from: http://www.diva-portal.,Non-OADS,/arxiv_data1/oa_pdf/08/6b/IJPhS-77-729.PMC4778233.pdf
Comparative modeling of GATA4  nsSNPs: Mutational effect on protein structure was determined  by using http://swissmodel.expasy.org/workspace[23].,OADS,/arxiv_data1/oa_pdf/25/ff/IJPhS-77-735.PMC4778234.pdf
Available from:  http://www.organic-chemistry.org/prog/peo/.,OADS,/arxiv_data1/oa_pdf/49/da/IJPhS-77-758.PMC4778237.pdf
Available from: http://www.scfbioiitd.,Non-OADS,/arxiv_data1/oa_pdf/49/da/IJPhS-77-758.PMC4778237.pdf
E-mail address: scj@medicine.wisc.edu http://dx.doi.org/10.1016/j.dadm.2015.11.006 2352-8729/Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/96/63/main.PMC4778249.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/63/main.PMC4778249.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2015.11.006 .,OADS,/arxiv_data1/oa_pdf/96/63/main.PMC4778249.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/f8/aqv011.PMC4778259.pdf
"Small DNA fragments were removed using the AMPure PCR purification system (Agenc ourt, Beverly, MA) following the manufacturer’s protocol (http://454.com/downloads/my454/documentation/gs-junior/method-manuals/454SeqSys_ AmpliconLibraryPrepMethodMa nual_Jun2013.pdf).",OADS,/arxiv_data1/oa_pdf/d9/f8/aqv011.PMC4778259.pdf
The emPCR was performed according to themanufacturer’s protocol (http://454.com/downloads/my454/ documentation/gs-junior/method-manuals/GSJunioremPCR AmplificationMethodManualLib-A_March2012.pdf).,OADS,/arxiv_data1/oa_pdf/d9/f8/aqv011.PMC4778259.pdf
"The beads carrying single-stranded DNA templates were enriched, counted, and deposited into the picotiterplate for sequencing (http://454.com/downloads/my454/ documentation/gs-junior/method-manuals/GSJuniorSequen cingManual_Jan2013.pdf).",OADS,/arxiv_data1/oa_pdf/d9/f8/aqv011.PMC4778259.pdf
"To reduce the single-nucleotide variant complexity, each single subset of sequences was clustered by cap3 soft- ware (http://bioweb.pasteur.fr/seqanal/interfaces/cap3.html) with more than 98% overlap identity by obtaining a list ofconsensus sequencing, and therefore the sequencing reads that differed by up to two single-nucleotide substitutions or gaps were aggregated.",OADS,/arxiv_data1/oa_pdf/d9/f8/aqv011.PMC4778259.pdf
"Finally, the consensus sequencing was multialigned by the Clustalw (http://www.ebi.ac.uk/tools/clustalw2) program with default parameters.",OADS,/arxiv_data1/oa_pdf/d9/f8/aqv011.PMC4778259.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in anymedium,providedtheoriginalwork isnotalteredortransformedinanyway,andthatthework isproperlycited.Forcommercialre-use, please contact journals.permissions@oup.com 182",Non-OADS,/arxiv_data1/oa_pdf/92/16/fuv045.PMC4778271.pdf
"The figure was redrafted with permission from Adjunct Associate Professor Mark Brundrett, Plant Biology, University of Western Australia; ( http://mycorrhizas.info/download/pdf/symb-assoc.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/92/16/fuv045.PMC4778271.pdf
"Definition of palliative  care, 2014, http://www.who.int/cancer/palliative/definition/ en/  32.",Non-OADS,/arxiv_data1/oa_pdf/77/23/10.1177_0269216315600103.PMC4778380.pdf
Online only supplementary tables are available at http://hth.sagepub.com/content/early/recent References 1.,Non-OADS,/arxiv_data1/oa_pdf/c9/e9/10.1177_1758998315614037.PMC4778382.pdf
"J.Roithov(o;w; Department ofOrganic Chemistry Faculty ofScience, Charles University inPrague Hlavova 2030/8, 12843 Prague 2(Czech Republic) E-mail :roithova@na tur.cuni.cz Dr.L.G(o[)3mez, Prof. M.Costas Departame ntdeQuimica andInstitute ofComputation alChemist ry andCatalysis (IQCC), Universi tyofGirona Campus Montilivi, Girona 17071 (Spain) E-mail :miquel.costas@ udg.edu Dr.L.G(o[)3mez Serveis T(o;zzcnics deRecerca (STR), Universi tatdeGirona Parc Cient(o[3xfic iTecnol(o[)[gic, 17003 Girona (Spain) Supportin ginforma tionandtheORCID identifica tionnumber(s) for theauthor(s) ofthisarticle canbefound under http://dx.doi.org/ 10.",Non-OADS,/arxiv_data1/oa_pdf/b2/79/ANIE-55-3637.PMC4778411.pdf
Version 2014.3.  http://www.iucnredlist.org .,Non-OADS,/arxiv_data1/oa_pdf/6e/8f/cov041.PMC4778440.pdf
"Volume 3 • 2015  10.1093/conphys/cov043 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),  which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author 2015.",Non-OADS,/arxiv_data1/oa_pdf/67/51/cov043.PMC4778442.pdf
"Volume 3 • 2015  10.1093/conphys/cov051 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),  which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author 2015.",Non-OADS,/arxiv_data1/oa_pdf/c3/55/cov051.PMC4778446.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/02/cov029.PMC4778449.pdf
"Can Assoc Zoo Aquariums  Nutr Advis Res Group , , http://www.caza-narg.ca/ref/amphibian%20 nutrition%20report%20CAZA%202008.pdf .",Non-OADS,/arxiv_data1/oa_pdf/ca/02/cov029.PMC4778449.pdf
"R package version 3.1- 117, http://cran.r-project.org/web/packages/nlme/index.html .",Non-OADS,/arxiv_data1/oa_pdf/ca/02/cov029.PMC4778449.pdf
"Therneau T (2014) A package for survival analysis in s. 2014, r package  version 2.37-7, http://CRAN.R-project.org/package =survival .",Non-OADS,/arxiv_data1/oa_pdf/ca/02/cov029.PMC4778449.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/9f/cov038.PMC4778453.pdf
http://osip.alberta.ca/map/ .Alberta Government (2010) Environmental Protection and Enhancement  Act.,Non-OADS,/arxiv_data1/oa_pdf/f1/9f/cov038.PMC4778453.pdf
http://www.qp.alberta.ca/documents/acts/e12.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f1/9f/cov038.PMC4778453.pdf
Chapter 22. http://laws-lois.justice.gc.ca/PDF/M-7.01.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f1/9f/cov038.PMC4778453.pdf
R. v. Syncrude Canada Ltd (2010) ABPC 229. http://www.canlii.org/en/ ab/abpc/doc/2010/2010abpc229/2010abpc229.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f1/9f/cov038.PMC4778453.pdf
https://www.tc.gc.ca/eng/marinesafety/oep-ers-regime- menu-1780.htm .,Non-OADS,/arxiv_data1/oa_pdf/f1/9f/cov038.PMC4778453.pdf
http://www2.epa.gov/nscep/ retrieving-ordering-and-printing-nscep-publications#ordering .,Non-OADS,/arxiv_data1/oa_pdf/f1/9f/cov038.PMC4778453.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/   by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/fd/cov022.PMC4778456.pdf
"Smears were stained with haema-toxylin and eosin, photographed at × 40 magnification, and  counted using the ImageJ Cell Counter plugin (ImageJ v. 1.46r; NIH, available at http://imagej.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/5c/fd/cov022.PMC4778456.pdf
"Volume 3 • 2015  10.1093/conphys/cov054 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),  which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author 2015.",Non-OADS,/arxiv_data1/oa_pdf/54/d8/cov054.PMC4778457.pdf
doi: http://dx.doi.org/10.1890/ES13- 00388.1.,Non-OADS,/arxiv_data1/oa_pdf/d6/86/cov031.PMC4778459.pdf
"Volume 3 • 2015  10.1093/conphys/cov052 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),  which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author 2015.",Non-OADS,/arxiv_data1/oa_pdf/5f/42/cov052.PMC4778462.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),  which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/21/cov040.PMC4778469.pdf
http://socserv.socsci.mcmaster.ca/ jfox/Books/Companion .,Non-OADS,/arxiv_data1/oa_pdf/e8/21/cov040.PMC4778469.pdf
"Final Report 2002, Report to Bonneville Power Administration,  http://tethys.pnnl.gov/sites/default/files/publications/Odeh_   et_al._2002.pdf .",OADS,/arxiv_data1/oa_pdf/e8/21/cov040.PMC4778469.pdf
"ISBN 3-900051-07-0, http://www.R-project.org/ .",Non-OADS,/arxiv_data1/oa_pdf/e8/21/cov040.PMC4778469.pdf
http://www.engr.colostate.edu/_pierre/ce_ old/classes/ce717/Fish%20Protection%20at%20Water%20 Diversions.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e8/21/cov040.PMC4778469.pdf
http://www.jstatsoft.org/v40/i01/ .,Non-OADS,/arxiv_data1/oa_pdf/e8/21/cov040.PMC4778469.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/b3/cov024.PMC4778470.pdf
http://www.euring.,Non-OADS,/arxiv_data1/oa_pdf/d2/b3/cov024.PMC4778470.pdf
"R Foundation  for Statistical Computing, Vienna, Austria,  http://www.R-project.org/ .",Non-OADS,/arxiv_data1/oa_pdf/d2/b3/cov024.PMC4778470.pdf
"Volume 3 • 2015  10.1093/conphys/cov050 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),  which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author 2015.",Non-OADS,/arxiv_data1/oa_pdf/78/23/cov050.PMC4778473.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/b8/cov036.PMC4778476.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/2c/cov037.PMC4778479.pdf
"Volume 3 • 2015  10.1093/conphys/cov053 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),  which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author 2015.",Non-OADS,/arxiv_data1/oa_pdf/30/b8/cov053.PMC4778480.pdf
"Volume 3 • 2015  10.1093/conphys/cov056 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),  which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author 2015.",Non-OADS,/arxiv_data1/oa_pdf/72/b2/cov056.PMC4778482.pdf
http://www.arctic.noaa.gov/detect/documents/AMSA_2009_ Report_2nd_print.pdf .,OADS,/arxiv_data1/oa_pdf/3f/57/cov028.PMC4778485.pdf
"Volume 3 • 2015  10.1093/conphys/cov042 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),  which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author 2015.",Non-OADS,/arxiv_data1/oa_pdf/44/2e/cov042.PMC4778488.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 248 –256 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.03.008 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/7f/49/main.PMC4778515.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/49/main.PMC4778515.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/49/main.PMC4778515.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 229 –236 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.02.010 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/af/3f/main.PMC4778516.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/3f/main.PMC4778516.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/3f/main.PMC4778516.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 181 –188 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.02.008 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/75/ee/main.PMC4778518.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/ee/main.PMC4778518.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/ee/main.PMC4778518.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 172 –180 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.02.006 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2b/0b/main.PMC4778519.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/0b/main.PMC4778519.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/0b/main.PMC4778519.pdf
World J. http://dx.doi.org/ 10.1155/2014/173574 .,Non-OADS,/arxiv_data1/oa_pdf/2b/0b/main.PMC4778519.pdf
http://dx.doi.org/ 10.1155/2014/657414 .,Non-OADS,/arxiv_data1/oa_pdf/2b/0b/main.PMC4778519.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/13/main.PMC4778521.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 211 –218 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.04.005 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5c/13/main.PMC4778521.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/13/main.PMC4778521.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 257 –267 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.03.011 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1111/ j.1365-2109.2007.01722.x .,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
"58, 67–73, URL: < http://epubs.icar.org.in/ejournal/index.",Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/ 10.1016/j.sjbs.2011.02.003 .,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
URL: < http://aciar.gov.au/ﬁles/ node/531/wp54web.pdf >.,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
"35, 1013–1024.http://dx.doi.org/10.1111/j.1365-2109.2004.01089.x .",Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1016/ j.aquaculture.2010.11.047 .,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1111/j.1749-7345.2004.tb01068.x .,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1023/A:1024188507215 .,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
URL: <http://aciar.gov.au/ﬁles/node/586/pr78-part1.pdf >.,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
URL: < http://aciar.gov.au/ﬁles/ node/586/pr78-part1.pdf >.,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1016/ s0044-8486(02)00662-2 .,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1016/j.aquaculture.2014.07.022 .,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/ 10.1007/BF00680211 .,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
URL: < ftp://ftp.fao.org/docrep/fao/007/ ad840e/ad840e00.pdf >.,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1016/j.ﬁshres.2011.01.001 .,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1016/S0044- 8486(01)00581-6 .,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
< http://aciar.gov.au/ﬁles/node/586/pr78-part1.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
URL: <http://aciar.gov.au/ﬁles/node/586/pr78-part1.pdf >.,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
URL: < http://eprints.cmfri.org.in/4590/1/17.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
URL: <http://eprints.cmfri.org.in/2251/1/Article_27.pdf >.,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1016/j.aquaculture.2007.05.031 .266 M.N.,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1016/S0044- 8486(99)00214-8 .,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
URL: <http://psasir.upm.edu.my/7175/1/FP_2007_7a.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.3923/jfas.2014.237.244 .,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
"34, 381–386, URL: < http://rdo.psu.ac.th/sjstweb/ journal/34-4/0353-3345-34-4-381-386.pdf >.",Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
URL: < http://journal.ipb.ac.id/index.php/jai/article/ view/4092/9110 >.,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1111/j.1753-5131.2012.01073.x .,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
"4, 36–42, URL: < http://www.david- publishing.com/DownLoad/?id=4648 >.",Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/ 10.1007/s10499-010-9381-0 .,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1111/j.1365- 2109.2005.01328.x .,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/ 10.1046/j.1444-2906.2003.00585.x .,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.3923/ pjbs.2000.389.391 .,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
161–164.URL: < ftp://ftp.fao.org/docrep/fao/007/ad840e/ad840e00.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
78pp.URL: < http://www.fao.org/docrep/015/ba0110e/ba0101e.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
"14, 191–200, URL: < http://www.hatcheryfeed.com/article-ﬁles/ﬁle_ 1326756685_2.pdf >.",Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1016/ j.fsi.2014.08.027 .,OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
http://dx.doi.org/10.1016/ j.anifeedsci.2014.08.002 .A review of maturation diets for mud crab genus Scylla broodstock 267,Non-OADS,/arxiv_data1/oa_pdf/b0/f0/main.PMC4778523.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 161 –171 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.01.001 1319-562X ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
The Consortium for the Barcode of Life (CBOL) was estab- lished to support worldwide DNA barcoding and subsequently an international online data management system – the Barcodeof Life Data Systems ( http://www.barcodinglife.org ) came into effect.,OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
"Subsequently, several countries and regions have also established barcoding networks as part of the iBOL like Europe (ECBOL; http://www.ecbol.org/ ), Norway (NorBOL; http://dnabarcoding.no/en/ ), Mexico (MexBOL; http://www.",Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
"mexbol.org/ ) and Japan (JBOLI; http://www.jboli.org/ ).Besides this, thematic programs like human health (Health- BOL), polar life (PolarBOL) and quarantine and plant patho- gens (QBOL, as a part of the ECBOL) are also in place.",Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
"Sponge Bar- coding Project, http://www.spongebarcoding.org is a global initiative.",Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
Two main global barcoding initiatives forﬁsh are FISH-BOL ( http://www.ﬁshbol.org ) and SHARK- BOL ( http://www.sharkbol.org ).,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
DNA barcoding of marine mammals Mammalia Barcode of Life ( http://www.mammaliabol.org )i s devoted to barcoding of mammals including the marine mam- mals.,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1016/j.algal.2012.10.003 .,OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.3897/zookeys.365.5873 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.3897/zookeys.365.6287 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.3897/zookeys.365.6409 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
"Biodiv., http://dxdoi.org/10.1155/2013/824543 .168 S. Trivedi et al.",OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/ 10.1371/journal.pone.0049950 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
6. http://dx.doi.org/10.1371/ currents.tol.cdf8b74881f87e3b01d56b43791626d2 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1371/ journal.pone.0035861 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/ 10.1139/B09-101 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/ 10.1017/S1477200009990120 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
"http://dx.doi.org/ 10.1371/journal.pone.0066686 .De Wit, P., Rota, E., Erse ´us, C., 2009.",Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.3109/19401736.2011.588217 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1098/ rspb.2002.2218 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
"26 (8), 564– 568, http://dx.doi.org/10.2108/zsj.26.564 .",Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
"http://dx.doi.org/10.1007/s00227-007-0651- y. Jennings, R.M., Bucklin, A., Ossenbrugger, H., Hopcroft, R.R., 2010a.",OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/ 10.1016/j.dsr2.2010.09.022 .,OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1371/ journal.pone.0009949 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1111/j.1420-9101.2009.01810.x .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1371/journal.pone.0012620 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
